
<html lang="en"     class="pb-page"  data-request-id="c252b0ea-1d96-43cf-ba67-7b3da94eb586"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-10;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.7b01714;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia" /></meta><meta name="dc.Creator" content="Haiyan  Yang" /></meta><meta name="dc.Creator" content="Lohitha Rao  Chennamaneni" /></meta><meta name="dc.Creator" content="Melvyn Wai Tuck  Ho" /></meta><meta name="dc.Creator" content="Shi Hua  Ang" /></meta><meta name="dc.Creator" content="Eldwin Sum Wai  Tan" /></meta><meta name="dc.Creator" content="Duraiswamy Athisayamani  Jeyaraj" /></meta><meta name="dc.Creator" content="Yoon Sheng  Yeap" /></meta><meta name="dc.Creator" content="Boping  Liu" /></meta><meta name="dc.Creator" content="Esther Hq  Ong" /></meta><meta name="dc.Creator" content="Joma Kanikadu  Joy" /></meta><meta name="dc.Creator" content="John Liang Kuan  Wee" /></meta><meta name="dc.Creator" content="Perlyn  Kwek" /></meta><meta name="dc.Creator" content="Priya  Retna" /></meta><meta name="dc.Creator" content="Nurul  Dinie" /></meta><meta name="dc.Creator" content="Thuy Thi Hanh  Nguyen" /></meta><meta name="dc.Creator" content="Shi Jing  Tai" /></meta><meta name="dc.Creator" content="Vithya  Manoharan" /></meta><meta name="dc.Creator" content="Vishal  Pendharkar" /></meta><meta name="dc.Creator" content="Choon Bing  Low" /></meta><meta name="dc.Creator" content="Yun Shan  Chew" /></meta><meta name="dc.Creator" content="Susmitha  Vuddagiri" /></meta><meta name="dc.Creator" content="Kanda  Sangthongpitag" /></meta><meta name="dc.Creator" content="Meng Ling  Choong" /></meta><meta name="dc.Creator" content="May Ann  Lee" /></meta><meta name="dc.Creator" content="Srinivasaraghavan  Kannan" /></meta><meta name="dc.Creator" content="Chandra S.  Verma" /></meta><meta name="dc.Creator" content="Anders  Poulsen" /></meta><meta name="dc.Creator" content="Sharon  Lim" /></meta><meta name="dc.Creator" content="Charles  Chuah" /></meta><meta name="dc.Creator" content="Tiong Sin  Ong" /></meta><meta name="dc.Creator" content="Jeffrey  Hill" /></meta><meta name="dc.Creator" content="Alex  Matter" /></meta><meta name="dc.Creator" content="Kassoum  Nacro" /></meta><meta name="dc.Description" content="Chronic myeloid leukemia (CML) is a myeloproliferative disease caused by bcr-abl1, a constitutively active tyrosine kinase fusion gene responsible for an abnormal proliferation of leukemic stem cel..." /></meta><meta name="Description" content="Chronic myeloid leukemia (CML) is a myeloproliferative disease caused by bcr-abl1, a constitutively active tyrosine kinase fusion gene responsible for an abnormal proliferation of leukemic stem cel..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 23, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01714" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01714" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01714" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01714" /></link>
        
    
    

<title>Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01714" /></meta><meta property="og:title" content="Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0017.jpeg" /></meta><meta property="og:description" content="Chronic myeloid leukemia (CML) is a myeloproliferative disease caused by bcr-abl1, a constitutively active tyrosine kinase fusion gene responsible for an abnormal proliferation of leukemic stem cells (LSCs). Inhibition of BCR-ABL1 kinase activity offers long-term relief to CML patients. However, for a proportion of them, BCR-ABL1 inhibition will become ineffective at treating the disease, and CML will progress to blast crisis (BC) CML with poor prognosis. BC-CML is often associated with excessive phosphorylated eukaryotic translation initiation factor 4E (eIF4E), which renders LSCs capable of proliferating via self-renewal, oblivious to BCR-ABL1 inhibition. In vivo, eIF4E is exclusively phosphorylated on Ser209 by MNK1/2. Consequently, a selective inhibitor of MNK1/2 should reduce the level of phosphorylated eIF4E and re-sensitize LSCs to BCR-ABL1 inhibition, thus hindering the proliferation of BC LSCs. We report herein the structure–activity relationships and pharmacokinetic properties of a selective MNK1/2 inhibitor clinical candidate, ETC-206, which in combination with dasatinib prevents BC-CML LSC self-renewal in vitro and enhances dasatinib antitumor activity in vivo." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01714"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01714">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01714&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01714&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01714&amp;href=/doi/10.1021/acs.jmedchem.7b01714" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 4348-4369</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01698" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01820" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Haiyan Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haiyan Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haiyan++Yang">Haiyan Yang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lohitha Rao Chennamaneni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lohitha Rao Chennamaneni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Organic Chemistry, Institute of Chemical and Engineering Sciences (ICES), A*STAR, 8 Biomedical Grove, Neuros, #07-01, 138665 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lohitha+Rao++Chennamaneni">Lohitha Rao Chennamaneni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Melvyn Wai Tuck Ho</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Melvyn Wai Tuck Ho</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Melvyn+Wai+Tuck++Ho">Melvyn Wai Tuck Ho</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shi Hua Ang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shi Hua Ang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shi+Hua++Ang">Shi Hua Ang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eldwin Sum Wai Tan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eldwin Sum Wai Tan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eldwin+Sum+Wai++Tan">Eldwin Sum Wai Tan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Duraiswamy Athisayamani Jeyaraj</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Duraiswamy Athisayamani Jeyaraj</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Duraiswamy+Athisayamani++Jeyaraj">Duraiswamy Athisayamani Jeyaraj</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yoon Sheng Yeap</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yoon Sheng Yeap</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yoon+Sheng++Yeap">Yoon Sheng Yeap</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Boping Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Boping Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Boping++Liu">Boping Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Esther Hq Ong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Esther Hq Ong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Esther+Hq++Ong">Esther Hq Ong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joma Kanikadu Joy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joma Kanikadu Joy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joma+Kanikadu++Joy">Joma Kanikadu Joy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John Liang Kuan Wee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Liang Kuan Wee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+Liang+Kuan++Wee">John Liang Kuan Wee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Perlyn Kwek</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Perlyn Kwek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Perlyn++Kwek">Perlyn Kwek</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Priya Retna</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Priya Retna</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Priya++Retna">Priya Retna</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nurul Dinie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nurul Dinie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nurul++Dinie">Nurul Dinie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thuy Thi Hanh Nguyen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thuy Thi Hanh Nguyen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thuy+Thi+Hanh++Nguyen">Thuy Thi Hanh Nguyen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shi Jing Tai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shi Jing Tai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shi+Jing++Tai">Shi Jing Tai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vithya Manoharan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vithya Manoharan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vithya++Manoharan">Vithya Manoharan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vishal Pendharkar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vishal Pendharkar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vishal++Pendharkar">Vishal Pendharkar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Choon Bing Low</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Choon Bing Low</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Choon+Bing++Low">Choon Bing Low</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yun Shan Chew</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yun Shan Chew</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yun+Shan++Chew">Yun Shan Chew</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Susmitha Vuddagiri</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Susmitha Vuddagiri</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Susmitha++Vuddagiri">Susmitha Vuddagiri</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kanda Sangthongpitag</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kanda Sangthongpitag</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kanda++Sangthongpitag">Kanda Sangthongpitag</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Meng Ling Choong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Meng Ling Choong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Meng+Ling++Choong">Meng Ling Choong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">May Ann Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">May Ann Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=May+Ann++Lee">May Ann Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Srinivasaraghavan Kannan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Srinivasaraghavan Kannan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bioinformatics Institute (BII), A*STAR, 30 Biopolis Street, #07-01 Matrix, 138671 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Srinivasaraghavan++Kannan">Srinivasaraghavan Kannan</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9539-5249" title="Orcid link">http://orcid.org/0000-0002-9539-5249</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chandra S. Verma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chandra S. Verma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bioinformatics Institute (BII), A*STAR, 30 Biopolis Street, #07-01 Matrix, 138671 Singapore</div><div class="loa-info-affiliations-info">School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551 Singapore</div><div class="loa-info-affiliations-info">Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, 117543 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chandra+S.++Verma">Chandra S. Verma</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0733-9798" title="Orcid link">http://orcid.org/0000-0003-0733-9798</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anders Poulsen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anders Poulsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anders++Poulsen">Anders Poulsen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2790-9340" title="Orcid link">http://orcid.org/0000-0002-2790-9340</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sharon Lim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sharon Lim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Duke-NUS Medical School, 8 College Road, 169857 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sharon++Lim">Sharon Lim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Charles Chuah</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Charles Chuah</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Duke-NUS Medical School, 8 College Road, 169857 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Charles++Chuah">Charles Chuah</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tiong Sin Ong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tiong Sin Ong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Duke-NUS Medical School, 8 College Road, 169857 Singapore</div><div class="loa-info-affiliations-info">Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tiong+Sin++Ong">Tiong Sin Ong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeffrey Hill</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeffrey Hill</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey++Hill">Jeffrey Hill</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alex Matter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alex Matter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alex++Matter">Alex Matter</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Kassoum Nacro</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kassoum Nacro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Experimental Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</div></div><span class="conrtib-corresp"><strong>*</strong>Tel: +65 6407 0343. Fax: +65 6478 8768. E-mail: <a href="/cdn-cgi/l/email-protection#91fafff0f2e3fed1f4e5f2bff0bce2e5f0e3bff4f5e4bfe2f6"><span class="__cf_email__" data-cfemail="89e2e7e8eafbe6c9ecfdeaa7e8a4fafde8fba7ecedfca7faee">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kassoum++Nacro">Kassoum Nacro</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3291-0215" title="Orcid link">http://orcid.org/0000-0002-3291-0215</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01714&amp;href=/doi/10.1021%2Facs.jmedchem.7b01714" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 4348–4369</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 23, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 November 2017</li><li><span class="item_label"><b>Published</b> online</span>23 April 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 May 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01714" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01714</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4348%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHaiyan%2BYang%252C%2BLohitha%2BRao%2BChennamaneni%252C%2BMelvyn%2BWai%2BTuck%2BHo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D10%26contentID%3Dacs.jmedchem.7b01714%26title%3DOptimization%2Bof%2BSelective%2BMitogen-Activated%2BProtein%2BKinase%2BInteracting%2BKinases%2B1%2Band%2B2%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BBlast%2BCrisis%2BLeukemia%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4369%26publicationDate%3DMay%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01714"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2349</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">23</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01714" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Haiyan&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Lohitha&quot;,&quot;last_name&quot;:&quot;Rao Chennamaneni&quot;},{&quot;first_name&quot;:&quot;Melvyn&quot;,&quot;last_name&quot;:&quot;Wai Tuck Ho&quot;},{&quot;first_name&quot;:&quot;Shi&quot;,&quot;last_name&quot;:&quot;Hua Ang&quot;},{&quot;first_name&quot;:&quot;Eldwin&quot;,&quot;last_name&quot;:&quot;Sum Wai Tan&quot;},{&quot;first_name&quot;:&quot;Duraiswamy&quot;,&quot;last_name&quot;:&quot;Athisayamani Jeyaraj&quot;},{&quot;first_name&quot;:&quot;Yoon&quot;,&quot;last_name&quot;:&quot;Sheng Yeap&quot;},{&quot;first_name&quot;:&quot;Boping&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Esther&quot;,&quot;last_name&quot;:&quot;Hq Ong&quot;},{&quot;first_name&quot;:&quot;Joma&quot;,&quot;last_name&quot;:&quot;Kanikadu Joy&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Liang Kuan Wee&quot;},{&quot;first_name&quot;:&quot;Perlyn&quot;,&quot;last_name&quot;:&quot;Kwek&quot;},{&quot;first_name&quot;:&quot;Priya&quot;,&quot;last_name&quot;:&quot;Retna&quot;},{&quot;first_name&quot;:&quot;Nurul&quot;,&quot;last_name&quot;:&quot;Dinie&quot;},{&quot;first_name&quot;:&quot;Thuy&quot;,&quot;last_name&quot;:&quot;Thi Hanh Nguyen&quot;},{&quot;first_name&quot;:&quot;Shi&quot;,&quot;last_name&quot;:&quot;Jing Tai&quot;},{&quot;first_name&quot;:&quot;Vithya&quot;,&quot;last_name&quot;:&quot;Manoharan&quot;},{&quot;first_name&quot;:&quot;Vishal&quot;,&quot;last_name&quot;:&quot;Pendharkar&quot;},{&quot;first_name&quot;:&quot;Choon&quot;,&quot;last_name&quot;:&quot;Bing Low&quot;},{&quot;first_name&quot;:&quot;Yun&quot;,&quot;last_name&quot;:&quot;Shan Chew&quot;},{&quot;first_name&quot;:&quot;Susmitha&quot;,&quot;last_name&quot;:&quot;Vuddagiri&quot;},{&quot;first_name&quot;:&quot;Kanda&quot;,&quot;last_name&quot;:&quot;Sangthongpitag&quot;},{&quot;first_name&quot;:&quot;Meng&quot;,&quot;last_name&quot;:&quot;Ling Choong&quot;},{&quot;first_name&quot;:&quot;May&quot;,&quot;last_name&quot;:&quot;Ann Lee&quot;},{&quot;first_name&quot;:&quot;Srinivasaraghavan&quot;,&quot;last_name&quot;:&quot;Kannan&quot;},{&quot;first_name&quot;:&quot;Chandra&quot;,&quot;last_name&quot;:&quot;S. Verma&quot;},{&quot;first_name&quot;:&quot;Anders&quot;,&quot;last_name&quot;:&quot;Poulsen&quot;},{&quot;first_name&quot;:&quot;Sharon&quot;,&quot;last_name&quot;:&quot;Lim&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;Chuah&quot;},{&quot;first_name&quot;:&quot;Tiong&quot;,&quot;last_name&quot;:&quot;Sin Ong&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;Hill&quot;},{&quot;first_name&quot;:&quot;Alex&quot;,&quot;last_name&quot;:&quot;Matter&quot;},{&quot;first_name&quot;:&quot;Kassoum&quot;,&quot;last_name&quot;:&quot;Nacro&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;4348-4369&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01714&quot;},&quot;abstract&quot;:&quot;Chronic myeloid leukemia (CML) is a myeloproliferative disease caused by bcr-abl1, a constitutively active tyrosine kinase fusion gene responsible for an abnormal proliferation of leukemic stem cells (LSCs). Inhibition of BCR-ABL1 kinase activity offers long-term relief to CML patients. However, for a proportion of them, BCR-ABL1 inhibition will become ineffective at treating the disease, and CML will progress to blast crisis (BC) CML with poor prognosis. BC-CML is often associated with excessive phosphorylated eukaryotic translation initiation factor 4E (eIF4E), which renders LSCs capable of proliferating via self-renewal, oblivious to BCR-ABL1 inhibition. In vivo, eIF4E is exclusively phosphorylated on Ser209 by MNK1/2. Consequently, a selective inhibitor of MNK1/2 should reduce the level of phosphorylated eIF4E and re-sensitize LSCs to BCR-ABL1 inhibition, thus hindering the proliferation of BC LSCs. We report herein the structure–activity relationships and pharmacokinetic properties of a selective MNK1/2 &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01714&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01714" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01714&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01714" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01714&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01714" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01714&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01714&amp;href=/doi/10.1021/acs.jmedchem.7b01714" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01714" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01714" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01714%26sid%3Dliteratum%253Aachs%26pmid%3D29683667%26genre%3Darticle%26aulast%3DYang%26date%3D2018%26atitle%3DOptimization%2Bof%2BSelective%2BMitogen-Activated%2BProtein%2BKinase%2BInteracting%2BKinases%2B1%2Band%2B2%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BBlast%2BCrisis%2BLeukemia%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D10%26spage%3D4348%26epage%3D4369%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291763" title="Noncovalent interactions">Noncovalent interactions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/jmcmar.2018.61.issue-10/20180524/jmcmar.2018.61.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0017.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Chronic myeloid leukemia (CML) is a myeloproliferative disease caused by <i>bcr-abl1</i>, a constitutively active tyrosine kinase fusion gene responsible for an abnormal proliferation of leukemic stem cells (LSCs). Inhibition of BCR-ABL1 kinase activity offers long-term relief to CML patients. However, for a proportion of them, BCR-ABL1 inhibition will become ineffective at treating the disease, and CML will progress to blast crisis (BC) CML with poor prognosis. BC-CML is often associated with excessive phosphorylated eukaryotic translation initiation factor 4E (eIF4E), which renders LSCs capable of proliferating via self-renewal, oblivious to BCR-ABL1 inhibition. <i>In vivo</i>, eIF4E is exclusively phosphorylated on Ser209 by MNK1/2. Consequently, a selective inhibitor of MNK1/2 should reduce the level of phosphorylated eIF4E and re-sensitize LSCs to BCR-ABL1 inhibition, thus hindering the proliferation of BC LSCs. We report herein the structure–activity relationships and pharmacokinetic properties of a selective MNK1/2 inhibitor clinical candidate, ETC-206, which in combination with dasatinib prevents BC-CML LSC self-renewal <i>in vitro</i> and enhances dasatinib antitumor activity <i>in vivo</i>.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34688" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34688" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Messenger RNA (mRNA) translation is a highly regulated process pervasive to many biological processes, in which eukaryotic translation initiation factor 4E (eIF4E), a cap-dependent translation factor, plays a crucial role. eIF4E, one of the five MAP kinase interacting serine/threonine kinases 1 and 2 (MNK1/2) substrates,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> is phosphorylated <i>in vivo</i> only by MNK1/2 on Ser209, and accordingly, phospho-eIF4E is not detected in Mnk1/2 knock-out mice.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Overexpression of phosphorylated eIF4E has been linked to inflammation,<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> central nervous system disorders,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and malignancies such as glioblastoma,<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7−9)</a> breast cancer,<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> pancreatic ductal adenocarcinoma,<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> and leukemias.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Abnormally high mRNA translation of oncogenic transcripts is thought to fuel the growth of cancers, including chronic myeloid leukemia (CML), where tumorigenic pathways are activated through eIF4E overexpression and/or phosphorylation.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22">(17−22)</a> Specifically, blast crisis chronic myeloid leukemia (BC-CML) is a dire stage of CML, where patients are no longer responsive to treatment with BCR-ABL1 kinase inhibitors<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> such as imatinib, dasatinib, or nilotinib,<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> that in most cases ensure long-term survival to patients in chronic phase (CP) CML. BC-CML patients have high levels of nuclear β-catenin,<a onclick="showRef(event, 'ref16 ref17 ref26'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref26">(16,17,26)</a> MNK1/2, eIF4E, and phosphorylated eIF4E<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> that are believed to promote not only resistance to treatment with BCR-ABL1 inhibitors, but also stimulate a proliferation of leukemic stems cells (LSCs)<a onclick="showRef(event, 'ref16 ref29'); return false;" href="javascript:void(0);" class="ref ref16 ref29">(16,29)</a> via self-renewal.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Lim  et al.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> have shown that phospho-mimetic eIF4E (eIF4E-209D) elicits LSC self-renewal ability whereas the un-phosphorylatable eIF4E (eIF4E-209A) does not. They have, along with others, also shown that inhibition of β-catenin impairs the ability of primary BC-CML cells to self-renew to form colonies<a onclick="showRef(event, 'ref16 ref26'); return false;" href="javascript:void(0);" class="ref ref16 ref26">(16,26)</a> and that the tumorigenic MNK/eIF4E/β-catenin axis plays an important role in BC-CML as well as in other cancers.<a onclick="showRef(event, 'ref28 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref28 ref31 ref32">(28,31,32)</a></div><div class="NLM_p">The current best and only option to cure BC-CML is an allogenic bone marrow transplantation<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (only beneficial to a small proportion of patients<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a>), and consequently, long-term treatment of patients with BC-CML remains an unmet medical need.</div><div class="NLM_p">Pharmacologic and knock-down inhibition of eIF4E phosphorylation by MNK1/2 prevents β-catenin activation<a onclick="showRef(event, 'ref28 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref28 ref31 ref32">(28,31,32)</a> and suppresses the ability of LSCs to self-renew,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> indicating that selective MNK1/2 kinase inhibition by a small molecule could be an avenue to treat patients with BC-CML. In addition, selective MNK1/2 kinase inhibition may be associated with minimal adverse effects, as <i>Mnk</i> knockout mice<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> are viable, healthy, and have normal hematopoiesis.</div><div class="NLM_p">Several inhibitors of MNK1/2 kinases have recently been reviewed,<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> notably CGP57380<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36−38)</a> and cercosporamide.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Both cercosporamide and CGP57380 lack kinase selectivity, and the latter is a weak MNK1/2 inhibitor with potency in the low micromolar range. Theodosia et al. have revealed MNK inhibitors with anti-proliferative activity against AML cell lines.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> Likewise, merestinib, a nonselective MEK inhibitor, was also shown to inhibit MNK1/2 in AML progenitors with anti-leukemic effects.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The effectiveness of pharmacologic co-inhibition of MNKs and mTORC1 against BC-CML cells was recently published.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> Han et al.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> have disclosed potent MNK1/2 inhibitors but revealed no disease relevant biological data. Recently, two MNK inhibitors, BAY1143269 and eFT508, have progressed to clinical trial. BAY1143269,<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> a predominantly MNK1 inhibitor, was administered in a phase I clinical study to patients with advanced solid tumors.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> eFT508, a potent and selective MNK1/2 inhibitor, is in phase II for the treatment of lymphoma, colorectal cancer, triple negative breast cancer, and hepatocellular carcinoma.<a onclick="showRef(event, 'ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51">(49−51)</a></div><div class="NLM_p last">To date there are little efficacy data and very few publications supporting the use of small-molecule MNK inhibitors to treat BC-CML. We have recently published our discovery efforts to generate a dual MNK and BCR-ABL1 inhibitor for the treatment of BC-CML<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> with a single agent, and we report herein a complementary approach with the design, synthesis, and structure–activity relationships of very selective MNK1/2 inhibitors. These compounds intentionally lack BCR-ABL1 inhibitory activity, and therefore can potentially be combined with the appropriate tyrosine kinase inhibitor for the treatment of BC-CML patients. Starting from fragments, small-molecule inhibitors of MNK1/2 were optimized, and a nominated preclinical development candidate was tested in a K562 mouse xenograft model.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48353" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48353" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The compounds described herein fall into three classes following the three central bicyclic rings explored, imidazopyrazine, imidazopyridazine, or imidazopyridine.</div><div id="sec3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Imidazopyrazines</h3><div class="NLM_p">Compounds <b>4</b> and <b>5</b>, as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, were prepared in three steps starting from commercially available 6-bromoimidazo[1,2-<i>a</i>]pyrazine <b>1</b>, which was submitted to a copper mediated amination leading to 6-amide imidazopyrazines <b>2a</b>,<b>b</b>. The amide derivatives were brominated using NBS to give 3-bromo-6-amide imidazopyrazines <b>3a</b>,<b>b</b>, which were subjected to a Suzuki cross coupling reaction to afford <b>4</b> and <b>5</b>, respectively. Compound <b>8</b> was prepared in two successive Suzuki coupling steps, as depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, with 66% overall yield.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>N</i>-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazinyl)-6 Amides <b>4</b> and <b>5</b>, and 6-Phenyl <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) acetamide or benzamide, <i>N,N</i>-dimethylethylenediamine, K<sub>2</sub>CO<sub>3</sub>, CuI, Toluene, 90 °C, 12 h; (ii) NBS, CH<sub>2</sub>Cl<sub>2</sub>, 1 h; (iii) (4-hydroxyphenyl)boronic acid, Na<sub>2</sub>CO<sub>3</sub>, Pd(OAc)<sub>2</sub>, P(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, 90 °C, 12 h; (iv) (4-hydroxyphenyl)boronic acid, Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, 90 °C, 12 h; (v) phenylboronic acid, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, H<sub>2</sub>O, 140 °C, 30 min.</p></p></figure><div class="NLM_p">Imidazopyrazine analogues <b>19</b>–<b>33</b>, shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, were prepared in a similar manner from <b>1</b>. Beginning with a Suzuki coupling to introduce a para-benzoyl ester at the imidazopyrazine 6-position to give <b>9</b>, which was halogenated at C-3 with either NBS or NIS to afford compounds <b>10</b> and <b>11</b>. The esters were hydrolyzed to carboxylic acids <b>12</b> and <b>13</b> that, in turn were converted to amides <b>14</b>–<b>18</b>. Arylation at C-3 using a second Suzuki cross coupling afforded <b>19</b>–<b>25</b> and <b>27</b>–<b>33</b>. Carboxylic acid <b>25</b> was converted into a protected hydroxamic acid intermediate, which was treated with an aqueous solution of hydrochloric acid to afford <b>26</b>.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Imidazopyrazine Analogues <b>19</b>–<b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (4-(ethoxycarbonyl)phenyl)boronic acid, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 90 °C, 12 h; (ii) NBS, MeOH, CCl<sub>4</sub> or NIS, DMF; (iii) LiOH, H<sub>2</sub>O, THF, CH<sub>3</sub>OH; (iv) R<sup>1</sup>R<sup>1′</sup>NH, HATU, NMM, DMF; (v) arylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 90 °C, 12 h; (vi) DIPEA, HOBt, EDCI·HCl, <i>O</i>-(tetrahydro-2<i>H</i>-pyran-2-yl)hydroxylamine, CH<sub>2</sub>Cl<sub>2</sub>, DMF, rt, 12 h; (vii) 1M aq HCl, CH<sub>3</sub>CN, MeOH, rt, 4 h.</p></p></figure><div class="NLM_p">Compounds <b>36</b> and <b>37</b> were synthesized in three steps comprising a Suzuki coupling, ester hydrolysis, and amide formation, as depicted in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Imidazopyrazine Analogues <b>36</b> and <b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (4-(ethoxycarbonyl)phenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DMF, 90 °C, 12 h for <b>34a</b>, 2 h for <b>34b</b>; (ii) LiOH, THF, CH<sub>3</sub>OH, rt, 5 h for <b>35a</b> and 12 h for <b>35b</b>; (iii) 1-(piperazin-1-yl)ethan-1-one or <i>N,N</i>-dimethylpiperidin-4-amine, HATU, NMM, DMF, rt, 3 h.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Imidazopyridazines</h3><div class="NLM_p">As illustrated in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, compounds <b>39</b> and <b>40</b> were both prepared in one step from <b>38</b>. Compound <b>42</b> was synthesized in two steps starting with a Suzuki cross coupling between <b>38</b> and 4-boronobenzoic acid to give <b>41</b>, which was converted to amide <b>42</b>. Compound <b>45</b> was also prepared in two steps from commercially available acid <b>43</b>, which was converted to amide <b>44</b> followed by a Suzuki cross-coupling reaction to give <b>45</b>.</div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Imidazopyridazine Analogues <b>39</b>, <b>40</b>, <b>42</b>, and <b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (4-(4-methylpiperazine-1-carbonyl)phenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, EtOH, K<sub>2</sub>CO<sub>3</sub>, 140 °C, microwave reactor, 30 min; or morpholino(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, DMF, H<sub>2</sub>O, Cs<sub>2</sub>CO<sub>3</sub>, microwave reactor, 140 °C, 30 min; (ii) 4-boronobenzoic acid, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, DMF, H<sub>2</sub>O; Cs<sub>2</sub>CO<sub>3</sub>, 90 °C, 18 h; (iii) <i>tert</i>-butyl piperazine-1-carboxylate, HATU, NMM, DMF, rt, 18 h; (iv) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (v) <i>N,N</i>-dimethylpiperidin-4-amine, HATU, NMM, DMF; (vi) (4-cyanophenyl)boronic acid, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, H<sub>2</sub>O, 90 °C, 6 h.</p></p></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Imidazopyridines</h3><div class="NLM_p">The preparation of <b>47</b> and <b>48</b> is depicted in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>.</div><figure id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Imidazopyridine <b>47</b> and <b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (4-methylpiperazin-1-yl)(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone, (A-Phos)<sub>2</sub>PdCl<sub>2</sub>, NaHCO<sub>3</sub>, DMF, H<sub>2</sub>O, 90 °C, 1 h; or morpholino(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, 1,4-dioxane, H<sub>2</sub>O, 90 °C, 19 h.</p></p></figure></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38635" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38635" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Fragment inhibitors of MNK1 published by Oyarzabal et al.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> offered a diversity of scaffolds among which, a few imidazopyridazine analogues displayed high ligand efficiencies ranging from 0.32 to 0.52 kcal/mol per heavy atom. We found the imidazopyridazine scaffold to be an attractive starting point to generate novel inhibitors of MNK1/2 with drug-like properties, suitable for proof of concept in man. Accordingly, we gave it the highest priority.</div><div class="NLM_p">Docking studies suggested that interactions with MNK1/2 could be improved by varying the bicyclic core and by modifying the substituents at C-3 and at C-6, whose alterations would considerably widen the structure–activity relationships (SAR) scope. Bicyclic cores were only selected, if modeling proposed a binding mode to the kinases similar to that of the imidazopyridazine. All these taken together suggested a need for SAR exploration of bicyclic analogues bearing substituents at both C-3 and C-6. Accordingly, our strategy was to divide this scaffold into three parts as outlined in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, where each part was investigated and the best of each were combined to give an optimized MNK1/2 inhibitor.</div><figure id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. SAR exploration strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Modeling</h3><div class="NLM_p">We relied on molecular modeling to understand how our bicyclic-derived inhibitors interact with MNK1/2 and to guide optimization of their potency. A common structural feature in both MNK kinases is the DFD<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> motif, in which an aspartic acid Asp193 and Asp228 for MNK1 and MNK2, respectively, replaces the glycine of the DFG motif that is more common to kinases. A DFD-out structure of MNK1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HW6">2HW6</a>)<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> is available, while MNK2 has been crystallized in both the DFD-in (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HW7">2HW7</a>)<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and DFD-out (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2AC3">2AC3</a>)<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> conformations. To validate our modeling, we searched the PDB for a co-crystal structure with inhibitors having the same scaffold. We found a structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YMJ">4YMJ</a>) of TRK kinase in the DFG-out conformation with a 4-(imidazo-pyridazin-3-yl)-benzonitrile inhibitor.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> This compound has the same core as some of our inhibitors, and docking studies supported that it binds similarly to the TRK and MNK kinases. Consequently, we used the MNK DFD-out conformation in our modeling studies. The ATP binding sites of MNK1 and MNK2 share high sequence homology,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and modeling indicates that the compounds bind similarly to both kinases. Specifically, the bicyclic core acceptor nitrogen (N-1) hydrogen bonds with the amide backbone of the kinase hinge residues Leu127 in MNK1 and Met162 in MNK2. The C-3 substituents reside in the hydrophobic pocket formed by residues Phe124, Val63, Leu108, and Cys190 in MNK1 and the homologous residues Phe159, Val98, Leu143, and Cys225 in MNK2. The substituents at the core 6-position occupy the phosphate binding pocket close to the ATP ribose binding pocket. A major part of the inhibitor is buried inside the protein except for the substituents at the 6-position, which interact with the glycine-rich P-loop and the loop connecting the hinge region and helix αD of the C-terminal lobe. Compounds were docked into MNK1 and MNK2 using the automated docking program Glide 2017-3 release<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> using standard settings, and showed that top-ranked poses had the same binding mode as when manually modeled. The compounds described in this article interact mostly with the same amino acid residues in both MNK1 and MNK2. Furthermore, they inhibit both MNK1 and MNK2 with similar potency (less than 2-fold difference in all cases). In light of the similarities of the amino acids engaged in compound binding to MNK1/2 and the similarity between the inhibitory activities of the compounds against both MNK1 and MNK2, we will only discuss the modeling of inhibitors bound to MNK2.</div><div class="NLM_p last">The inhibitory activity of all compounds against MNK1/2 was assessed in a biochemical assay<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> with ATP at <i>K</i><sub>m</sub> concentration of 1.2 mM and 250 μM for MNK1 and MNK2 assays, respectively. Compounds with a potency of 1 μM or lower against either MNK1 or MNK2, were assayed in a HeLa cell line<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> for their ability to inhibit the phosphorylation of eIF4E by MNK1/2. This functional assay relies on a sandwich immunoassay to quantify phosphorylated eIF4E. In both enzymatic and cell-based assays, each compound was tested in a dose-dependent manner, in duplicate, using eight points from a 3-fold serial dilution. IC<sub>50</sub> values were determined by nonlinear regression using GraphPad prism, and the values reported are the average of at least two experiments.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> C-6 Substituent Variation</h3><div class="NLM_p">A quick probing of bicyclic scaffolds led to the imidazopyrazine derivatives shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The acetamide of <b>4</b> was replaced by a benzamide as in <b>5</b> which resulted in potency loss. The inhibitory activity toward MNK1/2 was restored by reversing the benzamide in <b>5</b> resulting in <b>19</b>. The primary amide function was removed to yield compound <b>8</b>, which was slightly less potent than compound <b>19</b>, suggesting that the amide of <b>19</b> contributes to potency.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of MNK1 and MNK2 Inhibitor Analogues <b>4</b>, <b>5</b>, <b>8</b>, and <b>19</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0012.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char=".">MNK1<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">MNK2<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">HeLa<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">AcNH</td><td class="colsep0 rowsep0" align="char" char=".">0.789</td><td class="colsep0 rowsep0" align="char" char=".">0.515</td><td class="colsep0 rowsep0" align="char" char=".">>2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">PhCONH</td><td class="colsep0 rowsep0" align="char" char=".">3.35</td><td class="colsep0 rowsep0" align="char" char=".">1.08</td><td class="colsep0 rowsep0" align="char" char=".">n.a.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="char" char=".">0.528</td><td class="colsep0 rowsep0" align="char" char=".">0.415</td><td class="colsep0 rowsep0" align="char" char=".">0.819</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">4-PhCONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.310</td><td class="colsep0 rowsep0" align="char" char=".">0.193</td><td class="colsep0 rowsep0" align="char" char=".">1.08</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last"><i>In vitro</i> assay where a compound’s ability to inhibit MNK1 or MNK2 phosphorylation of a peptide substrate is determined as IC<sub>50</sub> values from the average of at least two measurements.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last"><i>In vitro</i> assay where a compound’s ability to inhibit MNK1/2 phosphorylation of eIF4E on Ser209 and IC<sub>50</sub> values were determined as the average of at least two measurements. n.a. = not available.</p></div></div></div><div class="NLM_p">Modeling of <b>4</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) into the ATP site of MNK2 shows that the imidazole N-1 hydrogen bond acceptor forms a hydrogen bond to the kinase hinge (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), very similar to that established by the N-1 of the adenine base of ATP. This is the backbone NH hydrogen bond donor of residues Leu127 in MNK1 and Met162 in MNK2. This hydrogen bond is stable during the molecular dynamics (MD) simulations (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_001.pdf" class="ext-link">Supporting Information</a>, MD file compound <b>4</b>). The 2-position of the imidazopyrazine is pointing toward the oxygen of the backbone carbonyl of Glu160, and the 8-position is pointing toward the oxygen of the backbone carbonyl of Met162.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>4</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) modeled into the MNK2 DFD-out X-ray structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2AC3">2AC3</a>). The binding site residues of MNK2 are shown in thin tube representation with gray carbon atoms. <b>4</b> is shown in thick tube with green carbon. Hydrogen bonds between MNK2 and <b>4</b> are shown with yellow dashed lines, π–π interactions with magenta dashed lines, and aromatic hydrogen bond with blue dashed line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interactions between the aromatic hydrogen at the 2- and 8-positions and the backbone carbonyls are expected to be favorable to inhibitor binding<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> to the kinases. When either the 2- or 8-position is substituted all activity is lost (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a>, Table S1).</div><div class="NLM_p">The phenyl in the 3-position has extensive hydrophobic interactions with the kinase. It is sandwiched between the gatekeeper residue Phe159 and the DFD-motive residue Phe227 and engages in van der Waals contacts with the side chains of Val98, Ala111, Leu143, Cys225, and Leu212. The hydroxyl of <b>4</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) forms a stable hydrogen bond per MD simulations, with the backbone carbonyl of Asp226 from the DFD motif. The acetamide is solvent exposed on one side and binds in a largely hydrophobic area, where it interacts with the side chains of Leu90, Leu212, and Phe227. During the MD simulations, the nitrogen or carbonyl of the amide (<b>4</b>, <b>5</b>) periodically hydrogen bonds with the backbone NH or side chain of Ser166 either directly or water mediated. However, these interactions are not stable during the MD simulations and probably do not contribute much to the binding affinity.</div><div class="NLM_p">The substitution of the methyl of acetamide (<b>4</b>) for a phenyl (<b>5</b>) led to a drop in potency, possibly due to a steric clash between the phenyl and Leu212 of the glycine-rich loop. Removing the amide linker favors a better interaction between the phenyl directly connected to C-6 (<b>8</b>, <b>19</b>) and residues Leu90, Leu212, and Phe227. Furthermore, the backbone NH of Ser166 is pointing toward the face of the phenyl resulting in an attractive electrostatic interaction between the negative π cloud of the phenyl and the partial positive charge of the NH donor (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). These observations are in favor of the improvement in potency observed when a phenyl occupies the C-6 position. The amide of <b>19</b> marginally improved potency relatively to <b>8</b>, probably due to a hydrogen bond between the carbonyl and the side-chain hydroxyl of Ser166. Both compounds <b>8</b> and <b>19</b> inhibit eIF4E phosphorylation in cells with similar potencies, and <b>19</b> exhibited good permeability and favorable <i>in vitro</i> ADME properties, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Profile of Hit Compound <b>19</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay/property</th><th class="colsep0 rowsep0" align="center">value<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">molecular weight (g/mol)</td><td class="colsep0 rowsep0" align="left">330.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LogD(7.4)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">2.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PAMPA (×10<sup>–6</sup> cm/s)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">22.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HLM/MLM <i>T</i><sub>1/2</sub> (min)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">60/46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cyp 3A4/2D6 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">>20/>20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Average of at least two determinations, except for MW.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Distribution coefficient between 1-octanol and aqueous phosphate buffer at pH 7.4.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Parallel artificial membrane permeability assay at pH 7.4.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Half-life in human and mouse liver microsomes.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">IC<sub>50</sub> for Cyp 3A4 and 2D6 inhibition.</p></div></div></div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>27</b> modeled into MNK2 DFD-out X-ray structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2AC3">2AC3</a>). The binding site residues of MNK2 are shown in thin tube representation with gray carbon atoms. <b>27</b> is shown in thick tube drawing with green carbons. Hydrogen bonds between MNK2 and <b>27</b> are shown with yellow dashed lines, π–π interactions with magenta dashed lines, and aromatic hydrogen bond with blue dashed line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The primary amide of <b>19</b> was replaced by larger amides to yield <i>N</i>-methylpiperazine benzamide <b>20</b> and morpholine benzamide <b>32</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), both equipotent with <b>19</b>, but with improved permeability and solubility. The inhibitory activities of <b>19</b>, <b>20</b>, <b>32</b>, and <b>36</b> showed that the substituents represented by the R<sup>1</sup> equal to O, NCH<sub>3</sub>, NAc (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) had a moderate impact on inhibitory potency toward MNK1/2. Modeling (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) shows that the phenyl at 6-position makes van der Waals contacts with the side chains of Leu90, Leu212, Ser166 β-carbon, and Gly165 α-carbon. In addition to the favorable interaction between the NH of Ser166 and the phenyl at C-6 described above, the piperazine substituent makes van der Waals contacts with the methylenes of Glu92 and Glu209. However, these residues are on the edge of the binding site and are solvated. Any interaction between the piperazine basic nitrogen and either acid is not likely to contribute much to the binding affinity. The methylpiperazine benzamide <b>20</b> and morpholine benzamide <b>32</b> amides appear to be the best overall C-6 substituents.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of Imidazopyrazine Derivatives <b>20</b>–<b>33</b>, <b>36</b>, and <b>37</b> and Their Physicochemical Properties</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0013.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" char="." /></col><col align="left" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char=".">MNK1<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">MNK2<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">HeLa<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">LogD(7.4)</th><th class="colsep0 rowsep0" align="center" char=".">PAMPA (×10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">solubility (μg/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-OH</td><td class="colsep0 rowsep0" align="char" char=".">0.284</td><td class="colsep0 rowsep0" align="char" char=".">0.140</td><td class="colsep0 rowsep0" align="char" char=".">0.189</td><td class="colsep0 rowsep0" align="char" char=".">2.25</td><td class="colsep0 rowsep0" align="left" char=".">34.7</td><td class="colsep0 rowsep0" align="left" char=".">114</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">2.68</td><td class="colsep0 rowsep0" align="char" char=".">1.43</td><td class="colsep0 rowsep0" align="char" char=".">1.92</td><td class="colsep0 rowsep0" align="char" char=".">n.a.</td><td class="colsep0 rowsep0" align="left" char=".">n.a.</td><td class="colsep0 rowsep0" align="left" char=".">n.a.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-OH</td><td class="colsep0 rowsep0" align="char" char=".">9.50</td><td class="colsep0 rowsep0" align="char" char=".">5.17</td><td class="colsep0 rowsep0" align="char" char=".">n.a.</td><td class="colsep0 rowsep0" align="char" char=".">n.a.</td><td class="colsep0 rowsep0" align="left" char=".">n.a.</td><td class="colsep0 rowsep0" align="left" char=".">n.a.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3-OH</td><td class="colsep0 rowsep0" align="char" char=".">1.30</td><td class="colsep0 rowsep0" align="char" char=".">0.742</td><td class="colsep0 rowsep0" align="char" char=".">1.33</td><td class="colsep0 rowsep0" align="char" char=".">2.31</td><td class="colsep0 rowsep0" align="left" char=".">33.2</td><td class="colsep0 rowsep0" align="left" char=".">116</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.600</td><td class="colsep0 rowsep0" align="char" char=".">0.410</td><td class="colsep0 rowsep0" align="char" char=".">1.21</td><td class="colsep0 rowsep0" align="char" char=".">n.a.</td><td class="colsep0 rowsep0" align="left" char=".">n.a.</td><td class="colsep0 rowsep0" align="left" char=".">n.a.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.700</td><td class="colsep0 rowsep0" align="char" char=".">0.355</td><td class="colsep0 rowsep0" align="char" char=".">>2.5</td><td class="colsep0 rowsep0" align="char" char=".">–1.37</td><td class="colsep0 rowsep0" align="left" char=".">0.10</td><td class="colsep0 rowsep0" align="left" char=".">>22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-CONH(OH)</td><td class="colsep0 rowsep0" align="char" char=".">0.060</td><td class="colsep0 rowsep0" align="char" char=".">0.031</td><td class="colsep0 rowsep0" align="char" char=".">>2.5</td><td class="colsep0 rowsep0" align="char" char=".">n.a.</td><td class="colsep0 rowsep0" align="left" char=".">n.a.</td><td class="colsep0 rowsep0" align="left" char=".">n.a.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="char" char=".">0.499</td><td class="colsep0 rowsep0" align="char" char=".">0.502</td><td class="colsep0 rowsep0" align="char" char=".">0.440</td><td class="colsep0 rowsep0" align="char" char=".">1.67</td><td class="colsep0 rowsep0" align="left" char=".">102</td><td class="colsep0 rowsep0" align="left" char=".">>125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.331</td><td class="colsep0 rowsep0" align="char" char=".">0.217</td><td class="colsep0 rowsep0" align="char" char=".">0.759</td><td class="colsep0 rowsep0" align="char" char=".">2.96</td><td class="colsep0 rowsep0" align="left" char=".">71.3</td><td class="colsep0 rowsep0" align="left" char=".">118</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.574</td><td class="colsep0 rowsep0" align="char" char=".">0.389</td><td class="colsep0 rowsep0" align="char" char=".">1.99</td><td class="colsep0 rowsep0" align="char" char=".">2.95</td><td class="colsep0 rowsep0" align="left" char=".">87.4</td><td class="colsep0 rowsep0" align="left" char=".">90.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.369</td><td class="colsep0 rowsep0" align="char" char=".">0.336</td><td class="colsep0 rowsep0" align="char" char=".">1.63</td><td class="colsep0 rowsep0" align="char" char=".">2.55</td><td class="colsep0 rowsep0" align="left" char=".">76.2</td><td class="colsep0 rowsep0" align="left" char=".">66.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.294</td><td class="colsep0 rowsep0" align="char" char=".">0.187</td><td class="colsep0 rowsep0" align="char" char=".">>2.5</td><td class="colsep0 rowsep0" align="char" char=".">0.98</td><td class="colsep0 rowsep0" align="left" char=".">1.78</td><td class="colsep0 rowsep0" align="left" char=".">126</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-OH</td><td class="colsep0 rowsep0" align="char" char=".">0.125</td><td class="colsep0 rowsep0" align="char" char=".">0.113</td><td class="colsep0 rowsep0" align="char" char=".">0.130</td><td class="colsep0 rowsep0" align="char" char=".">2.21</td><td class="colsep0 rowsep0" align="left" char=".">50.2</td><td class="colsep0 rowsep0" align="left" char=".">11.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="char" char=".">0.570</td><td class="colsep0 rowsep0" align="char" char=".">0.454</td><td class="colsep0 rowsep0" align="char" char=".">0.748</td><td class="colsep0 rowsep0" align="char" char=".">1.77</td><td class="colsep0 rowsep0" align="left" char=".">43.1</td><td class="colsep0 rowsep0" align="left" char=".">11.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">NCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-OH</td><td class="colsep0 rowsep0" align="char" char=".">0.224</td><td class="colsep0 rowsep0" align="char" char=".">0.160</td><td class="colsep0 rowsep0" align="char" char=".">>2.5</td><td class="colsep0 rowsep0" align="char" char=".">1.68</td><td class="colsep0 rowsep0" align="left" char=".">2.82</td><td class="colsep0 rowsep0" align="left" char=".">144</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">CHN(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="char" char=".">0.238</td><td class="colsep0 rowsep0" align="char" char=".">0.143</td><td class="colsep0 rowsep0" align="char" char=".">0.640</td><td class="colsep0 rowsep0" align="char" char=".">0.73</td><td class="colsep0 rowsep0" align="left" char=".">64.7</td><td class="colsep0 rowsep0" align="left" char=".">>45</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last"><i>In vitro</i> IC<sub>50</sub> against MNK1 and MNK2; average of at least two determinations.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">eIF4E phosphorylation inhibition measured using HeLa cell line, average of at least two determinations. n.a. = not available.</p></div></div></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> C-3 Substituent Variation</h3><div class="NLM_p">We next kept the methylpiperazine benzamide, our best solubilizing group, constant at C-6, and explored derivatization at C-3. Moieties such as pyridine derivatives, pyrimidine, bicyclic heterocycle, carbonyl bridged heterocycles failed to improve potencies relative to a phenyl substituent (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a>, Table S2). These observations are in agreement with modeling studies, that support the hydrophobic nature of the binding site occupied by the phenyl at C-3. Consequently, our SAR investigations were then narrowed to only substituting the para position of phenyl at C-3. Removing the hydroxyl (<b>21</b>) or moving it to the ortho (<b>22</b>) or meta (<b>23</b>) positions resulted in a 5- to 30-fold loss in potency. The following para substituents illustrate how this part of the binding pocket can accommodate both hydrophobic and hydrophilic groups. The OH was replaced by CH<sub>3</sub> (<b>24</b>), COOH (<b>25</b>), CONHOH (<b>26</b>), CN (<b>27</b>), Cl (<b>28</b>), CF<sub>3</sub> (<b>29</b>), CHF<sub>2</sub> (<b>30</b>), and CONH<sub>2</sub> (<b>31</b>) and led to derivatives that inhibit MNK1 and MNK2 with potencies similar to that of <b>20</b>.</div><div class="NLM_p">The hydroxamic acid derivative <b>26</b> showed a substantial improvement in potency relative to <b>20</b>, but <b>26</b> as well as the primary amide (<b>31</b>) and acid (<b>25</b>), all had poor permeability and consequently lacked cell-based activity. The carboxylic acid was replaced by a tetrazole (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a>, Table S3) to give an equipotent compound, but with a bad permeability and practically no cell activity. The benzonitrile <b>27</b>, with a LogD of 1.67 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) is less lipophilic than analogues of similar potency (<b>28</b>, <b>29</b>, <b>30</b>) and displayed excellent solubility and permeability properties. Accordingly, the benzonitrile group was selected as the preferred substituent at C-3. At this stage, the improved compounds, exemplified by <b>27</b> and <b>33</b>, exhibited an imidazopyrazine with a benzonitrile at C-3 and methylpiperazine or morpholine benzamide at C-6.</div><div class="NLM_p">MNK2 X-ray structures were examined to understand why the para position of the C-3 phenyl tolerates both hydrophobic and hydrophilic groups. <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> represents <b>4</b> docked into MNK2 and shows that the para position is surrounded by hydrophobic residues Val98, side chain methylenes of Lys113, Phe227, and Phe159. Consequently, compounds with small hydrophobic para substituents like Me (<b>24</b>), Cl (<b>28</b>), CF<sub>3</sub> (<b>29</b>), and CHF<sub>2</sub> (<b>30</b>) have more hydrophobic interactions with the kinase than compound <b>21</b> the unsubstituted analogue. On the other hand, compounds with more polar substituents such as 4-OH (<b>20</b>), 4-CO<sub>2</sub>H (<b>25</b>), 4-CONHOH (<b>26</b>), 4-CN (<b>27</b>), and 4-CONH<sub>2</sub> (<b>31</b>) also have good inhibitory activity that could be the result of hydrogen bonding to the backbone carbonyl of Asp226 for hydrogen bond donating substituents (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) or with the basic side chain of Lys113 for acidic or hydrogen bond accepting groups as shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>.</div><div class="NLM_p last">Modeling studies showed that the cyano group of <b>27</b> forms a hydrogen bond with Lys113, and during an MD simulation (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_002.pdf" class="ext-link">Supporting Information</a>, MD file compound <b>27</b>), this hydrogen bond was present for 60% of the time. The increased potency of <b>26</b> could be the result of two hydrogen bond interactions between the NH and OH of the hydroxamic acid group to Asp226 and Lys113, respectively.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> C-6 Substituent Variation</h3><div class="NLM_p">We re-examined the suitability of benzamide moieties at C-6 to verify that the SAR established with the C-3 phenol derivatives holds true for the C-3 benzonitrile analogues. Accordingly, two benzonitrile derivatives, morpholino (<b>33</b>) and <i>N,N</i>-dimethylamino piperidinyl (<b>37</b>) were generated. <b>27</b> and <b>33</b> are equipotent toward MNK1/2 inhibition, just as the phenolic derivatives <b>20</b> and <b>32</b> are. Analogues <b>27</b>, <b>33</b>, and <b>37</b> were all of similar potency toward MNK1 inhibition, but for MNK2, <b>37</b> is 3- and 4-fold more potent than <b>27</b> and <b>33</b>, respectively.</div><div class="NLM_p">Compounds <b>27</b>, <b>33</b>, and <b>37</b> were found to have favorable ADME properties as shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. They were administered orally to mice, and <b>27</b>, with a bioavailability of 48%, was the fastest absorbed, with a <i>C</i><sub>max</sub> and AUC 4–6 times higher than those of <b>33</b> and <b>37</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a>, Table S4). Compound <b>27</b> achieves an excellent selectivity and inhibits only four kinases at more than 50% out of 104 kinases when tested at a concentration of 10 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a>, Table S5). Overall, <b>27</b>, combines excellent physicochemical properties (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) with good <i>in vitro</i> and <i>in vivo</i> ADME properties and excellent PK properties and kinase selectivity profile. Thus, compound <b>27</b> was selected as the lead compound for the lead optimization phase.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Microsomal Stability, Cyp Inhibition, Permeability, and Plasma Protein Binding (PPB) Properties of Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="/" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="/"><i>T</i><sub>1/2</sub> (min)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center">PPB (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="/">HLM/MLM</th><th class="colsep0 rowsep0" align="center">RLM/DLM</th><th class="colsep0 rowsep0" align="center">Cyp 3A4/2D6 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">Caco-2 Papp A-B<a class="ref internalNav" href="#t4fn3" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">Caco-2 efflux ratio</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">mouse</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char="/">41/37</td><td class="colsep0 rowsep0" align="center">n.a.</td><td class="colsep0 rowsep0" align="center">>20/>20</td><td class="colsep0 rowsep0" align="char" char=".">6.87</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="center">98.4</td><td class="colsep0 rowsep0" align="center">87.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char="/">>60/>60</td><td class="colsep0 rowsep0" align="center">n.a.</td><td class="colsep0 rowsep0" align="center">>20/>20</td><td class="colsep0 rowsep0" align="char" char=".">17.9</td><td class="colsep0 rowsep0" align="char" char=".">1.73</td><td class="colsep0 rowsep0" align="center">n.a.</td><td class="colsep0 rowsep0" align="center">n.a.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char="/">>60/>60</td><td class="colsep0 rowsep0" align="center">n.a.</td><td class="colsep0 rowsep0" align="center">>20/>20</td><td class="colsep0 rowsep0" align="char" char=".">1.14</td><td class="colsep0 rowsep0" align="char" char=".">7.57</td><td class="colsep0 rowsep0" align="center">n.a.</td><td class="colsep0 rowsep0" align="center">n.a.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="char" char="/">17/23</td><td class="colsep0 rowsep0" align="center">n.a.</td><td class="colsep0 rowsep0" align="center">>20/>20</td><td class="colsep0 rowsep0" align="char" char=".">14.6</td><td class="colsep0 rowsep0" align="char" char=".">4.84</td><td class="colsep0 rowsep0" align="center">99.9</td><td class="colsep0 rowsep0" align="center">95.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="char" char="/">53/>60</td><td class="colsep0 rowsep0" align="center">>60/>60</td><td class="colsep0 rowsep0" align="center">>20/>20</td><td class="colsep0 rowsep0" align="char" char=".">38.5</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td><td class="colsep0 rowsep0" align="center">99.9</td><td class="colsep0 rowsep0" align="center">94.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char="/">>60/42</td><td class="colsep0 rowsep0" align="center">n.a.</td><td class="colsep0 rowsep0" align="center">5.6/n.a.</td><td class="colsep0 rowsep0" align="char" char=".">1.13</td><td class="colsep0 rowsep0" align="char" char=".">29.9</td><td class="colsep0 rowsep0" align="center">n.a.</td><td class="colsep0 rowsep0" align="center">n.a.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="char" char="/">47/>60</td><td class="colsep0 rowsep0" align="center">n.a.</td><td class="colsep0 rowsep0" align="center">n.a.</td><td class="colsep0 rowsep0" align="char" char=".">3.00</td><td class="colsep0 rowsep0" align="char" char=".">13.27</td><td class="colsep0 rowsep0" align="center">n.a.</td><td class="colsep0 rowsep0" align="center">n.a.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="char" char="/">20/11</td><td class="colsep0 rowsep0" align="center">n.a.</td><td class="colsep0 rowsep0" align="center">3.9/>20</td><td class="colsep0 rowsep0" align="char" char=".">5.43</td><td class="colsep0 rowsep0" align="char" char=".">4.84</td><td class="colsep0 rowsep0" align="center">99.7</td><td class="colsep0 rowsep0" align="center">90.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="char" char="/">48/56</td><td class="colsep0 rowsep0" align="center">>60/>60</td><td class="colsep0 rowsep0" align="center">>20/>20</td><td class="colsep0 rowsep0" align="char" char=".">30.50</td><td class="colsep0 rowsep0" align="char" char=".">1.42</td><td class="colsep0 rowsep0" align="center">99.7</td><td class="colsep0 rowsep0" align="center">84.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">HLM/MLM, metabolic stability measured in human and mouse liver microsomes; RLM/DLM, metabolic stability determined in rat and dog liver microsomes.</p></div><div class="footnote" id="t4fn3"><sup><sup>b</sup></sup><p class="last">Papp in 10<sup>–6</sup> cm/s. n.a. = not available.</p></div></div></div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Multiparameter Lead Optimization</h3><div id="sec6_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Increasing Potency: Swapping Cores</h4><div class="NLM_p">Alteration at C-3 and C-6 of the imidazopyrazine core produced <b>27</b> with an inhibitory potency of 0.5 μM against MNK1 and MNK2, in both enzymatic and cellular assays. At this stage, the core is the only part of the scaffold that was not modified, and we thought that its alterations could modulate potency and/or ADME properties as done by others.<a onclick="showRef(event, 'ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref60 ref61 ref62">(60−62)</a></div><div class="NLM_p">Accordingly, in addition to imidazopyrazine, six bicyclic rings were investigated (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a>, Table S6). Modeling studies have shown that their binding mode to MNK1/2 remain similar to that of imidazopyrazine analogues; all derived analogues have in common the N-1 binding to hinge Ser166 and the CN hydrogen bonding to Lys223, and exhibited previously described hydrophobic interactions for phenyl groups at both C-3 and C-6.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Influence of the Bicyclic Core on Potency: From Imidazopyrazine to Imidazopyridazine and Imidazopyridine</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0014.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" char="." /></col><col align="left" char="." /></col><col align="left" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X<sup>1</sup></th><th class="colsep0 rowsep0" align="center">X<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">MNK1<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">MNK2<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">HeLa<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">PAMPA (×10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">LogD7.4</th><th class="colsep0 rowsep0" align="center" char=".">solubility (μg/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.499</td><td class="colsep0 rowsep0" align="char" char=".">0.502</td><td class="colsep0 rowsep0" align="char" char=".">0.440</td><td class="colsep0 rowsep0" align="left" char=".">102</td><td class="colsep0 rowsep0" align="left" char=".">1.67</td><td class="colsep0 rowsep0" align="left" char=".">>125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.020</td><td class="colsep0 rowsep0" align="char" char=".">0.025</td><td class="colsep0 rowsep0" align="char" char=".">0.326</td><td class="colsep0 rowsep0" align="left" char=".">25.0</td><td class="colsep0 rowsep0" align="left" char=".">2.82</td><td class="colsep0 rowsep0" align="left" char=".">86.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="char" char=".">0.023</td><td class="colsep0 rowsep0" align="char" char=".">0.041</td><td class="colsep0 rowsep0" align="char" char=".">0.421</td><td class="colsep0 rowsep0" align="left" char=".">30.0</td><td class="colsep0 rowsep0" align="left" char=".">2.10</td><td class="colsep0 rowsep0" align="left" char=".">1.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="char" char=".">0.026</td><td class="colsep0 rowsep0" align="char" char=".">0.220</td><td class="colsep0 rowsep0" align="left" char=".">45.8</td><td class="colsep0 rowsep0" align="left" char=".">2.00</td><td class="colsep0 rowsep0" align="left" char=".">115</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CHN(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">0.431</td><td class="colsep0 rowsep0" align="left" char=".">75.3</td><td class="colsep0 rowsep0" align="left" char=".">2.19</td><td class="colsep0 rowsep0" align="left" char=".">148</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">NCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.084</td><td class="colsep0 rowsep0" align="char" char=".">0.072</td><td class="colsep0 rowsep0" align="char" char=".">0.229</td><td class="colsep0 rowsep0" align="left" char=".">81.9</td><td class="colsep0 rowsep0" align="left" char=".">2.48</td><td class="colsep0 rowsep0" align="left" char=".">137</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="char" char=".">0.064</td><td class="colsep0 rowsep0" align="char" char=".">0.086</td><td class="colsep0 rowsep0" align="char" char=".">0.321</td><td class="colsep0 rowsep0" align="left" char=".">74.4</td><td class="colsep0 rowsep0" align="left" char=".">2.61</td><td class="colsep0 rowsep0" align="left" char=".">55.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last"><i>In vitro</i> IC<sub>50</sub> against MNK1 and MNK2.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">eIF4E phosphorylation inhibition measured using HeLa cell line.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last"><b>27</b> was shown to illustrate the bicycle ring influence on potency in one table. IC<sub>50</sub>’s are the average of at least two determinations.</p></div></div></div><div class="NLM_p">Briefly, in comparison to the imidazopyrazine <b>27</b>, [1,2-<i>a</i>]pyrimidine and 1<i>H</i>-imidazo[4,5-<i>c</i>]pyridine analogue (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a>, Table S6) were less potent, and 1<i>H</i>-benzo[<i>d</i>]imidazole derivative (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a>, Table S6) was equipotent to <b>27</b>. In contrast, the pyrazolo[1,5-<i>a</i>]pyrimidine analogue was 10-fold more potent than <b>27</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a>, Table S6), and compounds from pyrazolo[1,5-<i>a</i>]pyrimidine series showed SAR, physicochemical, and PK properties similar to those of the imidazopyridazine analogues. Therefore, we focused on the imidazopyrazine, imidazopyridazine, and imidazopyridine cores, and derived analogues as shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>.</div><div class="NLM_p">Similarly, imidazopyridazine analogues <b>39</b>, <b>40</b>, and <b>42</b> are more potent than imidazopyrazine analogues <b>27</b> and <b>33</b>. This trend is also observed when the imidazopyrazine core is replaced by an imidazopyridine with an improvement in potency, of 6- to 9-fold for MNK1 and of 5- to 7-fold for MNK2, seen when comparing imidazopyrazines <b>27</b> and <b>33</b> to imidazopyridines <b>47</b> and <b>48</b>.</div><div class="NLM_p">In HeLa cells, inhibitory data of eIF4E phosphorylation shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> are clustered between 0.22 and 0.44 μM. This inhibition is often weaker by 3- to 47-fold in whole-cell as compared to cell-free assays, probably due to permeability issues (<b>39</b>, <b>40</b>, <b>42</b>), nonspecific binding or a combination of both. Highly permeable compounds (<b>27</b>, <b>47</b>, <b>48</b>) exhibit a smaller potency difference between enzymatic and cellular data, and <b>27</b>, the most permeable compound, is equally potent in both assays. Compound <b>45</b> is 47-fold less potent in cellular assays despite a good PAMPA permeability. However, <b>45</b> has a high Caco-2 efflux ratio of 13 (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) that could explain the loss of potency.</div><div class="NLM_p">To rationalize the impact of N-7 on potency, we examined the structural models which revealed that the imidazopyrazine N-7 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) is not involved in any hydrogen bond in any of the docked complexes studied. On the contrary, it resides in a hydrophobic environment and has van der Waals interactions with Gly165 α carbon and Leu90 side chain, as visualized in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. This may account for part of the approximately 5- to 10-fold gain in potency observed when this N-7 nitrogen is replaced by a CH (compare <b>33</b> to <b>48</b>). Indeed, our previous modeling studies<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> have also shown the important contribution of hydrophobic interactions to the potency of the compounds.</div><div class="NLM_p">It may be surprising that compounds with an imidazopyridazine scaffold were also substantially more potent than the imidazopyrazine analogues as both cores have two nitrogen atoms with a lone pair that can be solvated. The N-5 of the imidazopyridazine is also surrounded by hydrophobic residues (Leu90 and Leu212). We believe that the difference in exposure of the lone pairs plays a determining role in the influence of the core on potency. In the imidazopyrazines the lone pair is shielded by the C-6 phenyl where as in the imidazopyridazines the lone pair is shielded by both the C-3 and C-6 phenyls. This impacted the interaction between the ligand and protein as well as the solvation energy.</div><div class="NLM_p">DFT calculations indicate that the desolvation penalty for the imidazopyrazine N-7 may be much higher than that of the imidazopyridazine N-5, and it costs 10.8 kJ/mol more to remove the water from the imidazopyrazine complex in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. A single water molecule was placed in front of the imidazopyrazine N-7 (A) and imidazopyridazine N-5 (B). The complexes were minimized using DFT-B3LYP 6-31G**.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In contrast to the benzamide’s minor influence on binding in imidazopyrazine series, the 4-<i>N,N</i>-dimethylamino piperidine <b>45</b> in the imidazopyridazine series is substantially more potent than piperazine and morpholine benzamide analogues <b>39</b> and <b>40</b>, respectively.</div><div class="NLM_p">The piperidine-dimethylamine (<b>45</b>) in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> is sandwiched between hydrophobic residues Gly91, Leu168, and Phe227, while the base may interact with the acids Glu92 and Glu209. <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> shows the interactions of the dimethylamino piperidine group <b>45</b> with Glu209 and Phe227 of MNK2. In the MD simulations, the basic nitrogen interacts with the side chain of Glu209 during most of the simulation. However, when bound to MNK2, this part of the inhibitor is solvent exposed; solvent effects are likely to shield the contributions of any electrostatic interactions, and they may not contribute much to the binding affinity.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>45</b> docked into MNK2 catalytic site. MNK2 is shown as an electrostatic surface. The inhibitors are shown in stick with green carbon and a transparent green surface.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We speculate that the <i>N,N-</i>dimethylamino piperidine interacts better with Phe227 and Glu209 than the <i>N</i>-methylpiperazine. During the MD simulations (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_003.pdf" class="ext-link">Supporting Information</a>, MD file compound <b>45</b>), the interactions with these residues were stable for <b>45</b> while they were only observed during 50% of the simulations for <b>20</b>.</div></div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> ADME and PK</h3><div id="sec6_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Modulation of ADME Properties: Correcting Issues Related to <i>N</i>-Alkylated Benzamides</h4><div class="NLM_p last">A selection of compounds, shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, were evaluated <i>in vitro</i> to assess their metabolic stability, Cyp inhibition, and protein binding properties. It appears that substituting the imidazopyrazine core effectively led to more potent derivatives <b>39</b> and <b>47</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), but with an increased metabolic liability (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Methylpiperazine <b>39</b> and <b>47</b> are unstable in human and mouse liver microsomes, and this is most likely attributable to <i>N</i>-demethylation. To address that issue morpholine <b>40</b>, piperazine <b>42</b>, and <i>N,N</i>-dimethylamino piperidine <b>45</b> derivatives were generated and were found to be metabolically stable. Unfortunately, both piperazine <b>42</b> and dimethylamino piperidine <b>45</b> derivatives were subject to a high efflux ratio (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) which might negatively impact their PK properties. Morpholine derivatives <b>40</b> and <b>48</b> showed low metabolic liability in mouse, rat, dog, and human microsomes, and low Cyp 3A4 and 2D6 inhibition, and they exhibited a higher cell permeability as per the Caco-2 assay (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) compared to the basic piperazine and piperidine analogues.</div></div><div id="sec6_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Pharmacokinetic Properties</h4><div class="NLM_p">In spite of the high efflux ratio of <b>45</b>, it was orally administered to mice at 5 mg/kg and gave a poor systemic exposure with a <i>C</i><sub>max</sub> of 69 ng/mL and an AUC<sub>0-inf</sub> of 347 ng·h/mL. In contrast, <b>40</b> and <b>48</b> exhibited higher exposure and substantially improved PK properties relative to the lead <b>27</b> when comparing AUC and <i>C</i><sub>max</sub> values (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Indeed, compared to <b>27</b>, compounds <b>40</b> and <b>48</b> exhibited several characteristics favorable to good exposure, including lower basicity, higher Caco-2 permeability, and a lower Caco-2 efflux ratio.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Mouse Pharmacokinetics Data for Compounds <b>40</b> and <b>48</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center"><b>40</b></th><th class="colsep0 rowsep0" colspan="2" align="center"><b>48</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dose (mg/kg)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">route of administration</td><td class="colsep0 rowsep0" align="left">i.v.</td><td class="colsep0 rowsep0" align="left">p.o.</td><td class="colsep0 rowsep0" align="left">i.v.</td><td class="colsep0 rowsep0" align="left">p.o.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>0</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">2940</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2379</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4405</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2481</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">2.32</td><td class="colsep0 rowsep0" align="left">2.14</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">1.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL* (L/h/kg)</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.56</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0-<i>t</i></sub> (last) (ng·h/mL)</td><td class="colsep0 rowsep0" align="left">6124</td><td class="colsep0 rowsep0" align="left">24093</td><td class="colsep0 rowsep0" align="left">1761</td><td class="colsep0 rowsep0" align="left">5484</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" colspan="2" align="center">79</td><td class="colsep0 rowsep0" colspan="2" align="center">64</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last"><i>F</i> (%) calculated after i.v. and p.o. administration at 1 mg/kg and 5 mg/kg respectively of <b>40</b> and <b>48</b>. Formulations: p.o., 0.5% MC + 0.1% TW80 + sterile MQ water; i.v., 10% NMP + 40% PEG300 + sterile MQ water, 10% Cremophor + 10% DMA + sterile MQ water.</p></div></div></div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Kinase Selectivity</h4><div class="NLM_p">Compounds <b>40</b> and <b>48</b> were tested against a panel of 104 kinases together with representative MNK inhibitors such as CGP57380,<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36−38)</a> cercosporamide,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and AST-487.<a onclick="showRef(event, 'ref52 ref64'); return false;" href="javascript:void(0);" class="ref ref52 ref64">(52,64)</a> These known MNK inhibitors are often used in biological studies but their selectivity profiles were not readily available. CGP57380 is a multikinase inhibitor<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> as it was found to inhibit ABL1 (E255 K), ABL1 (WT), MEK1, MEK2, MNK1, MNK2, and RET at more than 99% (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a>, Table S5).</div><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a> shows that <b>40</b> and <b>48</b> are selective, and specifically, imidazopyridine <b>48</b> inhibits only two kinases at ≥65%, six kinases fewer than imidazopyridazine <b>40</b>. The bicyclic core of <b>48</b> had an unexpected influence on its kinase selectivity, and the difference in the torsion between the bicyclic ring and the phenyl at C-3 could be a plausible explanation of why <b>48</b> is more selective than <b>40</b>. There is a 29° versus 42° torsion variation in DFT-B3LYP 6-31** minimized structures. The more coplanar <b>40</b> probably has a shape that allows it to fit better to a greater number of kinases.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Kinase Selectivity Profile of <b>40</b> and <b>48</b> Screened against a Panel of 104 Kinases at 1 μM<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0016.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Kinase inhibition data are from a competition assay with a proprietary ligand to determine the compound’s binding affinity against a panel of 104 kinases.</p></div></div><div></div></div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Cell-Based Anti-proliferative Activity</h4><div class="NLM_p">The anti-proliferative effects of <b>40</b> and <b>48</b> were assessed <i>in vitro</i>, using CellTiter-Glo viability assay against 25 hematological cancer cell lines including the K562 cell line that overexpresses eIF4E (K562 o/e eIF4E)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a>, Table S7). The IC<sub>50</sub>’s were in general in the micromolar range similar to published data.<a onclick="showRef(event, 'ref34 ref43 ref45 ref66'); return false;" href="javascript:void(0);" class="ref ref34 ref43 ref45 ref66">(34,43,45,66)</a> Compound <b>40</b> appears to be more potent than <b>48</b> with submicromolar IC<sub>50</sub>, especially against GK-5, DOHH2, AHH-1, and P3HR-1 cell lines. We speculate that the superior activity of <b>40</b> against these cell lines could be the result of the combination of its potency and off-target inhibition of kinases such as PDGFRA and FLT3, against which <b>40</b> gave an inhibitory potency of 0.25 and 0.88 μM, respectively. MNK1/2 inhibitors that show strong anti-proliferative effects <i>in vitro</i> have been known to often inhibit other kinases.<a onclick="showRef(event, 'ref34 ref39'); return false;" href="javascript:void(0);" class="ref ref34 ref39">(34,39)</a></div><div class="NLM_p last">In contrast, <b>40</b> and <b>48</b> alone or in combination with imatinib or dasatinib were both able to suppress the ability of leukemic stem cells from BC-CML patient to form colony (data to be published elsewhere). This was previously described for nonselective MNK1/2 inhibitors AST-487, CGP57380, and cercosporamide, and it was shown that imatinib and dasatinib alone do not inhibit the self-renewal activity of LSCs.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Selection of Compound <b>48</b> as a Preclinical Candidate</h4><div class="NLM_p">A comparison of the two optimized compounds, <b>40</b> and <b>48</b>, shows that <b>40</b> is the most potent in the enzymatic assay, but that potency did not carry over to eIF4E phosphorylation inhibition in HeLa cells, where <b>48</b> is slightly more potent. Compound <b>48</b> has a greater solubility, permeability and an excellent kinase selectivity. In maximum tolerated dose studies, oral administration of <b>48</b>, showed no weight loss and no clinical adverse effects in healthy mice up to the tested dose of 200 mg/kg.</div><div class="NLM_p last">To avoid any ambiguities in interpreting efficacy studies, a compound which inhibits fewer kinases will be preferred for investigating the impact of the inhibition of MNK1/2 on biological processes. In light of these data, compound <b>48</b> was ranked higher and was selected as the preclinical candidate.</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>In Vivo</i> Efficacy</h4><div class="NLM_p">We have reported that dual specific MNK1/2 and BCR-ABL1 inhibitors potently inhibited the proliferation of five BC-CML lines <i>in vitro</i>, and these inhibitors elicited a dose-dependent anti-tumor activity in an <i>in vivo</i> mouse xenograft model.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> As MNK1/2 and BCR-ABL1 inhibitory activities were combined into one molecule, it was challenging to distinguish the contribution of MNK1/2 inhibition in the observed biological response. Now, we have shown that selective MNK1/2 inhibitors <b>40</b> and <b>48</b> are much less anti-proliferative against the five BC-CML cell lines (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a>, Table S7). However, there are emerging data<a onclick="showRef(event, 'ref67 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref67 ref68 ref69">(67−69)</a> that support that MNK1/2 inhibition effect <i>in vivo</i> could be greatly enhanced by the tumor microenvironment or the stroma without which, the amplitude of MNK1/2 inhibitors anti-proliferative effect on BC-CML cell lines in <i>in vitro</i> cellular assays could appear to be much weaker. Accordingly, compound <b>48</b> was selected for further evaluation <i>in vivo</i> in a mouse xenograft model. The antitumor effect of compound <b>48</b> was then assessed in a K562 e/o eIF4E mouse xenograft model after oral administration at 25, 50, or 100 mg/kg alone or in combination with a 2.5 mg/kg fixed dose of dasatinib throughout the study (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Antitumor efficacy of <b>48</b> after oral administration alone or in combination with dasatinib to K562 o/e eIF4E SCID mouse xenograft model with eight mice per group. (A) Mouse body weights expressed as (mean ± SEM). (B) Tumor growth rates expressed as volumes (mean ± SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A shows that the treatment was well tolerated, and the weight loss observed with the vehicle or compound <b>48</b> administered alone is due to the burden of the tumor growth on mice.</div><div class="NLM_p last">Dasatinib at 2.5 mg/kg elicited a tumor growth inhibition (TGI) of 88% (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B) with one tumor-free animal. In contrast, <b>48</b> alone only yields a maximum TGI of 23% at the highest administered dose of 100 mg/kg, which did not impede tumor growth, and was similar to the nontreated animals. Combining <b>48</b> with 2.5 mg/kg of dasatinib not only increased tumor growth inhibition in a dose-dependent manner but, more importantly led to 2, 5, and 8 out of 8 tumor-free animals at 25, 50, and 100 mg/kg, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a>, Table S8). The combination of <b>48</b> and dasatinib inhibited tumor growth at all tested doses, and no weight loss was recorded (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Both the combination of <b>48</b> and dasatinib and, on the other hand, the dual MNK1/2 and BCR-ABL1 inhibitors<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> prevented tumor growth in the same mouse xenograft model. The combination study clearly showed, that a selective MNK1/2 inhibitor plays a role in TGI by enhancing the antitumor effect of dasatinib.</div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Biomarker Study</h4><div class="NLM_p last">Western blot analysis of tumor samples excised from mice administered with 2.5 mg/kg of dasatinib and 100 mg/kg of <b>48</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a> Figure S1) revealed a maximum reduction in phosphorylated CRKL, a BCR-ABL1 substrate, from 4 to 8 h post dose. The reduction of phosphorylated eIF4e was significant after 1 h post dose and was sustained at 4 and 8 h post dose. These observations are consistent with the tumor growth inhibition induced by the combination of <b>48</b> and dasatinib and shows that both MNK1/2 and BCR-ABL1 kinases are inhibited <i>in vivo</i>.</div></div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Starting from bicyclic fragment hits, selective and potent MNK1/2 inhibitors were designed and synthesized. Substituents at both C-3 and C-6 and the bicyclic moiety were optimized. The imidazopyridazine and imidazopyridine derivatives, which required a nonbasic benzamide for optimal PK properties, also showed that these cores were equally effective at increasing potency for MNK1/2 inhibition and at modulating kinase selectivity profiles. Imidazopyridine derivative <b>48</b> displayed excellent kinase selectivity and significantly enhanced the anti-tumor activity of dasatinib in a BC-CML mouse xenograft model. This is in agreement with our previous anti-tumor data obtained with single compound dual MNK/BCR-ABL1 inhibitors, for which the impact of MNK inhibition could not be clearly established. Biomarker studies show that the combination effectively reduced the ability of both MNK1/2 and BCR-ABL1 kinases to phosphorylate their substrates eIF4E and CRKL, respectively. Treatment of patients resistant to dasatinib with a combination of MNK1/2 inhibitor and dasatinib should overcome the MNK-eIF4E axis-mediated resistance and restore sensitivity to dasatanib treatment. In addition, the combination might require a lower dose of dasatinib to achieve efficacy, alleviating dasatinib toxicity. This combination therapy with MNK1/2 inhibitors could be extended not only to other BCR-ABL1 inhibitors current or future, but also to other therapies using kinase inhibitors that have become ineffective due to an overexpression of phosphorylated eIF4E.</div><div class="NLM_p last">Compound <b>48</b> is currently in phase 1 clinical trial, where its benefit to BC-CML patients treated with dasatinib is being evaluated.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78501" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78501" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Molecular Modeling</h3><div class="NLM_p">The apo DFG-out MNK1 and MNK2 X-ray structure PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HW6">2HW6</a><a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2AC3">2AC3</a>,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> respectively, were downloaded from the Protein Data Bank<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> and prepared with the protein preparation wizard in Maestro 2017-3 release<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> using standard settings. This included the addition of hydrogen atoms, bond assignments, removal of water molecules farther than 5 Å from the ligand, protonation state assignment, optimization of the hydrogen bond network, and restrained minimization using the OPLS3 force field.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The missing loops were added to the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2AC3">2AC3</a> structure, these were adopted from a previously published model.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The inhibitors were built using Maestro and minimized using MacroModel 2017-3 release<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> before being manually docked into the MNK2 ATP-binding site. The inhibitor–protein complex was finally minimized using Macromodel. All residues more than 9 Å from the ligand were constrained before the complex was subjected to 500 steps of Polak–Ribiere conjugate-gradient<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> minimization using the OPLS3 force field<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> and the GB/SA continuum solvation method.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p">The protein complexes were then subjected to 250 ns of unconstrained MD simulation using Desmond 4.8.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The system for MD was build using the System Builder in Desmond. The protein–inhibitor complex was placed in an orthorhombic box with a 10 Å buffer in an orientation that minimized total box volume. The SPC explicit solvent model using water as solvent was employed. The system was neutralized by adding Na<sup>+</sup> ions, and the NaCl salt concentration was set to 0.15M. Under an NPT ensemble class with <i>T</i> = 300 K, <i>P</i> = 1.01325 bar, with the system relaxed MD simulations were carried out for 250 ns. Analyses of secondary structure, RMSF, and ligand–protein interactions were performed using the Simulation Interactions Diagram tool in Desmond (<a class="ref internalNav" href="#notes-100" aria-label="Supporting Information">Supporting Information</a>, MD files for compounds <b><a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_001.pdf" class="ext-link">4</a></b>, <b><a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_002.pdf" class="ext-link">27</a></b> and <b><a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_003.pdf" class="ext-link">45</a></b>). The binding orientation and ligand–protein interactions shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> are representative of the interactions observed during the MD simulation.</div><div class="NLM_p last">The model systems in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> were built in Maestro and minimized using the DFT-B3LYP with the 6-31G** basis set in Jaguar 2017-3 release.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The water interaction energy was calculated by subtracting the gas-phase energy of the free water and inhibitor from the energy of the complex.</div></div><div id="sec8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> General Chemistry</h3><div class="NLM_p">Reagents were purchased from commercial sources and were used as received.</div><div class="NLM_p"><sup>1</sup>H NMR spectra were recorded on a Bruker AVANCE 400 spectrometer at 400 MHz or Bruker AVANCE 300 spectrometer at 300 MHz with the solvent as reference. Samples were prepared as solutions in a deuterated solvent and referenced to the appropriate internal nondeuterated solvent peak. The following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, m = multiplet, pent = pentet, hex = hextet, b = broad. <sup>13</sup>C NMR spectra were recorded at 100 and 125 MHz using an internal deuterium lock.</div><div class="NLM_p">LC MS analyses were performed on a Agilent 1200 series with PDA detector and ion trap mass detector; Waters Acquity UPLC with PDA, ELSD, and Quattro micro mass detector; Waters Acquity UPLC with PDA and 3100 mass detector; Agilent 1100 and 1200 series with PDA detector and single quadrupole mass detector; and Shimadzu 2020 with PDA detector and single quadrupole mass detector. Electrospray-ionization time-of-flight high-resolution mass spectrometry (ESI-TOF-HRMS) was conducted on an Agilent 6210 ESI-TOF (Agilent Technologies). MS (ESI) were recorded on an Agilent 6120 Quadrupole LC/MS system.</div><div class="NLM_p">Reverse-phase HPLC analyses were performed on a Waters Alliance HPLC system with a PDA detector, Waters Acquity UPLC system with a PDA detector; Varian prostar system with PDA detector. The following columns were used: Waters Acquity BEH C18, 100 × 2.1 mm, 1.7 μm; Waters X-Bridge C18, 250 × 4.6 mm, 5 μm; Waters X-Bridge C8, 250 × 4.6 mm, 5 μm; Waters X-Bridge C18, 100 × 4.6 mm, 3.5 μm; Phenomenex Luna C18, 100 × 4.6 mm, 5 μm; and Phenomenex Luna C18, 250 × 4.6 mm, 5 μm. Purifications by preparative HPLC were performed on a Waters 2545 Binary Gradient prep system with 2767 Auto sampler, Gilson GX-281 with UV detector, Shimadzu Prominence UFLC with diode array; Shimadzu Prominence with UV detector; Varian Prostar with PDA detector. All reagents and solvents were commercial grade and were used as received unless noted otherwise.</div><div class="NLM_p">Flash chromatography was performed using a Teledyne Isco RF200 or on a Biotage SP1 combiflash purification, both systems using using prepacked silica gel columns. Thin-layer chromatography (TLC) was performed using EMD TLC silica-gel 60F<sub>254</sub> plates. Visualization of TLC plates was performed using UV light (254 nm). Melting points were determined by the capillary method on a Stuart SMP30 apparatus and are uncorrected.</div><div class="NLM_p last">The purity values for all biologically tested compounds were found to be greater than or equal to 95% determined from HPLC analyses.</div></div><div id="sec8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> General Synthetic Procedures</h3><div id="sec8_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> General Procedure A: Aromatic Halogenation</h4><div class="NLM_p last">A solution of bicyclic derivative (<i>N</i>-(imidazo[1,2-<i>a</i>]pyrazin-6-yl)acetamide) and <i>N</i>-bromosuccinimide or <i>N</i>-iodosuccinimide (1–4 equiv) in an organic solvent (CH<sub>3</sub>CN, DMF, CH<sub>2</sub>Cl<sub>2</sub>) (2 mL/mmol) was stirred at room temperature for 1 h then was filtered through a short pad of Celite. The filtrate was diluted with CH<sub>2</sub>Cl<sub>2</sub>, and the resulting solution was washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to afford the reaction crude product that was either used unpurified or purified as described.</div></div><div id="sec8_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> General Procedure B: Suzuki Coupling Using Pd(PPh<sub>3</sub>)<sub>4</sub></h4><div class="NLM_p last">To a slurry of the halide derivative, boronic acid (2 equiv), and a base (2 equiv of K<sub>3</sub>PO<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>) in a mixture of 1,4-dioxane (10 mL/mmol) and H<sub>2</sub>O (2 mL/mmol) was added Pd(PPh<sub>3</sub>)<sub>4</sub> (0.2 equiv). The reaction mixture was heated at 90 °C for 12 h under argon atmosphere, then cooled and filtered through a short pad of Celite. The filtrate was concentrated to dryness under reduced pressure, and the residue was purified as described in each case.</div></div><div id="sec8_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> General Procedure C: Ester Hydrolysis</h4><div class="NLM_p last">To a solution of carboxylic ester in a mixture of THF (4 mL/mmol) and CH<sub>3</sub>OH (1.28 mL/mmol) were added LiOH (8 equiv) and water (1.28 mL/mmol). The reaction mixture was stirred for 5 h at room temperature and then concentrated to a smaller volume, diluted with water (2.56 mL/mmol), and acidified with an aqueous solution of HCl until pH 3. The precipitate was isolated by filtration and dried to afford the desired product.</div></div><div id="sec8_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> General Procedure D: Amide Coupling</h4><div class="NLM_p last">To a solution of carboxylic acid derivative in DMF (2.8 mL/mmol) were added sequentially <i>N</i>-methylmorpholine (2 equiv), HATU (1.5 equiv), and the amine (1.5 equiv). The reaction mixture was stirred at room temperature for 3 h under nitrogen atmosphere. The reaction mixture was diluted with water (2 mL/mmol). At this stage, if the product precipitated it was isolated by filtration, or if it stayed in solution the aqueous phase was extracted with an organic solvent. The combined extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified as described.</div></div></div><div id="sec8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Synthesis</h3><div id="sec8_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)acetamide (<b>4</b>)</h4><div id="sec8_4_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> Step 1: <i>N</i>-(Imidazo[1,2-<i>a</i>]pyrazin-6-yl)acetamide (<b>2a</b>)</h5><div class="NLM_p last">To a slurry of 6-bromoimidazo[1,2-<i>a</i>]pyrazine (1.00 g, 5.00 mmol), acetamide (380 mg, 6.50 mmol), and K<sub>2</sub>CO<sub>3</sub> (1.38 g, 10.0 mmol) in toluene (30 mL) were added CuI (47 mg, 0.05 mmol) and <i>N,N</i>-dimethylethylenediamine (44 mg, 0.50 mmol). The resulting mixture was heated at 90 °C for 12 h under an inert atmosphere. The reaction mixture was filtered through a short pad of Celite, and the filtrate was concentrated under reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent <i>n</i>-hexane/EtOAc 50:50) to afford <i>N</i>-(imidazo[1,2-<i>a</i>]pyrazin-6-yl)acetamide (500 mg, 56%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.55 (s, 1H), 9.24 (s, 1H), 8.91 (s, 1H), 8.23 (s, 1H), 7.76 (s, 1H), 2.10 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 177 [C<sub>8</sub>H<sub>8</sub>N<sub>4</sub>O+H]<sup>+</sup>.</div></div><div id="sec8_4_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> Step 2: <i>N</i>-(3-Bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)acetamide (<b>3a</b>)</h5><div class="NLM_p last">A solution of <i>N</i>-(imidazo[1,2-<i>a</i>]pyrazin-6-yl)acetamide (1.00 g, 5.00 mmol) and <i>N</i>-bromosuccinimide (900 mg, 5.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was stirred at room temperature for 1 h and then filtered through a short pad of Celite. The filtrate was diluted with CH<sub>2</sub>Cl<sub>2</sub>, and the resulting solution was washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to afford <i>N</i>-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)acetamide (700 mg, 53%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 9.15 (s, 1H), 8.83 (s, 1H), 7.90 (bs, 1H), 7.79 (s, 1H), 2.28 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 255 [C<sub>8</sub>H<sub>7</sub>BrN<sub>4</sub>O]<sup>+</sup>.</div></div><div id="sec8_4_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> Step 3: <i>N</i>-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)acetamide (<b>4</b>)</h5><div class="NLM_p last">To a slurry of <i>N</i>-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)acetamide (600 mg, 2.35 mmol), (4-hydroxyphenyl)boronic acid (290 mg, 2.82 mmol), and Na<sub>2</sub>CO<sub>3</sub> (620 mg, 5.80 mmol) in a mixture of H<sub>2</sub>O (2.00 mL) and DMF (20 mL) were successively added Pd(OAc)<sub>2</sub> (26 mg, 0.11 mmol) and a solution of triphenylphosphine (120 mg, 0.47 mmol) in 1,4-dioxane. The reaction mixture was stirred at 90 °C for 12 h under argon and then filtered through a short pad of Celite. The filtrate was concentrated under reduced pressure, and the residue was purified by column chromatography (silica gel, eluent <i>n</i>-hexane/EtOAc 25:75) to afford <i>N</i>-(3-(4-hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)acetamide (70 mg, 11%, AUC HPLC 95.1%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.61 (s, 1H), 9.90 (s, 1H), 9.23 (s, 1H), 8.95 (s, 1H), 7.86 (s, 1H), 7.46 (d, <i>J</i> = 8.8 Hz, 2H), 6.96 (d, <i>J</i> = 8.4 Hz, 2H), 2.08 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 159.07, 154.65, 142.03, 136.38, 127.44, 126.63, 125.10, 114.48, 112.90, 112.44, 55.56, 28.35; MS (ESI) <i>m</i>/<i>z</i> 269.1 [C<sub>14</sub>H<sub>12</sub>N<sub>4</sub>O<sub>2</sub>+H]<sup>+</sup>.</div></div></div><div id="sec8_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (<b>5</b>)</h4><div id="sec8_4_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> Step 1: <i>N</i>-(Imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (<b>2b</b>)</h5><div class="NLM_p last">To a solution of 6-bromoimidazo[1,2-<i>a</i>]pyrazine (500 mg, 2.52 mmol), benzamide (305 mg, 2.51 mmol), and K<sub>2</sub>CO<sub>3</sub> (500 mg, 1.37 mmol) in toluene (20 mL) were added CuI (23 mg, 0.12 mmol) and <i>N,N</i>-dimethylethylenediamine (8 mg, 0.09 mmol). The resulting mixture was heated at 110 °C for 2 h, and the reaction mixture was filtered through a short pad of Celite. The filtrate was concentrated and purified by flash column chromatography (silica gel, eluent <i>n</i>-hexane/EtOAc 50:50) to afford <i>N</i>-(imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (200 mg, 33%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 9.43 (s, 1H), 8.90 (s, 1H), 8.52 (s, 1H), 7.95 (d, <i>J</i> = 7.2 Hz, 2H), 7.82 (d, <i>J</i> = 7.2 Hz, 2H), 7.45 (t, <i>J</i> = 7.2 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> 239 [C<sub>13</sub>H<sub>10</sub>N<sub>4</sub>O+H]<sup>+</sup>.</div></div><div id="sec8_4_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> Step 2: <i>N</i>-(3-Bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (<b>3b</b>)</h5><div class="NLM_p last">A solution of <i>N</i>-(imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (200 mg, 0.84 mmol) and <i>N</i>-bromosuccinimide (148 mg, 0.83 mmol) in CHCl<sub>3</sub> (9.00 mL) was stirred at room temperature for 5 min, and the reaction mixture was filtered through a short pad of Celite. The filtrate was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with water. The organic phase was dried and concentrated under reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent <i>n</i>-hexane/EtOAc 80:20) to afford <i>N</i>-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (100 mg, 37%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 9.38 (s, 1H), 9.86 (s, 1H), 8.59 (s, 1H), 7.97 (d, <i>J</i> = 7.2 Hz, 2H), 7.82 (d, <i>J</i> = 8.0 Hz, 1H), 7.55 (t, <i>J</i> = 2.4 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> 317 [C<sub>13</sub>H<sub>9</sub>BrN<sub>4</sub>O+H]<sup>+</sup>.</div></div><div id="sec8_4_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> Step 3: <i>N</i>-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (<b>5</b>)</h5><div class="NLM_p last">To a mixture of <i>N</i>-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (100 mg, 0.13 mmol), (4-hydroxyphenyl)boronic acid (52 mg, 0.37 mmol), Na<sub>2</sub>CO<sub>3</sub> (83 mg, 0.78 mmol), and H<sub>2</sub>O (1.0 mL) in DMF (5.0 mL) were added Pd(OAc)<sub>2</sub> (3 mg, 0.01 mmol) and triphenylphosphine (16 mg, 0.06 mmol) in 1,4-dioxane. The reaction mixture was heated at 90 °C for 2 h under argon and filtered through a short pad of Celite. The filtrate was concentrated under reduced pressure, and the residue was purified by flash column chromatography (silica gel, eluent <i>n</i>-hexane/EtOAc 25:75) to afford <i>N</i>-(3-(4-hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (5 mg, 5%, AUC HPLC 98.4%) as an off white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.98 (s, 1H), 9.42 (s, 1H), 9.04 (s, 1H), 8.02 (d, <i>J</i> = 7.2 Hz, 2H), 7.91 (s, 1H), 7.61–7.48 (m, 5H), 6.99 (d, <i>J</i> = 8.4 Hz, 2H); MS (ESI) <i>m</i>/<i>z</i> 331 [C<sub>19</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub>+H]<sup>+</sup>.</div></div></div><div id="sec8_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 4-(6-Bromoimidazo[1,2-<i>a</i>]pyrazin-3-yl)phenol (<b>7a</b>)</h4><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure B starting from 3-bromo-6-iodoimidazo[1,2-<i>a</i>]pyrazine (15 g, 4.63 mmol) and 4-hydroxyphenylboronic acid (6.4 g, 4.64 mmol). The residue was purified by column chromatography (silica gel, eluent <i>n</i>-hexane/EtOAc 50:50) to afford 4-(6-bromoimidazo[1,2-<i>a</i>]pyrazin-3-yl)phenol (10.0 g, 77%) as yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.92 (s, 1H), 8.98 (s, 1H), 8.62 (s, 1H), 7.98 (s, 1H), 7.52 (d, <i>J</i> = 8.4 Hz, 2H), 6.93 (d, <i>J</i> = 8.4 Hz, 2H); MS (ESI), <i>m</i>/<i>z</i> 290 [C<sub>12</sub>H<sub>8</sub>BrN<sub>3</sub>O]<sup>+</sup>.</div></div><div id="sec8_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-(6-Phenylimidazo[1,2-<i>a</i>]pyrazin-3-yl)phenol (<b>8</b>)</h4><div class="NLM_p last">A mixture of 4-(6-bromoimidazo[1,2-<i>a</i>]pyrazin-3-yl)phenol (93 mg, 0.32 mmol), Cs<sub>2</sub>CO<sub>3</sub> (203 mg, 0.64 mmol), phenylboronic acid (59 mg, 0.48 mmol), and PdCl<sub>2</sub>(dppf) (47 mg, 0.064 mmol) in a mixture of DMF (2.5 mL) and H<sub>2</sub>O (0.5 mL) was heated in microwave reactor at 140 °C for 30 min. The reaction mixture was concentrated to dryness under reduced pressure. The residue was purified by flash column chromatography (silica gel, DCM/methanol 10:1) to afford 4-(6-phenylimidazo[1,2-<i>a</i>]pyrazin-3-yl)phenol (61 mg, 66%, AUC HPLC 99.6%) as a yellow solid; mp: 249.7–251.3 °C; <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ (ppm): 9.08 (d, <i>J</i> = 1.2 Hz, 1H), 8.65 (d, <i>J</i> = 1.2 Hz, 1H), 7.92 (d, <i>J</i> = 7.3 Hz, 2H), 7.83 (s, 1H), 7.54 (d, <i>J</i> = 8.6 Hz, 2H), 7.46 (t, <i>J</i> = 7.4 Hz, 2H), 7.43–7.36 (m 1H), 7.02 (d, <i>J</i> = 8.6 Hz, 2H), 4.56 (s, 1H); <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ (ppm): 160.01, 143.47, 141.59, 141.35, 137.80, 134.78, 130.99, 129.99, 129.90, 129.87, 127.64, 119.58, 117.53, 114.37; MS (ESI) <i>m</i>/<i>z</i> 288.20 [C<sub>18</sub>H<sub>13</sub>N<sub>3</sub>O+H]<sup>+</sup>.</div></div><div id="sec8_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (4-(3-Bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (<b>15</b>)</h4><div id="sec8_4_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> Step 1: Ethyl 4-(Imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (<b>9</b>)</h5><div class="NLM_p last">To a solution of 6-bromoimidazo[1,2-<i>a</i>]pyrazine (30 g, 151 mmol) in toluene (400 mL) were sequentially added Cs<sub>2</sub>CO<sub>3</sub> (123 g, 378 mmol), 4-(ethoxycarbonyl)phenylboronic acid (35.2 g, 181 mmol), and PdCl<sub>2</sub>(dppf) (3.70 g, 4.50 mmol). The reaction mixture was stirred at 90 °C for 12 h under argon then, was filtered through Celite. The filtrate was concentrated under reduced pressure, and the residue was purified by flash column chromatography (silica gel, eluent <i>n</i>-hexane/EtOAc 70:30) to afford ethyl 4-(imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (16 g, 39%) as yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.35 (s, 1H), 9.17 (s, 1H), 8.15 (d, <i>J</i> = 8.4 Hz, 2H), 8.03 (d, <i>J</i> = 8.4 Hz, 2H), 7.88 (s, 1H), 7.79 (s, 1H), 4.32 (q, <i>J</i> = 6.8 Hz, 2H), 1.44 (t, <i>J</i> = 7.2 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> 268 [C<sub>15</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>+H]<sup>+</sup>.</div></div><div id="sec8_4_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> Step 2: Ethyl 4-(3-Bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (<b>10</b>)</h5><div class="NLM_p last">To a solution of ethyl 4-(imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (16.0 g, 59.8 mmol) in a mixture of CCl<sub>4</sub> (200 mL) and CH<sub>3</sub>OH (50 mL) was added <i>N</i>-bromosuccinamide (12.7 g, 71.8 mmol). The reaction mixture was stirred at room temperature for 30 min, then filtered through Celite. The filtrate was concentrated under reduced pressure, and the residue was suspended in water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic phase was concentrated under reduced pressure to afford ethyl 4-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (18.0 g, 87%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.17 (s, 1H), 8.78 (s, 1H), 8.28 (d, <i>J</i> = 8.4 Hz, 2H), 8.09 (d, <i>J</i> = 8.0 Hz, 2H), 7.94 (s, 1H), 4.34 (q, <i>J</i> = 7.2 Hz, 2H), 1.35 (t, <i>J</i> = 7.2 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> 345 [C<sub>15</sub>H<sub>12</sub>BrN<sub>3</sub>O<sub>2</sub>]<sup>+</sup></div></div><div id="sec8_4_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> Step 3: 4-(3-Bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic Acid (<b>12</b>)</h5><div class="NLM_p last">To a solution of ethyl 4-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (27.0 g, 77.9 mmol) in a mixture of THF (300 mL) and CH<sub>3</sub>OH (100 mL) were added LiOH (26.0 g, 623 mmol) and water (100 mL). The reaction mixture was stirred for 5 h at room temperature and then concentrated under reduced pressure. The residue was diluted with water (200 mL) and was acidified with an aqueous solution of HCl until pH 3. The precipitate was isolated by filtration and dried to afford 4-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic acid (14.0 g, 56%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 9.17 (s, 1H), 8.68 (s, 1H), 8.25 (d, <i>J</i> = 8.4 Hz 2H), 8.09 (d, <i>J</i> = 8.0 Hz, 2H), 7.99 (s, 1H); MS (ESI) <i>m</i>/<i>z</i> 316 [C<sub>13</sub>H<sub>8</sub>BrN<sub>3</sub>O<sub>2</sub>]<sup>+</sup>.</div></div><div id="sec8_4_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> Step 4: (4-(3-Bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (<b>15</b>)</h5><div class="NLM_p last"><i>N</i>-Methylmorpholine (4.8 mL, 44.0 mmol), HATU (12.5 g, 33 mmol) and <i>N</i>-methylpiperazine (3.6 mL, 33 mmol) were added to a solution of 4-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic acid (7.0 g, 22 mmol) in DMF (70 mL). The resulting reaction mixture was stirred at room temperature for 10 h. The reaction mixture was diluted with water, and the precipitate was isolated by filtration to afford (4-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (6.0 g, 68%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 9.15 (d, <i>J</i> = 1.2 Hz, 1H), 8.44–8.43 (d, <i>J</i> = 1.2 Hz, 1H), 8.05 (d, <i>J</i> = 8.0 Hz, 2H), 7.83 (s, 1H), 7.57 (d, <i>J</i> = 8.0 Hz, 2H), 3.85 (bs, 2H), 3.51 (bs, 2H), 2.53 (bs, 2H), 2.41 (bs, 2H), 2.35 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 400 [C<sub>18</sub>H<sub>18</sub>BrN<sub>5</sub>O ]<sup>+</sup>.</div></div></div><div id="sec8_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (4-(3-Iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (<b>16</b>)</h4><div id="sec8_4_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> Step 1: Ethyl 4-(3-Iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (<b>11</b>)</h5><div class="NLM_p last">To a solution of ethyl 4-(imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (8.00 g, 29.9 mmol) in DMF (200 mL) was added <i>N</i>-iodosuccinimide (8.10 g, 36.0 mmol), and the mixture was heated at 60 °C for 2 h and then poured into ice water. The precipitate was isolated by filtration and dried to afford ethyl 4-(3-iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (11 g, 94%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.13 (s, 1H), 8.80 (s, 1H), 8.29 (d, <i>J</i> = 8.4 Hz, 2H), 8.07 (d, <i>J</i> = 8.4 Hz, 2H), 8.00 (s, 1H), 4.37–4.31 (m, 2H), 1.34 (t, <i>J</i> = 7.2 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> 393 [C<sub>15</sub>H<sub>12</sub>IN<sub>3</sub>O<sub>2</sub>]<sup>+</sup>.</div></div><div id="sec8_4_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> Step 2: 4-(3-Iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic Acid (<b>13</b>)</h5><div class="NLM_p last">A solution of ethyl 4-(3-iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (11 g, 30.5 mmol) and LiOH·H<sub>2</sub>O (5.00 g, 121 mmol) in THF/CH<sub>3</sub>OH/H<sub>2</sub>O (200/50/50 mL) was stirred at room temperature for 12 h. The reaction mixture was concentrated under reduced pressure to a smaller volume. The residue was diluted with water (20 mL) and acidified with an aqueous solution of HCl until pH 2. The precipitate was isolated by filtration and dried to afford 4-(3-iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic acid (8.00 g, 72%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.12 (s, 1H), 8.78 (s, 1H), 8.26 (d, <i>J</i> = 8.4 Hz, 2H), 8.06 (d, <i>J</i> = 8.4 Hz, 2H), 8.05 (s, 1H); MS (ESI) <i>m</i>/<i>z</i> 366 [C<sub>13</sub>H<sub>8</sub>IN<sub>3</sub>O<sub>2</sub>+H]<sup>+</sup>.</div></div><div id="sec8_4_6_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> Step 3: (4-(3-Iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (<b>16</b>)</h5><div class="NLM_p last"><i>N</i>-Methylmorpholine (12 mL, 109.1 mmol), HATU (26.6 g, 77.84 mmol), and <i>N</i>-methylpiperazine (8.6 mL, 77.5 mmol) were added sequentially to a solution of 4-(3-iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic acid (19.0 g, 52.03 mmol) in DMF (170 mL). The resulting mixture was stirred under nitrogen at room temperature for 3 h and diluted with water (200 mL). The precipitate was isolated by filtration and was dried to afford (4(4-(3-iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (16.0 g, 70%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 9.15 (d, <i>J</i> = 1.2 Hz, 1H), 8.44 (d, <i>J</i> = 1.2 Hz, 1H), 8.05 (d, <i>J</i> = 8.0 Hz, 2H), 7.83 (s, 1H), 7.57 (d, <i>J</i> = 8.0 Hz, 2H), 3.85 (bs, 2H), 3.51 (bs, 2H), 2.53 (bs, 2H), 2.41 (bs, 2H), 2.35 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.14, 162.81, 142.88, 142.85, 142.75, 138.95, 137.45, 136.47, 127.99, 126.81, 116.56, 70.28, 54.98, 46.01, 36.26, 31.25; MS (ESI) <i>m</i>/<i>z</i> 447 [C<sub>18</sub>H<sub>18</sub>IN<sub>5</sub>O ]<sup>+</sup>.</div></div></div><div id="sec8_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (<b>19</b>)</h4><div id="sec8_4_7_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> Step 1: 4-(3-Bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (<b>14</b>)</h5><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure D starting from 4-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic acid (0.5 g, 1.57 mmol) and a 7 N solution of ammonia in THF (0.7 mL, 4.9 mmol). The residue was purified by flash column chromatography (silica gel, eluent CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 90:10) to afford 4-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (0.2 g, 40%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.16 (s, 1H), 8.80 (s, 1H), 8.08 (d, <i>J</i> = 8.0 Hz, 2H), 7.88 (s, 1H), 7.56 (d, <i>J</i> =  8.4 Hz, 2H); MS (ESI) <i>m</i>/<i>z</i> 317 [C<sub>13</sub>H<sub>9</sub>BrN<sub>4</sub>O]<sup>+</sup>.</div></div><div id="sec8_4_7_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> Step 2: 4-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (<b>19</b>)</h5><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure B with 4-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (0.5 g, 1.58 mmol) and 4-hydroxyphenylboronic acid (0.44, 3.16 mmol) as starting materials. The reaction crude product was purified by flash column chromatography (silica gel, eluent CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 85:15) and by preparative HPLC to afford 4-(3-(4-hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzamide (100 mg, 19%, AUC HPLC 98%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.20 (s, 1H), 8.85 (s, 1H), 8.12 (d, <i>J</i> = 8.0 Hz, 2H), 7.97 (d, <i>J</i> = 8.4 Hz, 2H), 7.92 (s, 1H), 7.56 (d, <i>J</i> =  8.4 Hz, 2H), 7.40 (bs, 1H), 6.91 (d, <i>J</i> = 8.4 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 166.90, 159.05, 142.21, 139.15, 138.45, 136.99, 133.74, 133.31, 128.86, 127.38, 127.35, 125.34, 116.15, 115.98, 113.30; MS (ESI) <i>m</i>/<i>z</i> 331 [C<sub>19</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub>+H]<sup>+</sup>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0018.gif" alt="" id="fx5" /></img></div></div></div><div id="sec8_4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Compounds <b>20</b>–<b>24</b></h4><div class="NLM_p">These compounds were prepared in a fashion similar to that described in general procedure B to afford the desired product after purification by flash column chromatography through silica gel. The details are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>, and their characterization data follow.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Purification Eluent, Yield, and Purity for Compounds <b>20</b>–<b>24</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">purification eluent</th><th class="colsep0 rowsep0" align="center">amount (yield, purity)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">4-OH</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 95:5</td><td class="colsep0 rowsep0" align="left">30 mg (19%, >99%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-hexane/EtOAc 60:40</td><td class="colsep0 rowsep0" align="left">60 mg (25%, >99%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">2-OH</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 98:2</td><td class="colsep0 rowsep0" align="left">15 mg (15%, 96.8%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">3-OH</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 95:5</td><td class="colsep0 rowsep0" align="left">60 mg (9%, 98.5%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>n</i>-hexane/EtOAc 30:70</td><td class="colsep0 rowsep0" align="left">50 mg (50%, >99%</td></tr></tbody></table></div></div><div id="sec8_4_7_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> (4-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (<b>20</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 9.21 (s, 1H), 8.54 (s, 1H), 7.96 (d, <i>J</i> = 8.4 Hz, 2H), 7.83 (s, 1H), 7.54 (d, <i>J</i> = 8.4 Hz, 2H), 7.43 (d, <i>J</i> = 8.4 Hz, 2H), 7.06 (d, <i>J</i> = 8.8 Hz, 2H), 3.86 (bs, 2H), 3.51 (bs, 2H), 2.53 (bs, 2H), 2.41 (bs, 2H), 2.35 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 168.07, 157.49, 142.24, 139.20, 137.14, 136.86, 135.10, 133.86, 128.95, 127.04, 126.83, 125.62, 117.39, 115.63, 113.09, 53.86, 46.44, 44.90, 40.70, 37.41; MS (ESI) <i>m</i>/<i>z</i> 414 [C<sub>24</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub>+H]<sup>+</sup>.</div></div><div id="sec8_4_7_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> (4-Methylpiperazin-1-yl)(4-(3-phenylimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)methanone (<b>21</b>)</h5><div class="NLM_p last">Mp: 222.9–223.9 °C, <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 9.25 (s, <i>J</i> = 1.2 Hz, 1H), 8.44 (s, 1H), 8.06 (d, <i>J</i> = 8.0 Hz, 2H), 7.83 (s, 1H), 7.58–7.56 (m, 4H), 7.50 (d, 3H) 3.85 (bs, 4H), 3.51 (bs, 4H), 2.41 (bs, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.14, 143.46, 140.70, 138.47, 137.84, 136.26, 135.80, 129.92, 129.21, 128.35, 128.05, 127.90, 127.78, 126.75, 116.11, 114.40, 54.85, 47.58, 46.01, 41.92; MS (ESI) <i>m</i>/<i>z</i> 398 [C<sub>24</sub>H<sub>23</sub>N<sub>5</sub>O+H]<sup>+</sup>.</div></div><div id="sec8_4_7_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> (4-(3-(2-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (<b>22</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 9.24 (s, 1H), 9.09 (s, 1H), 8.85 (s, 1H), 8.14 (d, <i>J</i> = 8.8 Hz, 2H), 7.99 (s, 1H), 7.62–7.56 (q, <i>J</i> = 8.4 Hz, 4H), 6.99 (d, 2H), 3.84 (bs, 4H), 3.15 (s, 4H), 2.31 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.14, 155.58, 142.83, 140.41, 138.01, 137.27, 136.14, 136.06, 131.86, 131.15, 128.01, 126.45, 126.31, 120.15, 116.87, 116.55, 114.914, 54.78, 47.55, 47.93, 45.93, 41.92. ; MS (ESI) <i>m</i>/<i>z</i> 414 [C<sub>24</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub>+H] <sup>+</sup>.</div></div><div id="sec8_4_7_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> (4-(3-(3-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (<b>23</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ (ppm): 9.15 (s, 1H), 8.74 (s, 1H), 8.06 (d, <i>J</i> = 8.0 Hz, 2H), 7.83 (s, 1H), 7.58–7.56 (m, 3H), 7.50 (d, 3H) 3.85 (bs, 4H), 3.51 (bs, 4H), 2.31 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 414 [C<sub>24</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub>+H] <sup>+</sup>.</div></div><div id="sec8_4_7_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> (4-Methylpiperazin-1-yl)(4-(3-<i>p</i>-tolylimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)methanone (<b>24</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.25 (s, 1H), 8.10 (s, 1H), 7.93–7.91 (d, <i>J</i> = 8.4 Hz, 2H), 7.83 (s, 1H), 7.51–7.47 (m, 4H), 7.41–7.40 (d, <i>J</i> = 8.8 Hz, 2H), 7.25 (s, 1H), 3.85 (bs, 1H), 3.50 (s, 4H), 2.55 (bs, 2H), 2.32 (s, 3H), 2.25 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.13, 143.41, 140.58, 138.81, 138.36, 137.86, 136.24, 135.48, 130.46, 128.31, 127.90, 127.83, 126.71, 125.12, 114.32, 54.84, 47.54, 46.03, 41.95, 21.40; MS (ESI) <i>m</i>/<i>z</i> 411.5 [C<sub>25</sub>H<sub>25</sub>N<sub>5</sub>O+H]<sup>+</sup></div></div></div><div id="sec8_4_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 4-(6-(4-(4-Methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzoic Acid (<b>25</b>)</h4><div id="sec8_4_7_9_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> Step 1: Ethyl 4-(6-(4-(4-Methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzoate</h5><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure B starting from (4-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (1.00 g, 2.5 mmol) and 4-(ethoxycarbonyl)phenylboronic acid (970 mg, 5.0 mmol). The reaction crude product was purified by flash column chromatography (silica gel, eluent CHCl<sub>3</sub>/MeOH 94:6) to afford ethyl 4-(6-(4-(4-methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzoate (600 mg, 55%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ (ppm) 9.28–9.27 (d, <i>J</i> = 1.2 Hz, 1H), 8.64–8.64 (d, <i>J</i> = 1.2 Hz, 1H), 8.29–8.27 (d, <i>J</i> = 8.0 Hz, 2H), 7.99–7.98 (d, <i>J</i> = 2.0 Hz, 2H), 7.96 (s, 1H), 7.74–7.72 (d, <i>J</i> = 8.4 Hz, 2H), 7.55–7.53 (d, <i>J</i> = 8.4 Hz, 2H), 4.48–4.43 (q, <i>J</i> = 7.2 Hz, 2H), 3.84 (bs, 2H), 3.50 (bs, 2H), 2.53 (bs, 2H), 2.39 (bs, 2H), 2.35 (s, 3H), 1.47–1.44 (t, <i>J</i> = 7.2 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> 470 [C<sub>27</sub>H<sub>27</sub>N<sub>5</sub>O<sub>3</sub>+H]<sup>+</sup>.</div></div><div id="sec8_4_7_9_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> Step 2: 4-(6-(4-(4-Methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzoic Acid (<b>25</b>)</h5><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure C starting from ethyl 4-(6-(4-(4-methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzoate (600 mg, 1.28 mmol) to afford the 4-(6-(4-(4-methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzoic acid as a solid (450 mg, 80%, AUC HPLC 97.1%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.28 (s, 1H), 9.01 (s, 1H), 8.17–8.11 (m, 5H), 7.94–7.92 (d, <i>J</i> = 8.0 Hz, 2H), 7.50–7.48 (d, <i>J</i> = 8.0 Hz, 2H), 3.61 (bs, 4H), 2.32 (bs, 4H), 2.19 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.23, 167.36, 143.57, 141.09, 138.71, 137.93, 136.65, 135.91, 132.26, 130.95, 130.75, 128.21, 127.97, 126.97, 126.89, 114.83, 53.746, 42.02, 12.67; MS (ESI) <i>m</i>/<i>z</i> 440 [C<sub>25</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub>+H ]<sup>+</sup>.</div></div></div><div id="sec8_4_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> <i>N</i>-Hydroxy-4-(6-(4-(4-methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzamide (<b>26</b>)</h4><div id="sec8_4_7_10_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> Step 1: 4-(6-(4-(4-Methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)-<i>N</i>-((tetrahydro-2<i>H</i>-pyran-2-yl)oxy)benzamide</h5><div class="NLM_p last">To a solution of 4-(6-(4-(4-methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzoic acid (50 mg, 0.113 mmol) in a mixture of CH<sub>2</sub>Cl<sub>2</sub> (3 mL) and DMF (1 mL) was added sequentially DIPEA (83 μL, 0.48 mmol), HOBt (32 mg, 0.24 mmol), EDCI·HCl (45 mg, 0.24 mmol), and <i>O</i>-(tetrahydro-2<i>H</i>-pyran-2-yl)hydroxylamine (26 mg, 0.23 mmol). The reaction mixture was stirred at room temperature under inert atmosphere for 12 h, diluted with H<sub>2</sub>O (3 mL), and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 10 mL). The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude residue was purified by flash column chromatography to afford 4-(6-(4-(4-methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)-<i>N</i>-((tetrahydro-2<i>H</i>-pyran-2-yl)oxy)benzamide (44.6 mg, 73%, AUC HPLC 94.5%) as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 11.81 (bs, 1H), 9.30 (s, 1H), 9.00 (s, 1H), 8.19 (s, 1H), 8.16 (d, <i>J</i> = 12 Hz, 2H), 7.99 (dd, <i>J</i> = 10.6, 8.3 Hz, 4H), 7.51 (d, <i>J</i> = 12 Hz, 2H), 5.08–5.04 (m, 1H), 4.13–4.06 (m, 1H), 3.70–3.53 (m, 3H), 3.45–3.25 (m, 2H), 2.43–2.27 (m, 4H), 2.22 (s, 3H), 1.79–1.73 (m, 3H), 1.63–1.53 (m, 3H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.1, 164.0, 143.5, 141.0, 138.6, 137.7, 136.3, 132.4, 131.1, 128.7, 128.1, 127.8, 127.0, 126.8, 114.6, 101.5, 61.8, 54.9, 46.0, 28.3, 25.1, 18.7; MS (ESI) <i>m</i>/<i>z</i> 541 [C<sub>30</sub>H<sub>32</sub>N<sub>6</sub>O<sub>4</sub>+H]<sup>+</sup>.</div></div><div id="sec8_4_7_10_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> Step 2: <i>N</i>-Hydroxy-4-(6-(4-(4-methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzamide (<b>26</b>)</h5><div class="NLM_p last">To a solution of 4-(6-(4-(4-methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)-<i>N</i>-((tetrahydro-2<i>H</i>-pyran-2-yl)oxy)benzamide (10 mg, 0.018 mmol) in a mixture of CH<sub>3</sub>CN/MeOH (1:1, 0.6 mL) was added a 1 M aqueous solution of HCl (110 μL, 0.11 mmol) at room temperature. The reaction mixture was stirred for 4 h and was concentrated <i>in vacuo.</i> The residue was diluted with hexane, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to dryness under reduced pressure to yield the <i>N</i>-hydroxy-4-(6-(4-(4-methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzamide as a hydrochloride salt (5.3 mg, 63%, AUC HPLC > 99%), light yellow solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 11.39 (bs, 1H), 9.35 (s, 1H), 9.04 (s, 1H), 8.26 (s, 1H), 8.20 (d, <i>J</i> = 8.4 Hz, 2H), 8.00 (d, <i>J</i> = 7.8 Hz, 2H), 7.95 (d, <i>J</i> = 8.4 Hz, 2H), 7.59 (d, <i>J</i> = 8.4 Hz, 2H), 4.39–3.60 (m, 6H), 3.05–3.15 (m, 2H), 2.77 (s, 3H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 168.8, 163.3, 142.5, 139.6, 138.4, 137.5, 134.7, 134.5, 132.6, 129.7, 127.8, 127.7, 127.6, 126.7, 126.4, 114.4, 51.8, 41.9; MS (ESI) <i>m</i>/<i>z</i> 457 [C<sub>25</sub>H<sub>24</sub>N<sub>6</sub>O<sub>3</sub>+H]<sup>+</sup>.</div></div></div><div id="sec8_4_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 4-(6-(4-(4-Methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzonitrile (<b>27</b>)</h4><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure B starting from (4-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (200 mg, 0.50 mmol) and 4-cyanophenylboronic acid (110 mg, 0.75 mmol). The reaction crude product was purified by flash column chromatography (silica gel, eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95:5 to 90:10) to afford 4-(6-(4-(4-methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzonitrile (154.7 mg, 73%, AUC HPLC > 99%) as a yellow solid, mp: 223.9–225.1 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.31 (s, 1H), 9.04 (s, 1H), 8.25 (s, 1H), 8.16 (d, <i>J</i> = 8.1 Hz, 2H), 8.11–8.04 (m, 4H), 7.51 (d, <i>J</i> = 8.1 Hz, 2H), 3.63 (bs, 2H), 3.46–3.20 (m, 2H), 2.32 (bs, 4H), 2.20 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 168.04, 142.47, 140.18, 137.77, 136.63, 136.07, 135.32, 132.61, 131.74, 127.76, 126.79, 125.80, 125.21, 118.08, 113.92, 110.09, 53.743, 46.44, 44.93, 40.87; MS (ESI) <i>m</i>/<i>z</i> 423 [C<sub>25</sub>H<sub>22</sub>N<sub>6</sub>O+H]<sup>+</sup>.</div></div><div id="sec8_4_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> (4-(3-(4-Chlorophenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (<b>28</b>)</h4><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure B starting from (4-(3-iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (150 mg, 0.34 mmol) and 4-chlorophenylboronic acid (79 mg, 0.50 mmol). The reaction crude product was purified by flash column chromatography (silica gel, eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95:5 to 90:10) to afford (4-(3-(4-chlorophenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (128.4 mg, 66%, AUC HPLC > 99%) as a yellow solid, mp: 208.0–208.5 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 9.24 (d, <i>J</i> = 1.4 Hz, 1H), 8.54 (d, <i>J</i> = 1.4 Hz, 1H), 7.95 (d, <i>J</i> = 8.4 Hz, 2H), 7.89 (s, 1H), 7.60–7.55 (m, 4H), 7.52 (d, <i>J</i> = 8.4 Hz, 2H), 3.82 (bs, 2H), 3.49 (s, 2H), 2.50–2.33 (m, 7H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ (ppm) 169.78, 143.84, 140.70, 139.63, 137.76, 136.14, 135.34, 135.33, 129.98, 129.36, 127.84, 126.45, 126.41, 126.24, 112.54, 55.27, 54.79, 46.03; MS (ESI) <i>m</i>/<i>z</i> 432 [C<sub>24</sub>H<sub>22</sub>ClN<sub>5</sub>O+H]<sup>+</sup>.</div></div><div id="sec8_4_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> (4-methylpiperazin-1-yl)(4-(3-(4-(trifluoromethyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)methanone (<b>29</b>)</h4><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure B starting from (4-(3-iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (200 mg, 0.45 mmol) and 4-(trifluoromethyl)phenylboronic acid (101 mg, 0.54 mmol). The reaction crude product was purified by column chromatography (silica gel, eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95:5 to 90:10) to afford (4-methylpiperazin-1-yl)(4-(3-(4-(trifluoromethyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)methanone (150 mg, 72%, AUC HPLC 97%) as a yellow solid, mp: 190.5–191.5 °C. <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ (ppm): 9.18 (s, 1H), 8.91 (s, 1H), 8.11 (d, <i>J</i> = 8.20 Hz, 2H), 8.08 (s, 1H), 8.00 (d, <i>J</i> = 8.2 Hz, 2H), 7.94 (d, <i>J</i> = 8.2 Hz, 2H), 7.54 (d, <i>J</i> = 8.3 Hz, 2H), 3.81 (bs, 2H), 3.54 (bs, 2H), 2.55–2.47 (m, 4H), 2.36 (s, 3H); <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ (ppm) 172.00, 143.96, 142.16, 140.93, 139.31, 136.90, 136.43, 132.89 (q, <i>J</i> = 1.3 Hz), 131.85 (q, <i>J</i> = 32.4 Hz), 129.77, 128.75, 128.19, 127.90, 127.57, 125.52 (q, <i>J</i> = 269.6 Hz), 115.24, 45.99; MS (ESI) <i>m</i>/<i>z</i> 466 [C<sub>25</sub>H<sub>22</sub>F<sub>3</sub>N<sub>5</sub>O+H]<sup>+</sup>.</div></div><div id="sec8_4_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> (4-(3-(4-(Difluoromethyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (<b>30</b>)</h4><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure B starting from (4-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (200 mg, 0.5 mmol) and 2-(4-(difluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (317 mg, 1.25 mmol). The reaction crude product was purified by flash column chromatography (silica gel, eluent CHCl<sub>3</sub>/MeOH 96.5:3.5%) and by preparative HPLC to give (4-(3-(4-(difluoromethyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone (50 mg, 23%, AUC HPLC > 99%) as an off-white solid; mp: 73–86 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 9.26 (s, 1 H), 8.60 (s, 1H), 7.96–7.94 (m, 3H), 7.77–7.71 (m, 4H), 7.52 (d, <i>J</i> = 8.0 Hz, 2H), 6.76 (t, <i>J</i> = 5.6 Hz, 1H), 3.82 (bs, 2H), 3.47 (bs, 2H), 2.51 (bs, 2H), 2.34 (bs, 2H), 2.33 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.13, 143.50, 140.93, 138.64, 137.75, 136.37, 136.31, 134.40 (t, <i>J</i> = 22.33, CF<sub>2</sub>H), 130.62, 128.66, 127.86, 127.28, 127.22, 127.16, 126.92, 126.81, 117.55, 115.20, 114.65, 112.86, 55.00, 47.59, 46.03, 41.93; MS (ESI) <i>m</i>/<i>z</i> 448.46 [C<sub>25</sub>H<sub>23</sub>F<sub>2</sub>N<sub>5</sub>O+H]<sup>+</sup>.</div></div><div id="sec8_4_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 4-(6-(4-(4-Methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzamide (<b>31</b>)</h4><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure B starting from (4-(3-iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone and 4-carbamoylphenylboronic acid (110.6 mg, 0.671 mmol). The reaction crude product was purified by flash column chromatography (silica gel, eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH 90:10) to afford 4-(6-(4-(4-methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzamide (189 mg, 96%, AUC HPLC 96%) as a light brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.29 (d, <i>J</i> = 1.2 Hz, 1H), 9.01 (d, <i>J</i> = 1.2 Hz, 1H), 8.18–8.09 (m, 6H), 7.95 (d, <i>J</i> = 8.4 Hz, 2H), 7.52–7.50 (m, 3H), 3.63–3.31 (m, 4H), 2.35 (bs, 4H), 2.22 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 441 [C<sub>25</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub>+H]<sup>+</sup>.</div></div><div id="sec8_4_7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> (4-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(morpholino)methanone (<b>32</b>)</h4><div id="sec8_4_7_16_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> Step 1: (4-(3-Bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(morpholino)methanone (<b>17</b>)</h5><div class="NLM_p last">To a solution of 4-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic acid (8.00 g, 25.14 mmol) in DMF (70 mL), were sequentially added <i>N</i>-methylmorpholine (5.5 mL, 50.28 mmol), HATU (14.4 g, 37.71 mmol), and morpholine (3.32 mL, 37.71 mmol). The reaction mixture was stirred at room temperature for 3 h under nitrogen, then diluted with water (50 mL). The precipitate was isolated by filtration and dried to afford (4-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(morpholino)methanone (6.40 g, 66%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 9.15 (d, <i>J</i> = 1.2 Hz, 1H), 8.44 (d, <i>J</i> = 1.2 Hz, 1H), 8.05 (d, <i>J</i> = 8.0 Hz, 2H), 7.83 (s, 1H), 7.57 (d, <i>J</i> = 8.0 Hz, 2H), 3.85 (bs, 2H), 3.51 (bs, 2H), 2.53 (bs, 2H), 2.41 (bs, 2H); MS (ESI) <i>m</i>/<i>z</i> 387 [C<sub>17</sub>H<sub>15</sub>BrN<sub>4</sub><i>O</i><sub>2</sub>+H]<sup><i>+</i></sup>.</div></div><div id="sec8_4_7_16_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i87" class="anchor-spacer"></div><h5 class="article-section__title" id="_i87"> Step 2: (4-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(morpholino)methanone (<b>32</b>)</h5><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure B starting from (4-(3-bromoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(morpholino)methanone and 4-hydroxyphenylboronic acid. The reaction crude product was purified by flash column chromatography (silica gel, eluent CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 95:5) to afford (4-(3-(4-hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(morpholino)methanone (150 mg, 32%, AUC HPLC 97.6%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ (ppm): 9.88 (s, 1H), 9.21 (s, 1H), 8.83 (s, 1H), 8.11 (d, <i>J</i> = 8.0 Hz, 2H), 7.94 (s, 1H), 7.61 (d, <i>J</i> = 8.4 Hz, 2H), 7.51 (d, <i>J</i> = 8.4 Hz, 2H), 6.97 (d, <i>J</i> = 8.4 Hz, 2H), 3.60 (bs, 8H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 168.20, 157.48, 142.25, 139.21, 137.12, 136.97, 134.74, 133.87, 128.95, 127.04, 126.97, 126.87, 125.62, 117.40, 115.63, 113.12, 65.49, 47.14, 41.49; MS (ESI) <i>m</i>/<i>z</i> 401 [C<sub>23</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub>+H]<sup>+</sup>.</div></div></div><div id="sec8_4_7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 4-(6-(4-(Morpholine-4-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzonitrile (<b>33</b>)</h4><div id="sec8_4_7_17_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i89" class="anchor-spacer"></div><h5 class="article-section__title" id="_i89"> Step 1: (4-(3-Iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(morpholino)methanone (<b>18</b>)</h5><div class="NLM_p last"><i>N</i>-Methylmorpholine (3.0 mL, 7.5 mmol), HATU (7.5 g, 27 mmol), and morpholine (1.26 g, 14.85 mmol) were added sequentially to a solution of 4-(3-iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic acid (5.0 g, 3.25 mmol) in DMF (10 mL), and the resulting mixture was stirred at room temperature for 3 h under nitrogen. The reaction mixture was diluted with water (50 mL), and the precipitate was isolated by filtration and dried to afford (4-(3-iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(morpholino)methanone (2.0 g, 65%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 9.10 (s, 1H), 8.50 (s, 1H), 8.10 (d, 2H), 7.90 (s, 1H), 7.60 (d, 2H), 3.4–3.9 (m, 8H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.23, 142.84, 142.74, 138.90, 137.54, 136.09, 130.28, 128.12, 126.78, 116.57, 70.31, 66.57, 48.13, 42.55; MS (ESI) <i>m</i>/<i>z</i> 434 [C<sub>17</sub>H<sub>15</sub>IN<sub>4</sub>O<sub>2</sub>+H]<sup>+</sup>.</div></div><div id="sec8_4_7_17_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i90" class="anchor-spacer"></div><h5 class="article-section__title" id="_i90"> Step 2: 4-(6-(4-(Morpholine-4-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzonitrile (<b>33</b>)</h5><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure B starting from (4-(3-iodoimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)(morpholino)methanone (200 mg, 0.52 mmol) and 4-cyanophenylboronic acid. The reaction crude product was purified by flash column chromatography (silica gel, eluent DCM/MeOH 95:5) to afford 4-(6-(4-(morpholine-4-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzonitrile (100 mg, 53%, AUC HPLC 95%) as a yellow solid; mp: 238.2–239.5 °C. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ (ppm): 9.17 (d, <i>J</i> = 0.7 Hz, 1H), 8.55 (d, <i>J</i> = 1.0 Hz, 1H), 7.95–7.86 (m, 3H), 7.80 (d, <i>J</i> = 8.3 Hz, 2H), 7.72 (d, <i>J</i> = 8.3 Hz, 2H), 7.43 (d, <i>J</i> = 8.2 Hz, 2H), 3.88–3.22 (m, 8H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.24, 143.55, 141.25, 138.81, 137.80, 137.15, 136.02, 133.68, 132.81, 128.82, 128.01, 126.86, 126.28, 119.16, 115.01, 111.16, 66.554, 48.15, 42.53; MS (ESI) <i>m</i>/<i>z</i> 410 [C<sub>24</sub>H<sub>19</sub>N<sub>5</sub>O<sub>2</sub>+H]<sup>+</sup>.</div></div></div><div id="sec8_4_7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 1-(4-(4-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoyl)piperazin-1-yl)ethanone (<b>36</b>)</h4><div id="sec8_4_7_18_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i92" class="anchor-spacer"></div><h5 class="article-section__title" id="_i92"> Step 1: Ethyl 4-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (<b>34a</b>)</h5><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure B starting from 4-(6-bromoimidazo[1,2-<i>a</i>]pyrazin-3-yl)phenol (3.00 g, 10.3 mmol) and 4-(ethoxycarbonyl)phenylboronic acid (2.20 g, 11.3 mmol). The residue was purified by flash column chromatography (silica gel, eluent CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 97:3) to afford ethyl 4-(3-(4-hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (600 mg, 16%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.87 (s, 1H), 9.22 (s, 1H), 8.89 (s, 1H), 7.95 (s, 1H), 7.80 (s, 1H), 7.73 (s, 1H), 7.61 (d, <i>J</i> = 8.0 Hz, 4H), 6.98 (d, <i>J</i> = 8.0 Hz, 2H), 4.34 (q, <i>J</i> = 7.2 Hz, 2H), 1.35 (t, <i>J</i> = 7.2 Hz, 3H); MS (ESI), <i>m</i>/<i>z</i> 360.3 [C<sub>21</sub>H<sub>17</sub>N<sub>3</sub>O<sub>3</sub>+H]<sup>+</sup>.</div></div><div id="sec8_4_7_18_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i93" class="anchor-spacer"></div><h5 class="article-section__title" id="_i93"> Step 2: 4-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic Acid (<b>35a</b>)</h5><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure C starting from ethyl 4-(3-(4-hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (600 mg, 1.60 mmol) to afford 4-(3-(4-hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic acid (100 mg, 20%) as a light yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.91 (s, 1H), 9.23 (s, 1H), 8.89 (s, 1H), 7.97 (s, 1H), 7.78 (s, 1H), 7.73 (d, <i>J</i> = 8.0 Hz, 2H), 7.61 (d, <i>J</i> = 8.0 Hz, 2H), 6.98 (d, <i>J</i> = 8.0 Hz, 2H); MS (ESI), <i>m</i>/<i>z</i> 332.3 [C<sub>19</sub>H<sub>13</sub>N<sub>3</sub>O<sub>3</sub>+H]<sup>+</sup>.</div></div><div id="sec8_4_7_18_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i94" class="anchor-spacer"></div><h5 class="article-section__title" id="_i94"> Step 3: 1-(4-(4-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoyl)piperazin-1-yl)ethanone (<b>36</b>)</h5><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure D starting from 4-(3-(4-hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic acid (200 mg, 0.60 mmol) and 1-(piperazin-1-yl)ethanone (92 mg, 0.71 mmol). The precipitate was isolated by filtration and dried to afford 1-(4-(4-(3-(4-hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoyl)piperazin-1-yl)ethanone (103 mg, 38%, AUC HPLC 95.5%) as a yellow solid; mp: 199.9–200.7 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 9.90 (s, 1H), 9.20 (s, 1H), 8.85 (s, 1H), 8.13 (d, <i>J</i> = 8.0 Hz, 2H), 7.90 (s, 1H), 7.60 (d, <i>J</i> = 8.0 Hz, 2H), 7.52 (d, <i>J</i> = 8.0 Hz, 2H), 6.98 (d, <i>J</i> = 6.0 Hz, 2H), 3.40–3.70 (m, 8H), 2.10 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 168.36, 167.89, 157.49, 142.25, 139.22, 137.10, 137.02, 134.85, 133.88, 128.95, 127.05, 126.96, 125.63, 117.39, 115.63, 113.14, 44.87, 41.29, 40.11, 20.64; MS (ESI) <i>m</i>/<i>z</i> 442 [C<sub>25</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub>+H] <sup>+</sup>.</div></div></div><div id="sec8_4_7_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 4-(6-(4-(4-(Dimethylamino)piperidine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzonitrile (<b>37</b>)</h4><div id="sec8_4_7_19_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i96" class="anchor-spacer"></div><h5 class="article-section__title" id="_i96"> Step 1: 4-(6-Bromoimidazo[1,2-<i>a</i>]pyrazin-3-yl)benzonitrile (<b>7b</b>)</h5><div class="NLM_p last">To a solution of 3-bromo-6-iodoimidazo[1,2-<i>a</i>]pyrazine (6.0 g, 18.6 mmol), 4-cyanophenylboronic acid (3.67 g, 27.9 mmol), in 1,4-dioxane (100 mL), were successively added an aqueous solution of Na<sub>2</sub>CO<sub>3</sub> (4.0 g, 37.2 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (1.42 g, 13 mmol). The reaction mixture was heated at 90 °C for 3 h then, filtered through a short pad of Celite. The filtrate was concentrated under reduced pressure, and the residue was purified by flash column chromatography (silica gel, eluent <i>n</i>-hexane/EtOAc 50:50) to afford 4-(6-bromoimidazo[1,2-<i>a</i>]pyrazin-3-yl)benzonitrile (3.6 g, 67%) as a yellow solid which was used in next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.10 (s, 1H), 8.89 (s, 1H), 8.38 (s, 1H), 8.10–7.92 (m, 4H); MS (ESI), <i>m</i>/<i>z</i> 299.13 [C<sub>13</sub>H<sub>7</sub>BrN<sub>4</sub>]<sup>+</sup>.</div></div><div id="sec8_4_7_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i97" class="anchor-spacer"></div><h5 class="article-section__title" id="_i97"> Step 2: Ethyl 4-(3-(4-Cyanophenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (<b>34b</b>)</h5><div class="NLM_p last">A mixture of 4-(6-bromoimidazo[1,2-<i>a</i>]pyrazin-3-yl)benzonitrile (5.00 g, 16.7 mmol), 4-(ethoxycarbonyl)phenylboronic acid (4.90 g, 25.2 mmol), Na<sub>2</sub>CO<sub>3</sub> (4.40 g, 41.5 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (386 mg, 0.33 mmol) in H<sub>2</sub>O (5.00 mL) and DMF (100 mL) was heated at 90 °C for 2 h. The reaction mixture was diluted with water. The precipitate was isolated by filtration and dried under vacuum to afford ethyl 4-(3-(4-cyanophenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (2.80 g, 46%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.28 (s, 1H), 9.07 (s, 1H), 8.25 (s, 1H), 8.22 (d, <i>J</i> = 6.0 Hz, 2H), 8.08–8.02 (m, 6H), 4.38–4.33 (m, 2H), 1.36 (t, <i>J</i> = 7.2 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> 369 [C<sub>22</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub>+H]<sup>+</sup>.</div></div><div id="sec8_4_7_20_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i98" class="anchor-spacer"></div><h5 class="article-section__title" id="_i98"> Step 3: 4-(3-(4-Cyanophenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic Acid (<b>35b</b>)</h5><div class="NLM_p last">A mixture of ethyl 4-(3-(4-cyanophenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoate (2.80 g, 7.61 mmol) and LiOH·H<sub>2</sub>O (1.25 g, 30.5 mmol) in THF/CH<sub>3</sub>OH/H<sub>2</sub>O (50 mL/20 mL/20 mL) was stirred at room temperature for 12 h. The reaction mixture was concentrated under reduced pressure. The residue was diluted with water (20 mL) and an aqueous solution of HCl until pH 2. The precipitate was isolated by filtration and dried to afford 4-(3-(4-cyanophenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic acid (2.00 g, 80%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.30 (s, 1H), 9.08 (s, 1H), 8.22 (d, <i>J</i> = 9.6 Hz, 3H), 8.06–8.02 (m, 6H); MS (ESI) <i>m</i>/<i>z</i> 341 [C<sub>20</sub>H<sub>12</sub>N<sub>4</sub>O<sub>2</sub>+H]<sup>+</sup>.</div></div><div id="sec8_4_7_20_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i99" class="anchor-spacer"></div><h5 class="article-section__title" id="_i99"> Step 4: 4-(6-(4-(4-(Dimethylamino)piperidine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzonitrile (<b>37</b>)</h5><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure B starting from 4-(3-(4-cyanophenyl)imidazo[1,2-<i>a</i>]pyrazin-6-yl)benzoic acid (180 mg, 0.52 mmol) and <i>N,N</i>-dimethyl-4-aminopiperidine (1.5 equiv). The reaction crude product was purified by flash column chromatography (silica gel, eluent CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 96:4) to afford 4-(6-(4-(4-(dimethylamino)piperidine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyrazin-3-yl)benzonitrile (65 mg, 22%, AUC HPLC 96%) as an off-white solid, mp: 177.2–178.5 °C; <sup>1</sup>H NMR (400 MHz, DMSO) δ(ppm): 9.31 (d, <i>J</i> =  1.1 Hz, 1H), 9.04 (d, <i>J</i> =  1.1 Hz, 1H), 8.24 (s, 1H), 8.15 (d, <i>J</i> =  8.2 Hz, 2H), 8.10–8.00 (m, 4H), 7.50 (d, <i>J</i> =  8.2 Hz, 2H), 4.46 (bs, 1H), 3.65 (bs, 1H), 3.20–2.75 (m, 2H), 2.45–2.30 (m, 1H), 2.33 (s, 6H), 1.95–1.60 (m, 2H), 1.50–1.30 (m, 2H); MS (ESI) <i>m</i>/<i>z</i> 451.20 [C<sub>27</sub>H<sub>26</sub>N<sub>6</sub>O+H]<sup>+</sup>.</div></div></div><div id="sec8_4_7_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 4-(6-(4-(4-Methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>b</i>]pyridazin-3-yl)benzonitrile (<b>39</b>)</h4><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure B starting from 4-(6-chloroimidazo[1,2-<i>b</i>]pyridazin-3-yl)benzonitrile (200 mg, 0.785 mmol) and (4-(4-methylpiperazine-1-carbonyl)phenyl)boronic acid HCl salt (268 mg, 0.942 mmol). The residue was purified by flash column chromatography (silica gel, eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95:5 to 90:10) to afford 4-(6-(4-(4-methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>b</i>]pyridazin-3-yl)benzonitrile (91.2 mg, 43%, AUC HPLC 99%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 8.30 (d, <i>J</i> = 8.6 Hz, 2H), 8.23–8.21 (m, 2H), 8.06 (d, <i>J</i> = 8.4 Hz, 2H), 7.81 (d, <i>J</i> = 8.6 Hz, 2H), 7.66–7.61 (m, 3H), 7.31 (bs, 1H), 3.97–3.74 (m, 4H), 2.84 (bs, 4H), 2.56 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ (ppm): 169.57, 165.35, 151.41, 140.15, 137.01, 136.67, 134.25, 132.82, 132.60, 128.12, 127.49, 127.05, 126.70, 126.54, 118.75, 116.71, 111.15, 53.78, 44.43; MS (ESI) <i>m</i>/<i>z</i> 423 [C<sub>25</sub>H<sub>22</sub>N<sub>6</sub>O+H]<sup>+</sup>.</div></div><div id="sec8_4_7_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 4-(6-(4-(Morpholine-4-carbonyl)phenyl)imidazo[1,2-<i>b</i>]pyridazin-3-yl)benzonitrile (<b>40</b>)</h4><div class="NLM_p last">To a solution of 4-(6-chloroimidazo[1,2-<i>b</i>]pyridazin-3-yl)benzonitrile (150 mg, 0.59 mmol) in DMF (2.5 mL) and water (0.5 mL) under inert atmosphere were added Cs<sub>2</sub>CO<sub>3</sub> (384 mg, 1.18 mmol), morpholino(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone (279 mg, 0.88 mmol), and PdCl<sub>2</sub>(dppf) (86 mg, 0.118 mmol). The resulting mixture was heated in a microwave reactor at 140 °C for 30 min and then diluted with H<sub>2</sub>O (10 mL) and extracted with DCM (3 × 15 mL). The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude residue was purified by flash column chromatography (silica gel, eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95:5 to 90:10) to afford 4-(6-(4-(morpholine-4-carbonyl)phenyl)imidazo[1,2-<i>b</i>]pyridazin-3-yl)benzonitrile (72.1 mg, 35%, AUC HPLC 96%) as a yellow solid; mp: 263–266 °C; IR (neat) ν cm<sup>–1</sup>: 3096.85 (C–H), 2213.41 (C≡N), 1627.03 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 8.31–8.25 (m, 4H), 8.06–8.05 (m, 2H), 7.82–7.81 (m, 2H), 7.70–7.61 (m, 3H), 3.78–3.53 (m, 8H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ (ppm): 169.39, 151.86, 137.43, 136.45, 133.24, 132.63, 132.52, 128.14, 128.08, 127.47, 127.26, 126.86, 126.30, 118.66, 117.32, 111.39, 66.87, 48.21, 42.67; MS (ESI) <i>m</i>/<i>z</i> 410 [C<sub>24</sub>H<sub>19</sub>N<sub>5</sub>O<sub>2</sub>+H]<sup>+</sup>. Anal. Calculated for C<sub>24</sub>H<sub>19</sub>N<sub>5</sub>O<sub>2</sub>•0.75(H<sub>2</sub>O): C, 68.15; H, 4.89; N, 16.56. Found: C, 68.05; H, 4.63; N, 16.41.</div></div><div id="sec8_4_7_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 4-(6-(4-(Piperazine-1-carbonyl)phenyl)imidazo[1,2-<i>b</i>]pyridazin-3-yl)benzonitrile (<b>42</b>)</h4><div id="sec8_4_7_23_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i103" class="anchor-spacer"></div><h5 class="article-section__title" id="_i103"> Step 1: 4-(3-(4-Cyanophenyl)imidazo[1,2-<i>b</i>]pyridazin-6-yl)benzoic Acid (<b>41</b>)</h5><div class="NLM_p last">To a solution of 4-(6-chloroimidazo[1,2-<i>b</i>]pyridazin-3-yl)benzonitrile (484 mg, 1.9 mmol) in DMF (20 mL) and water (4 mL) under an inert atmosphere were added Cs<sub>2</sub>CO<sub>3</sub> (1.24 g, 3.8 mmol), 4-boronobenzoic acid (473 mg, 2.85 mmol), and Pd(dppf)<sub>2</sub>Cl<sub>2</sub> (278 mg, 0.38 mmol). The resulting mixture was heated at 90 °C for 18 h and then diluted with water (20 mL) and extracted with DCM (3 × 40 mL). The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95:5 to 90:10) to afford 4-(3-(4-cyanophenyl)imidazo[1,2-<i>b</i>]pyridazin-6-yl)benzoic acid (310 mg, 48%) as a brown solid, mp: 260.1–261.3 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.54 (s, 1H), 8.51 (d, <i>J</i> = 8.6 Hz, 2H), 8.40 (d, <i>J</i> = 9.6 Hz, 1H), 8.26 (d, <i>J</i> = 8.4 Hz, 2H), 8.13 (d, <i>J</i> = 8.4 Hz, 2H), 8.03 (d, <i>J</i> = 8.6 Hz, 2H), 8.02 (d, <i>J</i> = 9.6 Hz, 1H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 167.53, 151.29, 140.69, 138.86, 136.06, 133.37, 133.25, 130.47, 127.70, 127.19, 126.81, 126.48, 119.37, 117.53, 110.05. MS (ESI) <i>m</i>/<i>z</i> 341 [C<sub>20</sub>H<sub>12</sub>N<sub>4</sub>O<sub>2</sub>+H]<sup>+</sup>.</div></div><div id="sec8_4_7_23_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i104" class="anchor-spacer"></div><h5 class="article-section__title" id="_i104"> Step 2: 4-(6-(4-(Piperazine-1-carbonyl)phenyl)imidazo[1,2-<i>b</i>]pyridazin-3-yl)benzonitrile (<b>42</b>)</h5><div class="NLM_p">The title compound was prepared in a similar fashion as described in general procedure D starting from 4-(3-(4-cyanophenyl)imidazo[1,2-<i>b</i>]pyridazin-6-yl)benzoic acid (764 mg, 1.57 mmol) and <i>tert</i>-butyl piperazine-1-carboxylate (347 mg, 2.36 mmol) to afford the reaction crude product. MS (ESI) <i>m</i>/<i>z</i> 509 [C<sub>29</sub>H<sub>28</sub>N<sub>6</sub>O+H]<sup>+</sup>. The crude product was carried forth to the next step without further purification.</div><div class="NLM_p last">To a solution of <i>tert</i>-butyl 4-(4-(3-(4-cyanophenyl)imidazo[1,2-<i>b</i>]pyridazin-6-yl)benzoyl)piperazine-1-carboxylate (∼1.57 mmol) in DCM (1 mL) was added TFA (1 mL). The resulting mixture was stirred at room temperature for 18 h and concentrated under reduced pressure. The residue was purified by flash column chromatography to afford 4-(6-(4-(piperazine-1-carbonyl)phenyl)imidazo[1,2-<i>b</i>]pyridazin-3-yl)benzonitrile (200 mg, 31% over 2 steps, AUC HPLC 98%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ (ppm): 8.45 (d, <i>J</i> = 8.6 Hz, 2H), 8.34 (s, 1H), 8.26–8.22 (m, 3H), 7.95 (d, <i>J</i> = 9.6 Hz, 1H), 7.89 (d, <i>J</i> = 8.6 Hz, 2H), 7.71 (d, <i>J</i> = 8.4 Hz, 2H), 3.87 (bs, 4H), 3.27 (bs, 4H); <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ (ppm): 171.80, 152.88, 138.46, 137.54, 135.28, 134.19, 133.64, 129.23, 129.11, 128.72, 128.27, 127.85, 127.14, 119.70, 118.58, 112.00, 44.56; MS (ESI) <i>m</i>/<i>z</i> 409 [C<sub>24</sub>H<sub>20</sub>N<sub>6</sub>O+H]<sup>+</sup>.</div></div></div><div id="sec8_4_7_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> 4-(6-(4-(4-(Dimethylamino)piperidine-1-carbonyl)phenyl)imidazo[1,2-<i>b</i>]pyridazin-3-yl)benzonitrile (<b>45</b>)</h4><div id="sec8_4_7_24_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i106" class="anchor-spacer"></div><h5 class="article-section__title" id="_i106"> Step 1: (4-(3-Bromoimidazo[1,2-<i>b</i>]pyridazin-6-yl)phenyl)(4-(dimethylamino)piperidin-1-yl)methanone (<b>44</b>)</h5><div class="NLM_p last">To a solution of 4-(3-bromoimidazo[1,2-<i>b</i>]pyridazin-6-yl)benzoic acid (500 mg, 1.57 mmol) in DMF (5 mL) was added NMM (317 mg, 3.14 mmol) followed by HATU (754.7 mg, 2.35 mmol), and the solution was stirred for 30 min at room temperature prior to the addition of <i>N,N</i>-dimethylpiperidin-4-amine (221 mg, 1.72 mmol). The mixture was stirred for an additional 16 h. The reaction mixture was diluted with EtOAc and washed with water and brine. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude residue was purified by flash column chromatography (silica gel, eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95:5) to afford (4-(3-bromoimidazo[1,2-<i>b</i>]pyridazin-6-yl)phenyl)(4-(dimethylamino)piperidin-1-yl)methanone (350 mg, 52%) as an off-white solid. MS (ESI) <i>m</i>/<i>z</i> 429 [C<sub>20</sub>H<sub>22</sub>BrN<sub>5</sub>O+H]<sup>+</sup>.</div></div><div id="sec8_4_7_24_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i107" class="anchor-spacer"></div><h5 class="article-section__title" id="_i107"> Step 2: 4-(6-(4-(4-(Dimethylamino)piperidine-1-carbonyl)phenyl)imidazo[1,2-<i>b</i>]pyridazin-3-yl)benzonitrile (<b>45</b>)</h5><div class="NLM_p last">To a mixture of (4-(3-bromoimidazo[1,2-<i>b</i>]pyridazin-6-yl)phenyl)(4-(dimethylamino)piperidin-1-yl)methanone (350 mg, 0.817 mmol), 4-cyanophenylboronic acid (144 mg, 0.981 mmol), and K<sub>3</sub>PO<sub>4</sub> (346 mg, 1.63 mmol) in 1,4-dioxane (25 mL) and water (5 mL) was added Pd(PPh<sub>3</sub>)<sub>4</sub> (47 mg, 0.04 mmol). The reaction mixture was heated at 90 °C for 6 h under an argon atmosphere, then diluted with water (200 mL). The precipitate was isolated by filtration, then purified by flash column chromatography (silica gel<sub>,</sub> eluent CHCl<sub>3</sub>/MeOH 95:5) to afford 4-(6-(4-(4-(dimethylamino)piperidine-1-carbonyl)phenyl)imidazo[1,2-<i>b</i>]pyridazin-3-yl)benzonitrile (150 mg, 41%, AUC HPLC 98.9%) as a yellow solid; mp: 123–127 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 8.78 (d, <i>J</i> = 8.7 Hz, 1H), 8.52 (s, 1H), 8.30 (d, <i>J</i> = 8.2 Hz, 2H), 8.23 (d, <i>J</i> = 8.2 Hz, 2H), 7.76 (d, <i>J</i> = 7.7 Hz, 2H), 7.62 (d, <i>J</i> = 7.6 Hz, 2H), 7.41 (d, <i>J</i> = 7.4 Hz, 1H), 4.9 (bs, 1H), 3.9 (bs, 1H), 3.17 (bs, 1H), 2.91 (bs, 1H), 2.45 (bs, 1H), 2.38 (bs, 6H), 2.08 (bs, 1H), 1.95 (bs, 1H), 1.52 (bs, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 168.63, 151.47, 140.68, 138.52, 136.21, 135.96, 133.42, 133.24, 128.01, 127.74, 127.19, 126.84, 126.47, 119.37, 117.49, 110.06, 61.71, 46.77, 41.76, 28.80, 28.19; MS (ESI) <i>m</i>/<i>z</i> 451.2 [C<sub>27</sub>H<sub>26</sub>N<sub>6</sub>O+H]<sup>+</sup>.</div></div></div><div id="sec8_4_7_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 4-(6-(4-(4-Methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyridin-3-yl)benzonitrile (<b>47</b>)</h4><div class="NLM_p last">To a solution of 4-(6-bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)benzonitrile (210 mg, 0.9 mmol), (4-methylpiperazin-1-yl)(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone (388 mg, 1.17 mmol), and NaHCO<sub>3</sub> (228 mg, 2.71 mmol) in a mixture of DMF (11 mL) and water (2 mL) was added (A-Phos)<sub>2</sub>PdCl<sub>2</sub> (31 mg, 0.04 mmol). The reaction mixture was heated at 90 °C for 1 h under argon, diluted with water, and extracted with EtOAc (3×). The organic phase was washed in turn with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by preparative TLC to afford of 4-(6-(4-(4-methylpiperazine-1-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyridin-3-yl)benzonitrile (130 mg, 45%, AUC HPLC 98.4%) as a yellow solid; mp: 98–103 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 8.50 (s, 1H), 7.85–7.79 (m, 4H), 7.74 (d, <i>J</i> = 8.0 Hz, 2H), 7.60–7.52 (m, 5H), 3.83 (bs, 2H), 3.50 (bs, 2H), 2.51 (bs, 2H), 2.37 (bs, 2H), 2.34 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ (ppm): 169.5, 146.3, 138.5, 135.6, 134.8, 133.8, 133.2, 128.1, 127.8, 127.2, 127.1, 125.6, 124.5, 120.6, 118.7, 118.4, 111.5, 55.3, 47.7, 46.0; MS (ESI) <i>m</i>/<i>z</i> 422.30 [C<sub>26</sub>H<sub>23</sub>N<sub>5</sub>O+H]<sup>+</sup>.</div></div><div id="sec8_4_7_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 4-(6-(4-(Morpholine-4-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyridin-3-yl)benzonitrile (<b>48</b>)</h4><div class="NLM_p last">The title compound was prepared in a similar fashion as described in general procedure B starting from 4-(6-bromoimidazo[1,2-<i>a</i>]pyridin-3-yl)benzonitrile (2.0 g, 6.70 mmol) and morpholino(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone (2.13 g, 6.71 mmol). The reaction crude product was purified by flash column chromatography (silica gel, eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95:5) to afford 4-(6-(4-(morpholine-4-carbonyl)phenyl)imidazo[1,2-<i>a</i>]pyridin-3-yl)benzonitrile (2.4 g, 88%, AUC HPLC 96.3%) as a yellow solid; mp: 117–120 °C. IR (neat) ν cm<sup>–1</sup>: 3065.12 (C–H), 2219.20 (C ≡ N), 1623.17(C = O); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.80 (s, 1H), 8.01–7.99 (m, 5H), 7.84–7.81 (m, 3H), 7.73 (d, <i>J</i> = 8.8 Hz, 1H), 7.53 (d, <i>J</i> = 8.4 Hz, 2H), 3.72 (bs, 8H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 168.72, 145.74, 137.84, 135.08, 134.92, 133.48, 133.17, 127,82, 127.70, 127.04, 125.74, 125.53, 124.42, 121.82, 118.82, 117.77, 109.79, 66.08; MS (ESI) <i>m</i>/<i>z</i> 409.19 [C<sub>25</sub>H<sub>20</sub>N<sub>4</sub>O<sub>2</sub>+H]<sup>+</sup>. Anal. Calcd for C<sub>25</sub>H<sub>20</sub>N<sub>4</sub>O<sub>2</sub>•H<sub>2</sub>O: C, 70.41; H, 5.20; N, 13.14. Found: C, 70.74; H, 5.15; N, 13.15.</div></div></div><div id="sec8_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Biology</h3><div class="NLM_p">MNK1 and MNK2 protein expression, purification, and activation, MNK1 and MNK2 enzymatic assays, eIF4E phosphorylation inhibition in HeLa cell-based Assay, and cell growth inhibition using K562 cell line (GI<sub>50</sub>) were described by Cherian et al.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_p">Kinase selectivity profiling using DiscoveRx proprietary binding assay was described by Karaman et al.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">Thermodynamic solubility determination assay was described by Duraiswamy et al.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_p">Cyp inhibition, microsomal metabolic stability, plasma protein binding, Caco-2 permeability, and LogD determination assays are described in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">Supporting Information</a>.</div><div id="sec8_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> <i>In Vivo</i> Studies</h4><div class="NLM_p last">All procedures used for animals studies including <i>in vivo</i> anti-tumor efficacy studies and <i>in vivo</i> pharmacokinetics studies were approved by the BRC-IACUC Committee (Approval No. 110622) in Singapore. Female Balb/C nude mice of approximately 8–10 weeks old were purchased from Biolasco, Taiwan. CD-1 female mice were purchased from InVivos, Singapore. Food and water were given ad libitum. General protocol for <i>in vivo</i> pharmacokinetic studies were described by Ho et al.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div></div><div id="sec8_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> <i>In Vivo</i> PK Studies for <b>48</b></h4><div id="sec8_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i113" class="anchor-spacer"></div><h5 class="article-section__title" id="_i113"> Compound Preparation</h5><div class="NLM_p">Compound <b>48</b> was weighed and dissolved in 1/10 volumes of 100% DMA solution and 1/10 volumes of 100% CremophorEL. The mixtures were vortexed and sonicated in the ultrasonic bath for 30 min. The sterile Milli-Q water (8/10 volumes) was subsequently added and mixed. The final concentration of DMA and CremophorEL in the compound dosing solution was 10% (v/v) each. The final concentration was 0.25 mg/mL for intravenous administration at 1 mg/kg. Compound <b>48</b> was dissolved in a mixture of 0.5% methylcellulose and 0.1% Tween80 to a final concentration of 0.625 mg/mL for oral administration at 5 mg/kg.</div><div class="NLM_p last">CD-1 female mice (6–8 weeks old) were weighed, and those selected for dosing were 24 ± 2 g. Three mice were randomly grouped per time point. Mice were administered a single dose of 1 mg/kg of <b>48</b> via tail vein injection or a single dose of 5 mg/kg of <b>48</b> via oral gavage. The volume of injection for intravenous (i.v.) and oral (p.o.) administration was 4 mL/kg and 8 mL/kg, respectively. Mice were sacrificed using CO<sub>2</sub> gas at the predefined time points (predose and post dose at 5 or 10 and 30 min, 1, 2, 4, 8, 16, and 24 h). Blood samples were taken from euthanized mice by cardiac puncture and placed into tubes containing K<sub>3</sub>EDTA. Plasma was obtained by centrifugation of the blood samples at 15700<i>g</i>, 4 °C, for 2 min, and it was stored at −80 °C until analysis. Standard curves of compound were prepared in blank mouse plasma matrices at the concentration ranging from 1 to 1000 ng/mL. First, 10 μL of the internal standard, carbamazepine (50 ng/mL in the mixture of 50% acetonitrile and 0.1% formic acid), and 250 μL of the extract solvent (70% acetonitrile and 0.1% formic acid in Milli-Q water) were added into 50 μL of the standards and the PK plasma samples. After extraction, the samples were centrifuged at 4500<i>g</i> for 20 min in a refrigerated centrifuge (Eppendorf 5415R) at 4 °C. 70 μL of the supernatants were transferred to a fresh 96 well-plate. Samples were analyzed using the UHPLC-1290 unit (Agilent Technologies, Singapore) coupled with a triple stage quadrupole MS unit (ABI5500Qtrap, AB Sciex, Singapore). The samples were resolved on a Kinetex C18 column (50 mm × 2.1 mm internal diameter; Phenomenex, USA) maintained at 25 °C. The mobile phase A consisted of 0.1% formic acid in deionized water, and the mobile phase B consisted of acetonitrile. The gradient program was 5% B to 95% B from 0.01 to 1.0 min, maintaining 95% B from 1.0 to 1.6 min, then switched back to 5% B from 1.65 to 2.5 min, with a constant flow rate of 0.4 mL/min. The injection volume was 2 μL. The total eluent from the liquid chromatography was injected directly into the ABI5500Qtrap mass spectrometer for analysis. MS/MS detection was operated in electrospray ionization positive ion mode. The ion spray voltage was 5.5 kV, and the vaporization temperature was set to 550 °C. The curtain gas was set at 30 (arbitrary units). The flow rates of ion source gases 1 and 2 were set at 50 (arbitrary units/min). Quantitation was carried out using the multiple reaction monitoring (MRM) of the transitions. The MS parameters for <b>48</b>-MRM were <i>m</i>/<i>z</i> 490.04 → <i>m</i>/<i>z</i> 295.2; collision energy, 61 V; declustering potential, 120 V; and collision cell exit, 20 V. The MS parameters for carbamazepine–MRM were <i>m</i>/<i>z</i> 237.1 → <i>m</i>/<i>z</i> 194.1; collision energy, 27 V; DP, 100 V; and CXP, 26 V.</div></div><div id="sec8_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i114" class="anchor-spacer"></div><h5 class="article-section__title" id="_i114"> Maximum Tolerated Dose (MTD) Determination</h5><div class="NLM_p last">Female NOD-SCID mice (7–9 weeks old) were randomly in groups of three mice. They received either vehicle or a single dose of 10, 50, 100, and 200 mg/kg of <b>48</b> via oral gavage daily for 7 consecutive days. The volume of used for oral administration was 10 mL/kg. After a treatment that lasted 7 days, mice were observed for delayed clinical abnormality for another 7 days. Mice were sacrificed using CO<sub>2</sub> gas at the end of 14-day MTD study.</div></div></div></div><div id="sec8_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> Efficacy Experiments: Combination of <b>48</b> and Dasatinib</h3><div id="sec8_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> <i>In Vivo</i> Antitumor Efficacy Studies</h4><div class="NLM_p">Dasatinib and <b>48</b> were weighed and dissolved in 0.5% MC/0.1% TW80 solution. The mixtures were vortexed and sonicated in the ultrasonic bath for 30 min. The final concentration of <b>48</b> dosing solution was 2.5, 5, and 10 mg/mL for oral dosing levels at 25, 50, and 100 mg/kg, respectively. The final concentration of dasatinib was 0.25 mg/mL for an oral dosing level at 2.5 mg/kg.</div><div class="NLM_p">The chronic myeloid leukemic K562-eIF4E cells were obtained from Dr. Ong Sin Tiong, DUKE-NUS. They were generated by retroviral batch transfection of K562 cells (CCL-243 from the American Tissue Type Collection) with the MSCV-IRES-GFP vector_ENREF_76<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> encoding full-length murine eIF4E. The K562 transfected cells were FACS sorted for cells expressing high levels of eIF4E, which were used for xenograft studies. The K562-eIF4E cells were free of mycoplasma contamination. They were cultured in the RPMI medium supplemented with 10% fetal bovine serum (Life Technologies, Singapore) and antibiotic solution (100 units/mL penicillin and 100 μg/mL streptomycin) at 37 °C under 5% CO<sub>2</sub>.</div><div class="NLM_p">The K562-eIF4E cells (10<sup>7</sup> cells/mouse) were subcutaneously implanted into the right flank of female SCID mice. The volume of injection was 100 μL/mouse. After implantation, the tumor was monitored twice a week using a digital caliper. The K562-eIF4E tumor volume was estimated according to the following formula: Tumor volume (mm<sup>3</sup>) = (<i>w</i><sup>2</sup> × <i>l</i>)/2, where <i>w</i> = width and <i>l</i> = length in mm.</div><div class="NLM_p">When the tumors attained a volume between 75 to 196 mm<sup>3</sup>, mice were randomly distributed into different groups of 8 mice per group. After randomization, mice bearing K562-eIF4E tumors received vehicle (0.5% MC/0.1% TW80) or <b>48</b> once daily for 14 days (qd × 14); or dasatinib for two cycles of 5 days on and 2 days off schedule (5d On_2d Off × 2) via oral gavage. For combination drugs treatment group, mice received dasatinib followed by <b>48</b> at 1 h post dasatinib dose. The schedule used for combination drug treatment was the same as dasatinib monotherapy (5d On_2d Off × 2) and <b>48</b> monotherapy (qd × 14). The volume of oral administration was 10 mL/kg. The dosing levels for <b>48</b> were 25, 50, and 100 mg/kg. The dosing level of dasatinib was 2.5 mg/kg. The dosing levels for dasatinib and <b>48</b> combination therapy were 2.5 mg/kg and 25, 50, or 100 mg/kg.</div><div class="NLM_p">The end point used to measure the response of the K562-eIF4E tumors after compound treatment was tumor growth inhibition at day 14 and was expressed as %TGI and <i>T</i>/<i>C</i> ratio. The percentage of tumor growth inhibition (%TGI) was calculated as follows: %TGI = (<i>C</i><sub>day a</sub> – <i>T</i><sub>day a</sub>)/(<i>C</i><sub>day a</sub> – <i>C</i><sub>day 1</sub>) × 100, where <i>C</i><sub>day a</sub> = mean tumor volume of the vehicle control group at the indicated day a; <i>T</i><sub>day a</sub> = mean tumor volume of the group treated with the test compound at the indicated day a; and <i>C</i><sub>day 1</sub> = mean tumor volume of the vehicle control group at Day 1. The <i>T</i>/<i>C</i> ratio was calculated as follows: <i>T</i>/<i>C</i> ratio = <i>T</i><sub>day a</sub>/<i>C</i><sub>day a</sub>.</div><div class="NLM_p last">One-way ANOVA followed by Bonferroni Multiple Comparison Test was used to determine statistically significant differences between:<ul class="NLM_list-list_type-bullet"><li><p class="inline">the tumor volumes of the vehicle control group, and the tumor volumes of the dasatinib monotherapy group, the <b>48</b> monotherapy group, or the dasatinib and <b>48</b> combination therapy group;</p></li><li><p class="inline">the tumor volumes of the dasatinib monotherapy group, and the tumor volumes of the dasatinib and <b>48</b> combination therapy group;</p></li><li><p class="inline">the tumor volumes of the <b>48</b> monotherapy group, and the tumor volumes of the dasatinib and <b>48</b> combination therapy group.</p></li></ul>GraphPad Prism version 5.1 was used for all statistical analyses.</div></div><div id="sec8_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> Western Blot</h4><div class="NLM_p last">K562-eIF4E tumor mouse model was established with CB17 SCID mice. Single dose of 100 mg/kg of <b>48</b> and 2.5 mg/kg of dasatinib was orally administered. The mice were sacrificed at the stated time point (predose, 1 h, 4 h, and 8 h after compound was administered), and the tumor was excised and flash frozen in liquid nitrogen. The tumor was homogenized three times at 3000 rpm for 5 min in RipaBuffer containing SDS, a cocktail of protease and phosphatase inhibitor (Santa Cruz Biotechnology, Inc.), and stainless steel beads with a TOMY MS-100 homogenizer. The lysate was clarified via 2 rounds of centrifugation at 13 200 rpm for 15 min at a temperature of 4 °C. The lysates were quantitated with Quick Start Bradford Protein Assay (Bio-Rad) and denatured by boiling with 2× Laemmli sample buffer supplemented with β-mercaptoethanol (Bio-Rad) for 10 min. Equal amounts of protein were loaded and separated using the NuPAGE Novex 4–12% gradient. Bis-Tris Protein Gel (Life Technologies) and subsequently transferred to a nitrocellulose membrane. Membrane was blocked for 1 h at room temperature in 5% w/v BSA in PBST. Incubation with primary antibody (anti-eIF4E abcam#130210, anti-eIF4E phospho-S209 abcam#4774, anti-pCRKL cell signaling#3181, anti-CRKL cell signaling#3182, anti-GAPDH AM#4300) were performed overnight at 4 °C followed by secondary antibody (ECL anti-mouse IgG-HRP, GE Healthcare #NA9310 or ECL-anti-rabbit IgG-HRP, GE Healthcare #NA9340) incubation for 1 h at room temperature. ECL-Plus (Amersham #RPN2235) was used for Western blot detection using the FluorChem R Imaging system (ProteinSimple) Chemiluminescent channel.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-100"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i118"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01714" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22678" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22678" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the ACS Publications Web site at DOI: The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01714" class="ext-link">10.1021/acs.jmedchem.7b01714</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Analysis of molecular dynamics of MNK2 with compound <b>4</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Analysis of molecular dynamics of MNK2 with compound <b>27</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Analysis of molecular dynamics of MNK2 with compound <b>45</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_003.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_004.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Table S1, compounds with substitution at the 2 and 8 positions; Table S2, inactive C-3 heterocycles; Table S3, tetrazole replacement; Table S4, mouse pharmacokinetics data after p.o. administration for compounds <b>27</b>, <b>33</b>, and <b>37</b>; Table S5, selectivity screen of CGP-57380 and cercosporamide and <b>27</b> tested against a panel of 104 kinases; Table S6, other bicyclic cores; Table S7, CellTiter-Glo viability assay screen against 25 cell lines; Table S8, single agents and combination studies using <b>48</b> (ETC-206) and/or dasatinib on K562 mouse xenograft model; Figure S1, <i>in vivo</i> biomarker analysis of compound <b>48</b> and dasatinib combination on eIF4E and CRKL; microsomal stability determination; Cyp inhibition (IC<sub>50</sub>) determination; LogD determination; mouse and human PPB determination; and Caco-2 permeability (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_001.pdf">jm7b01714_si_001.pdf (3.07 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_002.pdf">jm7b01714_si_002.pdf (3.16 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_003.pdf">jm7b01714_si_003.pdf (3.23 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_004.csv">jm7b01714_si_004.csv (3.39 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf">jm7b01714_si_005.pdf (0.99 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01714" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46240" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46240" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kassoum Nacro</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3291-0215" title="Orcid link">http://orcid.org/0000-0002-3291-0215</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ee85808f8d9c81ae8b9a8dc08fc39d9a8f9cc08b8a9bc09d89"><span class="__cf_email__" data-cfemail="b7dcd9d6d4c5d8f7d2c3d499d69ac4c3d6c599d2d3c299c4d0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haiyan Yang</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lohitha Rao Chennamaneni</span> - <span class="hlFld-Affiliation affiliation">Organic
Chemistry, Institute of Chemical and Engineering Sciences (ICES),
A*STAR, 8 Biomedical
Grove, Neuros, #07-01, 138665 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melvyn Wai Tuck Ho</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shi Hua Ang</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eldwin Sum Wai Tan</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Duraiswamy Athisayamani Jeyaraj</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoon Sheng Yeap</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Boping Liu</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Esther Hq Ong</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joma Kanikadu Joy</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Liang Kuan Wee</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Perlyn Kwek</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Priya Retna</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nurul Dinie</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thuy Thi Hanh Nguyen</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shi Jing Tai</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vithya Manoharan</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vishal Pendharkar</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Choon Bing Low</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yun Shan Chew</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susmitha Vuddagiri</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kanda Sangthongpitag</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meng Ling Choong</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">May Ann Lee</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Srinivasaraghavan Kannan</span> - <span class="hlFld-Affiliation affiliation">Bioinformatics
Institute (BII), A*STAR, 30 Biopolis Street, #07-01 Matrix, 138671 Singapore</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9539-5249" title="Orcid link">http://orcid.org/0000-0002-9539-5249</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chandra S. Verma</span> - <span class="hlFld-Affiliation affiliation">Bioinformatics
Institute (BII), A*STAR, 30 Biopolis Street, #07-01 Matrix, 138671 Singapore</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Biological Sciences, Nanyang Technological
University, 60 Nanyang
Drive, 637551 Singapore</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biological Sciences, National University
of Singapore, 14 Science
Drive 4, 117543 Singapore</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0733-9798" title="Orcid link">http://orcid.org/0000-0003-0733-9798</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anders Poulsen</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2790-9340" title="Orcid link">http://orcid.org/0000-0002-2790-9340</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sharon Lim</span> - <span class="hlFld-Affiliation affiliation">Duke-NUS
Medical School, 8 College
Road, 169857 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles Chuah</span> - <span class="hlFld-Affiliation affiliation">Duke-NUS
Medical School, 8 College
Road, 169857 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tiong Sin Ong</span> - <span class="hlFld-Affiliation affiliation">Duke-NUS
Medical School, 8 College
Road, 169857 Singapore</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicine, Duke University Medical Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey Hill</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alex Matter</span> - <span class="hlFld-Affiliation affiliation">Experimental
Therapeutics Centre (ETC), A*STAR, 31 Biopolis Way, Nanos #03-01, 138669 Singapore</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): All authors (except Chandra Verma) are current or former employees of the Experimental Therapeutics Centre or Duke-NUS Graduate Medical School Singapore. Both institutes have a commercial interest in the development of MNK1/2 inhibitors.<br /></br></div></li></ul></div><div class="ack" id="ACK-d50e8619-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i120">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are thankful to Dr. Thomas Keller for helpful discussions in preparation of this manuscript. This work was financially supported by Biomedical Sciences Institutes (BMSI) and Joint Council Office (JCO Project 11 03 FG 07 05), Agency for Science, Technology and Research (A*STAR), Singapore, which is gratefully acknowledged. We thank Dr. Subir Sadhukhan and his team at AMRI Hyderabad, and Dr. Joseph Shambabu Maddirala and Dr. Sreenivasa Reddy Anugu and his team at GVK Biosciences, for the synthesis of compounds. We also thank Sudhir Tiwari and Dr. Pratima Srivastava at GVK Biosciences for compounds ADME and physiochemical properties determination.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">BC</td><td class="NLM_def"><p class="first last">blast crisis</p></td></tr><tr><td class="NLM_term">CP</td><td class="NLM_def"><p class="first last">chronic phase</p></td></tr><tr><td class="NLM_term">LSC</td><td class="NLM_def"><p class="first last">leukemic stem cell</p></td></tr><tr><td class="NLM_term">CML</td><td class="NLM_def"><p class="first last">chronic myeloid leukemia</p></td></tr><tr><td class="NLM_term">MNK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase interacting kinase</p></td></tr><tr><td class="NLM_term">eIF4E</td><td class="NLM_def"><p class="first last">eukaryotic translation initiation factor 4E</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">LSCs</td><td class="NLM_def"><p class="first last">leukemic stem cells</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i122">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 75 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span> <span> </span><span class="NLM_article-title">Mnk kinase pathway: Cellular functions and biological outcomes</span>. <i>World J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.4331/wjbc.v5.i3.321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.4331%2Fwjbc.v5.i3.321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=25225600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A280%3ADC%252BC2M7hvVCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=321-333&issue=3&author=S.+Joshiauthor=L.+C.+Platanias&title=Mnk+kinase+pathway%3A+Cellular+functions+and+biological+outcomes&doi=10.4331%2Fwjbc.v5.i3.321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mnk kinase pathway: Cellular functions and biological outcomes</span></div><div class="casAuthors">Joshi Sonali; Platanias Leonidas C</div><div class="citationInfo"><span class="NLM_cas:title">World journal of biological chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">321-33</span>
        ISSN:<span class="NLM_cas:issn">1949-8454</span>.
    </div><div class="casAbstract">The mitogen-activated protein kinase (MAPK) interacting protein kinases 1 and 2 (Mnk1 and Mnk2) play important roles in controlling signals involved in mRNA translation.  In addition to the MAPKs (p38 or Erk), multiple studies suggest that the Mnk kinases can be regulated by other known kinases such as Pak2 and/or other unidentified kinases by phosphorylation of residues distinct from the sites phosphorylated by the MAPKs.  Several studies have established multiple Mnk protein targets, including PSF, heterogenous nuclear ribonucleoprotein A1, Sprouty 2 and have lead to the identification of distinct biological functions and substrate specificity for the Mnk kinases.  In this review we discuss the pathways regulating the Mnk kinases, their known substrates as well as the functional consequences of engagement of pathways controlled by Mnk kinases.  These kinases play an important role in mRNA translation via their regulation of eukaryotic initiation factor 4E (eIF4E) and their functions have important implications in tumor biology as well as the regulation of drug resistance to anti-oncogenic therapies.  Other studies have identified a role for the Mnk kinases in cap-independent mRNA translation, suggesting that the Mnk kinases can exert important functional effects independently of the phosphorylation of eIF4E.  The role of Mnk kinases in inflammation and inflammation-induced malignancies is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQFICkwsHpykh5eUSa2oe_fW6udTcc2ebw7E1EZLz_ibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7hvVCgtQ%253D%253D&md5=765d4facdd3bb2c0c393ef6f8d0b8fc8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.4331%2Fwjbc.v5.i3.321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4331%252Fwjbc.v5.i3.321%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26atitle%3DMnk%2520kinase%2520pathway%253A%2520Cellular%2520functions%2520and%2520biological%2520outcomes%26jtitle%3DWorld%2520J.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D5%26issue%3D3%26spage%3D321%26epage%3D333%26doi%3D10.4331%2Fwjbc.v5.i3.321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe-Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, R.</span></span> <span> </span><span class="NLM_article-title">Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6539</span>– <span class="NLM_lpage">6549</span>, <span class="refDoi"> DOI: 10.1128/MCB.24.15.6539-6549.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1128%2FMCB.24.15.6539-6549.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=15254222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlKltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=6539-6549&issue=15&author=T.+Uedaauthor=R.+Watanabe-Fukunagaauthor=H.+Fukuyamaauthor=S.+Nagataauthor=R.+Fukunaga&title=Mnk2+and+Mnk1+are+essential+for+constitutive+and+inducible+phosphorylation+of+eukaryotic+initiation+factor+4E+but+not+for+cell+growth+or+development&doi=10.1128%2FMCB.24.15.6539-6549.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development</span></div><div class="casAuthors">Ueda, Takeshi; Watanabe-Fukunaga, Rie; Fukuyama, Hidehiro; Nagata, Shigekazu; Fukunaga, Rikiro</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6539-6549</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Mnk1 and Mnk2 are protein kinases that are directly phosphorylated and activated by extracellular signal-regulated kinase (ERK) or p38 mitogen-activated protein (MAP) kinases and implicated in the regulation of protein synthesis through their phosphorylation of eukaryotic translation initiation factor 4E (eIF4E) at Ser209.  To investigate their physiol. functions, we generated mice lacking the Mnk1 or Mnk2 gene or both; the resulting KO mice were viable, fertile, and developed normally.  In embryonic fibroblasts prepd. from Mnk1-Mnk2 DKO mice, eIF4E was not detectably phosphorylated at Ser209, even when the ERK and/or p38 MAP kinases were activated.  Anal. of embryonic fibroblasts from single KO mice revealed that Mnk1 is responsible for the inducible phosphorylation of eIF4E in response to MAP kinase activation, whereas Mnk2 mainly contributes to eIF4E's basal, constitutive phosphorylation.  Lipopolysaccharide (LPS)- or insulin-induced upregulation of eIF4E phosphorylation in the spleen, liver, or skeletal muscle was abolished in Mnk1-/- mice, whereas the basal eIF4E phosphorylation levels were decreased in Mnk2-/- mice.  In Mnk1-Mnk2 DKO mice, no phosphorylated eIF4E was detected in any tissue studied, even after LPS or insulin injection.  However, neither general protein synthesis nor cap-dependent translation, as assayed by a bicistronic reporter assay system, was affected in Mnk-deficient embryonic fibroblasts, despite the absence of phosphorylated eIF4E.  Thus, Mnk1 and Mnk2 are exclusive eIF4E kinases both in cultured fibroblasts and adult tissues, and they regulate inducible and constitutive eIF4E phosphorylation, resp.  These results strongly suggest that eIF4E phosphorylation at Ser209 is not essential for cell growth during development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6LIGS-bIJs7Vg90H21EOLACvtfcHk0lhliPA_oxx6Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlKltLw%253D&md5=8ad9391afbf76148f4609f38d60b82aa</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.15.6539-6549.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.15.6539-6549.2004%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DWatanabe-Fukunaga%26aufirst%3DR.%26aulast%3DFukuyama%26aufirst%3DH.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DFukunaga%26aufirst%3DR.%26atitle%3DMnk2%2520and%2520Mnk1%2520are%2520essential%2520for%2520constitutive%2520and%2520inducible%2520phosphorylation%2520of%2520eukaryotic%2520initiation%2520factor%25204E%2520but%2520not%2520for%2520cell%2520growth%2520or%2520development%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26issue%3D15%26spage%3D6539%26epage%3D6549%26doi%3D10.1128%2FMCB.24.15.6539-6549.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowlett, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrestensen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harp, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelo, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cominelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturgill, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worthington, M. T.</span></span> <span> </span><span class="NLM_article-title">MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages</span>. <i>Am. J. Physiol. Gastrointest. Liver Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>294</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">G452</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1152/ajpgi.00077.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1152%2Fajpgi.00077.2007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=G452-459&issue=2&author=R.+M.+Rowlettauthor=C.+A.+Chrestensenauthor=M.+Nyceauthor=M.+G.+Harpauthor=J.+W.+Peloauthor=F.+Cominelliauthor=P.+B.+Ernstauthor=T.+T.+Pizarroauthor=T.+W.+Sturgillauthor=M.+T.+Worthington&title=MNK+kinases+regulate+multiple+TLR+pathways+and+innate+proinflammatory+cytokines+in+macrophages&doi=10.1152%2Fajpgi.00077.2007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1152%2Fajpgi.00077.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpgi.00077.2007%26sid%3Dliteratum%253Aachs%26aulast%3DRowlett%26aufirst%3DR.%2BM.%26aulast%3DChrestensen%26aufirst%3DC.%2BA.%26aulast%3DNyce%26aufirst%3DM.%26aulast%3DHarp%26aufirst%3DM.%2BG.%26aulast%3DPelo%26aufirst%3DJ.%2BW.%26aulast%3DCominelli%26aufirst%3DF.%26aulast%3DErnst%26aufirst%3DP.%2BB.%26aulast%3DPizarro%26aufirst%3DT.%2BT.%26aulast%3DSturgill%26aufirst%3DT.%2BW.%26aulast%3DWorthington%26aufirst%3DM.%2BT.%26atitle%3DMNK%2520kinases%2520regulate%2520multiple%2520TLR%2520pathways%2520and%2520innate%2520proinflammatory%2520cytokines%2520in%2520macrophages%26jtitle%3DAm.%2520J.%2520Physiol.%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2008%26volume%3D294%26issue%3D2%26spage%3DG452%26epage%3D459%26doi%3D10.1152%2Fajpgi.00077.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundler, R.</span></span> <span> </span><span class="NLM_article-title">Posttranscriptional regulation of TNFalpha expression via eukaryotic initiation factor 4E (eIF4E) phosphorylation in mouse macrophages</span>. <i>Cytokine+</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1016/j.cyto.2005.11.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.cyto.2005.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=16431125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlalurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=52-57&issue=1&author=K.+Anderssonauthor=R.+Sundler&title=Posttranscriptional+regulation+of+TNFalpha+expression+via+eukaryotic+initiation+factor+4E+%28eIF4E%29+phosphorylation+in+mouse+macrophages&doi=10.1016%2Fj.cyto.2005.11.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Posttranscriptional regulation of TNFα expression via eukaryotic initiation factor 4E (eIF4E) phosphorylation in mouse macrophages</span></div><div class="casAuthors">Andersson, Karolina; Sundler, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine+</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-57</span>CODEN:
                <span class="NLM_cas:coden">CYTIE9</span>;
        ISSN:<span class="NLM_cas:issn">1043-4666</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Resident mouse macrophages secrete tumor necrosis factor α (TNFα) upon challenge with LPS.  The prodn. of TNFα is controlled not only at the transcription of the gene, but also by strong posttranscriptional regulation.  When macrophages are stimulated with LPS different signal transduction pathways become activated.  Here the authors show that the combination of the 2 kinases, p38 and MEK and presumably ERK1/2 regulate translation of TNFα, through the downstream kinase Mnk1.  TNFα prodn. is inhibited in a concn.-dependent manner by CGP57380 (Mnk1 inhibitor).  The corresponding mRNA results show that the inhibition targets posttranscriptional regulation and is paralleled by inhibition of the phosphorylation of eukaryotic initiation factor 4E (eIF4E).  Unexpectedly, the activation/inhibition of MAPKAP kinase-2 (MK2) did not parallel TNFα prodn., arguing against a direct/immediate role for this kinase.  Based on these and previous results the authors propose that ARE-contg. TNFα mRNA requires phosphorylation of eIF4E for initiation of translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotHnMmgYJX9LVg90H21EOLACvtfcHk0lhliPA_oxx6Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlalurg%253D&md5=20b113e5c71f8bf01eff8f2ce50cbe94</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2005.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2005.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DK.%26aulast%3DSundler%26aufirst%3DR.%26atitle%3DPosttranscriptional%2520regulation%2520of%2520TNFalpha%2520expression%2520via%2520eukaryotic%2520initiation%2520factor%25204E%2520%2528eIF4E%2529%2520phosphorylation%2520in%2520mouse%2520macrophages%26jtitle%3DCytokine%252B%26date%3D2006%26volume%3D33%26issue%3D1%26spage%3D52%26epage%3D57%26doi%3D10.1016%2Fj.cyto.2005.11.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buxade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousseau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrice, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proud, C. G.</span></span> <span> </span><span class="NLM_article-title">The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2005.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.immuni.2005.06.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=177-189&issue=2&author=M.+Buxadeauthor=J.+L.+Parraauthor=S.+Rousseauauthor=N.+Shpiroauthor=R.+Marquezauthor=N.+Morriceauthor=J.+Bainauthor=E.+Espelauthor=C.+G.+Proud&title=The+Mnks+are+novel+components+in+the+control+of+TNF+alpha+biosynthesis+and+phosphorylate+and+regulate+hnRNP+A1&doi=10.1016%2Fj.immuni.2005.06.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2005.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2005.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DBuxade%26aufirst%3DM.%26aulast%3DParra%26aufirst%3DJ.%2BL.%26aulast%3DRousseau%26aufirst%3DS.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DMarquez%26aufirst%3DR.%26aulast%3DMorrice%26aufirst%3DN.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DEspel%26aufirst%3DE.%26aulast%3DProud%26aufirst%3DC.%2BG.%26atitle%3DThe%2520Mnks%2520are%2520novel%2520components%2520in%2520the%2520control%2520of%2520TNF%2520alpha%2520biosynthesis%2520and%2520phosphorylate%2520and%2520regulate%2520hnRNP%2520A1%26jtitle%3DImmunity%26date%3D2005%26volume%3D23%26issue%3D2%26spage%3D177%26epage%3D189%26doi%3D10.1016%2Fj.immuni.2005.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gkogkas, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoutorsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafarnejad, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prager-Khoutorsky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannakas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragkouli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nader, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konicek, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzinia, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacaille, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span> <span> </span><span class="NLM_article-title">Pharmacogenetic inhibition of eIF4E-dependent Mmp9 mRNA translation reverses fragile X syndrome-like phenotypes</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1742</span>– <span class="NLM_lpage">1755</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2014.10.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.celrep.2014.10.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=25466251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2gs7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1742-1755&issue=5&author=C.+G.+Gkogkasauthor=A.+Khoutorskyauthor=R.+Caoauthor=S.+M.+Jafarnejadauthor=M.+Prager-Khoutorskyauthor=N.+Giannakasauthor=A.+Kaminariauthor=A.+Fragkouliauthor=K.+Naderauthor=T.+J.+Priceauthor=B.+W.+Konicekauthor=J.+R.+Graffauthor=A.+K.+Tziniaauthor=J.+C.+Lacailleauthor=N.+Sonenberg&title=Pharmacogenetic+inhibition+of+eIF4E-dependent+Mmp9+mRNA+translation+reverses+fragile+X+syndrome-like+phenotypes&doi=10.1016%2Fj.celrep.2014.10.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacogenetic Inhibition of eIF4E-Dependent Mmp9 mRNA Translation Reverses Fragile X Syndrome-like Phenotypes</span></div><div class="casAuthors">Gkogkas, Christos G.; Khoutorsky, Arkady; Cao, Ruifeng; Jafarnejad, Seyed Mehdi; Prager-Khoutorsky, Masha; Giannakas, Nikolaos; Kaminari, Archontia; Fragkouli, Apostolia; Nader, Karim; Price, Theodore J.; Konicek, Bruce W.; Graff, Jeremy R.; Tzinia, Athina K.; Lacaille, Jean-Claude; Sonenberg, Nahum</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1742-1755</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Fragile X syndrome (FXS) is the leading genetic cause of autism.  Mutations in Fmr1 (fragile X mental retardation 1 gene) engender exaggerated translation resulting in dendritic spine dysmorphogenesis, synaptic plasticity alterations, and behavioral deficits in mice, which are reminiscent of FXS phenotypes.  Using postmortem brains from FXS patients and Fmr1 knockout mice (Fmr1-/y), we show that phosphorylation of the mRNA 5' cap binding protein, eukaryotic initiation factor 4E (eIF4E), is elevated concomitant with increased expression of matrix metalloproteinase 9 (MMP-9) protein.  Genetic or pharmacol. redn. of eIF4E phosphorylation rescued core behavioral deficits, synaptic plasticity alterations, and dendritic spine morphol. defects via reducing exaggerated translation of Mmp9 mRNA in Fmr1-/y mice, whereas MMP-9 overexpression produced several FXS-like phenotypes.  These results uncover a mechanism of regulation of synaptic function by translational control of Mmp-9 in FXS, which opens the possibility of new treatment avenues for the diverse neurol. and psychiatric aspects of FXS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDYFY_NYb2mbVg90H21EOLACvtfcHk0ljVU762qJxaOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2gs7zM&md5=352bf1476c5f6c94d48e15026468767e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.10.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.10.064%26sid%3Dliteratum%253Aachs%26aulast%3DGkogkas%26aufirst%3DC.%2BG.%26aulast%3DKhoutorsky%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DR.%26aulast%3DJafarnejad%26aufirst%3DS.%2BM.%26aulast%3DPrager-Khoutorsky%26aufirst%3DM.%26aulast%3DGiannakas%26aufirst%3DN.%26aulast%3DKaminari%26aufirst%3DA.%26aulast%3DFragkouli%26aufirst%3DA.%26aulast%3DNader%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DT.%2BJ.%26aulast%3DKonicek%26aufirst%3DB.%2BW.%26aulast%3DGraff%26aufirst%3DJ.%2BR.%26aulast%3DTzinia%26aufirst%3DA.%2BK.%26aulast%3DLacaille%26aufirst%3DJ.%2BC.%26aulast%3DSonenberg%26aufirst%3DN.%26atitle%3DPharmacogenetic%2520inhibition%2520of%2520eIF4E-dependent%2520Mmp9%2520mRNA%2520translation%2520reverses%2520fragile%2520X%2520syndrome-like%2520phenotypes%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D9%26issue%3D5%26spage%3D1742%26epage%3D1755%26doi%3D10.1016%2Fj.celrep.2014.10.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grzmil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seebacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schibli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moncayo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmings, B. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of MNK pathways enhances cancer cell response to chemotherapy with Temozolomide and targeted radionuclide therapy</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1412</span>– <span class="NLM_lpage">1421</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2016.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.cellsig.2016.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=27289018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSqtLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2016&pages=1412-1421&issue=9&author=M.+Grzmilauthor=J.+Seebacherauthor=D.+Hessauthor=M.+Beheauthor=R.+Schibliauthor=G.+Moncayoauthor=S.+Frankauthor=B.+A.+Hemmings&title=Inhibition+of+MNK+pathways+enhances+cancer+cell+response+to+chemotherapy+with+Temozolomide+and+targeted+radionuclide+therapy&doi=10.1016%2Fj.cellsig.2016.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy</span></div><div class="casAuthors">Grzmil, Michal; Seebacher, Jan; Hess, Daniel; Behe, Martin; Schibli, Roger; Moncayo, Gerald; Frank, Stephan; Hemmings, Brian A.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1412-1421</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Current std.-of-care treatment for malignant cancers includes radiotherapy and adjuvant chemotherapy.  Here, we report increased MAP kinase-interacting kinase (MNK)-regulated phosphorylation of translation initiation factor 4E (eIF4E) in glioma cells upon temozolomide (TMZ) treatment and in medullary thyroid carcinoma (MTC) cells in response to targeted radionuclide therapy.  Depletion of MNK activity by using two MNK inhibitors, CGP57380 or cercosporamide, as well as by MNK1-specific knockdown sensitized glioblastoma (GBM) cells and GBM-derived spheres to TMZ.  Furthermore, CGP57380 treatment enhanced response of MTC cells to 177Lu-labeled gastrin analog.  In order to understand how MNK signaling pathways support glioma survival we analyzed putative MNK substrates by quant. phosphoproteomics in normal condition and in the presence of TMZ.  We identified MNK inhibitor-sensitive phosphorylation sites on eIF4G1, mutations of which either influenced eIF4E phosphorylation or glioma cell response to TMZ, pointing to altered regulation of translation initiation as a resistance mechanism.  Pharmacol. inhibition of overexpressed MNK1 by CGP57380 reduced eIF4E phosphorylation and induced assocn. of inactive MNK1 with eIF4G1.  Taken together, our data show an activation of MNK-mediated survival mechanisms in response to either glioma chemotherapy or MTC targeted radiation and suggest that inhibition of MNK activity represents an attractive sensitizing strategy for cancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5g475rtcdA7Vg90H21EOLACvtfcHk0ljVU762qJxaOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSqtLrK&md5=6bea5edacac34f3517525bba93184643</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2016.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2016.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DGrzmil%26aufirst%3DM.%26aulast%3DSeebacher%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DD.%26aulast%3DBehe%26aufirst%3DM.%26aulast%3DSchibli%26aufirst%3DR.%26aulast%3DMoncayo%26aufirst%3DG.%26aulast%3DFrank%26aufirst%3DS.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26atitle%3DInhibition%2520of%2520MNK%2520pathways%2520enhances%2520cancer%2520cell%2520response%2520to%2520chemotherapy%2520with%2520Temozolomide%2520and%2520targeted%2520radionuclide%2520therapy%26jtitle%3DCell.%2520Signalling%26date%3D2016%26volume%3D28%26issue%3D9%26spage%3D1412%26epage%3D1421%26doi%3D10.1016%2Fj.cellsig.2016.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grzmil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lino, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moncayo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmings, B. A.</span></span> <span> </span><span class="NLM_article-title">MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-beta signaling pathway in human glioblastoma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2392</span>– <span class="NLM_lpage">2402</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-3112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1158%2F0008-5472.CAN-10-3112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=2392-2402&issue=6&author=M.+Grzmilauthor=P.+Morinauthor=M.+M.+Linoauthor=A.+Merloauthor=S.+Frankauthor=Y.+Wangauthor=G.+Moncayoauthor=B.+A.+Hemmings&title=MAP+kinase-interacting+kinase+1+regulates+SMAD2-dependent+TGF-beta+signaling+pathway+in+human+glioblastoma&doi=10.1158%2F0008-5472.CAN-10-3112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-3112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-3112%26sid%3Dliteratum%253Aachs%26aulast%3DGrzmil%26aufirst%3DM.%26aulast%3DMorin%26aufirst%3DP.%26aulast%3DLino%26aufirst%3DM.%2BM.%26aulast%3DMerlo%26aufirst%3DA.%26aulast%3DFrank%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMoncayo%26aufirst%3DG.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26atitle%3DMAP%2520kinase-interacting%2520kinase%25201%2520regulates%2520SMAD2-dependent%2520TGF-beta%2520signaling%2520pathway%2520in%2520human%2520glioblastoma%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D6%26spage%3D2392%26epage%3D2402%26doi%3D10.1158%2F0008-5472.CAN-10-3112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckerdt, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arslan, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clymer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horbinski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davuluri, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span> <span> </span><span class="NLM_article-title">MNK inhibition disrupts mesenchymal glioma stem cells and prolongs survival in a mouse model of glioblastoma</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">984</span>– <span class="NLM_lpage">993</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-16-0172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1158%2F1541-7786.MCR-16-0172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=27364770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslGisbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=984-993&issue=10&author=J.+B.+Bellauthor=F.+D.+Eckerdtauthor=K.+Alleyauthor=L.+P.+Magnussonauthor=H.+Hussainauthor=Y.+Biauthor=A.+D.+Arslanauthor=J.+Clymerauthor=A.+A.+Alvarezauthor=S.+Goldmanauthor=S.+Y.+Chengauthor=I.+Nakanoauthor=C.+Horbinskiauthor=R.+V.+Davuluriauthor=C.+D.+Jamesauthor=L.+C.+Platanias&title=MNK+inhibition+disrupts+mesenchymal+glioma+stem+cells+and+prolongs+survival+in+a+mouse+model+of+glioblastoma&doi=10.1158%2F1541-7786.MCR-16-0172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma</span></div><div class="casAuthors">Bell, Jonathan B.; Eckerdt, Frank D.; Alley, Kristen; Magnusson, Lisa P.; Hussain, Hridi; Bi, Yingtao; Arslan, Ahmet Dirim; Clymer, Jessica; Alvarez, Angel A.; Goldman, Stewart; Cheng, Shi-Yuan; Nakano, Ichiro; Horbinski, Craig; Davuluri, Ramana V.; James, C. David; Platanias, Leonidas C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">984-993</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Glioblastoma multiforme remains the deadliest malignant brain tumor, with glioma stem cells (GSC) contributing to treatment resistance and tumor recurrence.  We have identified MAPK-interacting kinases (MNK) as potential targets for the GSC population in glioblastoma multiforme.  Isoform-level subtyping using The Cancer Genome Atlas revealed that both MNK genes (MKNK1 and MKNK2) are upregulated in mesenchymal glioblastoma multiforme as compared with other subtypes.  Expression of MKNK1 is assocd. with increased glioma grade and correlated with the mesenchymal GSC marker, CD44, and coexpression of MKNK1 and CD44 predicts poor survival in glioblastoma multiforme.  In established and patient-derived cell lines, pharmacol. MNK inhibition using LY2801653 (merestinib) inhibited phosphorylation of the eukaryotic translation initiation factor 4E, a crucial effector for MNK-induced mRNA translation in cancer cells and a marker of transformation.  Importantly, merestinib inhibited growth of GSCs grown as neurospheres as detd. by extreme limiting diln. anal.  When the effects of merestinib were assessed in vivo using an intracranial xenograft mouse model, improved overall survival was obsd. in merestinib-treated mice.  Taken together, these data provide strong preclin. evidence that pharmacol. MNK inhibition targets mesenchymal glioblastoma multiforme and its GSC population.  These findings raise the possibility of MNK inhibition as a viable therapeutic approach to target the mesenchymal subtype of glioblastoma multiforme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzbXOivkr8_7Vg90H21EOLACvtfcHk0lhor4Qtrwnttg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslGisbbM&md5=690d5b41dbbdfa81a470c54e09ad3a92</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-16-0172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-16-0172%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DJ.%2BB.%26aulast%3DEckerdt%26aufirst%3DF.%2BD.%26aulast%3DAlley%26aufirst%3DK.%26aulast%3DMagnusson%26aufirst%3DL.%2BP.%26aulast%3DHussain%26aufirst%3DH.%26aulast%3DBi%26aufirst%3DY.%26aulast%3DArslan%26aufirst%3DA.%2BD.%26aulast%3DClymer%26aufirst%3DJ.%26aulast%3DAlvarez%26aufirst%3DA.%2BA.%26aulast%3DGoldman%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DS.%2BY.%26aulast%3DNakano%26aufirst%3DI.%26aulast%3DHorbinski%26aufirst%3DC.%26aulast%3DDavuluri%26aufirst%3DR.%2BV.%26aulast%3DJames%26aufirst%3DC.%2BD.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26atitle%3DMNK%2520inhibition%2520disrupts%2520mesenchymal%2520glioma%2520stem%2520cells%2520and%2520prolongs%2520survival%2520in%2520a%2520mouse%2520model%2520of%2520glioblastoma%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2016%26volume%3D14%26issue%3D10%26spage%3D984%26epage%3D993%26doi%3D10.1158%2F1541-7786.MCR-16-0172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chrestensen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuman, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eschenroeder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worthington, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gram, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturgill, T. W.</span></span> <span> </span><span class="NLM_article-title">MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">4243</span>– <span class="NLM_lpage">4252</span>, <span class="refDoi"> DOI: 10.1074/jbc.M607368200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1074%2Fjbc.M607368200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=4243-4252&issue=7&author=C.+A.+Chrestensenauthor=J.+K.+Shumanauthor=A.+Eschenroederauthor=M.+Worthingtonauthor=H.+Gramauthor=T.+W.+Sturgill&title=MNK1+and+MNK2+regulation+in+HER2-overexpressing+breast+cancer+lines&doi=10.1074%2Fjbc.M607368200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M607368200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M607368200%26sid%3Dliteratum%253Aachs%26aulast%3DChrestensen%26aufirst%3DC.%2BA.%26aulast%3DShuman%26aufirst%3DJ.%2BK.%26aulast%3DEschenroeder%26aufirst%3DA.%26aulast%3DWorthington%26aufirst%3DM.%26aulast%3DGram%26aufirst%3DH.%26aulast%3DSturgill%26aufirst%3DT.%2BW.%26atitle%3DMNK1%2520and%2520MNK2%2520regulation%2520in%2520HER2-overexpressing%2520breast%2520cancer%2520lines%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26issue%3D7%26spage%3D4243%26epage%3D4252%26doi%3D10.1074%2Fjbc.M607368200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wheater, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaydes, J. P.</span></span> <span> </span><span class="NLM_article-title">The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.4161/cbt.10.7.12965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.4161%2Fcbt.10.7.12965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=20686366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVKrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=728-735&issue=7&author=M.+J.+Wheaterauthor=P.+W.+Johnsonauthor=J.+P.+Blaydes&title=The+role+of+MNK+proteins+and+eIF4E+phosphorylation+in+breast+cancer+cell+proliferation+and+survival&doi=10.4161%2Fcbt.10.7.12965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival</span></div><div class="casAuthors">Wheater, Matthew J.; Johnson, Peter W. M.; Blaydes, Jeremy P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">728-735</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">EIF4E is overexpressed in many tumors, including a high proportion of breast cancers.  EIF4E is an oncogene, and signaling pathways which promote eIF4E activity represent potential targets for therapeutic intervention in cancer.  MNKs phosphorylate eIF4E on serine 209, a modification that can be required for eIF4E-dependent cell transformation.  There is therefore a clear requirement to det. the role of MNKs in the proliferation and survival of cells from the major human tumors, such as breast cancer.  Phosphorylated eIF4E protein was readily detectable in some breast tumor samples, but was below the limits of detection in others.  Of six breast cancer cell lines representing the major subtypes of breast cancer, phosphorylated eIF4E was readily detectable in five of them, with MCF-7 cells displaying markedly lower levels.  Long term colony forming assays demonstrated that all the five lines with high levels of phosphorylated eIF4E were highly sensitive to a MNK inhibitor.  In short term assays, a range of responses was revealed.  MCF-7 cells were insensitive in both assays.  The anti-proliferative effects of the MNK inhibitor in breast cancer cells are primarily cytostatic, rather than cytotoxic, and are potentially due to the inhibition of cyclin D1 synthesis.  Our data provide evidence that the sensitivity of breast cancer cells to MNK inhibition may correlate with baseline levels of eIF4E phosphorylation, and suggest that a proportion of breast cancers could be sensitive to inhibiting MNK kinase activity, and that the presence of phosphorylated eIF4E could provide a biomarker for the identification of responsive tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV-LNAQtLdjbVg90H21EOLACvtfcHk0lhor4Qtrwnttg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVKrtQ%253D%253D&md5=b2ad022bde5142aa92b6e46d32c36c01</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4161%2Fcbt.10.7.12965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.10.7.12965%26sid%3Dliteratum%253Aachs%26aulast%3DWheater%26aufirst%3DM.%2BJ.%26aulast%3DJohnson%26aufirst%3DP.%2BW.%26aulast%3DBlaydes%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520role%2520of%2520MNK%2520proteins%2520and%2520eIF4E%2520phosphorylation%2520in%2520breast%2520cancer%2520cell%2520proliferation%2520and%2520survival%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2010%26volume%3D10%26issue%3D7%26spage%3D728%26epage%3D735%26doi%3D10.4161%2Fcbt.10.7.12965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nasr, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porco, J. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span> <span> </span><span class="NLM_article-title">EIF4F suppression in breast cancer affects maintenance and progression</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1038%2Fonc.2012.105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=861-871&issue=7&author=Z.+Nasrauthor=F.+Robertauthor=J.+A.+Porcoauthor=W.+J.+Mullerauthor=J.+Pelletier&title=EIF4F+suppression+in+breast+cancer+affects+maintenance+and+progression&doi=10.1038%2Fonc.2012.105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.105%26sid%3Dliteratum%253Aachs%26aulast%3DNasr%26aufirst%3DZ.%26aulast%3DRobert%26aufirst%3DF.%26aulast%3DPorco%26aufirst%3DJ.%2BA.%26aulast%3DMuller%26aufirst%3DW.%2BJ.%26aulast%3DPelletier%26aufirst%3DJ.%26atitle%3DEIF4F%2520suppression%2520in%2520breast%2520cancer%2520affects%2520maintenance%2520and%2520progression%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26issue%3D7%26spage%3D861%26epage%3D871%26doi%3D10.1038%2Fonc.2012.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adesso, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabretta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbagallo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capurso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilozzi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geremia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delle Fave, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sette, C.</span></span> <span> </span><span class="NLM_article-title">Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">2848</span>– <span class="NLM_lpage">2857</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1038%2Fonc.2012.306" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2848-2857&issue=23&author=L.+Adessoauthor=S.+Calabrettaauthor=F.+Barbagalloauthor=G.+Capursoauthor=E.+Pilozziauthor=R.+Geremiaauthor=G.+Delle+Faveauthor=C.+Sette&title=Gemcitabine+triggers+a+pro-survival+response+in+pancreatic+cancer+cells+through+activation+of+the+MNK2%2FeIF4E+pathway&doi=10.1038%2Fonc.2012.306"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.306%26sid%3Dliteratum%253Aachs%26aulast%3DAdesso%26aufirst%3DL.%26aulast%3DCalabretta%26aufirst%3DS.%26aulast%3DBarbagallo%26aufirst%3DF.%26aulast%3DCapurso%26aufirst%3DG.%26aulast%3DPilozzi%26aufirst%3DE.%26aulast%3DGeremia%26aufirst%3DR.%26aulast%3DDelle%2BFave%26aufirst%3DG.%26aulast%3DSette%26aufirst%3DC.%26atitle%3DGemcitabine%2520triggers%2520a%2520pro-survival%2520response%2520in%2520pancreatic%2520cancer%2520cells%2520through%2520activation%2520of%2520the%2520MNK2%252FeIF4E%2520pathway%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26issue%3D23%26spage%3D2848%26epage%3D2857%26doi%3D10.1038%2Fonc.2012.306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arslan, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentrem, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckerdt, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, H. G.</span></span> <span> </span><span class="NLM_article-title">Differential regulation of ZEB1 and EMT by MAPK-interacting protein kinases (MNK) and eIF4E in pancreatic cancer</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">216</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-15-0285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1158%2F1541-7786.MCR-15-0285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=26609108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFGlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=216-227&issue=2&author=K.+Kumarauthor=C.+R.+Chowauthor=K.+Ebineauthor=A.+D.+Arslanauthor=B.+Kwokauthor=D.+J.+Bentremauthor=F.+D.+Eckerdtauthor=L.+C.+Plataniasauthor=H.+G.+Munshi&title=Differential+regulation+of+ZEB1+and+EMT+by+MAPK-interacting+protein+kinases+%28MNK%29+and+eIF4E+in+pancreatic+cancer&doi=10.1158%2F1541-7786.MCR-15-0285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer</span></div><div class="casAuthors">Kumar, Krishan; Chow, Christina R.; Ebine, Kazumi; Arslan, Ahmet D.; Kwok, Benjamin; Bentrem, David J.; Eckerdt, Frank D.; Platanias, Leonidas C.; Munshi, Hidayatullah G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">216-227</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Human pancreatic ductal adenocarcinoma (PDAC) tumors are assocd. with dysregulation of mRNA translation.  In this report, it is demonstrated that PDAC cells grown in collagen exhibit increased activation of the MAPK-interacting protein kinases (MNK) that mediate eIF4E phosphorylation.  Pharmacol. and genetic targeting of MNKs reverse epithelial-mesenchymal transition (EMT), decrease cell migration, and reduce protein expression of the EMT-regulator ZEB1 without affecting ZEB1 mRNA levels.  Paradoxically, targeting eIF4E, the best-characterized effector of MNKs, increases ZEB1 mRNA expression through repression of ZEB1-targeting miRNAs, miR-200c and miR-141.  In contrast, targeting the MNK effector hnRNPA1, which can function as a translational repressor, increases ZEB1 protein without increasing ZEB1 mRNA levels.  Importantly, treatment with MNK inhibitors blocks growth of chemoresistant PDAC cells in collagen and decreases the no. of aldehyde dehydrogenase activity-pos. (Aldefluor+) cells.  Significantly, MNK inhibitors increase E-cadherin mRNA levels and decrease vimentin mRNA levels in human PDAC organoids without affecting ZEB1 mRNA levels.  Importantly, MNK inhibitors also decrease growth of human PDAC organoids.  Implications: These results demonstrate differential regulation of ZEB1 and EMT by MNKs and eIF4E, and identify MNKs as potential targets in pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodfpbuGZcxsbVg90H21EOLACvtfcHk0lhVvsYkCjmIfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFGlsLo%253D&md5=6fc52c2da0159cf4940dfc65de947394</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-15-0285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-15-0285%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DChow%26aufirst%3DC.%2BR.%26aulast%3DEbine%26aufirst%3DK.%26aulast%3DArslan%26aufirst%3DA.%2BD.%26aulast%3DKwok%26aufirst%3DB.%26aulast%3DBentrem%26aufirst%3DD.%2BJ.%26aulast%3DEckerdt%26aufirst%3DF.%2BD.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26aulast%3DMunshi%26aufirst%3DH.%2BG.%26atitle%3DDifferential%2520regulation%2520of%2520ZEB1%2520and%2520EMT%2520by%2520MAPK-interacting%2520protein%2520kinases%2520%2528MNK%2529%2520and%2520eIF4E%2520in%2520pancreatic%2520cancer%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2016%26volume%3D14%26issue%3D2%26spage%3D216%26epage%3D227%26doi%3D10.1158%2F1541-7786.MCR-15-0285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Altman, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe-Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span> <span> </span><span class="NLM_article-title">Negative regulatory effects of Mnk kinases in the generation of chemotherapy-induced antileukemic responses</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">778</span>– <span class="NLM_lpage">784</span>, <span class="refDoi"> DOI: 10.1124/mol.110.064642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1124%2Fmol.110.064642" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=778-784&issue=4&author=J.+K.+Altmanauthor=H.+Glaserauthor=A.+Sassanoauthor=S.+Joshiauthor=T.+Uedaauthor=R.+Watanabe-Fukunagaauthor=R.+Fukunagaauthor=M.+S.+Tallmanauthor=L.+C.+Platanias&title=Negative+regulatory+effects+of+Mnk+kinases+in+the+generation+of+chemotherapy-induced+antileukemic+responses&doi=10.1124%2Fmol.110.064642"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.064642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.064642%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DJ.%2BK.%26aulast%3DGlaser%26aufirst%3DH.%26aulast%3DSassano%26aufirst%3DA.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DWatanabe-Fukunaga%26aufirst%3DR.%26aulast%3DFukunaga%26aufirst%3DR.%26aulast%3DTallman%26aufirst%3DM.%2BS.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26atitle%3DNegative%2520regulatory%2520effects%2520of%2520Mnk%2520kinases%2520in%2520the%2520generation%2520of%2520chemotherapy-induced%2520antileukemic%2520responses%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26issue%3D4%26spage%3D778%26epage%3D784%26doi%3D10.1124%2Fmol.110.064642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ailles, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dylla, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muijtjens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zehnder, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotlib, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manz, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keating, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyers, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, I. L.</span></span> <span> </span><span class="NLM_article-title">Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>351</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa040258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1056%2FNEJMoa040258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=15306667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD2cXms1Oktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2004&pages=657-667&issue=7&author=C.+H.+Jamiesonauthor=L.+E.+Aillesauthor=S.+J.+Dyllaauthor=M.+Muijtjensauthor=C.+Jonesauthor=J.+L.+Zehnderauthor=J.+Gotlibauthor=K.+Liauthor=M.+G.+Manzauthor=A.+Keatingauthor=C.+L.+Sawyersauthor=I.+L.+Weissman&title=Granulocyte-macrophage+progenitors+as+candidate+leukemic+stem+cells+in+blast-crisis+CML&doi=10.1056%2FNEJMoa040258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML</span></div><div class="casAuthors">Jamieson, Catriona H. M.; Ailles, Laurie E.; Dylla, Scott J.; Muijtjens, Manja; Jones, Carol; Zehnder, James L.; Gotlib, Jason; Li, Kevin; Manz, Markus G.; Keating, Armand; Sawyers, Charles L.; Weissman, Irving L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">657-667</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: The progression of chronic myelogenous leukemia (CML) to blast crisis is supported by self-renewing leukemic stem cells.  In normal mouse hematopoietic stem cells, the process of self-renewal involves the β-catenin-signaling pathway.  The authors investigated whether leukemic stem cells in CML also use the β-catenin pathway for self-renewal.  METHODS: the authors used fluorescence-activated cell sorting to isolate hematopoietic stem cells, common myeloid progenitors, granulocyte-macrophage progenitors, and megakaryocyte-erythroid progenitors from marrow during several phases ofCML and from normal marrow.  BCR-ABL, β-catenin, and LEF-1 transcripts were compared by a quant. reverse-transcriptase-polymerase-chain-reaction assay in normal and CML hematopoietic stem cells and granulocyte-macrophage progenitors.  Confocal fluorescence microscopy and a lymphoid enhancer factor/T-cell factor reporter assay were used to detect nuclear,/3-catenin in these cells.  In vitro replatingv assays were used to identify self-renewing cells as candidate leukemic stem cells, and the dependence of self-renewal on β-catenin activation was tested by lentiviral transduction of hematopoietic progenitors with axin, an inhibitor of the β-catenin pathway.  RESULTS: The granulocyte-macrophage progenitor pool from patients with CML in blast crisis and imatinib-resistant CML was expanded, expressed BCR-ABL, and had elevated levels of nuclear β-catenin as compared with the levels in progenitors from normal marrow.  Unlike normal granulocyte-macrophage progenitors, CML granulocyte-macrophage progenitors formed self-renewing, replatable myeloid colonies, and in vitro self-renewal capacity was reduced by enforced expression of axin.  CONCLUSIONS: Activation of β-catenin in CML granulocyte-macrophage progenitors appears to enhance the self-renewal activity and leukemic potential of these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnCZBoiSHbTLVg90H21EOLACvtfcHk0lhVvsYkCjmIfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXms1Oktbg%253D&md5=92e0552ff2c3db8ba805919514e24b01</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa040258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa040258%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%2BH.%26aulast%3DAilles%26aufirst%3DL.%2BE.%26aulast%3DDylla%26aufirst%3DS.%2BJ.%26aulast%3DMuijtjens%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DZehnder%26aufirst%3DJ.%2BL.%26aulast%3DGotlib%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DManz%26aufirst%3DM.%2BG.%26aulast%3DKeating%26aufirst%3DA.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26aulast%3DWeissman%26aufirst%3DI.%2BL.%26atitle%3DGranulocyte-macrophage%2520progenitors%2520as%2520candidate%2520leukemic%2520stem%2520cells%2520in%2520blast-crisis%2520CML%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D351%26issue%3D7%26spage%3D657%26epage%3D667%26doi%3D10.1056%2FNEJMoa040258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arechiga, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melo, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, S. T.</span></span> <span> </span><span class="NLM_article-title">Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5716</span>– <span class="NLM_lpage">5722</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=5716-5722&issue=18&author=C.+Lyauthor=A.+F.+Arechigaauthor=J.+V.+Meloauthor=C.+M.+Walshauthor=S.+T.+Ong&title=Bcr-Abl+kinase+modulates+the+translation+regulators+ribosomal+protein+S6+and+4E-BP1+in+chronic+myelogenous+leukemia+cells+via+the+mammalian+target+of+rapamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLy%26aufirst%3DC.%26aulast%3DArechiga%26aufirst%3DA.%2BF.%26aulast%3DMelo%26aufirst%3DJ.%2BV.%26aulast%3DWalsh%26aufirst%3DC.%2BM.%26aulast%3DOng%26aufirst%3DS.%2BT.%26atitle%3DBcr-Abl%2520kinase%2520modulates%2520the%2520translation%2520regulators%2520ribosomal%2520protein%2520S6%2520and%25204E-BP1%2520in%2520chronic%2520myelogenous%2520leukemia%2520cells%2520via%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26issue%3D18%26spage%3D5716%26epage%3D5722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prabhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saadat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halbur, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruehauf, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, S. T.</span></span> <span> </span><span class="NLM_article-title">A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translation</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1188</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1209901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1038%2Fsj.onc.1209901" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1188-1200&issue=8&author=S.+Prabhuauthor=D.+Saadatauthor=M.+Zhangauthor=L.+Halburauthor=J.+P.+Fruehaufauthor=S.+T.+Ong&title=A+novel+mechanism+for+Bcr-Abl+action%3A+Bcr-Abl-mediated+induction+of+the+eIF4F+translation+initiation+complex+and+mRNA+translation&doi=10.1038%2Fsj.onc.1209901"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1209901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1209901%26sid%3Dliteratum%253Aachs%26aulast%3DPrabhu%26aufirst%3DS.%26aulast%3DSaadat%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHalbur%26aufirst%3DL.%26aulast%3DFruehauf%26aufirst%3DJ.%2BP.%26aulast%3DOng%26aufirst%3DS.%2BT.%26atitle%3DA%2520novel%2520mechanism%2520for%2520Bcr-Abl%2520action%253A%2520Bcr-Abl-mediated%2520induction%2520of%2520the%2520eIF4F%2520translation%2520initiation%2520complex%2520and%2520mRNA%2520translation%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26issue%3D8%26spage%3D1188%26epage%3D1200%26doi%3D10.1038%2Fsj.onc.1209901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landon, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muniandy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shetty, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehrmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peroutka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazan-Mamczarz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhardt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahurkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borden, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gartenhaus, R. B.</span></span> <span> </span><span class="NLM_article-title">MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">5413</span>, <span class="refDoi"> DOI: 10.1038/ncomms6413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1038%2Fncomms6413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=25403230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A280%3ADC%252BC2M3ptVOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=5413&author=A.+L.+Landonauthor=P.+A.+Muniandyauthor=A.+C.+Shettyauthor=E.+Lehrmannauthor=L.+Volponauthor=S.+Houngauthor=Y.+Zhangauthor=B.+Daiauthor=R.+Peroutkaauthor=K.+Mazan-Mamczarzauthor=J.+Steinhardtauthor=A.+Mahurkarauthor=K.+G.+Beckerauthor=K.+L.+Bordenauthor=R.+B.+Gartenhaus&title=MNKs+act+as+a+regulatory+switch+for+eIF4E1+and+eIF4E3+driven+mRNA+translation+in+DLBCL&doi=10.1038%2Fncomms6413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL</span></div><div class="casAuthors">Landon Ari L; Peroutka Raymond; Mazan-Mamczarz Krystyna; Steinhardt James; Muniandy Parameswary A; Houng Simone; Dai Bojie; Gartenhaus Ronald B; Shetty Amol C; Mahurkar Anup; Lehrmann Elin; Zhang Yongqing; Becker Kevin G; Volpon Laurent; Borden Katherine L</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5413</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The phosphorylation of eIF4E1 at serine 209 by MNK1 or MNK2 has been shown to initiate oncogenic mRNA translation, a process that favours cancer development and maintenance.  Here, we interrogate the MNK-eIF4E axis in diffuse large B-cell lymphoma (DLBCL) and show a distinct distribution of MNK1 and MNK2 in germinal centre B-cell (GCB) and activated B-cell (ABC) DLBCL.  Despite displaying a differential distribution in GCB and ABC, both MNKs functionally complement each other to sustain cell survival.  MNK inhibition ablates eIF4E1 phosphorylation and concurrently enhances eIF4E3 expression.  Loss of MNK protein itself downregulates total eIF4E1 protein level by reducing eIF4E1 mRNA polysomal loading without affecting total mRNA level or stability.  Enhanced eIF4E3 expression marginally suppresses eIF4E1-driven translation but exhibits a unique translatome that unveils a novel role for eIF4E3 in translation initiation.  We propose that MNKs can modulate oncogenic translation by regulating eIF4E1-eIF4E3 levels and activity in DLBCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRAX0_1tXXk2gRQsDqrjW_fW6udTcc2eYn116xF2Zic7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3ptVOnuw%253D%253D&md5=c74031f79715242324239fc9022c5cc6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fncomms6413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms6413%26sid%3Dliteratum%253Aachs%26aulast%3DLandon%26aufirst%3DA.%2BL.%26aulast%3DMuniandy%26aufirst%3DP.%2BA.%26aulast%3DShetty%26aufirst%3DA.%2BC.%26aulast%3DLehrmann%26aufirst%3DE.%26aulast%3DVolpon%26aufirst%3DL.%26aulast%3DHoung%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDai%26aufirst%3DB.%26aulast%3DPeroutka%26aufirst%3DR.%26aulast%3DMazan-Mamczarz%26aufirst%3DK.%26aulast%3DSteinhardt%26aufirst%3DJ.%26aulast%3DMahurkar%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DK.%2BG.%26aulast%3DBorden%26aufirst%3DK.%2BL.%26aulast%3DGartenhaus%26aufirst%3DR.%2BB.%26atitle%3DMNKs%2520act%2520as%2520a%2520regulatory%2520switch%2520for%2520eIF4E1%2520and%2520eIF4E3%2520driven%2520mRNA%2520translation%2520in%2520DLBCL%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D5413%26doi%3D10.1038%2Fncomms6413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span> <span> </span><span class="NLM_article-title">Targeting the eIF4F translation initiation complex: a critical nexus for cancer development</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-2789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1158%2F0008-5472.CAN-14-2789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=25593033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslWjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=250-263&issue=2&author=J.+Pelletierauthor=J.+Graffauthor=D.+Ruggeroauthor=N.+Sonenberg&title=Targeting+the+eIF4F+translation+initiation+complex%3A+a+critical+nexus+for+cancer+development&doi=10.1158%2F0008-5472.CAN-14-2789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development</span></div><div class="casAuthors">Pelletier, Jerry; Graff, Jeremy; Ruggero, Davide; Sonenberg, Nahum</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">250-263</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Elevated protein synthesis is an important feature of many cancer cells and often arises as a consequence of increased signaling flux channeled to eukaryotic initiation factor 4F (eIF4F), the key regulator of the mRNA-ribosome recruitment phase of translation initiation.  In many cellular and preclin. models of cancer, eIF4F deregulation results in changes in translational efficiency of specific mRNA classes.  Importantly, many of these mRNAs code for proteins that potently regulate crit. cellular processes, such as cell growth and proliferation, enhanced cell survival and cell migration that ultimately impinge on several hallmarks of cancer, including increased angiogenesis, deregulated growth control, enhanced cellular survival, epithelial-to-mesenchymal transition, invasion, and metastasis.  By being positioned as the mol. nexus downstream of key oncogenic signaling pathways (e.g., Ras, PI3K/AKT/TOR, and MYC), eIF4F serves as a direct link between important steps in cancer development and translation initiation.  Identification of mRNAs particularly responsive to elevated eIF4F activity that typifies tumorigenesis underscores the crit. role of eIF4F in cancer and raises the exciting possibility of developing new-in-class small mols. targeting translation initiation as antineoplastic agents.  Cancer Res; 75(2); 250-63. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrANjeFfkVBWLVg90H21EOLACvtfcHk0lgpW0iwFYSqXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslWjsQ%253D%253D&md5=2b463beb4fa91704c0eb0ea32f9f2d8f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-2789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-2789%26sid%3Dliteratum%253Aachs%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DGraff%26aufirst%3DJ.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DSonenberg%26aufirst%3DN.%26atitle%3DTargeting%2520the%2520eIF4F%2520translation%2520initiation%2520complex%253A%2520a%2520critical%2520nexus%2520for%2520cancer%2520development%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26issue%3D2%26spage%3D250%26epage%3D263%26doi%3D10.1158%2F0008-5472.CAN-14-2789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koumakpayi, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brueschke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petroulakis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaboury, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandolfi, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span> <span> </span><span class="NLM_article-title">eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span> (<span class="NLM_issue">32</span>),  <span class="NLM_fpage">14134</span>– <span class="NLM_lpage">14139</span>, <span class="refDoi"> DOI: 10.1073/pnas.1005320107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1073%2Fpnas.1005320107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=20679199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCkt77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=14134-14139&issue=32&author=L.+Furicauthor=L.+Rongauthor=O.+Larssonauthor=I.+H.+Koumakpayiauthor=K.+Yoshidaauthor=A.+Brueschkeauthor=E.+Petroulakisauthor=N.+Robichaudauthor=M.+Pollakauthor=L.+A.+Gabouryauthor=P.+P.+Pandolfiauthor=F.+Saadauthor=N.+Sonenberg&title=eIF4E+phosphorylation+promotes+tumorigenesis+and+is+associated+with+prostate+cancer+progression&doi=10.1073%2Fpnas.1005320107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression</span></div><div class="casAuthors">Furic, Luc; Rong, Liwei; Larsson, Ola; Koumakpayi, Ismael Herve; Yoshida, Kaori; Brueschke, Andrea; Petroulakis, Emmanuel; Robichaud, Nathaniel; Pollak, Michael; Gaboury, Louis A.; Pandolfi, Pier Paolo; Saad, Fred; Sonenberg, Nahum</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">14134-14139, S14134/1-S14134/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Translational regulation plays a crit. role in the control of cell growth and proliferation.  A key player in translational control is eIF4E, the mRNA 5' cap-binding protein.  Aberrant expression of eIF4E promotes tumorigenesis and has been implicated in cancer development and progression.  The activity of eIF4e is dysregulated in cancer.  Regulation of eIF4E is partly achieved through phosphorylation.  However, the physiol. significance of eIF4E phosphorylation in mammals is not clear.  Here, we show that knock-in mice expressing a nonphosphorylatable form of eIF4E are resistant to tumorigenesis in a prostate cancer model.  By using a genome-wide anal. of translated mRNAs, we show that the phosphorylation of eIF4E is required for translational up-regulation of several proteins implicated in tumorigenesis.  Accordingly, increased phospho-eIF4E levels correlate with disease progression in patients with prostate cancer.  Our findings establish eIF4E phosphorylation as a crit. event in tumorigenesis.  These findings raise the possibility that chem. compds. that prevent the phosphorylation of eIF4E could act as anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ8P8LhNfeprVg90H21EOLACvtfcHk0lgpW0iwFYSqXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCkt77O&md5=591da9e2c3b401f12acbace4f1986221</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1005320107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1005320107%26sid%3Dliteratum%253Aachs%26aulast%3DFuric%26aufirst%3DL.%26aulast%3DRong%26aufirst%3DL.%26aulast%3DLarsson%26aufirst%3DO.%26aulast%3DKoumakpayi%26aufirst%3DI.%2BH.%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DBrueschke%26aufirst%3DA.%26aulast%3DPetroulakis%26aufirst%3DE.%26aulast%3DRobichaud%26aufirst%3DN.%26aulast%3DPollak%26aufirst%3DM.%26aulast%3DGaboury%26aufirst%3DL.%2BA.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26aulast%3DSaad%26aufirst%3DF.%26aulast%3DSonenberg%26aufirst%3DN.%26atitle%3DeIF4E%2520phosphorylation%2520promotes%2520tumorigenesis%2520and%2520is%2520associated%2520with%2520prostate%2520cancer%2520progression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26issue%3D32%26spage%3D14134%26epage%3D14139%26doi%3D10.1073%2Fpnas.1005320107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druker, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruehauf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gram, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, S. T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6496</span>– <span class="NLM_lpage">6509</span>, <span class="refDoi"> DOI: 10.1128/MCB.00477-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1128%2FMCB.00477-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=18694961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CitL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=6496-6509&issue=20&author=M.+Zhangauthor=W.+Fuauthor=S.+Prabhuauthor=J.+C.+Mooreauthor=J.+Koauthor=J.+W.+Kimauthor=B.+J.+Drukerauthor=V.+Trappauthor=J.+Fruehaufauthor=H.+Gramauthor=H.+Y.+Fanauthor=S.+T.+Ong&title=Inhibition+of+polysome+assembly+enhances+imatinib+activity+against+chronic+myelogenous+leukemia+and+overcomes+imatinib+resistance&doi=10.1128%2FMCB.00477-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance</span></div><div class="casAuthors">Zhang, Min; Fu, Wuxia; Prabhu, Sharmila; Moore, James C.; Ko, Je; Kim, Jung Woo; Druker, Brian J.; Trapp, Valerie; Fruehauf, John; Gram, Hermann; Fan, Hung Y.; Ong, S. Tiong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6496-6509</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Dysregulated mRNA translation is implicated in the pathogenesis of many human cancers including chronic myelogenous leukemia (CML).  Because our prior work has specifically implicated translation initiation in CML, we tested compds. that could modulate translation initiation and polysomal mRNA assembly.  Here, we evaluated the activity of one such compd., CGP57380, against CML cells and explored its mechanisms of action.  First, using polysomal mRNA profiles, we found that imatinib and CGP57380 could independently, and cooperatively, impair polysomal mRNA loading.  Imatinib and CGP57380 also synergistically inhibited the growth of Ba/F3-Bcr-Abl and K562 cells via impaired cell cycle entry and increased apoptosis.  Mechanistically, CGP57380 inhibited efficient polysomal assembly via two processes.  First, it enhanced imatinib-mediated inhibition of eukaryotic initiation factor 4F induction, and second, it independently impaired phosphorylation of ribosomal protein S6 on the preinitiation complex.  We also identified multiple substrates of the mTOR, Rsk, and Mnk kinases as targets of CGP57380.  Finally, we found a novel neg.-feedback loop to the mitogen-activated protein kinase/Mnk pathway that is triggered by CGP57380 and demonstrated that an interruption of the loop further increased the activity of the combination against imatinib-sensitive and -resistant CML cells.  Together, this work supports the inhibition of translation initiation as a therapeutic strategy for treating cancers fueled by dysregulated translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ_MpGlackBLVg90H21EOLACvtfcHk0liEO4axYBlmwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CitL%252FL&md5=f68b04dfb7c777c7582f499e66056937</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FMCB.00477-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00477-08%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DW.%26aulast%3DPrabhu%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DJ.%2BC.%26aulast%3DKo%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DTrapp%26aufirst%3DV.%26aulast%3DFruehauf%26aufirst%3DJ.%26aulast%3DGram%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DH.%2BY.%26aulast%3DOng%26aufirst%3DS.%2BT.%26atitle%3DInhibition%2520of%2520polysome%2520assembly%2520enhances%2520imatinib%2520activity%2520against%2520chronic%2520myelogenous%2520leukemia%2520and%2520overcomes%2520imatinib%2520resistance%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26issue%3D20%26spage%3D6496%26epage%3D6509%26doi%3D10.1128%2FMCB.00477-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">American Cancer Society</span>. <span> </span><span class="NLM_article-title">Treating Chronic
Myeloid Leukemia by Phase</span>. <a href="http://www.cancer.org/cancer/leukemia-chronicmyeloidcml/detailedguide/leukemia-chronic-myeloid-myelogenous-treating-treating-by-phase" class="extLink">http://www.cancer.org/cancer/leukemia-chronicmyeloidcml/detailedguide/leukemia-chronic-myeloid-myelogenous-treating-treating-by-phase</a> (accessed Aug 5, <span class="NLM_year">2015</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=American+Cancer+Society&title=Treating+Chronic%0AMyeloid+Leukemia+by+Phase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DTreating%2520Chronic%250AMyeloid%2520Leukemia%2520by%2520Phase%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loriaux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deininger, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druker, B. J.</span></span> <span> </span><span class="NLM_article-title">Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">396</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1172/JCI35721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1172%2FJCI35721" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=396-409&issue=1&author=A.+S.+Corbinauthor=A.+Agarwalauthor=M.+Loriauxauthor=J.+Cortesauthor=M.+W.+Deiningerauthor=B.+J.+Druker&title=Human+chronic+myeloid+leukemia+stem+cells+are+insensitive+to+imatinib+despite+inhibition+of+BCR-ABL+activity&doi=10.1172%2FJCI35721"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1172%2FJCI35721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI35721%26sid%3Dliteratum%253Aachs%26aulast%3DCorbin%26aufirst%3DA.%2BS.%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DLoriaux%26aufirst%3DM.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26atitle%3DHuman%2520chronic%2520myeloid%2520leukemia%2520stem%2520cells%2520are%2520insensitive%2520to%2520imatinib%2520despite%2520inhibition%2520of%2520BCR-ABL%2520activity%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26issue%3D1%26spage%3D396%26epage%3D409%26doi%3D10.1172%2FJCI35721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wieczorek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uharek, L.</span></span> <span> </span><span class="NLM_article-title">Management of Chronic Myeloid Leukemia Patients Resistant to Tyrosine Kinase Inhibitors Treatment</span>. <i>Biomarker Insights</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">Suppl 3</span>),  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.4137/BMI.S22431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.4137%2FBMI.S22431" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=49-54&issue=Suppl+3&author=A.+Wieczorekauthor=L.+Uharek&title=Management+of+Chronic+Myeloid+Leukemia+Patients+Resistant+to+Tyrosine+Kinase+Inhibitors+Treatment&doi=10.4137%2FBMI.S22431"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.4137%2FBMI.S22431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4137%252FBMI.S22431%26sid%3Dliteratum%253Aachs%26aulast%3DWieczorek%26aufirst%3DA.%26aulast%3DUharek%26aufirst%3DL.%26atitle%3DManagement%2520of%2520Chronic%2520Myeloid%2520Leukemia%2520Patients%2520Resistant%2520to%2520Tyrosine%2520Kinase%2520Inhibitors%2520Treatment%26jtitle%3DBiomarker%2520Insights%26date%3D2015%26volume%3D10%26issue%3DSuppl%25203%26spage%3D49%26epage%3D54%26doi%3D10.4137%2FBMI.S22431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eiring, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khorashad, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redwine, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gantz, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomicter, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraft, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowler, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partlin, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hare, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deininger, M. W.</span></span> <span> </span><span class="NLM_article-title">Beta-catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2328</span>– <span class="NLM_lpage">2337</span>, <span class="refDoi"> DOI: 10.1038/leu.2015.196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1038%2Fleu.2015.196" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=2328-2337&issue=12&author=A.+M.+Eiringauthor=J.+S.+Khorashadauthor=D.+J.+Andersonauthor=F.+Yuauthor=H.+M.+Redwineauthor=C.+C.+Masonauthor=K.+R.+Reynoldsauthor=P.+M.+Clairauthor=K.+C.+Gantzauthor=T.+Y.+Zhangauthor=A.+D.+Pomicterauthor=I.+L.+Kraftauthor=A.+D.+Bowlerauthor=K.+Johnsonauthor=M.+M.+Partlinauthor=T.+O%E2%80%99Hareauthor=M.+W.+Deininger&title=Beta-catenin+is+required+for+intrinsic+but+not+extrinsic+BCR-ABL1+kinase-independent+resistance+to+tyrosine+kinase+inhibitors+in+chronic+myeloid+leukemia&doi=10.1038%2Fleu.2015.196"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fleu.2015.196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2015.196%26sid%3Dliteratum%253Aachs%26aulast%3DEiring%26aufirst%3DA.%2BM.%26aulast%3DKhorashad%26aufirst%3DJ.%2BS.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DRedwine%26aufirst%3DH.%2BM.%26aulast%3DMason%26aufirst%3DC.%2BC.%26aulast%3DReynolds%26aufirst%3DK.%2BR.%26aulast%3DClair%26aufirst%3DP.%2BM.%26aulast%3DGantz%26aufirst%3DK.%2BC.%26aulast%3DZhang%26aufirst%3DT.%2BY.%26aulast%3DPomicter%26aufirst%3DA.%2BD.%26aulast%3DKraft%26aufirst%3DI.%2BL.%26aulast%3DBowler%26aufirst%3DA.%2BD.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DPartlin%26aufirst%3DM.%2BM.%26aulast%3DO%25E2%2580%2599Hare%26aufirst%3DT.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%26atitle%3DBeta-catenin%2520is%2520required%2520for%2520intrinsic%2520but%2520not%2520extrinsic%2520BCR-ABL1%2520kinase-independent%2520resistance%2520to%2520tyrosine%2520kinase%2520inhibitors%2520in%2520chronic%2520myeloid%2520leukemia%26jtitle%3DLeukemia%26date%3D2015%26volume%3D29%26issue%3D12%26spage%3D2328%26epage%3D2337%26doi%3D10.1038%2Fleu.2015.196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Topisirovic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culjkovic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neering, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borden, K. L.</span></span> <span> </span><span class="NLM_article-title">Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">8992</span>– <span class="NLM_lpage">9002</span>, <span class="refDoi"> DOI: 10.1128/MCB.23.24.8992-9002.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1128%2FMCB.23.24.8992-9002.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=14645512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslGqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=8992-9002&issue=24&author=I.+Topisirovicauthor=M.+L.+Guzmanauthor=M.+J.+McConnellauthor=J.+D.+Lichtauthor=B.+Culjkovicauthor=S.+J.+Neeringauthor=C.+T.+Jordanauthor=K.+L.+Borden&title=Aberrant+eukaryotic+translation+initiation+factor+4E-dependent+mRNA+transport+impedes+hematopoietic+differentiation+and+contributes+to+leukemogenesis&doi=10.1128%2FMCB.23.24.8992-9002.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis</span></div><div class="casAuthors">Topisirovic, Ivan; Guzman, Monica L.; McConnell, Melanie J.; Licht, Jonathan D.; Culjkovic, Biljana; Neering, Sarah J.; Jordan, Craig T.; Borden, Katherine L. B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8992-9002</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The eukaryotic translation initiation factor 4E (eIF4E) acts as both a key translation factor and as a promoter of nucleocytoplasmic transport of specific transcripts.  Traditionally, its transformation capacity in vivo is attributed to its role in translation initiation in the cytoplasm.  Here, we demonstrate that elevated eIF4E impedes granulocytic and monocytic differentiation.  Our subsequent mutagenesis studies indicate that this block is a result of dysregulated eIF4E-dependent mRNA transport.  These studies indicate that the RNA transport function of eIF4E could contribute to leukemogenesis.  We extended our studies to provide the first evidence that the nuclear transport function of eIF4E contributes to human malignancy, specifically in a subset of acute and chronic myelogenous leukemia patients.  We observe an increase in eIF4E-dependent cyclin D1 mRNA transport and a concomitant increase in cyclin D1 protein levels.  The aberrant nuclear function of eIF4E is due to abnormally large eIF4E bodies and the loss of regulation by the proline-rich homeodomain PRH.  We developed a novel tool to modulate this transport activity.  The introduction of IκB, the repressor of NF-κB, leads to suppression of eIF4E, elevation of PRH, reorganization of eIF4E nuclear bodies, and subsequent downregulation of eIF4E-dependent mRNA transport.  Thus, our findings indicate that this nuclear function of eIF4E can contribute to leukemogenesis by promoting growth and by impeding differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqza9v1b2g5TLVg90H21EOLACvtfcHk0lg2O9qzYRBROA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslGqtrg%253D&md5=3ddc2e0431d096aab2b3e15a8aee708c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.24.8992-9002.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.24.8992-9002.2003%26sid%3Dliteratum%253Aachs%26aulast%3DTopisirovic%26aufirst%3DI.%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DMcConnell%26aufirst%3DM.%2BJ.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DCuljkovic%26aufirst%3DB.%26aulast%3DNeering%26aufirst%3DS.%2BJ.%26aulast%3DJordan%26aufirst%3DC.%2BT.%26aulast%3DBorden%26aufirst%3DK.%2BL.%26atitle%3DAberrant%2520eukaryotic%2520translation%2520initiation%2520factor%25204E-dependent%2520mRNA%2520transport%2520impedes%2520hematopoietic%2520differentiation%2520and%2520contributes%2520to%2520leukemogenesis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26issue%3D24%26spage%3D8992%26epage%3D9002%26doi%3D10.1128%2FMCB.23.24.8992-9002.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saw, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janes, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, A. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzieri, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuah, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, S. T.</span></span> <span> </span><span class="NLM_article-title">Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">E2298</span>– <span class="NLM_lpage">2307</span>, <span class="refDoi"> DOI: 10.1073/pnas.1301838110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1073%2Fpnas.1301838110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E2298-2307&issue=25&author=S.+Limauthor=T.+Y.+Sawauthor=M.+Zhangauthor=M.+R.+Janesauthor=K.+Nacroauthor=J.+Hillauthor=A.+Q.+Limauthor=C.+T.+Changauthor=D.+A.+Frumanauthor=D.+A.+Rizzieriauthor=S.+Y.+Tanauthor=H.+Fanauthor=C.+T.+Chuahauthor=S.+T.+Ong&title=Targeting+of+the+MNK-eIF4E+axis+in+blast+crisis+chronic+myeloid+leukemia+inhibits+leukemia+stem+cell+function&doi=10.1073%2Fpnas.1301838110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1301838110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1301838110%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DS.%26aulast%3DSaw%26aufirst%3DT.%2BY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DJanes%26aufirst%3DM.%2BR.%26aulast%3DNacro%26aufirst%3DK.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DA.%2BQ.%26aulast%3DChang%26aufirst%3DC.%2BT.%26aulast%3DFruman%26aufirst%3DD.%2BA.%26aulast%3DRizzieri%26aufirst%3DD.%2BA.%26aulast%3DTan%26aufirst%3DS.%2BY.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DChuah%26aufirst%3DC.%2BT.%26aulast%3DOng%26aufirst%3DS.%2BT.%26atitle%3DTargeting%2520of%2520the%2520MNK-eIF4E%2520axis%2520in%2520blast%2520crisis%2520chronic%2520myeloid%2520leukemia%2520inhibits%2520leukemia%2520stem%2520cell%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D25%26spage%3DE2298%26epage%3D2307%26doi%3D10.1073%2Fpnas.1301838110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, M.</span></span> <span> </span><span class="NLM_article-title">BCR-ABL kinase is dead; long live the CML stem cell</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1172/JCI43605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1172%2FJCI43605" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=22-25&issue=1&author=A.+Perlauthor=M.+Carroll&title=BCR-ABL+kinase+is+dead%3B+long+live+the+CML+stem+cell&doi=10.1172%2FJCI43605"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1172%2FJCI43605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI43605%26sid%3Dliteratum%253Aachs%26aulast%3DPerl%26aufirst%3DA.%26aulast%3DCarroll%26aufirst%3DM.%26atitle%3DBCR-ABL%2520kinase%2520is%2520dead%253B%2520long%2520live%2520the%2520CML%2520stem%2520cell%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26issue%3D1%26spage%3D22%26epage%3D25%26doi%3D10.1172%2FJCI43605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sands, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copland, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheadon, H.</span></span> <span> </span><span class="NLM_article-title">Targeting self-renewal pathways in myeloid malignancies</span>. <i>Cell Commun. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">33</span>, <span class="refDoi"> DOI: 10.1186/1478-811X-11-33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1186%2F1478-811X-11-33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=23675967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVaqsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=33&issue=1&author=W.+A.+Sandsauthor=M.+Coplandauthor=H.+Wheadon&title=Targeting+self-renewal+pathways+in+myeloid+malignancies&doi=10.1186%2F1478-811X-11-33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting self-renewal pathways in myeloid malignancies</span></div><div class="casAuthors">Sands, William A.; Copland, Mhairi; Wheadon, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Cell Communication and Signaling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33</span>CODEN:
                <span class="NLM_cas:coden">CCSEC6</span>;
        ISSN:<span class="NLM_cas:issn">1478-811X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  A fundamental property of hematopoietic stem cells (HSCs) is the ability to self-renew.  This is a complex process involving multiple signal transduction cascades which control the fine balance between self-renewal and differentiation through transcriptional networks.  Key activators/regulators of self-renewal include chemokines, cytokines and morphogens which are expressed in the bone marrow niche, either in a paracrine or autocrine fashion, and modulate stem cell behavior.  Increasing evidence suggests that the downstream signaling pathways induced by these ligands converge at multiple levels providing a degree of redundancy in steady state hematopoiesis.  Here we will focus on how these pathways cross-talk to regulate HSC self-renewal highlighting potential therapeutic windows which could be targeted to prevent leukemic stem cell self-renewal in myeloid malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolwoPnMgpyurVg90H21EOLACvtfcHk0lg2O9qzYRBROA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVaqsrbJ&md5=6ca20b3a52e89051a60b8845e7f97522</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1186%2F1478-811X-11-33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1478-811X-11-33%26sid%3Dliteratum%253Aachs%26aulast%3DSands%26aufirst%3DW.%2BA.%26aulast%3DCopland%26aufirst%3DM.%26aulast%3DWheadon%26aufirst%3DH.%26atitle%3DTargeting%2520self-renewal%2520pathways%2520in%2520myeloid%2520malignancies%26jtitle%3DCell%2520Commun.%2520Signaling%26date%3D2013%26volume%3D11%26issue%3D1%26spage%3D33%26doi%3D10.1186%2F1478-811X-11-33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span> <span> </span><span class="NLM_article-title">Inhibiting the MNK-eIF4E-beta-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapy</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">2906</span>– <span class="NLM_lpage">2915</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.13772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.18632%2Foncotarget.13772" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=2906-2915&issue=2&author=Z.+Liauthor=Y.+Sunauthor=M.+Quauthor=H.+Wanauthor=F.+Caiauthor=P.+Zhang&title=Inhibiting+the+MNK-eIF4E-beta-catenin+axis+increases+the+responsiveness+of+aggressive+breast+cancer+cells+to+chemotherapy&doi=10.18632%2Foncotarget.13772"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.13772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.13772%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DP.%26atitle%3DInhibiting%2520the%2520MNK-eIF4E-beta-catenin%2520axis%2520increases%2520the%2520responsiveness%2520of%2520aggressive%2520breast%2520cancer%2520cells%2520to%2520chemotherapy%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26issue%3D2%26spage%3D2906%26epage%3D2915%26doi%3D10.18632%2Foncotarget.13772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">Targeting the eIF4E/beta-catenin axis sensitizes cervical carcinoma squamous cells to chemotherapy</span>. <i>Am. J. Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1203</span>– <span class="NLM_lpage">1212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=28386346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A280%3ADC%252BC1cvlsFWhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1203-1212&issue=3&author=H.+Xuauthor=Z.+Wangauthor=L.+Xuauthor=G.+Moauthor=G.+Duanauthor=Y.+Wangauthor=Z.+Sunauthor=H.+Chen&title=Targeting+the+eIF4E%2Fbeta-catenin+axis+sensitizes+cervical+carcinoma+squamous+cells+to+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the eIF4E/β-catenin axis sensitizes cervical carcinoma squamous cells to chemotherapy</span></div><div class="casAuthors">Xu Hai; Wang Zhiyin; Xu Lang; Mo Guoyan; Duan Gangfeng; Wang Yali; Sun Zhengang; Chen Hao</div><div class="citationInfo"><span class="NLM_cas:title">American journal of translational research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1203-1212</span>
        ISSN:<span class="NLM_cas:issn">1943-8141</span>.
    </div><div class="casAbstract">Chemotherapy has improved the clinical outcomes of cervical cancer patients.  However, patients develop chemoresistance, whose underlying mechanisms are not well understood.  In this study, we investigated the phosphorylation levels of eukaryotic translation initiation factor 4E (eIF4E) in cervical cancer cells subjected to chemotherapy.  Results showed that chemotherapeutic drugs significantly increased eIF4E phosphorylation at S209 in HeLa and SiHa cells.  Upregulation of phosphorylated eIF4E (p-eIF4E) levels has also been shown in cisplatin-resistant HeLa cells and has been observed to be a common response of cervical cancer patients undergoing chemotherapy.  We further showed that chemotherapeutic drugs increase β-catenin activity and mRNA levels of Wnt/β-catenin target genes in cervical cancer cells but not in eIF4E-depleted cells, suggesting that chemotherapeutic drugs activate Wnt/β-catenin signaling in an eIF4E-dependent manner.  Inhibiting eIF4E via siRNA knockdown or Wnt/β-catenin using the Wnt inhibitor pyrvinium effectively enhanced the anti-proliferative and pro-apoptotic effects of cisplatin in cervical cancer cells both in vitro and in vivo.  Our findings demonstrate that eIF4E/β-catenin signaling plays a positive regulatory role in the resistance of cervical cancer cell to chemotherapy and thus highlight the therapeutic value of eIF4E or β-catenin inhibition in overcoming chemoresistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSK455vL2Kz2K_dlEzl_fBafW6udTcc2eYPb29nsluYirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvlsFWhtA%253D%253D&md5=57e3d89a5d737ee722201f30f3c00d7c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DMo%26aufirst%3DG.%26aulast%3DDuan%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DTargeting%2520the%2520eIF4E%252Fbeta-catenin%2520axis%2520sensitizes%2520cervical%2520carcinoma%2520squamous%2520cells%2520to%2520chemotherapy%26jtitle%3DAm.%2520J.%2520Transl.%2520Res.%26date%3D2017%26volume%3D9%26issue%3D3%26spage%3D1203%26epage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hehlmann, R.</span></span> <span> </span><span class="NLM_article-title">How I treat CML blast crisis</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1182/blood-2012-03-380147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1182%2Fblood-2012-03-380147" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=737-747&issue=4&author=R.+Hehlmann&title=How+I+treat+CML+blast+crisis&doi=10.1182%2Fblood-2012-03-380147"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-03-380147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-03-380147%26sid%3Dliteratum%253Aachs%26aulast%3DHehlmann%26aufirst%3DR.%26atitle%3DHow%2520I%2520treat%2520CML%2520blast%2520crisis%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26issue%3D4%26spage%3D737%26epage%3D747%26doi%3D10.1182%2Fblood-2012-03-380147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dreas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikulski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabritius, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzozka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rzymski, T.</span></span> <span> </span><span class="NLM_article-title">Mitogen-activated protein kinase (MAPK) interacting kinases 1 and 2 (MNK1 and MNK2) as targets for cancer therapy: recent progress in the development of MNK inhibitors</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">3025</span>– <span class="NLM_lpage">3053</span>, <span class="refDoi"> DOI: 10.2174/0929867324666170203123427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.2174%2F0929867324666170203123427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=28164761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1SqsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=3025-3053&issue=28&author=A.+Dreasauthor=M.+Mikulskiauthor=M.+Milikauthor=C.+H.+Fabritiusauthor=K.+Brzozkaauthor=T.+Rzymski&title=Mitogen-activated+protein+kinase+%28MAPK%29+interacting+kinases+1+and+2+%28MNK1+and+MNK2%29+as+targets+for+cancer+therapy%3A+recent+progress+in+the+development+of+MNK+inhibitors&doi=10.2174%2F0929867324666170203123427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors</span></div><div class="casAuthors">Dreas, Agnieszka; Mikulski, Maciej; Milik, Mariusz; Fabritius, Charles-Henry; Brzozka, Krzysztof; Rzymski, Tomasz</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3025-3053</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">MAP kinase-interacting kinases (MNK1 and MNK2) are often activated downstream of ERK and p38 MAPK in the MAP kinase family.  The role of MNKs in the development and progression of solid tumors and hematol. malignancies has been widely discussed, particularly in the context of cap dependent translation, regulated by phosphorylation of eIF4E.  MNK/eIF4E axis is involved in the expression of pro angiogenic, antiapoptotic, cell cycle, and motility proteins, such as MCL1, VEGF, MMP3, SNAIL, SMAD2, β-catenin or cyclin D1, and is essential during Ras and c Myc-induced transformation.  MNK1/2 emerged as eligible targets for drug discovery in oncol., based on the antitumor effects obsd. in genetic knockout and RNA interference expts. and at the same time lack of adverse effects in dual knockout animals. </P><P> There is a high interest in the development of pharmacol. inhibitors of MNK1/2 as not only tools for further basic research studies but also potential drugs in diseases characterized by deregulated translation.  Unfortunately, the role of MNK1/2 in cancer still remains elusive due to the absence of potent and selective probes.  Moreover, in many instances, hypotheses have been built reliant upon unspecific MNK1/2 inhibitors such as CGP57380 or cercosporamide.  Lately, the first two clin. programs targeting MNKs in oncol. have been revealed (eFT508 and BAY 1143269), although several other MNK programs are currently running at the preclin. stage.  This review aims to provide an overview of recent progress in the development of MNK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjWDeCrlHD07Vg90H21EOLACvtfcHk0li4Ckqi4xsY5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1SqsrnI&md5=c2a37d37d69521b11a38bb100e7964af</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F0929867324666170203123427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867324666170203123427%26sid%3Dliteratum%253Aachs%26aulast%3DDreas%26aufirst%3DA.%26aulast%3DMikulski%26aufirst%3DM.%26aulast%3DMilik%26aufirst%3DM.%26aulast%3DFabritius%26aufirst%3DC.%2BH.%26aulast%3DBrzozka%26aufirst%3DK.%26aulast%3DRzymski%26aufirst%3DT.%26atitle%3DMitogen-activated%2520protein%2520kinase%2520%2528MAPK%2529%2520interacting%2520kinases%25201%2520and%25202%2520%2528MNK1%2520and%2520MNK2%2529%2520as%2520targets%2520for%2520cancer%2520therapy%253A%2520recent%2520progress%2520in%2520the%2520development%2520of%2520MNK%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2017%26volume%3D24%26issue%3D28%26spage%3D3025%26epage%3D3053%26doi%3D10.2174%2F0929867324666170203123427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Targeting Mnks for cancer therapy</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.18632%2Foncotarget.453" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=118-131&issue=2&author=J.+Houauthor=F.+Lamauthor=C.+Proudauthor=S.+Wang&title=Targeting+Mnks+for+cancer+therapy&doi=10.18632%2Foncotarget.453"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.453%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DLam%26aufirst%3DF.%26aulast%3DProud%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DTargeting%2520Mnks%2520for%2520cancer%2520therapy%26jtitle%3DOncotarget%26date%3D2012%26volume%3D3%26issue%3D2%26spage%3D118%26epage%3D131%26doi%3D10.18632%2Foncotarget.453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knauf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brauchle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glueck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">New, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gram, H.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of eIF-4E on Ser 209 in response to mitogenic and inflammatory stimuli is faithfully detected by specific antibodies</span>. <i>Mol. Cell Biol. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1006/mcbr.2000.0217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1006%2Fmcbr.2000.0217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10891393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1Oksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2000&pages=205-211&issue=4&author=C.+Tschoppauthor=U.+Knaufauthor=M.+Brauchleauthor=M.+Zuriniauthor=P.+Ramageauthor=D.+Glueckauthor=L.+Newauthor=J.+Hanauthor=H.+Gram&title=Phosphorylation+of+eIF-4E+on+Ser+209+in+response+to+mitogenic+and+inflammatory+stimuli+is+faithfully+detected+by+specific+antibodies&doi=10.1006%2Fmcbr.2000.0217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of eIF-4E on Ser 209 in Response to Mitogenic and Inflammatory Stimuli Is Faithfully Detected by Specific Antibodies</span></div><div class="casAuthors">Tschopp, C.; Knauf, U.; Brauchle, M.; Zurini, M.; Ramage, P.; Glueck, D.; New, L.; Han, J.; Gram, H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell Biology Research Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">205-211</span>CODEN:
                <span class="NLM_cas:coden">MCBCFS</span>;
        ISSN:<span class="NLM_cas:issn">1522-4724</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Phosphorylation of Ser 209 is thought to modulate the activity of the cap-binding factor eIF-4E which is a crucial component in the initiation complex for cap-dependent translation of mRNA.  We report here the full reconstitution of the p38 Map kinase cascade leading to phosphorylation of eIF-4E in vitro and the generation of antibodies specific for phospho-serine 209 in eIF-4E.  These antibodies were used to probe the phosphorylation of eIF-4E in mammalian cells stimulated with mitogens and pro-inflammatory cytokines.  Treatment of human dermal fibroblasts with FCS led to a transient hyperphosphorylation, followed by hypophosphorylation and return to normal state phosphorylation at 16 h after the initial stimulation.  By using a potent small mol. wt. inhibitor of Mnk1, the upstream kinase for eIF-4E, we obsd. a rapid dephosphorylation of eIF-4E within 45 min after addn. of the inhibitor, suggesting a high turnover of phosphate on eIF-4E mediated by Mnk1 and a yet unidentified phosphatase.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotCmUVSQhgrLVg90H21EOLACvtfcHk0li4Ckqi4xsY5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1Oksr8%253D&md5=48874e603139eb9d71cb28884905bd3a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1006%2Fmcbr.2000.0217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcbr.2000.0217%26sid%3Dliteratum%253Aachs%26aulast%3DTschopp%26aufirst%3DC.%26aulast%3DKnauf%26aufirst%3DU.%26aulast%3DBrauchle%26aufirst%3DM.%26aulast%3DZurini%26aufirst%3DM.%26aulast%3DRamage%26aufirst%3DP.%26aulast%3DGlueck%26aufirst%3DD.%26aulast%3DNew%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DGram%26aufirst%3DH.%26atitle%3DPhosphorylation%2520of%2520eIF-4E%2520on%2520Ser%2520209%2520in%2520response%2520to%2520mitogenic%2520and%2520inflammatory%2520stimuli%2520is%2520faithfully%2520detected%2520by%2520specific%2520antibodies%26jtitle%3DMol.%2520Cell%2520Biol.%2520Res.%2520Commun.%26date%3D2000%26volume%3D3%26issue%3D4%26spage%3D205%26epage%3D211%26doi%3D10.1006%2Fmcbr.2000.0217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knauf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gram, H.</span></span> <span> </span><span class="NLM_article-title">Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">5500</span>– <span class="NLM_lpage">5511</span>, <span class="refDoi"> DOI: 10.1128/MCB.21.16.5500-5511.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1128%2FMCB.21.16.5500-5511.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=11463832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslOjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=5500-5511&issue=16&author=U.+Knaufauthor=C.+Tschoppauthor=H.+Gram&title=Negative+regulation+of+protein+translation+by+mitogen-activated+protein+kinase-interacting+kinases+1+and+2&doi=10.1128%2FMCB.21.16.5500-5511.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2</span></div><div class="casAuthors">Knauf, Ursula; Tschopp, Claude; Gram, Hermann</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5500-5511</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Eukaryotic initiation factor 4E (eIF4E) is a key component of the translational machinery and an important modulator of cell growth and proliferation.  The activity of eIF4E is thought to be regulated by interaction with inhibitory binding proteins (4E-BPs) and phosphorylation by mitogen-activated protein (MAP) kinase-interacting kinase (MNK) on Ser209 in response to mitogens and cellular stress.  Here we demonstrate that phosphorylation of eIF4E via MNK1 is mediated via the activation of either the Erk or p38 pathway.  We further show that expression of active mutants of MNK1 and MNK2 in 293 cells diminishes cap-dependent translation relative to cap-independent translation in a transient reporter assay.  The same effect on cap-dependent translation was obsd. when MNK1 was activated by the Erk or p38 pathway.  In line with these findings, addn. of recombinant active MNK1 to rabbit reticulocyte lysate resulted in a reduced protein synthesis in vitro, and overexpression of MNK2 caused a decreased rate of protein synthesis in 293 cells.  By using CGP 57380, a novel low-mol.-wt. kinase inhibitor of MNK1, we demonstrate that eIF4E phosphorylation is not crucial to the formation of the initiation complex, mitogen-stimulated increase in cap-dependent translation, and cell proliferation.  Our results imply that activation of MNK by MAP kinase pathways does not constitute a pos. regulatory mechanism to cap-dependent translation.  Instead, we propose that the kinase activity of MNKs, eventually through phosphorylation of eIF4E, may serve to limit cap-dependent translation under physiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruNOjANWg6jLVg90H21EOLACvtfcHk0li1UHS99T_2sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslOjtb0%253D&md5=e50d12905c25505de246ca9a80e3da83</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1128%2FMCB.21.16.5500-5511.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.21.16.5500-5511.2001%26sid%3Dliteratum%253Aachs%26aulast%3DKnauf%26aufirst%3DU.%26aulast%3DTschopp%26aufirst%3DC.%26aulast%3DGram%26aufirst%3DH.%26atitle%3DNegative%2520regulation%2520of%2520protein%2520translation%2520by%2520mitogen-activated%2520protein%2520kinase-interacting%2520kinases%25201%2520and%25202%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D21%26issue%3D16%26spage%3D5500%26epage%3D5511%26doi%3D10.1128%2FMCB.21.16.5500-5511.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kambe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizumi, M.</span></span> <span> </span><span class="NLM_article-title">Mnk1 is required for angiotensin II-induced protein synthesis in vascular smooth muscle cells</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1218</span>– <span class="NLM_lpage">1224</span>, <span class="refDoi"> DOI: 10.1161/01.RES.0000105570.34585.F2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1161%2F01.RES.0000105570.34585.F2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2003&pages=1218-1224&issue=12&author=M.+Ishidaauthor=T.+Ishidaauthor=H.+Nakashimaauthor=N.+Mihoauthor=K.+Miyagawaauthor=K.+Chayamaauthor=T.+Oshimaauthor=M.+Kambeauthor=M.+Yoshizumi&title=Mnk1+is+required+for+angiotensin+II-induced+protein+synthesis+in+vascular+smooth+muscle+cells&doi=10.1161%2F01.RES.0000105570.34585.F2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000105570.34585.F2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000105570.34585.F2%26sid%3Dliteratum%253Aachs%26aulast%3DIshida%26aufirst%3DM.%26aulast%3DIshida%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DMiho%26aufirst%3DN.%26aulast%3DMiyagawa%26aufirst%3DK.%26aulast%3DChayama%26aufirst%3DK.%26aulast%3DOshima%26aufirst%3DT.%26aulast%3DKambe%26aufirst%3DM.%26aulast%3DYoshizumi%26aufirst%3DM.%26atitle%3DMnk1%2520is%2520required%2520for%2520angiotensin%2520II-induced%2520protein%2520synthesis%2520in%2520vascular%2520smooth%2520muscle%2520cells%26jtitle%3DCirc.%2520Res.%26date%3D2003%26volume%3D93%26issue%3D12%26spage%3D1218%26epage%3D1224%26doi%3D10.1161%2F01.RES.0000105570.34585.F2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konicek, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peery, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumstorf, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowless, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iversen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yingling, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stancato, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1849</span>– <span class="NLM_lpage">1857</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-3298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1158%2F0008-5472.CAN-10-3298" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=1849-1857&issue=5&author=B.+W.+Konicekauthor=J.+R.+Stephensauthor=A.+M.+McNultyauthor=N.+Robichaudauthor=R.+B.+Peeryauthor=C.+A.+Dumstorfauthor=M.+S.+Dowlessauthor=P.+W.+Iversenauthor=S.+Parsonsauthor=K.+E.+Ellisauthor=D.+J.+McCannauthor=J.+Pelletierauthor=L.+Furicauthor=J.+M.+Yinglingauthor=L.+F.+Stancatoauthor=N.+Sonenbergauthor=J.+R.+Graff&title=Therapeutic+inhibition+of+MAP+kinase+interacting+kinase+blocks+eukaryotic+initiation+factor+4E+phosphorylation+and+suppresses+outgrowth+of+experimental+lung+metastases&doi=10.1158%2F0008-5472.CAN-10-3298"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-3298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-3298%26sid%3Dliteratum%253Aachs%26aulast%3DKonicek%26aufirst%3DB.%2BW.%26aulast%3DStephens%26aufirst%3DJ.%2BR.%26aulast%3DMcNulty%26aufirst%3DA.%2BM.%26aulast%3DRobichaud%26aufirst%3DN.%26aulast%3DPeery%26aufirst%3DR.%2BB.%26aulast%3DDumstorf%26aufirst%3DC.%2BA.%26aulast%3DDowless%26aufirst%3DM.%2BS.%26aulast%3DIversen%26aufirst%3DP.%2BW.%26aulast%3DParsons%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DK.%2BE.%26aulast%3DMcCann%26aufirst%3DD.%2BJ.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DFuric%26aufirst%3DL.%26aulast%3DYingling%26aufirst%3DJ.%2BM.%26aulast%3DStancato%26aufirst%3DL.%2BF.%26aulast%3DSonenberg%26aufirst%3DN.%26aulast%3DGraff%26aufirst%3DJ.%2BR.%26atitle%3DTherapeutic%2520inhibition%2520of%2520MAP%2520kinase%2520interacting%2520kinase%2520blocks%2520eukaryotic%2520initiation%2520factor%25204E%2520phosphorylation%2520and%2520suppresses%2520outgrowth%2520of%2520experimental%2520lung%2520metastases%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D5%26spage%3D1849%26epage%3D1857%26doi%3D10.1158%2F0008-5472.CAN-10-3298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basnet, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diab, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.ejmech.2015.09.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=539-550&author=T.+Teoauthor=Y.+Yangauthor=M.+Yuauthor=S.+K.+Basnetauthor=T.+Gillamauthor=J.+Houauthor=R.+M.+Schmidauthor=M.+Kumarasiriauthor=S.+Diabauthor=H.+Albrechtauthor=M.+J.+Sykesauthor=S.+Wang&title=An+integrated+approach+for+discovery+of+highly+potent+and+selective+Mnk+inhibitors%3A+Screening%2C+synthesis+and+SAR+analysis&doi=10.1016%2Fj.ejmech.2015.09.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DBasnet%26aufirst%3DS.%2BK.%26aulast%3DGillam%26aufirst%3DT.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DSchmid%26aufirst%3DR.%2BM.%26aulast%3DKumarasiri%26aufirst%3DM.%26aulast%3DDiab%26aufirst%3DS.%26aulast%3DAlbrecht%26aufirst%3DH.%26aulast%3DSykes%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DAn%2520integrated%2520approach%2520for%2520discovery%2520of%2520highly%2520potent%2520and%2520selective%2520Mnk%2520inhibitors%253A%2520Screening%252C%2520synthesis%2520and%2520SAR%2520analysis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D103%26spage%3D539%26epage%3D550%26doi%3D10.1016%2Fj.ejmech.2015.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diab, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basnet, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5-(2-(phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one derivatives as potent Mnk2 inhibitors: synthesis, SAR analysis and biological evaluation</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">972</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1002%2Fcmdc.201300552" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=962-972&issue=5&author=S.+Diabauthor=T.+Teoauthor=M.+Kumarasiriauthor=P.+Liauthor=M.+Yuauthor=F.+Lamauthor=S.+K.+Basnetauthor=M.+J.+Sykesauthor=H.+Albrechtauthor=R.+Milneauthor=S.+Wang&title=Discovery+of+5-%282-%28phenylamino%29pyrimidin-4-yl%29thiazol-2%283H%29-one+derivatives+as+potent+Mnk2+inhibitors%3A+synthesis%2C+SAR+analysis+and+biological+evaluation&doi=10.1002%2Fcmdc.201300552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300552%26sid%3Dliteratum%253Aachs%26aulast%3DDiab%26aufirst%3DS.%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DKumarasiri%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DF.%26aulast%3DBasnet%26aufirst%3DS.%2BK.%26aulast%3DSykes%26aufirst%3DM.%2BJ.%26aulast%3DAlbrecht%26aufirst%3DH.%26aulast%3DMilne%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25205-%25282-%2528phenylamino%2529pyrimidin-4-yl%2529thiazol-2%25283H%2529-one%2520derivatives%2520as%2520potent%2520Mnk2%2520inhibitors%253A%2520synthesis%252C%2520SAR%2520analysis%2520and%2520biological%2520evaluation%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26issue%3D5%26spage%3D962%26epage%3D972%26doi%3D10.1002%2Fcmdc.201300552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kosciuczuk, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleiro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroczynska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckerdt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blyth, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abedin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span> <span> </span><span class="NLM_article-title">Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1182/blood-2016-02-698704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1182%2Fblood-2016-02-698704" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=410-414&issue=3&author=E.+M.+Kosciuczukauthor=D.+Saleiroauthor=B.+Kroczynskaauthor=E.+M.+Beauchampauthor=F.+Eckerdtauthor=G.+T.+Blythauthor=S.+M.+Abedinauthor=F.+J.+Gilesauthor=J.+K.+Altmanauthor=L.+C.+Platanias&title=Merestinib+blocks+Mnk+kinase+activity+in+acute+myeloid+leukemia+progenitors+and+exhibits+antileukemic+effects+in+vitro+and+in+vivo&doi=10.1182%2Fblood-2016-02-698704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1182%2Fblood-2016-02-698704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2016-02-698704%26sid%3Dliteratum%253Aachs%26aulast%3DKosciuczuk%26aufirst%3DE.%2BM.%26aulast%3DSaleiro%26aufirst%3DD.%26aulast%3DKroczynska%26aufirst%3DB.%26aulast%3DBeauchamp%26aufirst%3DE.%2BM.%26aulast%3DEckerdt%26aufirst%3DF.%26aulast%3DBlyth%26aufirst%3DG.%2BT.%26aulast%3DAbedin%26aufirst%3DS.%2BM.%26aulast%3DGiles%26aufirst%3DF.%2BJ.%26aulast%3DAltman%26aufirst%3DJ.%2BK.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26atitle%3DMerestinib%2520blocks%2520Mnk%2520kinase%2520activity%2520in%2520acute%2520myeloid%2520leukemia%2520progenitors%2520and%2520exhibits%2520antileukemic%2520effects%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26issue%3D3%26spage%3D410%26epage%3D414%26doi%3D10.1182%2Fblood-2016-02-698704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic co-inhibition of Mnks and mTORC1 synergistically suppresses proliferation and perturbs cell cycle progression in blast crisis-chronic myeloid leukemia cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>357</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">612</span>– <span class="NLM_lpage">623</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2014.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.canlet.2014.12.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=25527453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislKguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2015&pages=612-623&issue=2&author=T.+Teoauthor=M.+Yuauthor=Y.+Yangauthor=T.+Gillamauthor=F.+Lamauthor=M.+J.+Sykesauthor=S.+Wang&title=Pharmacologic+co-inhibition+of+Mnks+and+mTORC1+synergistically+suppresses+proliferation+and+perturbs+cell+cycle+progression+in+blast+crisis-chronic+myeloid+leukemia+cells&doi=10.1016%2Fj.canlet.2014.12.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic co-inhibition of Mnks and mTORC1 synergistically suppresses proliferation and perturbs cell cycle progression in blast crisis-chronic myeloid leukemia cells</span></div><div class="casAuthors">Teo, Theodosia; Yu, Mingfeng; Yang, Yuchao; Gillam, Todd; Lam, Frankie; Sykes, Matthew J.; Wang, Shudong</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">612-623</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The Ras/Raf/MAPK and PI3K/Akt/mTORC1 cascades are two most aberrantly regulated pathways in cancers.  As MAPK-interacting kinases (Mnks) are part of the convergent node of these two pathways, and play a pivotal role in cellular transformation, targeting Mnks has emerged as a potential therapeutic strategy.  Herein, a dual-specific Mnk1/2 inhibitor MNKI-57 and a potent Mnk2-specific inhibitor MNKI-4 were selected for a panel screen against 28 human cancer cell lines.  The study reveals that MNKI-57 and MNKI-4 are most potent against leukemia cells KYO-1 (i.e. BC-CML) and KG-1 (i.e. AML).  Interestingly, we found that sensitivity of selected leukemia cells to Mnk inhibitors is correlated with the level of phosphorylated 4E-BP1 at Thr70.  The anti-proliferative effects of Mnk inhibitors are cytostatic in the sensitive KYO-1 cells, inducing significant G1 arrest via down-regulation of cyclin D1 expression.  In KYO-1 cells where Akt is not constitutively active, Mnk inhibitors increase the sensitivity of cells to rapamycin, resulting in a more pronounced anti-proliferative activity.  Remarkably, the synergistic anti-proliferative effects are assocd. with a marked de-phosphorylation of 4E-BP1 at Thr70.  Collectively, these data highlight the importance of 4E-BP1 as a key integrator in the MAPK and mTORC1 cascades, and suggest that a combined pharmacol. inhibition of mTORC1 and Mnk kinases offers an innovative therapeutic opportunity in BC-CML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonXVLjuzQn5rVg90H21EOLACvtfcHk0liToEGVgxOdCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislKguw%253D%253D&md5=a6b1457af0a8430b7976195e8e1b9c5d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGillam%26aufirst%3DT.%26aulast%3DLam%26aufirst%3DF.%26aulast%3DSykes%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPharmacologic%2520co-inhibition%2520of%2520Mnks%2520and%2520mTORC1%2520synergistically%2520suppresses%2520proliferation%2520and%2520perturbs%2520cell%2520cycle%2520progression%2520in%2520blast%2520crisis-chronic%2520myeloid%2520leukemia%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D357%26issue%3D2%26spage%3D612%26epage%3D623%26doi%3D10.1016%2Fj.canlet.2014.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basnet, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic inhibition of MNKs in acute myeloid leukemia</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1124/mol.115.098012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1124%2Fmol.115.098012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=380-389&issue=2&author=T.+Teoauthor=F.+Lamauthor=M.+Yuauthor=Y.+Yangauthor=S.+K.+Basnetauthor=H.+Albrechtauthor=M.+J.+Sykesauthor=S.+Wang&title=Pharmacologic+inhibition+of+MNKs+in+acute+myeloid+leukemia&doi=10.1124%2Fmol.115.098012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.098012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.098012%26sid%3Dliteratum%253Aachs%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DLam%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBasnet%26aufirst%3DS.%2BK.%26aulast%3DAlbrecht%26aufirst%3DH.%26aulast%3DSykes%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPharmacologic%2520inhibition%2520of%2520MNKs%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26issue%3D2%26spage%3D380%26epage%3D389%26doi%3D10.1124%2Fmol.115.098012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amiri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafer, C. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a selective and potent inhibitor of mitogen-activated protein kinase-interacting kinases 1 and 2 (MNK1/2) utilizing structure-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3034</span>– <span class="NLM_lpage">3045</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01657</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3034-3045&issue=7&author=W.+Hanauthor=Y.+Dingauthor=Y.+Xuauthor=K.+Pfisterauthor=S.+Zhuauthor=B.+Warneauthor=M.+Doyleauthor=M.+Aikawaauthor=P.+Amiriauthor=B.+Appletonauthor=D.+D.+Stuartauthor=A.+Fanidiauthor=C.+M.+Shafer&title=Discovery+of+a+selective+and+potent+inhibitor+of+mitogen-activated+protein+kinase-interacting+kinases+1+and+2+%28MNK1%2F2%29+utilizing+structure-based+drug+design&doi=10.1021%2Facs.jmedchem.5b01657"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01657%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DW.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DPfister%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DWarne%26aufirst%3DB.%26aulast%3DDoyle%26aufirst%3DM.%26aulast%3DAikawa%26aufirst%3DM.%26aulast%3DAmiri%26aufirst%3DP.%26aulast%3DAppleton%26aufirst%3DB.%26aulast%3DStuart%26aufirst%3DD.%2BD.%26aulast%3DFanidi%26aufirst%3DA.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520selective%2520and%2520potent%2520inhibitor%2520of%2520mitogen-activated%2520protein%2520kinase-interacting%2520kinases%25201%2520and%25202%2520%2528MNK1%252F2%2529%2520utilizing%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D7%26spage%3D3034%26epage%3D3045%26doi%3D10.1021%2Facs.jmedchem.5b01657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eis, K.</span></span> <span> </span><span class="NLM_article-title">Amino-Substituted Imidazopyridazines</span>. <span class="NLM_patent">WO/2013/034570</span>, March 14, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=K.+Eis&title=Amino-Substituted+Imidazopyridazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEis%26aufirst%3DK.%26atitle%3DAmino-Substituted%2520Imidazopyridazines%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eis, K. P. F.</span>; <span class="NLM_string-name">Zorn, L.</span>; <span class="NLM_string-name">Scholz, A.</span>; <span class="NLM_string-name">Lienau, P.</span>; <span class="NLM_string-name">Gnoth, M.
J.</span>; <span class="NLM_string-name">Bömer, U.</span>; <span class="NLM_string-name">Günther, J.</span>; <span class="NLM_string-name">Hitchcock, M.</span></span> <span> </span><span class="NLM_article-title">Amino-Substituted Imidazopyridazines</span>. <span class="NLM_patent">WO/2013/087581</span>, June 20, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=K.+P.+F.+Eis&author=L.+Zorn&author=A.+Scholz&author=P.+Lienau&author=M.%0AJ.+Gnoth&author=U.+B%C3%B6mer&author=J.+G%C3%BCnther&author=M.+Hitchcock&title=Amino-Substituted+Imidazopyridazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEis%26aufirst%3DK.%2BP.%2BF.%26atitle%3DAmino-Substituted%2520Imidazopyridazines%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">National
Institutes of Health,
U.S. National Library of Medicine</span>. <span> </span><span class="NLM_article-title">Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination
With Intravenous Docetaxel</span>. <a href="https://clinicaltrials.gov/ct2/show/NCT02439346" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02439346</a> (accessed February 2, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=National%0AInstitutes+of+Health%2C%0AU.S.+National+Library+of+Medicine&title=Phase+I+Dose+Escalation+and+Expansion+of+Oral+BAY+1143269+in+Combination%0AWith+Intravenous+Docetaxel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DPhase%2520I%2520Dose%2520Escalation%2520and%2520Expansion%2520of%2520Oral%2520BAY%25201143269%2520in%2520Combination%250AWith%2520Intravenous%2520Docetaxel%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Webster, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegerski, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengeler, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reich, S. H.</span></span> <span> </span><span class="NLM_article-title">eFT508, a potent and selective mitogen-activated protein kinase interacting kinase (MNK) 1 and 2 inhibitor, is efficacious in preclinical models of diffuse large b-cell lymphoma (DLBCL)</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">1554</span>– <span class="NLM_lpage">1554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=1554-1554&issue=23&author=K.+R.+Websterauthor=V.+K.+Goelauthor=I.+N.+Hungauthor=G.+S.+Parkerauthor=J.+Stauntonauthor=M.+Nealauthor=J.+Molterauthor=G.+G.+Chiangauthor=K.+A.+Jessenauthor=C.+J.+Wegerskiauthor=S.+Sperryauthor=V.+Huangauthor=J.+Chenauthor=P.+A.+Thompsonauthor=J.+R.+Applemanauthor=S.+E.+Webberauthor=P.+A.+Sprengelerauthor=S.+H.+Reich&title=eFT508%2C+a+potent+and+selective+mitogen-activated+protein+kinase+interacting+kinase+%28MNK%29+1+and+2+inhibitor%2C+is+efficacious+in+preclinical+models+of+diffuse+large+b-cell+lymphoma+%28DLBCL%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWebster%26aufirst%3DK.%2BR.%26aulast%3DGoel%26aufirst%3DV.%2BK.%26aulast%3DHung%26aufirst%3DI.%2BN.%26aulast%3DParker%26aufirst%3DG.%2BS.%26aulast%3DStaunton%26aufirst%3DJ.%26aulast%3DNeal%26aufirst%3DM.%26aulast%3DMolter%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DJessen%26aufirst%3DK.%2BA.%26aulast%3DWegerski%26aufirst%3DC.%2BJ.%26aulast%3DSperry%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DP.%2BA.%26aulast%3DAppleman%26aufirst%3DJ.%2BR.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DReich%26aufirst%3DS.%2BH.%26atitle%3DeFT508%252C%2520a%2520potent%2520and%2520selective%2520mitogen-activated%2520protein%2520kinase%2520interacting%2520kinase%2520%2528MNK%2529%25201%2520and%25202%2520inhibitor%252C%2520is%2520efficacious%2520in%2520preclinical%2520models%2520of%2520diffuse%2520large%2520b-cell%2520lymphoma%2520%2528DLBCL%2529%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26issue%3D23%26spage%3D1554%26epage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Webster, K. R.</span></span> <span> </span><span class="NLM_article-title">eFT508: An oral, potent and highly selective inhibitor of mitogen-activated protein kinase interacting kinase (MNK) 1 and 2, a novel approach for the treatment of cancer</span>. Presented at the Annual Meeting of the American Association for Cancer Research, New Orleans, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=K.+R.+Webster&title=eFT508%3A+An+oral%2C+potent+and+highly+selective+inhibitor+of+mitogen-activated+protein+kinase+interacting+kinase+%28MNK%29+1+and+2%2C+a+novel+approach+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DWebster%26aufirst%3DK.%2BR.%26atitle%3DeFT508%253A%2520An%2520oral%252C%2520potent%2520and%2520highly%2520selective%2520inhibitor%2520of%2520mitogen-activated%2520protein%2520kinase%2520interacting%2520kinase%2520%2528MNK%2529%25201%2520and%25202%252C%2520a%2520novel%2520approach%2520for%2520the%2520treatment%2520of%2520cancer%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reich, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengeler, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemison, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaghafi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumpf, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegerski, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, K. R.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of pyridone-aminal eFT508 targeting dysregulated translation by selective mitogen-activated protein kinase interacting kinases 1 and 2 (MNK1/2) inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3516</span>– <span class="NLM_lpage">3540</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01795</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01795" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3516-3540&author=S.+H.+Reichauthor=P.+A.+Sprengelerauthor=G.+G.+Chiangauthor=J.+R.+Applemanauthor=J.+Chenauthor=J.+Clarineauthor=B.+Eamauthor=J.+T.+Ernstauthor=Q.+Hanauthor=V.+K.+Goelauthor=E.+Z.+Hanauthor=V.+Huangauthor=I.+N.+Hungauthor=A.+Jemisonauthor=K.+A.+Jessenauthor=J.+Molterauthor=D.+Murphyauthor=M.+Nealauthor=G.+S.+Parkerauthor=M.+Shaghafiauthor=S.+Sperryauthor=J.+Stauntonauthor=C.+R.+Stumpfauthor=P.+A.+Thompsonauthor=C.+Tranauthor=S.+E.+Webberauthor=C.+J.+Wegerskiauthor=H.+Zhengauthor=K.+R.+Webster&title=Structure-based+design+of+pyridone-aminal+eFT508+targeting+dysregulated+translation+by+selective+mitogen-activated+protein+kinase+interacting+kinases+1+and+2+%28MNK1%2F2%29+inhibition&doi=10.1021%2Facs.jmedchem.7b01795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition</span></div><div class="casAuthors">Reich, Siegfried H.; Sprengeler, Paul A.; Chiang, Gary G.; Appleman, James R.; Chen, Joan; Clarine, Jeff; Eam, Boreth; Ernst, Justin T.; Han, Qing; Goel, Vikas K.; Han, Edward Z. R.; Huang, Vera; Hung, Ivy N. J.; Jemison, Adrianna; Jessen, Katti A.; Molter, Jolene; Murphy, Douglas; Neal, Melissa; Parker, Gregory S.; Shaghafi, Michael; Sperry, Samuel; Staunton, Jocelyn; Stumpf, Craig R.; Thompson, Peggy A.; Tran, Chinh; Webber, Stephen E.; Wegerski, Christopher J.; Zheng, Hong; Webster, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3516-3540</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dysregulated translation of mRNA plays a major role in tumorigenesis.  Mitogen-activated protein kinase interacting kinases (MNK)1/2 are key regulators of mRNA translation integrating signals from oncogenic and immune signaling pathways through phosphorylation of eIF4E and other mRNA binding proteins.  Modulation of these key effector proteins regulates mRNA, which controls tumor/stromal cell signaling.  Compd. 23 (eFT508, 6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-2'H-spiro-[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione hydrochloride), an exquisitely selective, potent dual MNK1/2 inhibitor, was designed to assess the potential for control of oncogene signaling at the level of mRNA translation.  The crystal structure-guided design leverages stereoelectronic interactions unique to MNK culminating in a novel pyridone-aminal structure described for the first time in the kinase literature.  Compd. 23 has potent in vivo antitumor activity in models of diffuse large cell B-cell lymphoma and solid tumors, suggesting that controlling dysregulated translation has real therapeutic potential.  Compd. 23 is currently being evaluated in Phase 2 clin. trials in solid tumors and lymphoma.  Compd. 23 is the first highly selective dual MNK inhibitor targeting dysregulated translation being assessed clin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAp-3GOuZu8bVg90H21EOLACvtfcHk0li4Yipr-mtRwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlGhs7s%253D&md5=1254b674aa7e6d2037a06bc10e64e4da</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01795%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DS.%2BH.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DAppleman%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DClarine%26aufirst%3DJ.%26aulast%3DEam%26aufirst%3DB.%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DHan%26aufirst%3DQ.%26aulast%3DGoel%26aufirst%3DV.%2BK.%26aulast%3DHan%26aufirst%3DE.%2BZ.%26aulast%3DHuang%26aufirst%3DV.%26aulast%3DHung%26aufirst%3DI.%2BN.%26aulast%3DJemison%26aufirst%3DA.%26aulast%3DJessen%26aufirst%3DK.%2BA.%26aulast%3DMolter%26aufirst%3DJ.%26aulast%3DMurphy%26aufirst%3DD.%26aulast%3DNeal%26aufirst%3DM.%26aulast%3DParker%26aufirst%3DG.%2BS.%26aulast%3DShaghafi%26aufirst%3DM.%26aulast%3DSperry%26aufirst%3DS.%26aulast%3DStaunton%26aufirst%3DJ.%26aulast%3DStumpf%26aufirst%3DC.%2BR.%26aulast%3DThompson%26aufirst%3DP.%2BA.%26aulast%3DTran%26aufirst%3DC.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DWegerski%26aufirst%3DC.%2BJ.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DWebster%26aufirst%3DK.%2BR.%26atitle%3DStructure-based%2520design%2520of%2520pyridone-aminal%2520eFT508%2520targeting%2520dysregulated%2520translation%2520by%2520selective%2520mitogen-activated%2520protein%2520kinase%2520interacting%2520kinases%25201%2520and%25202%2520%2528MNK1%252F2%2529%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3516%26epage%3D3540%26doi%3D10.1021%2Facs.jmedchem.7b01795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cherian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poh, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraj, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joy, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwek, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wee, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choong, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies of mitogen activated protein kinase interacting kinase (MNK) 1 and 2 and BCR-ABL1 inhibitors targeting chronic myeloid leukemic cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3063</span>– <span class="NLM_lpage">3078</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01712</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01712" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3063-3078&issue=7&author=J.+Cherianauthor=K.+Nacroauthor=Z.+Y.+Pohauthor=S.+Guoauthor=D.+A.+Jeyarajauthor=Y.+X.+Wongauthor=M.+Hoauthor=H.+Y.+Yangauthor=J.+K.+Joyauthor=Z.+P.+Kwekauthor=B.+Liuauthor=J.+L.+Weeauthor=E.+H.+Ongauthor=M.+L.+Choongauthor=A.+Poulsenauthor=M.+A.+Leeauthor=V.+Pendharkarauthor=L.+J.+Dingauthor=V.+Manoharanauthor=Y.+S.+Chewauthor=K.+Sangthongpitagauthor=S.+Limauthor=S.+T.+Ongauthor=J.+Hillauthor=T.+H.+Keller&title=Structure-activity+relationship+studies+of+mitogen+activated+protein+kinase+interacting+kinase+%28MNK%29+1+and+2+and+BCR-ABL1+inhibitors+targeting+chronic+myeloid+leukemic+cells&doi=10.1021%2Facs.jmedchem.5b01712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01712%26sid%3Dliteratum%253Aachs%26aulast%3DCherian%26aufirst%3DJ.%26aulast%3DNacro%26aufirst%3DK.%26aulast%3DPoh%26aufirst%3DZ.%2BY.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DJeyaraj%26aufirst%3DD.%2BA.%26aulast%3DWong%26aufirst%3DY.%2BX.%26aulast%3DHo%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%2BY.%26aulast%3DJoy%26aufirst%3DJ.%2BK.%26aulast%3DKwek%26aufirst%3DZ.%2BP.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DWee%26aufirst%3DJ.%2BL.%26aulast%3DOng%26aufirst%3DE.%2BH.%26aulast%3DChoong%26aufirst%3DM.%2BL.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DDing%26aufirst%3DL.%2BJ.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DChew%26aufirst%3DY.%2BS.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DOng%26aufirst%3DS.%2BT.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26atitle%3DStructure-activity%2520relationship%2520studies%2520of%2520mitogen%2520activated%2520protein%2520kinase%2520interacting%2520kinase%2520%2528MNK%2529%25201%2520and%25202%2520and%2520BCR-ABL1%2520inhibitors%2520targeting%2520chronic%2520myeloid%2520leukemic%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D7%26spage%3D3063%26epage%3D3078%26doi%3D10.1021%2Facs.jmedchem.5b01712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarich, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albarran, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbano-Cuadrado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mateos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymundo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corrionero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fominaya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, J. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">6618</span>– <span class="NLM_lpage">6628</span>, <span class="refDoi"> DOI: 10.1021/jm1005513</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1005513" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6618-6628&issue=18&author=J.+Oyarzabalauthor=N.+Zarichauthor=M.+I.+Albarranauthor=I.+Palaciosauthor=M.+Urbano-Cuadradoauthor=G.+Mateosauthor=I.+Reymundoauthor=O.+Rabalauthor=A.+Salgadoauthor=A.+Corrioneroauthor=J.+Fominayaauthor=J.+Pastorauthor=J.+R.+Bischoff&title=Discovery+of+mitogen-activated+protein+kinase-interacting+kinase+1+inhibitors+by+a+comprehensive+fragment-oriented+virtual+screening+approach&doi=10.1021%2Fjm1005513"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm1005513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005513%26sid%3Dliteratum%253Aachs%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DZarich%26aufirst%3DN.%26aulast%3DAlbarran%26aufirst%3DM.%2BI.%26aulast%3DPalacios%26aufirst%3DI.%26aulast%3DUrbano-Cuadrado%26aufirst%3DM.%26aulast%3DMateos%26aufirst%3DG.%26aulast%3DReymundo%26aufirst%3DI.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DSalgado%26aufirst%3DA.%26aulast%3DCorrionero%26aufirst%3DA.%26aulast%3DFominaya%26aufirst%3DJ.%26aulast%3DPastor%26aufirst%3DJ.%26aulast%3DBischoff%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520mitogen-activated%2520protein%2520kinase-interacting%2520kinase%25201%2520inhibitors%2520by%2520a%2520comprehensive%2520fragment-oriented%2520virtual%2520screening%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D18%26spage%3D6618%26epage%3D6628%26doi%3D10.1021%2Fjm1005513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jauch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, M. C.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of the Mnk2 kinase domain reveal an inhibitory conformation and a zinc binding site</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1559</span>– <span class="NLM_lpage">1568</span>, <span class="refDoi"> DOI: 10.1016/j.str.2005.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.str.2005.07.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=1559-1568&issue=10&author=R.+Jauchauthor=S.+Jakelauthor=C.+Netterauthor=K.+Schreiterauthor=B.+Aicherauthor=H.+Jackleauthor=M.+C.+Wahl&title=Crystal+structures+of+the+Mnk2+kinase+domain+reveal+an+inhibitory+conformation+and+a+zinc+binding+site&doi=10.1016%2Fj.str.2005.07.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2005.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2005.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DJauch%26aufirst%3DR.%26aulast%3DJakel%26aufirst%3DS.%26aulast%3DNetter%26aufirst%3DC.%26aulast%3DSchreiter%26aufirst%3DK.%26aulast%3DAicher%26aufirst%3DB.%26aulast%3DJackle%26aufirst%3DH.%26aulast%3DWahl%26aufirst%3DM.%2BC.%26atitle%3DCrystal%2520structures%2520of%2520the%2520Mnk2%2520kinase%2520domain%2520reveal%2520an%2520inhibitory%2520conformation%2520and%2520a%2520zinc%2520binding%2520site%26jtitle%3DStructure%26date%3D2005%26volume%3D13%26issue%3D10%26spage%3D1559%26epage%3D1568%26doi%3D10.1016%2Fj.str.2005.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jauch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zweckstetter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, M. C.</span></span> <span> </span><span class="NLM_article-title">Mitogen-activated protein kinases interacting kinases are autoinhibited by a reprogrammed activation segment</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">4020</span>– <span class="NLM_lpage">4032</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1038%2Fsj.emboj.7601285" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=4020-4032&issue=17&author=R.+Jauchauthor=M.+K.+Choauthor=S.+Jakelauthor=C.+Netterauthor=K.+Schreiterauthor=B.+Aicherauthor=M.+Zweckstetterauthor=H.+Jackleauthor=M.+C.+Wahl&title=Mitogen-activated+protein+kinases+interacting+kinases+are+autoinhibited+by+a+reprogrammed+activation+segment&doi=10.1038%2Fsj.emboj.7601285"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601285%26sid%3Dliteratum%253Aachs%26aulast%3DJauch%26aufirst%3DR.%26aulast%3DCho%26aufirst%3DM.%2BK.%26aulast%3DJakel%26aufirst%3DS.%26aulast%3DNetter%26aufirst%3DC.%26aulast%3DSchreiter%26aufirst%3DK.%26aulast%3DAicher%26aufirst%3DB.%26aulast%3DZweckstetter%26aufirst%3DM.%26aulast%3DJackle%26aufirst%3DH.%26aulast%3DWahl%26aufirst%3DM.%2BC.%26atitle%3DMitogen-activated%2520protein%2520kinases%2520interacting%2520kinases%2520are%2520autoinhibited%2520by%2520a%2520reprogrammed%2520activation%2520segment%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26issue%3D17%26spage%3D4020%26epage%3D4032%26doi%3D10.1038%2Fsj.emboj.7601285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rucker, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albaugh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopiuk, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adrian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tompkins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreusch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prashad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, V.</span></span> <span> </span><span class="NLM_article-title">(R)-2-Phenylpyrrolidine substituted imidazopyridazines: a new class of potent and selective pan-TRK inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">567</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00050</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=562-567&issue=5&author=H.+S.+Choiauthor=P.+V.+Ruckerauthor=Z.+Wangauthor=Y.+Fanauthor=P.+Albaughauthor=G.+Chopiukauthor=F.+Gessierauthor=F.+Sunauthor=F.+Adrianauthor=G.+Liuauthor=T.+Hoodauthor=N.+Liauthor=Y.+Jiaauthor=J.+Cheauthor=S.+McCormackauthor=A.+Liauthor=J.+Liauthor=A.+Steffyauthor=A.+Culazzoauthor=C.+Tompkinsauthor=V.+Phungauthor=A.+Kreuschauthor=M.+Luauthor=B.+Huauthor=A.+Chaudharyauthor=M.+Prashadauthor=T.+Tuntlandauthor=B.+Liuauthor=J.+Harrisauthor=H.+M.+Seidelauthor=J.+Lorenauthor=V.+Molteni&title=%28R%29-2-Phenylpyrrolidine+substituted+imidazopyridazines%3A+a+new+class+of+potent+and+selective+pan-TRK+inhibitors&doi=10.1021%2Facsmedchemlett.5b00050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00050%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BS.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAlbaugh%26aufirst%3DP.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DGessier%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DHood%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DMcCormack%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSteffy%26aufirst%3DA.%26aulast%3DCulazzo%26aufirst%3DA.%26aulast%3DTompkins%26aufirst%3DC.%26aulast%3DPhung%26aufirst%3DV.%26aulast%3DKreusch%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DChaudhary%26aufirst%3DA.%26aulast%3DPrashad%26aufirst%3DM.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DHarris%26aufirst%3DJ.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DLoren%26aufirst%3DJ.%26aulast%3DMolteni%26aufirst%3DV.%26atitle%3D%2528R%2529-2-Phenylpyrrolidine%2520substituted%2520imidazopyridazines%253A%2520a%2520new%2520class%2520of%2520potent%2520and%2520selective%2520pan-TRK%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D5%26spage%3D562%26epage%3D567%26doi%3D10.1021%2Facsmedchemlett.5b00050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roux, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blenis, J.</span></span> <span> </span><span class="NLM_article-title">ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions</span>. <i>Microbiol. Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1128/MMBR.68.2.320-344.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1128%2FMMBR.68.2.320-344.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=15187187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsl2hu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2004&pages=320-344&issue=2&author=P.+P.+Rouxauthor=J.+Blenis&title=ERK+and+p38+MAPK-activated+protein+kinases%3A+a+family+of+protein+kinases+with+diverse+biological+functions&doi=10.1128%2FMMBR.68.2.320-344.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions</span></div><div class="casAuthors">Roux, Philippe P.; Blenis, John</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">320-344</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1092-2172</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  Conserved signaling pathways that activate the mitogen-activated protein kinases (MAPKs) are involved in relaying extracellular stimulations to intracellular responses.  The MAPKs coordinately regulate cell proliferation, differentiation, motility, and survival, which are functions also known to be mediated by members of a growing family of MAPK-activated protein kinases (MKs; formerly known as MAPKAP kinases).  The MKs are related serine/threonine kinases that respond to mitogenic and stress stimuli through proline-directed phosphorylation and activation of the kinase domain by extracellular signal-regulated kinases 1 and 2 and p38 MAPKs.  There are currently 11 vertebrate MKs in five subfamilies based on primary sequence homol.: the ribosomal S6 kinases, the mitogen- and stress-activated kinases, the MAPK-interacting kinases, MAPK activated protein kinases 2 and 3, and MK5.  In the last 5 yr, several MK substrates have been identified, which has helped tremendously to identify the biol. role of the members of this family.  Together with data from the study of MK-knockout mice, the identities of the MK substrates indicate that they play important roles in diverse biol. processes, including mRNA translation, cell proliferation and survival, and the nuclear genomic response to mitogens and cellular stresses.  In this article, we review the existing data on the MKs and discuss their physiol. functions based on recent discoveries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdh5NfM1SHwbVg90H21EOLACvtfcHk0lghQmcLfittyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsl2hu7Y%253D&md5=62f54354912521eef889470360e019a7</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FMMBR.68.2.320-344.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.68.2.320-344.2004%26sid%3Dliteratum%253Aachs%26aulast%3DRoux%26aufirst%3DP.%2BP.%26aulast%3DBlenis%26aufirst%3DJ.%26atitle%3DERK%2520and%2520p38%2520MAPK-activated%2520protein%2520kinases%253A%2520a%2520family%2520of%2520protein%2520kinases%2520with%2520diverse%2520biological%2520functions%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2004%26volume%3D68%26issue%3D2%26spage%3D320%26epage%3D344%26doi%3D10.1128%2FMMBR.68.2.320-344.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><a href="http://www.schrodinger.com" class="extLink">www.schrodinger.com</a> (accessed
July 8, <span class="NLM_year">2012</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.schrodinger.com+%28accessed%0AJuly+8%2C+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desiraju, G. R.</span>; <span class="NLM_string-name">Steiner, T.</span></span> <i>The Weak Hydrogen Bond: In Structural Chemistry and Biology</i>; Oxford Scholarship Online; <span class="NLM_publisher-name">Oxford University Press</span>, <span class="NLM_year">2001</span>; p  <span class="NLM_fpage">507</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1093%2Facprof%3Aoso%2F9780198509707.001.0001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=507&author=G.+R.+Desiraju&author=T.+Steiner&title=The+Weak+Hydrogen+Bond%3A+In+Structural+Chemistry+and+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Facprof%3Aoso%2F9780198509707.001.0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1093%252Facprof%253Aoso%252F9780198509707.001.0001%26sid%3Dliteratum%253Aachs%26aulast%3DDesiraju%26aufirst%3DG.%2BR.%26btitle%3DThe%2520Weak%2520Hydrogen%2520Bond%253A%2520In%2520Structural%2520Chemistry%2520and%2520Biology%26pub%3DOxford%2520University%2520Press%26date%3D2001%26spage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guntapalli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abas, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodenreider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbeck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roland, J.</span></span> <span> </span><span class="NLM_article-title">Lead optimization of imidazopyrazines: a new class of antimalarial with activity on plasmodium liver stages</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">947</span>– <span class="NLM_lpage">950</span>, <span class="refDoi"> DOI: 10.1021/ml500244m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500244m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWjtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=947-950&issue=8&author=B.+Zouauthor=A.+Nagleauthor=A.+K.+Chatterjeeauthor=S.+Y.+Leongauthor=L.+J.+Tanauthor=W.+L.+Simauthor=P.+Mishraauthor=P.+Guntapalliauthor=D.+C.+Tullyauthor=S.+B.+Lakshminarayanaauthor=C.+S.+Limauthor=Y.+C.+Tanauthor=S.+N.+Abasauthor=C.+Bodenreiderauthor=K.+L.+Kuhenauthor=K.+Gagaringauthor=R.+Borboaauthor=J.+Changauthor=C.+Liauthor=T.+Hollenbeckauthor=T.+Tuntlandauthor=A.+M.+Zeemanauthor=C.+H.+Kockenauthor=C.+McNamaraauthor=N.+Katoauthor=E.+A.+Winzelerauthor=B.+K.+Yeungauthor=T.+T.+Diaganaauthor=P.+W.+Smithauthor=J.+Roland&title=Lead+optimization+of+imidazopyrazines%3A+a+new+class+of+antimalarial+with+activity+on+plasmodium+liver+stages&doi=10.1021%2Fml500244m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Optimization of Imidazopyrazines: A New Class of Antimalarial with Activity on Plasmodium Liver Stages</span></div><div class="casAuthors">Zou, Bin; Nagle, Advait; Chatterjee, Arnab K.; Leong, Seh Yong; Tan, Liying Jocelyn; Sim, Wei Lin Sandra; Mishra, Pranab; Guntapalli, Prasuna; Tully, David C.; Lakshminarayana, Suresh B.; Lim, Chek Shik; Tan, Yong Cheng; Abas, Siti Nurdiana; Bodenreider, Christophe; Kuhen, Kelli L.; Gagaring, Kerstin; Borboa, Rachel; Chang, Jonathan; Li, Chun; Hollenbeck, Thomas; Tuntland, Tove; Zeeman, Anne-Marie; Kocken, Clemens H. M.; McNamara, Case; Kato, Nobutaka; Winzeler, Elizabeth A.; Yeung, Bryan K. S.; Diagana, Thierry T.; Smith, Paul W.; Roland, Jason</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">947-950</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Imidazopyridine 1 was identified from a phenotypic screen against P. falciparum (Pf) blood stages and subsequently optimized for activity on liver-stage schizonts of the rodent parasite P. yoelii (Py) as well as hypnozoites of the simian parasite P. cynomolgi (Pc).  We applied these various assays to the cell-based lead optimization of the imidazopyrazines, exemplified by 3 (KAI407), and show that optimized compds. within the series with improved pharmacokinetic properties achieve causal prophylactic activity in vivo and may have the potential to target the dormant stages of P. vivax malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Svl3huKCOrVg90H21EOLACvtfcHk0lghQmcLfittyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWjtrbN&md5=f52e2a7f04d1eba383794096bf283c2e</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fml500244m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500244m%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DB.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DLeong%26aufirst%3DS.%2BY.%26aulast%3DTan%26aufirst%3DL.%2BJ.%26aulast%3DSim%26aufirst%3DW.%2BL.%26aulast%3DMishra%26aufirst%3DP.%26aulast%3DGuntapalli%26aufirst%3DP.%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DTan%26aufirst%3DY.%2BC.%26aulast%3DAbas%26aufirst%3DS.%2BN.%26aulast%3DBodenreider%26aufirst%3DC.%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHollenbeck%26aufirst%3DT.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DZeeman%26aufirst%3DA.%2BM.%26aulast%3DKocken%26aufirst%3DC.%2BH.%26aulast%3DMcNamara%26aufirst%3DC.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DYeung%26aufirst%3DB.%2BK.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DRoland%26aufirst%3DJ.%26atitle%3DLead%2520optimization%2520of%2520imidazopyrazines%253A%2520a%2520new%2520class%2520of%2520antimalarial%2520with%2520activity%2520on%2520plasmodium%2520liver%2520stages%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D8%26spage%3D947%26epage%3D950%26doi%3D10.1021%2Fml500244m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7686</span>– <span class="NLM_lpage">7698</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.bmc.2013.10.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=7686-7698&issue=24&author=S.+Matsumotoauthor=N.+Miyamotoauthor=T.+Hirayamaauthor=H.+Okiauthor=K.+Okadaauthor=M.+Tawadaauthor=H.+Iwataauthor=K.+Nakamuraauthor=S.+Yamasakiauthor=H.+Mikiauthor=A.+Horiauthor=S.+Imamura&title=Structure-based+design%2C+synthesis%2C+and+evaluation+of+imidazo%5B1%2C2-b%5Dpyridazine+and+imidazo%5B1%2C2-a%5Dpyridine+derivatives+as+novel+dual+c-Met+and+VEGFR2+kinase+inhibitors&doi=10.1016%2Fj.bmc.2013.10.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DMiyamoto%26aufirst%3DN.%26aulast%3DHirayama%26aufirst%3DT.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DTawada%26aufirst%3DM.%26aulast%3DIwata%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DYamasaki%26aufirst%3DS.%26aulast%3DMiki%26aufirst%3DH.%26aulast%3DHori%26aufirst%3DA.%26aulast%3DImamura%26aufirst%3DS.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520imidazo%255B1%252C2-b%255Dpyridazine%2520and%2520imidazo%255B1%252C2-a%255Dpyridine%2520derivatives%2520as%2520novel%2520dual%2520c-Met%2520and%2520VEGFR2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D24%26spage%3D7686%26epage%3D7698%26doi%3D10.1016%2Fj.bmc.2013.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oguro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cary, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of novel VEGFR2 kinase inhibitors: discovery of [1,2,4]triazolo[1,5-a]pyridine derivatives with slow dissociation kinetics</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4714</span>– <span class="NLM_lpage">4729</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.bmc.2013.04.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=4714-4729&issue=15&author=Y.+Oguroauthor=D.+R.+Caryauthor=N.+Miyamotoauthor=M.+Tawadaauthor=H.+Iwataauthor=H.+Mikiauthor=A.+Horiauthor=S.+Imamura&title=Design%2C+synthesis%2C+and+evaluation+of+novel+VEGFR2+kinase+inhibitors%3A+discovery+of+%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5Dpyridine+derivatives+with+slow+dissociation+kinetics&doi=10.1016%2Fj.bmc.2013.04.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.042%26sid%3Dliteratum%253Aachs%26aulast%3DOguro%26aufirst%3DY.%26aulast%3DCary%26aufirst%3DD.%2BR.%26aulast%3DMiyamoto%26aufirst%3DN.%26aulast%3DTawada%26aufirst%3DM.%26aulast%3DIwata%26aufirst%3DH.%26aulast%3DMiki%26aufirst%3DH.%26aulast%3DHori%26aufirst%3DA.%26aulast%3DImamura%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520novel%2520VEGFR2%2520kinase%2520inhibitors%253A%2520discovery%2520of%2520%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255Dpyridine%2520derivatives%2520with%2520slow%2520dissociation%2520kinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D15%26spage%3D4714%26epage%3D4729%26doi%3D10.1016%2Fj.bmc.2013.04.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kannan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldwin, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraj, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chennamaneni, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacro, K.</span></span> <span> </span><span class="NLM_article-title">Probing the binding mechanism of Mnk inhibitors by docking and molecular dynamics simulations</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1021/bi501261j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi501261j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=32-46&issue=1&author=S.+Kannanauthor=A.+Poulsenauthor=H.+Y.+Yangauthor=M.+Hoauthor=S.+H.+Angauthor=T.+S.+Eldwinauthor=D.+A.+Jeyarajauthor=L.+R.+Chennamaneniauthor=B.+Liuauthor=J.+Hillauthor=C.+S.+Vermaauthor=K.+Nacro&title=Probing+the+binding+mechanism+of+Mnk+inhibitors+by+docking+and+molecular+dynamics+simulations&doi=10.1021%2Fbi501261j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fbi501261j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi501261j%26sid%3Dliteratum%253Aachs%26aulast%3DKannan%26aufirst%3DS.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DH.%2BY.%26aulast%3DHo%26aufirst%3DM.%26aulast%3DAng%26aufirst%3DS.%2BH.%26aulast%3DEldwin%26aufirst%3DT.%2BS.%26aulast%3DJeyaraj%26aufirst%3DD.%2BA.%26aulast%3DChennamaneni%26aufirst%3DL.%2BR.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DVerma%26aufirst%3DC.%2BS.%26aulast%3DNacro%26aufirst%3DK.%26atitle%3DProbing%2520the%2520binding%2520mechanism%2520of%2520Mnk%2520inhibitors%2520by%2520docking%2520and%2520molecular%2520dynamics%2520simulations%26jtitle%3DBiochemistry%26date%3D2015%26volume%3D54%26issue%3D1%26spage%3D32%26epage%3D46%26doi%3D10.1021%2Fbi501261j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karaman, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallant, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteridge, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edeen, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faraoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanov, Z. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritchard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span> <span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1038/nbt1358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&issue=1&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt1358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0li5FYIdEgVJKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26issue%3D1%26spage%3D127%26epage%3D132%26doi%3D10.1038%2Fnbt1358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plater, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastie, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klevernic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>408</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1042/BJ20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&issue=3&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+McLauchlanauthor=I.+Klevernicauthor=J.+S.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update&doi=10.1042%2FBJ20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0lg4WtD84-14JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26issue%3D3%26spage%3D297%26epage%3D315%26doi%3D10.1042%2FBJ20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basnet, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diab, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure-activity relationship analysis and biological evaluation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.03.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.ejmech.2015.03.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=116-126&author=M.+Yuauthor=P.+Liauthor=S.+K.+Basnetauthor=M.+Kumarasiriauthor=S.+Diabauthor=T.+Teoauthor=H.+Albrechtauthor=S.+Wang&title=Discovery+of+4-%28dihydropyridinon-3-yl%29amino-5-methylthieno%5B2%2C3-d%5Dpyrimidine+derivatives+as+potent+Mnk+inhibitors%3A+synthesis%2C+structure-activity+relationship+analysis+and+biological+evaluation&doi=10.1016%2Fj.ejmech.2015.03.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.03.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.03.032%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DBasnet%26aufirst%3DS.%2BK.%26aulast%3DKumarasiri%26aufirst%3DM.%26aulast%3DDiab%26aufirst%3DS.%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DAlbrecht%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25204-%2528dihydropyridinon-3-yl%2529amino-5-methylthieno%255B2%252C3-d%255Dpyrimidine%2520derivatives%2520as%2520potent%2520Mnk%2520inhibitors%253A%2520synthesis%252C%2520structure-activity%2520relationship%2520analysis%2520and%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D95%26spage%3D116%26epage%3D126%26doi%3D10.1016%2Fj.ejmech.2015.03.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dabbah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar-Schneider, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zismanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartakover
Matalon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lishner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drucker, L.</span></span> <span> </span><span class="NLM_article-title">Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">770</span>, <span class="refDoi"> DOI: 10.1189/jlb.3A1115-510RR</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1189%2Fjlb.3A1115-510RR" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=27272311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFertLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2016&pages=761-770&issue=4&author=M.+Dabbahauthor=O.+Attar-Schneiderauthor=V.+Zismanovauthor=S.+Tartakover%0AMatalonauthor=M.+Lishnerauthor=L.+Drucker&title=Multiple+myeloma+cells+promote+migration+of+bone+marrow+mesenchymal+stem+cells+by+altering+their+translation+initiation&doi=10.1189%2Fjlb.3A1115-510RR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation</span></div><div class="casAuthors">Dabbah, Mahmoud; Attar-Schneider, Oshrat; Zismanov, Victoria; Matalon, Shelly Tartakover; Lishner, Michael; Drucker, Liat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">761-770</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Society for Leukocyte Biology</span>)
        </div><div class="casAbstract">The role of the bone marrow microenvironment in multiple myeloma pathogenesis and progression is well recognized.  Indeed, we have shown that coculture of bone marrow mesenchymal stem cells from normal donors and multiple myeloma cells comodulated translation initiation.  Here, we characterized the timeline of mesenchymal stem cells conditioning by multiple myeloma cells, the persistence of this effect, and the consequences on cell phenotype.  Normal donor mesenchymal stem cells were cocultured with multiple myeloma cell lines (U266, ARP1) (multiple myeloma-conditioned mesenchymal stem cells) (1.5 h,12 h, 24 h, 48 h, and 3 d) and were assayed for translation initiation status (eukaryotic translation initiation factor 4E; eukaryotic translation initiation factor 4G; regulators: mechanistic target of rapamycin, MNK, 4EBP; targets: SMAD family 5, nuclear factor κB, cyclin D1, hypoxia inducible factor 1, c-Myc) (immunoblotting) and migration (scratch assay, inhibitors).  Involvement of mitogen-activated protein kinases in mesenchymal stem cell conditioning and altered migration was also tested (immunoblotting, inhibitors).  Multiple myeloma-conditioned mesenchymal stem cells were recultured alone (1-7 d) and were assayed for translation initiation (immunoblotting).  Quant. polymerase chain reaction of extd. RNA was tested for microRNAs levels.  Mitogen-activated protein kinases were activated within 1.5 h of coculture and were responsible for multiple myeloma-conditioned mesenchymal stem cell translation initiation status (an increase of >200%, P < 0.05) and elevated migration (16 h, an increase of >400%, P < 0.05).  The bone marrow mesenchymal stem cells conditioned by multiple myeloma cells were reversible after only 1 d of multiple myeloma-conditioned mesenchymal stem cell culture alone.  Decreased expression of microRNA-199b and microRNA-125a (an increase of <140%, P < 0.05) in multiple myeloma-conditioned mesenchymal stem cells supported elevated migration.  The time- and proximity-dependent conditioning of normal donor mesenchymal stem cells in our model points to a dynamic interaction between multiple myeloma cells and the bone marrow niche, which causes profound changes in the nonmalignant bone marrow constituents.  Future studies are warranted to identify clin. relevant means of blocking this crosstalk and improving multiple myeloma therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgjDbkv0afFrVg90H21EOLACvtfcHk0lg4WtD84-14JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFertLzE&md5=f510f3a13fe5b722e02fac1bc9a3162d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1189%2Fjlb.3A1115-510RR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.3A1115-510RR%26sid%3Dliteratum%253Aachs%26aulast%3DDabbah%26aufirst%3DM.%26aulast%3DAttar-Schneider%26aufirst%3DO.%26aulast%3DZismanov%26aufirst%3DV.%26aulast%3DTartakover%2BMatalon%26aufirst%3DS.%26aulast%3DLishner%26aufirst%3DM.%26aulast%3DDrucker%26aufirst%3DL.%26atitle%3DMultiple%2520myeloma%2520cells%2520promote%2520migration%2520of%2520bone%2520marrow%2520mesenchymal%2520stem%2520cells%2520by%2520altering%2520their%2520translation%2520initiation%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2016%26volume%3D100%26issue%3D4%26spage%3D761%26epage%3D770%26doi%3D10.1189%2Fjlb.3A1115-510RR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Timpano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uniacke, J.</span></span> <span> </span><span class="NLM_article-title">Human cells cultured under physiological oxygen utilize two cap-binding proteins to recruit distinct mRNAs for translation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">10772</span>– <span class="NLM_lpage">10782</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.717363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1074%2Fjbc.M116.717363" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=10772-10782&issue=20&author=S.+Timpanoauthor=J.+Uniacke&title=Human+cells+cultured+under+physiological+oxygen+utilize+two+cap-binding+proteins+to+recruit+distinct+mRNAs+for+translation&doi=10.1074%2Fjbc.M116.717363"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.717363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.717363%26sid%3Dliteratum%253Aachs%26aulast%3DTimpano%26aufirst%3DS.%26aulast%3DUniacke%26aufirst%3DJ.%26atitle%3DHuman%2520cells%2520cultured%2520under%2520physiological%2520oxygen%2520utilize%2520two%2520cap-binding%2520proteins%2520to%2520recruit%2520distinct%2520mRNAs%2520for%2520translation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26issue%3D20%26spage%3D10772%26epage%3D10782%26doi%3D10.1074%2Fjbc.M116.717363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar-Schneider, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dabbah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zismanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartakover-Matalon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lishner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drucker, L.</span></span> <span> </span><span class="NLM_article-title">Mesenchymal stem cells secretomes’ affect multiple myeloma translation initiation</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">620</span>– <span class="NLM_lpage">630</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2016.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.cellsig.2016.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=26976208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVOisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2016&pages=620-630&issue=6&author=H.+Marcusauthor=O.+Attar-Schneiderauthor=M.+Dabbahauthor=V.+Zismanovauthor=S.+Tartakover-Matalonauthor=M.+Lishnerauthor=L.+Drucker&title=Mesenchymal+stem+cells+secretomes%E2%80%99+affect+multiple+myeloma+translation+initiation&doi=10.1016%2Fj.cellsig.2016.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation</span></div><div class="casAuthors">Marcus, H.; Attar-Schneider, O.; Dabbah, M.; Zismanov, V.; Tartakover-Matalon, S.; Lishner, M.; Drucker, L.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">620-630</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Bone marrow mesenchymal stem cells' (BM-MSCs) role in multiple myeloma (MM) pathogenesis is recognized.  Recently, we have published that co-culture of MM cell lines with BM-MSCs results in mutual modulation of phenotype and proteome (via translation initiation (TI) factors eIF4E/eIF4GI) and that there are differences between normal donor BM-MSCs (ND-MSCs) and MM BM-MSCs (MM-MSCs) in this crosstalk.  Here, we aimed to assess the involvement of sol. BM-MSCs' (ND, MM) components, more easily targeted, in manipulation of MM cell lines phenotype and TI with specific focus on microvesicles (MVs) capable of transferring crit. biol. material.  We applied ND and MM-MSCs 72 h secretomes to MM cell lines (U266 and ARP-1) for 12-72 h and then assayed the cells' (viability, cell count, cell death, proliferation, cell cycle, autophagy) and TI (factors: eIF4E, teIF4GI; regulators: mTOR, MNK1/2, 4EBP; targets: cyclin D1, NFκB, SMAD5, cMyc, HIF1α).  Furthermore, we dissected the secretome into > 100 kDa and < 100 kDa fractions and repeated the expts.  Finally, MVs were isolated from the ND and MM-MSCs secretomes and applied to MM cell lines.  Phenotype and TI were assessed.  Secretomes of BM-MSCs (ND, MM) significantly stimulated MM cell lines' TI, autophagy and proliferation.  The dissected secretome yielded different effects on MM cell lines phenotype and TI according to fraction (> 100 kDa- repressed; < 100 kDa- stimulated) but with no assocn. to source (ND, MM).  Finally, in analyses of MVs extd. from BM-MSCs (ND, MM) we witnessed differences in accordance with source: ND-MSCs MVs inhibited proliferation, autophagy and TI whereas MM-MSCs MVs stimulated them.  These observations highlight the very complex communication between MM and BM-MSCs and underscore its significance to major processes in the malignant cells.  Studies into the influential MVs cargo are underway and expected to uncover targetable signals in the regulation of the TI/proliferation/autophagy cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4-PYAzhr54bVg90H21EOLACvtfcHk0lgVp1BUq4A56Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVOisrg%253D&md5=517dcd2dac3dfea0e7b9c94134eaa00a</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2016.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2016.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DMarcus%26aufirst%3DH.%26aulast%3DAttar-Schneider%26aufirst%3DO.%26aulast%3DDabbah%26aufirst%3DM.%26aulast%3DZismanov%26aufirst%3DV.%26aulast%3DTartakover-Matalon%26aufirst%3DS.%26aulast%3DLishner%26aufirst%3DM.%26aulast%3DDrucker%26aufirst%3DL.%26atitle%3DMesenchymal%2520stem%2520cells%2520secretomes%25E2%2580%2599%2520affect%2520multiple%2520myeloma%2520translation%2520initiation%26jtitle%3DCell.%2520Signalling%26date%3D2016%26volume%3D28%26issue%3D6%26spage%3D620%26epage%3D630%26doi%3D10.1016%2Fj.cellsig.2016.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">RCSB</span>. <span> </span><span class="NLM_article-title">Protein Data Bank</span>, <a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a> (accessed March
5, <span class="NLM_year">2013</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=RCSB&title=Protein+Data+Bank"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DProtein%2520Data%2520Bank%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS3: a force field providing broad coverage of drug-like small molecules and proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&issue=1&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+a+force+field+providing+broad+coverage+of+drug-like+small+molecules+and+proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0lgVp1BUq4A56Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520a%2520force%2520field%2520providing%2520broad%2520coverage%2520of%2520drug-like%2520small%2520molecules%2520and%2520proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26issue%3D1%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribiere, G.</span></span> <span> </span><span class="NLM_article-title">Note sur la convergence de méthodes de directions conjuguées</span>. <i>Rev. Franc. Informat. Recherche Opérationelle, Sér. Rouge</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1051/m2an/196903R100351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1051%2Fm2an%2F196903R100351" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1969&pages=35-43&author=E.+Polakauthor=G.+Ribiere&title=Note+sur+la+convergence+de+m%C3%A9thodes+de+directions+conjugu%C3%A9es&doi=10.1051%2Fm2an%2F196903R100351"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1051%2Fm2an%2F196903R100351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1051%252Fm2an%252F196903R100351%26sid%3Dliteratum%253Aachs%26aulast%3DPolak%26aufirst%3DE.%26aulast%3DRibiere%26aufirst%3DG.%26atitle%3DNote%2520sur%2520la%2520convergence%2520de%2520m%25C3%25A9thodes%2520de%2520directions%2520conjugu%25C3%25A9es%26jtitle%3DRev.%2520Franc.%2520Informat.%2520Recherche%2520Op%25C3%25A9rationelle%252C%2520S%25C3%25A9r.%2520Rouge%26date%3D1969%26volume%3D16%26spage%3D35%26epage%3D43%26doi%3D10.1051%2Fm2an%2F196903R100351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duraiswamy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E. S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, W. W. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of a porcupine inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5889</span>– <span class="NLM_lpage">5899</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5889-5899&issue=15&author=A.+J.+Duraiswamyauthor=M.+A.+Leeauthor=B.+Madanauthor=S.+H.+Angauthor=E.+S.+W.+Tanauthor=W.+W.+V.+Cheongauthor=Z.+Keauthor=V.+Pendharkarauthor=L.+J.+Dingauthor=Y.+S.+Chewauthor=V.+Manoharanauthor=K.+Sangthongpitagauthor=J.+Alamauthor=A.+Poulsenauthor=S.+Y.+Hoauthor=D.+M.+Virshupauthor=T.+H.+Keller&title=Discovery+and+optimization+of+a+porcupine+inhibitor&doi=10.1021%2Facs.jmedchem.5b00507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00507%26sid%3Dliteratum%253Aachs%26aulast%3DDuraiswamy%26aufirst%3DA.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DAng%26aufirst%3DS.%2BH.%26aulast%3DTan%26aufirst%3DE.%2BS.%2BW.%26aulast%3DCheong%26aufirst%3DW.%2BW.%2BV.%26aulast%3DKe%26aufirst%3DZ.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DDing%26aufirst%3DL.%2BJ.%26aulast%3DChew%26aufirst%3DY.%2BS.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520porcupine%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D15%26spage%3D5889%26epage%3D5899%26doi%3D10.1021%2Facs.jmedchem.5b00507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraj, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E. S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span> <span> </span><span class="NLM_article-title">Scaffold hopping and optimization of maleimide based porcupine inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6678</span>– <span class="NLM_lpage">6692</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00662</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00662" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6678-6692&issue=15&author=S.+Y.+Hoauthor=J.+Alamauthor=D.+A.+Jeyarajauthor=W.+Wangauthor=G.+R.+Linauthor=S.+H.+Angauthor=E.+S.+W.+Tanauthor=M.+A.+Leeauthor=Z.+Keauthor=B.+Madanauthor=D.+M.+Virshupauthor=L.+J.+Dingauthor=V.+Manoharanauthor=Y.+S.+Chewauthor=C.+B.+Lowauthor=V.+Pendharkarauthor=K.+Sangthongpitagauthor=J.+Hillauthor=T.+H.+Kellerauthor=A.+Poulsen&title=Scaffold+hopping+and+optimization+of+maleimide+based+porcupine+inhibitors&doi=10.1021%2Facs.jmedchem.7b00662"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00662%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DJeyaraj%26aufirst%3DD.%2BA.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DG.%2BR.%26aulast%3DAng%26aufirst%3DS.%2BH.%26aulast%3DTan%26aufirst%3DE.%2BS.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DKe%26aufirst%3DZ.%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26aulast%3DDing%26aufirst%3DL.%2BJ.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DChew%26aufirst%3DY.%2BS.%26aulast%3DLow%26aufirst%3DC.%2BB.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DPoulsen%26aufirst%3DA.%26atitle%3DScaffold%2520hopping%2520and%2520optimization%2520of%2520maleimide%2520based%2520porcupine%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D15%26spage%3D6678%26epage%3D6692%26doi%3D10.1021%2Facs.jmedchem.7b00662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wendel, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe-Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teruya-Feldstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span> <span> </span><span class="NLM_article-title">Dissecting eIF4E action in tumorigenesis</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">3232</span>– <span class="NLM_lpage">3237</span>, <span class="refDoi"> DOI: 10.1101/gad.1604407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1101%2Fgad.1604407" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=3232-3237&issue=24&author=H.+G.+Wendelauthor=R.+L.+Silvaauthor=A.+Malinaauthor=J.+R.+Millsauthor=H.+Zhuauthor=T.+Uedaauthor=R.+Watanabe-Fukunagaauthor=R.+Fukunagaauthor=J.+Teruya-Feldsteinauthor=J.+Pelletierauthor=S.+W.+Lowe&title=Dissecting+eIF4E+action+in+tumorigenesis&doi=10.1101%2Fgad.1604407"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1101%2Fgad.1604407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1604407%26sid%3Dliteratum%253Aachs%26aulast%3DWendel%26aufirst%3DH.%2BG.%26aulast%3DSilva%26aufirst%3DR.%2BL.%26aulast%3DMalina%26aufirst%3DA.%26aulast%3DMills%26aufirst%3DJ.%2BR.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DWatanabe-Fukunaga%26aufirst%3DR.%26aulast%3DFukunaga%26aufirst%3DR.%26aulast%3DTeruya-Feldstein%26aufirst%3DJ.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DDissecting%2520eIF4E%2520action%2520in%2520tumorigenesis%26jtitle%3DGenes%2520Dev.%26date%3D2007%26volume%3D21%26issue%3D24%26spage%3D3232%26epage%3D3237%26doi%3D10.1101%2Fgad.1604407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 23 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Frédéric Vuillermet, Joanick Bourret, <span class="NLM_string-name hlFld-ContribAuthor">Guillaume Pelletier</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Imidazo[1,2-a]pyridines: Triflic Anhydride-Mediated Annulation of 2H-Azirines with 2-Chloropyridines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (1)
                                     , 388-402. <a href="https://doi.org/10.1021/acs.joc.0c02148" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02148%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BImidazo%25255B1%25252C2-a%25255Dpyridines%25253A%252BTriflic%252BAnhydride-Mediated%252BAnnulation%252Bof%252B2H-Azirines%252Bwith%252B2-Chloropyridines%26aulast%3DVuillermet%26aufirst%3DFr%25C3%25A9d%25C3%25A9ric%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D05092020%26date%3D03122020%26volume%3D86%26issue%3D1%26spage%3D388%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aurélie Gernet, Nicolas Sevrain, Jean-Noël Volle, Tahar Ayad, Jean-Luc Pirat, <span class="NLM_string-name hlFld-ContribAuthor">David Virieux</span>. </span><span class="cited-content_cbyCitation_article-title">Diversity-Oriented Synthesis toward Aryl- and Phosphoryl-Functionalized Imidazo[1,2-a]pyridines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (22)
                                     , 14730-14743. <a href="https://doi.org/10.1021/acs.joc.0c02059" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02059%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDiversity-Oriented%252BSynthesis%252Btoward%252BAryl-%252Band%252BPhosphoryl-Functionalized%252BImidazo%25255B1%25252C2-a%25255Dpyridines%26aulast%3DGernet%26aufirst%3DAur%25C3%25A9lie%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26082020%26date%3D09112020%26volume%3D85%26issue%3D22%26spage%3D14730%26epage%3D14743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Daniel A. Erlanson, Iwan J. P. de Esch, Wolfgang Jahnke, Christopher N. Johnson, <span class="NLM_string-name hlFld-ContribAuthor">Paul N. Mortenson</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2018. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4430-4444. <a href="https://doi.org/10.1021/acs.jmedchem.9b01581" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01581%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-to-Lead%252BMedicinal%252BChemistry%252BPublications%252Bin%252B2018%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D22092019%26date%3D22012020%26date%3D08012020%26volume%3D63%26issue%3D9%26spage%3D4430%26epage%3D4444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christian Kersten, Edmond Fleischer, Josef Kehrein, Christoph Borek, Elmar Jaenicke, Christoph Sotriffer, <span class="NLM_string-name hlFld-ContribAuthor">Ruth Brenk</span>. </span><span class="cited-content_cbyCitation_article-title">How To Design Selective Ligands for Highly Conserved Binding Sites: A Case Study Using N-Myristoyltransferases as a Model System. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2095-2113. <a href="https://doi.org/10.1021/acs.jmedchem.9b00586" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00586</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00586%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHow%252BTo%252BDesign%252BSelective%252BLigands%252Bfor%252BHighly%252BConserved%252BBinding%252BSites%25253A%252BA%252BCase%252BStudy%252BUsing%252BN-Myristoyltransferases%252Bas%252Ba%252BModel%252BSystem%26aulast%3DKersten%26aufirst%3DChristian%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D05042019%26date%3D19082019%26volume%3D63%26issue%3D5%26spage%3D2095%26epage%3D2113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jacek Kwiatkowski, Boping Liu, Shermaine Pang, Nur Huda Binte Ahmad, Gang Wang, Anders Poulsen, Haiyan Yang, Yong Rui Poh, Doris Hui Ying Tee, Esther Ong, Priya Retna, Nurul Dinie, Perlyn Kwek, John Liang Kuan Wee, Vithya Manoharan, Choon Bing Low, Peck Gee Seah, Vishal Pendharkar, Kanda Sangthongpitag, Joma Joy, Nithya Baburajendran, Anna Elisabet Jansson, Kassoum Nacro, Jeffrey Hill, Thomas H. Keller, <span class="NLM_string-name hlFld-ContribAuthor">Alvin W. Hung</span>. </span><span class="cited-content_cbyCitation_article-title">Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (2)
                                     , 621-637. <a href="https://doi.org/10.1021/acs.jmedchem.9b01582" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01582</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01582%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStepwise%252BEvolution%252Bof%252BFragment%252BHits%252Bagainst%252BMAPK%252BInteracting%252BKinases%252B1%252Band%252B2%26aulast%3DKwiatkowski%26aufirst%3DJacek%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D23092019%26date%3D07012020%26volume%3D63%26issue%3D2%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Jin</span>, <span class="hlFld-ContribAuthor ">Rilei  Yu</span>, <span class="hlFld-ContribAuthor ">Xuemin  Wang</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Proud</span>, <span class="hlFld-ContribAuthor ">Tao  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in developing MNK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113420. <a href="https://doi.org/10.1016/j.ejmech.2021.113420" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113420</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113420%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bin%252Bdeveloping%252BMNK%252Binhibitors%26aulast%3DJin%26aufirst%3DXin%26date%3D2021%26volume%3D219%26spage%3D113420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Bu</span>, <span class="hlFld-ContribAuthor ">Xinrui  Yuan</span>, <span class="hlFld-ContribAuthor ">Hanshu  Wu</span>, <span class="hlFld-ContribAuthor ">Jinpei  Zhou</span>, <span class="hlFld-ContribAuthor ">Huibin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of imidazopyridazine derivatives containing isoquinoline group as potent MNK1/2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>40 </em>, 116186. <a href="https://doi.org/10.1016/j.bmc.2021.116186" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116186%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bimidazopyridazine%252Bderivatives%252Bcontaining%252Bisoquinoline%252Bgroup%252Bas%252Bpotent%252BMNK1%25252F2%252Binhibitors%26aulast%3DBu%26aufirst%3DHong%26date%3D2021%26volume%3D40%26spage%3D116186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Xu</span>, <span class="hlFld-ContribAuthor ">Ye  Chen</span>, <span class="hlFld-ContribAuthor ">Yulun  Huang</span>, <span class="hlFld-ContribAuthor ">Edwin  Sandanaraj</span>, <span class="hlFld-ContribAuthor ">John S.  Yu</span>, <span class="hlFld-ContribAuthor ">Ruby Yu-Tong  Lin</span>, <span class="hlFld-ContribAuthor ">Pushkar  Dakle</span>, <span class="hlFld-ContribAuthor ">Xin-Yu  Ke</span>, <span class="hlFld-ContribAuthor ">Yuk Kien  Chong</span>, <span class="hlFld-ContribAuthor ">Lynnette  Koh</span>, <span class="hlFld-ContribAuthor ">Anand  Mayakonda</span>, <span class="hlFld-ContribAuthor ">Kassoum  Nacro</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Hill</span>, <span class="hlFld-ContribAuthor ">Mo-Li  Huang</span>, <span class="hlFld-ContribAuthor ">Sigal  Gery</span>, <span class="hlFld-ContribAuthor ">See Wee  Lim</span>, <span class="hlFld-ContribAuthor ">Zhengyun  Huang</span>, <span class="hlFld-ContribAuthor ">Ying  Xu</span>, <span class="hlFld-ContribAuthor ">Jianxiang  Chen</span>, <span class="hlFld-ContribAuthor ">Longchuan  Bai</span>, <span class="hlFld-ContribAuthor ">Shaomeng  Wang</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Wakimoto</span>, <span class="hlFld-ContribAuthor ">Tseng Tsai  Yeo</span>, <span class="hlFld-ContribAuthor ">Beng Ti  Ang</span>, <span class="hlFld-ContribAuthor ">Markus  Müschen</span>, <span class="hlFld-ContribAuthor ">Carol  Tang</span>, <span class="hlFld-ContribAuthor ">Tuan Zea  Tan</span>, <span class="hlFld-ContribAuthor ">H. Phillip  Koeffler</span>. </span><span class="cited-content_cbyCitation_article-title">Topography of transcriptionally active chromatin in glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Science Advances</span><span> <strong>2021,</strong> <em>7 </em>
                                    (18)
                                     , eabd4676. <a href="https://doi.org/10.1126/sciadv.abd4676" title="DOI URL">https://doi.org/10.1126/sciadv.abd4676</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/sciadv.abd4676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fsciadv.abd4676%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Advances%26atitle%3DTopography%252Bof%252Btranscriptionally%252Bactive%252Bchromatin%252Bin%252Bglioblastoma%26aulast%3DXu%26aufirst%3DLiang%26date%3D2021%26date%3D2021%26volume%3D7%26issue%3D18%26spage%3Deabd4676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin-Yu  Ke</span>, <span class="hlFld-ContribAuthor ">Ye  Chen</span>, <span class="hlFld-ContribAuthor ">Valarie Yu-Yan  Tham</span>, <span class="hlFld-ContribAuthor ">Ruby Yu-Tong  Lin</span>, <span class="hlFld-ContribAuthor ">Pushkar  Dakle</span>, <span class="hlFld-ContribAuthor ">Kassoum  Nacro</span>, <span class="hlFld-ContribAuthor ">Mark Edward  Puhaindran</span>, <span class="hlFld-ContribAuthor ">Peter  Houghton</span>, <span class="hlFld-ContribAuthor ">Angela  Pang</span>, <span class="hlFld-ContribAuthor ">Victor Kwanmin  Lee</span>, <span class="hlFld-ContribAuthor ">Ling-Wen  Ding</span>, <span class="hlFld-ContribAuthor ">Sigal  Gery</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Hill</span>, <span class="hlFld-ContribAuthor ">Leilei  Chen</span>, <span class="hlFld-ContribAuthor ">Liang  Xu</span>, <span class="hlFld-ContribAuthor ">H. Phillip  Koeffler</span>. </span><span class="cited-content_cbyCitation_article-title">MNK1 and MNK2 enforce expression of E2F1, FOXM1, and WEE1 to drive soft tissue sarcoma. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2021,</strong> <em>40 </em>
                                    (10)
                                     , 1851-1867. <a href="https://doi.org/10.1038/s41388-021-01661-4" title="DOI URL">https://doi.org/10.1038/s41388-021-01661-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-021-01661-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-021-01661-4%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DMNK1%252Band%252BMNK2%252Benforce%252Bexpression%252Bof%252BE2F1%25252C%252BFOXM1%25252C%252Band%252BWEE1%252Bto%252Bdrive%252Bsoft%252Btissue%252Bsarcoma%26aulast%3DKe%26aufirst%3DXin-Yu%26date%3D2021%26date%3D2021%26volume%3D40%26issue%3D10%26spage%3D1851%26epage%3D1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Dreas</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kucwaj-Brysz</span>, <span class="hlFld-ContribAuthor ">Karolina  Pyziak</span>, <span class="hlFld-ContribAuthor ">Urszula  Kulesza</span>, <span class="hlFld-ContribAuthor ">Ewelina  Wincza</span>, <span class="hlFld-ContribAuthor ">Charles-Henry  Fabritius</span>, <span class="hlFld-ContribAuthor ">Kinga  Michalik</span>, <span class="hlFld-ContribAuthor ">Ewelina  Gabor-Worwa</span>, <span class="hlFld-ContribAuthor ">Aniela  Gołas</span>, <span class="hlFld-ContribAuthor ">Mariusz  Milik</span>, <span class="hlFld-ContribAuthor ">Magdalena  Masiejczyk</span>, <span class="hlFld-ContribAuthor ">Eliza  Majewska</span>, <span class="hlFld-ContribAuthor ">Kazimiera  Pyśniak</span>, <span class="hlFld-ContribAuthor ">Urszula  Wójcik-Trechcińska</span>, <span class="hlFld-ContribAuthor ">Zuzanna  Sandowska-Markiewicz</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Brzózka</span>, <span class="hlFld-ContribAuthor ">Jerzy  Ostrowski</span>, <span class="hlFld-ContribAuthor ">Tomasz  Rzymski</span>, <span class="hlFld-ContribAuthor ">Michal  Mikula</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of indazole-pyridinone derivatives as a novel class of potent and selective MNK1/2 kinase inhibitors that protecting against endotoxin-induced septic shock. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113057. <a href="https://doi.org/10.1016/j.ejmech.2020.113057" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113057%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bindazole-pyridinone%252Bderivatives%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Bpotent%252Band%252Bselective%252BMNK1%25252F2%252Bkinase%252Binhibitors%252Bthat%252Bprotecting%252Bagainst%252Bendotoxin-induced%252Bseptic%252Bshock%26aulast%3DDreas%26aufirst%3DAgnieszka%26date%3D2021%26volume%3D213%26spage%3D113057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno Junior  Neves</span>, <span class="hlFld-ContribAuthor ">Melina  Mottin</span>, <span class="hlFld-ContribAuthor ">José Teofilo  Moreira-Filho</span>, <span class="hlFld-ContribAuthor ">Bruna Katiele de Paula  Sousa</span>, <span class="hlFld-ContribAuthor ">Sabrina Silva  Mendonca</span>, <span class="hlFld-ContribAuthor ">Carolina Horta  Andrade</span>. </span><span class="cited-content_cbyCitation_article-title">Best Practices for Docking-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 75-98. <a href="https://doi.org/10.1016/B978-0-12-822312-3.00001-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-822312-3.00001-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-822312-3.00001-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-822312-3.00001-1%26sid%3Dliteratum%253Aachs%26atitle%3DBest%252BPractices%252Bfor%252BDocking-Based%252BVirtual%252BScreening%26aulast%3DNeves%26aufirst%3DBruno%2BJunior%26date%3D2021%26spage%3D75%26epage%3D98%26pub%3DElsevier%26atitle%3DMolecular%252BDocking%252Bfor%252BComputer-Aided%252BDrug%252BDesign%26date%3D2021%26volume%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad Saad  Yousuf</span>, <span class="hlFld-ContribAuthor ">Stephanie I.  Shiers</span>, <span class="hlFld-ContribAuthor ">James J.  Sahn</span>, <span class="hlFld-ContribAuthor ">Theodore J.  Price</span>, . </span><span class="cited-content_cbyCitation_article-title">Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2021,</strong> <em>73 </em>
                                    (1)
                                     , 59-88. <a href="https://doi.org/10.1124/pharmrev.120.000030" title="DOI URL">https://doi.org/10.1124/pharmrev.120.000030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pharmrev.120.000030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpharmrev.120.000030%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DPharmacological%252BManipulation%252Bof%252BTranslation%252Bas%252Ba%252BTherapeutic%252BTarget%252Bfor%252BChronic%252BPain%26aulast%3DYousuf%26aufirst%3DMuhammad%2BSaad%26date%3D2021%26date%3D2020%26volume%3D73%26issue%3D1%26spage%3D59%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rubin  Cheng</span>, <span class="hlFld-ContribAuthor ">Yilan  Huang</span>, <span class="hlFld-ContribAuthor ">Yun  Fang</span>, <span class="hlFld-ContribAuthor ">Qirui  Wang</span>, <span class="hlFld-ContribAuthor ">Meixiu  Yan</span>, <span class="hlFld-ContribAuthor ">Yuqing  Ge</span>. </span><span class="cited-content_cbyCitation_article-title">Cryptotanshinone enhances the efficacy of Bcr-Abl tyrosine kinase inhibitors via inhibiting STAT3 and eIF4E signalling pathways in chronic myeloid leukaemia. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Biology</span><span> <strong>2021,</strong> <em>59 </em>
                                    (1)
                                     , 893-903. <a href="https://doi.org/10.1080/13880209.2021.1944224" title="DOI URL">https://doi.org/10.1080/13880209.2021.1944224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13880209.2021.1944224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13880209.2021.1944224%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Biology%26atitle%3DCryptotanshinone%252Benhances%252Bthe%252Befficacy%252Bof%252BBcr-Abl%252Btyrosine%252Bkinase%252Binhibitors%252Bvia%252Binhibiting%252BSTAT3%252Band%252BeIF4E%252Bsignalling%252Bpathways%252Bin%252Bchronic%252Bmyeloid%252Bleukaemia%26aulast%3DCheng%26aufirst%3DRubin%26date%3D2021%26date%3D2021%26volume%3D59%26issue%3D1%26spage%3D893%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lauren Y.  Sandeman</span>, <span class="hlFld-ContribAuthor ">Wan Xian  Kang</span>, <span class="hlFld-ContribAuthor ">Xuemin  Wang</span>, <span class="hlFld-ContribAuthor ">Kirk B.  Jensen</span>, <span class="hlFld-ContribAuthor ">Derick  Wong</span>, <span class="hlFld-ContribAuthor ">Tao  Bo</span>, <span class="hlFld-ContribAuthor ">Ling  Gao</span>, <span class="hlFld-ContribAuthor ">Jiajun  Zhao</span>, <span class="hlFld-ContribAuthor ">Christopher D.  Byrne</span>, <span class="hlFld-ContribAuthor ">Amanda J.  Page</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Proud</span>. </span><span class="cited-content_cbyCitation_article-title">Disabling MNK protein kinases promotes oxidative metabolism and protects against diet-induced obesity. </span><span class="cited-content_cbyCitation_journal-name">Molecular Metabolism</span><span> <strong>2020,</strong> <em>42 </em>, 101054. <a href="https://doi.org/10.1016/j.molmet.2020.101054" title="DOI URL">https://doi.org/10.1016/j.molmet.2020.101054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molmet.2020.101054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molmet.2020.101054%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Metabolism%26atitle%3DDisabling%252BMNK%252Bprotein%252Bkinases%252Bpromotes%252Boxidative%252Bmetabolism%252Band%252Bprotects%252Bagainst%252Bdiet-induced%252Bobesity%26aulast%3DSandeman%26aufirst%3DLauren%2BY.%26date%3D2020%26volume%3D42%26spage%3D101054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kun  Xing</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Han</span>, <span class="hlFld-ContribAuthor ">Tong  Tong</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>, <span class="hlFld-ContribAuthor ">Linxiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Bioactivity Evaluation of 4,6-Disubstituted Pyrido[3,2-d]pyrimidine Derivatives as Mnk and HDAC Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (18)
                                     , 4318. <a href="https://doi.org/10.3390/molecules25184318" title="DOI URL">https://doi.org/10.3390/molecules25184318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25184318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25184318%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBioactivity%252BEvaluation%252Bof%252B4%25252C6-Disubstituted%252BPyrido%25255B3%25252C2-d%25255Dpyrimidine%252BDerivatives%252Bas%252BMnk%252Band%252BHDAC%252BInhibitors%26aulast%3DXing%26aufirst%3DKun%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D18%26spage%3D4318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanna  Hörnberg</span>, <span class="hlFld-ContribAuthor ">Enrique  Pérez-Garci</span>, <span class="hlFld-ContribAuthor ">Dietmar  Schreiner</span>, <span class="hlFld-ContribAuthor ">Laetitia  Hatstatt-Burklé</span>, <span class="hlFld-ContribAuthor ">Fulvio  Magara</span>, <span class="hlFld-ContribAuthor ">Stephane  Baudouin</span>, <span class="hlFld-ContribAuthor ">Alex  Matter</span>, <span class="hlFld-ContribAuthor ">Kassoum  Nacro</span>, <span class="hlFld-ContribAuthor ">Eline  Pecho-Vrieseling</span>, <span class="hlFld-ContribAuthor ">Peter  Scheiffele</span>. </span><span class="cited-content_cbyCitation_article-title">Rescue of oxytocin response and social behaviour in a mouse model of autism. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2020,</strong> <em>584 </em>
                                    (7820)
                                     , 252-256. <a href="https://doi.org/10.1038/s41586-020-2563-7" title="DOI URL">https://doi.org/10.1038/s41586-020-2563-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41586-020-2563-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41586-020-2563-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DRescue%252Bof%252Boxytocin%252Bresponse%252Band%252Bsocial%252Bbehaviour%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Bautism%26aulast%3DH%25C3%25B6rnberg%26aufirst%3DHanna%26date%3D2020%26date%3D2020%26volume%3D584%26issue%3D7820%26spage%3D252%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zarko  Gagic</span>, <span class="hlFld-ContribAuthor ">Dusan  Ruzic</span>, <span class="hlFld-ContribAuthor ">Nemanja  Djokovic</span>, <span class="hlFld-ContribAuthor ">Teodora  Djikic</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>. </span><span class="cited-content_cbyCitation_article-title">In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2020,</strong> <em>7 </em><a href="https://doi.org/10.3389/fchem.2019.00873" title="DOI URL">https://doi.org/10.3389/fchem.2019.00873</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2019.00873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2019.00873%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DIn%252Bsilico%252BMethods%252Bfor%252BDesign%252Bof%252BKinase%252BInhibitors%252Bas%252BAnticancer%252BDrugs%26aulast%3DGagic%26aufirst%3DZarko%26date%3D2020%26date%3D2020%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincenzo  Teneggi</span>, <span class="hlFld-ContribAuthor ">Veronica  Novotny‐Diermayr</span>, <span class="hlFld-ContribAuthor ">Lay Hoon  Lee</span>, <span class="hlFld-ContribAuthor ">Maryam  Yasin</span>, <span class="hlFld-ContribAuthor ">Pauline  Yeo</span>, <span class="hlFld-ContribAuthor ">Kantharaj  Ethirajulu</span>, <span class="hlFld-ContribAuthor ">Sylvia Bong Hwa  Gan</span>, <span class="hlFld-ContribAuthor ">Stephanie E.  Blanchard</span>, <span class="hlFld-ContribAuthor ">Ranjani  Nellore</span>, <span class="hlFld-ContribAuthor ">Dhananjay N.  Umrani</span>, <span class="hlFld-ContribAuthor ">Roberto  Gomeni</span>, <span class="hlFld-ContribAuthor ">Darren Lim Wan  Teck</span>, <span class="hlFld-ContribAuthor ">Greg  Li</span>, <span class="hlFld-ContribAuthor ">Qing Shu  Lu</span>, <span class="hlFld-ContribAuthor ">Yang  Cao</span>, <span class="hlFld-ContribAuthor ">Alex  Matter</span>. </span><span class="cited-content_cbyCitation_article-title">First‐in‐Human, Healthy Volunteers Integrated Protocol of
              ETC
              ‐206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Science</span><span> <strong>2020,</strong> <em>13 </em>
                                    (1)
                                     , 57-66. <a href="https://doi.org/10.1111/cts.12678" title="DOI URL">https://doi.org/10.1111/cts.12678</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cts.12678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcts.12678%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Science%26atitle%3DFirst%2525E2%252580%252590in%2525E2%252580%252590Human%25252C%252BHealthy%252BVolunteers%252BIntegrated%252BProtocol%252Bof%252BETC%252B%2525E2%252580%252590206%25252C%252Ban%252BOral%252BMnk%252B1%25252F2%252BKinase%252BInhibitor%252BOncology%252BDrug%26aulast%3DTeneggi%26aufirst%3DVincenzo%26date%3D2020%26date%3D2019%26volume%3D13%26issue%3D1%26spage%3D57%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinrui  Yuan</span>, <span class="hlFld-ContribAuthor ">Hanshu  Wu</span>, <span class="hlFld-ContribAuthor ">Hong  Bu</span>, <span class="hlFld-ContribAuthor ">Peiyuan  Zheng</span>, <span class="hlFld-ContribAuthor ">Jinpei  Zhou</span>, <span class="hlFld-ContribAuthor ">Huibin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyridone–aminal derivatives as MNK1/2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (7)
                                     , 1211-1225. <a href="https://doi.org/10.1016/j.bmc.2019.02.007" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyridone%2525E2%252580%252593aminal%252Bderivatives%252Bas%252BMNK1%25252F2%252Binhibitors%26aulast%3DYuan%26aufirst%3DXinrui%26date%3D2019%26volume%3D27%26issue%3D7%26spage%3D1211%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristen  Pettit</span>, <span class="hlFld-ContribAuthor ">Srdan  Verstovsek</span>, <span class="hlFld-ContribAuthor ">Moshe  Talpaz</span>. </span><span class="cited-content_cbyCitation_article-title">SOHO State of the Art Updates and Next Questions: Myelofibrosis. </span><span class="cited-content_cbyCitation_journal-name">Clinical Lymphoma Myeloma and Leukemia</span><span> <strong>2019,</strong> <em>19 </em>
                                    (4)
                                     , 191-199. <a href="https://doi.org/10.1016/j.clml.2019.03.011" title="DOI URL">https://doi.org/10.1016/j.clml.2019.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.clml.2019.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.clml.2019.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Lymphoma%2520Myeloma%2520and%2520Leukemia%26atitle%3DSOHO%252BState%252Bof%252Bthe%252BArt%252BUpdates%252Band%252BNext%252BQuestions%25253A%252BMyelofibrosis%26aulast%3DPettit%26aufirst%3DKristen%26date%3D2019%26volume%3D19%26issue%3D4%26spage%3D191%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianling  Xie</span>, <span class="hlFld-ContribAuthor ">James E.  Merrett</span>, <span class="hlFld-ContribAuthor ">Kirk B.  Jensen</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Proud</span>. </span><span class="cited-content_cbyCitation_article-title">The MAP kinase-interacting kinases (MNKs) as targets in oncology. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2019,</strong> <em>23 </em>
                                    (3)
                                     , 187-199. <a href="https://doi.org/10.1080/14728222.2019.1571043" title="DOI URL">https://doi.org/10.1080/14728222.2019.1571043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2019.1571043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2019.1571043%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DThe%252BMAP%252Bkinase-interacting%252Bkinases%252B%252528MNKs%252529%252Bas%252Btargets%252Bin%252Boncology%26aulast%3DXie%26aufirst%3DJianling%26date%3D2019%26date%3D2019%26volume%3D23%26issue%3D3%26spage%3D187%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinrui  Yuan</span>, <span class="hlFld-ContribAuthor ">Hanshu  Wu</span>, <span class="hlFld-ContribAuthor ">Hong  Bu</span>, <span class="hlFld-ContribAuthor ">Jinpei  Zhou</span>, <span class="hlFld-ContribAuthor ">Huibin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the immunity protein kinases for immuno-oncology. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 413-427. <a href="https://doi.org/10.1016/j.ejmech.2018.11.072" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.11.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.11.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.11.072%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bthe%252Bimmunity%252Bprotein%252Bkinases%252Bfor%252Bimmuno-oncology%26aulast%3DYuan%26aufirst%3DXinrui%26date%3D2019%26volume%3D163%26spage%3D413%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Jin</span>, <span class="hlFld-ContribAuthor ">James  Merrett</span>, <span class="hlFld-ContribAuthor ">Sheng  Tong</span>, <span class="hlFld-ContribAuthor ">Bartholomew  Flower</span>, <span class="hlFld-ContribAuthor ">Jianling  Xie</span>, <span class="hlFld-ContribAuthor ">Rilei  Yu</span>, <span class="hlFld-ContribAuthor ">Shuye  Tian</span>, <span class="hlFld-ContribAuthor ">Ling  Gao</span>, <span class="hlFld-ContribAuthor ">Jiajun  Zhao</span>, <span class="hlFld-ContribAuthor ">Xuemin  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Jiang</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Proud</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and activity of Mnk1 and Mnk2 selective inhibitors containing thieno[2,3-d]pyrimidine scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>162 </em>, 735-751. <a href="https://doi.org/10.1016/j.ejmech.2018.10.070" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.070%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bactivity%252Bof%252BMnk1%252Band%252BMnk2%252Bselective%252Binhibitors%252Bcontaining%252Bthieno%25255B2%25252C3-d%25255Dpyrimidine%252Bscaffold%26aulast%3DJin%26aufirst%3DXin%26date%3D2019%26volume%3D162%26spage%3D735%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0017.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>N</i>-(3-(4-Hydroxyphenyl)imidazo[1,2-<i>a</i>]pyrazinyl)-6 Amides <b>4</b> and <b>5</b>, and 6-Phenyl <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) acetamide or benzamide, <i>N,N</i>-dimethylethylenediamine, K<sub>2</sub>CO<sub>3</sub>, CuI, Toluene, 90 °C, 12 h; (ii) NBS, CH<sub>2</sub>Cl<sub>2</sub>, 1 h; (iii) (4-hydroxyphenyl)boronic acid, Na<sub>2</sub>CO<sub>3</sub>, Pd(OAc)<sub>2</sub>, P(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, 90 °C, 12 h; (iv) (4-hydroxyphenyl)boronic acid, Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, 90 °C, 12 h; (v) phenylboronic acid, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, H<sub>2</sub>O, 140 °C, 30 min.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Imidazopyrazine Analogues <b>19</b>–<b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (4-(ethoxycarbonyl)phenyl)boronic acid, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 90 °C, 12 h; (ii) NBS, MeOH, CCl<sub>4</sub> or NIS, DMF; (iii) LiOH, H<sub>2</sub>O, THF, CH<sub>3</sub>OH; (iv) R<sup>1</sup>R<sup>1′</sup>NH, HATU, NMM, DMF; (v) arylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 90 °C, 12 h; (vi) DIPEA, HOBt, EDCI·HCl, <i>O</i>-(tetrahydro-2<i>H</i>-pyran-2-yl)hydroxylamine, CH<sub>2</sub>Cl<sub>2</sub>, DMF, rt, 12 h; (vii) 1M aq HCl, CH<sub>3</sub>CN, MeOH, rt, 4 h.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Imidazopyrazine Analogues <b>36</b> and <b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (4-(ethoxycarbonyl)phenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DMF, 90 °C, 12 h for <b>34a</b>, 2 h for <b>34b</b>; (ii) LiOH, THF, CH<sub>3</sub>OH, rt, 5 h for <b>35a</b> and 12 h for <b>35b</b>; (iii) 1-(piperazin-1-yl)ethan-1-one or <i>N,N</i>-dimethylpiperidin-4-amine, HATU, NMM, DMF, rt, 3 h.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Imidazopyridazine Analogues <b>39</b>, <b>40</b>, <b>42</b>, and <b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (4-(4-methylpiperazine-1-carbonyl)phenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, EtOH, K<sub>2</sub>CO<sub>3</sub>, 140 °C, microwave reactor, 30 min; or morpholino(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, DMF, H<sub>2</sub>O, Cs<sub>2</sub>CO<sub>3</sub>, microwave reactor, 140 °C, 30 min; (ii) 4-boronobenzoic acid, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, DMF, H<sub>2</sub>O; Cs<sub>2</sub>CO<sub>3</sub>, 90 °C, 18 h; (iii) <i>tert</i>-butyl piperazine-1-carboxylate, HATU, NMM, DMF, rt, 18 h; (iv) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (v) <i>N,N</i>-dimethylpiperidin-4-amine, HATU, NMM, DMF; (vi) (4-cyanophenyl)boronic acid, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, H<sub>2</sub>O, 90 °C, 6 h.</p></p></figure><figure data-id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Imidazopyridine <b>47</b> and <b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (4-methylpiperazin-1-yl)(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone, (A-Phos)<sub>2</sub>PdCl<sub>2</sub>, NaHCO<sub>3</sub>, DMF, H<sub>2</sub>O, 90 °C, 1 h; or morpholino(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, 1,4-dioxane, H<sub>2</sub>O, 90 °C, 19 h.</p></p></figure><figure data-id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. SAR exploration strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>4</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) modeled into the MNK2 DFD-out X-ray structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2AC3">2AC3</a>). The binding site residues of MNK2 are shown in thin tube representation with gray carbon atoms. <b>4</b> is shown in thick tube with green carbon. Hydrogen bonds between MNK2 and <b>4</b> are shown with yellow dashed lines, π–π interactions with magenta dashed lines, and aromatic hydrogen bond with blue dashed line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>27</b> modeled into MNK2 DFD-out X-ray structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2AC3">2AC3</a>). The binding site residues of MNK2 are shown in thin tube representation with gray carbon atoms. <b>27</b> is shown in thick tube drawing with green carbons. Hydrogen bonds between MNK2 and <b>27</b> are shown with yellow dashed lines, π–π interactions with magenta dashed lines, and aromatic hydrogen bond with blue dashed line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. A single water molecule was placed in front of the imidazopyrazine N-7 (A) and imidazopyridazine N-5 (B). The complexes were minimized using DFT-B3LYP 6-31G**.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>45</b> docked into MNK2 catalytic site. MNK2 is shown as an electrostatic surface. The inhibitors are shown in stick with green carbon and a transparent green surface.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/medium/jm-2017-01714a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Antitumor efficacy of <b>48</b> after oral administration alone or in combination with dasatinib to K562 o/e eIF4E SCID mouse xenograft model with eight mice per group. (A) Mouse body weights expressed as (mean ± SEM). (B) Tumor growth rates expressed as volumes (mean ± SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.7b01714/20180517/images/large/jm-2017-01714a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01714&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i122">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 75 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span> <span> </span><span class="NLM_article-title">Mnk kinase pathway: Cellular functions and biological outcomes</span>. <i>World J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.4331/wjbc.v5.i3.321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.4331%2Fwjbc.v5.i3.321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=25225600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A280%3ADC%252BC2M7hvVCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=321-333&issue=3&author=S.+Joshiauthor=L.+C.+Platanias&title=Mnk+kinase+pathway%3A+Cellular+functions+and+biological+outcomes&doi=10.4331%2Fwjbc.v5.i3.321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mnk kinase pathway: Cellular functions and biological outcomes</span></div><div class="casAuthors">Joshi Sonali; Platanias Leonidas C</div><div class="citationInfo"><span class="NLM_cas:title">World journal of biological chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">321-33</span>
        ISSN:<span class="NLM_cas:issn">1949-8454</span>.
    </div><div class="casAbstract">The mitogen-activated protein kinase (MAPK) interacting protein kinases 1 and 2 (Mnk1 and Mnk2) play important roles in controlling signals involved in mRNA translation.  In addition to the MAPKs (p38 or Erk), multiple studies suggest that the Mnk kinases can be regulated by other known kinases such as Pak2 and/or other unidentified kinases by phosphorylation of residues distinct from the sites phosphorylated by the MAPKs.  Several studies have established multiple Mnk protein targets, including PSF, heterogenous nuclear ribonucleoprotein A1, Sprouty 2 and have lead to the identification of distinct biological functions and substrate specificity for the Mnk kinases.  In this review we discuss the pathways regulating the Mnk kinases, their known substrates as well as the functional consequences of engagement of pathways controlled by Mnk kinases.  These kinases play an important role in mRNA translation via their regulation of eukaryotic initiation factor 4E (eIF4E) and their functions have important implications in tumor biology as well as the regulation of drug resistance to anti-oncogenic therapies.  Other studies have identified a role for the Mnk kinases in cap-independent mRNA translation, suggesting that the Mnk kinases can exert important functional effects independently of the phosphorylation of eIF4E.  The role of Mnk kinases in inflammation and inflammation-induced malignancies is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQFICkwsHpykh5eUSa2oe_fW6udTcc2eaqJsxxTbfwkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7hvVCgtQ%253D%253D&md5=765d4facdd3bb2c0c393ef6f8d0b8fc8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.4331%2Fwjbc.v5.i3.321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4331%252Fwjbc.v5.i3.321%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26atitle%3DMnk%2520kinase%2520pathway%253A%2520Cellular%2520functions%2520and%2520biological%2520outcomes%26jtitle%3DWorld%2520J.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D5%26issue%3D3%26spage%3D321%26epage%3D333%26doi%3D10.4331%2Fwjbc.v5.i3.321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe-Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, R.</span></span> <span> </span><span class="NLM_article-title">Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6539</span>– <span class="NLM_lpage">6549</span>, <span class="refDoi"> DOI: 10.1128/MCB.24.15.6539-6549.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1128%2FMCB.24.15.6539-6549.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=15254222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlKltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=6539-6549&issue=15&author=T.+Uedaauthor=R.+Watanabe-Fukunagaauthor=H.+Fukuyamaauthor=S.+Nagataauthor=R.+Fukunaga&title=Mnk2+and+Mnk1+are+essential+for+constitutive+and+inducible+phosphorylation+of+eukaryotic+initiation+factor+4E+but+not+for+cell+growth+or+development&doi=10.1128%2FMCB.24.15.6539-6549.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development</span></div><div class="casAuthors">Ueda, Takeshi; Watanabe-Fukunaga, Rie; Fukuyama, Hidehiro; Nagata, Shigekazu; Fukunaga, Rikiro</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6539-6549</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Mnk1 and Mnk2 are protein kinases that are directly phosphorylated and activated by extracellular signal-regulated kinase (ERK) or p38 mitogen-activated protein (MAP) kinases and implicated in the regulation of protein synthesis through their phosphorylation of eukaryotic translation initiation factor 4E (eIF4E) at Ser209.  To investigate their physiol. functions, we generated mice lacking the Mnk1 or Mnk2 gene or both; the resulting KO mice were viable, fertile, and developed normally.  In embryonic fibroblasts prepd. from Mnk1-Mnk2 DKO mice, eIF4E was not detectably phosphorylated at Ser209, even when the ERK and/or p38 MAP kinases were activated.  Anal. of embryonic fibroblasts from single KO mice revealed that Mnk1 is responsible for the inducible phosphorylation of eIF4E in response to MAP kinase activation, whereas Mnk2 mainly contributes to eIF4E's basal, constitutive phosphorylation.  Lipopolysaccharide (LPS)- or insulin-induced upregulation of eIF4E phosphorylation in the spleen, liver, or skeletal muscle was abolished in Mnk1-/- mice, whereas the basal eIF4E phosphorylation levels were decreased in Mnk2-/- mice.  In Mnk1-Mnk2 DKO mice, no phosphorylated eIF4E was detected in any tissue studied, even after LPS or insulin injection.  However, neither general protein synthesis nor cap-dependent translation, as assayed by a bicistronic reporter assay system, was affected in Mnk-deficient embryonic fibroblasts, despite the absence of phosphorylated eIF4E.  Thus, Mnk1 and Mnk2 are exclusive eIF4E kinases both in cultured fibroblasts and adult tissues, and they regulate inducible and constitutive eIF4E phosphorylation, resp.  These results strongly suggest that eIF4E phosphorylation at Ser209 is not essential for cell growth during development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6LIGS-bIJs7Vg90H21EOLACvtfcHk0lg-gWTIgmVjrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlKltLw%253D&md5=8ad9391afbf76148f4609f38d60b82aa</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.15.6539-6549.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.15.6539-6549.2004%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DWatanabe-Fukunaga%26aufirst%3DR.%26aulast%3DFukuyama%26aufirst%3DH.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DFukunaga%26aufirst%3DR.%26atitle%3DMnk2%2520and%2520Mnk1%2520are%2520essential%2520for%2520constitutive%2520and%2520inducible%2520phosphorylation%2520of%2520eukaryotic%2520initiation%2520factor%25204E%2520but%2520not%2520for%2520cell%2520growth%2520or%2520development%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26issue%3D15%26spage%3D6539%26epage%3D6549%26doi%3D10.1128%2FMCB.24.15.6539-6549.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowlett, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrestensen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harp, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelo, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cominelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturgill, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worthington, M. T.</span></span> <span> </span><span class="NLM_article-title">MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages</span>. <i>Am. J. Physiol. Gastrointest. Liver Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>294</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">G452</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1152/ajpgi.00077.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1152%2Fajpgi.00077.2007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=G452-459&issue=2&author=R.+M.+Rowlettauthor=C.+A.+Chrestensenauthor=M.+Nyceauthor=M.+G.+Harpauthor=J.+W.+Peloauthor=F.+Cominelliauthor=P.+B.+Ernstauthor=T.+T.+Pizarroauthor=T.+W.+Sturgillauthor=M.+T.+Worthington&title=MNK+kinases+regulate+multiple+TLR+pathways+and+innate+proinflammatory+cytokines+in+macrophages&doi=10.1152%2Fajpgi.00077.2007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1152%2Fajpgi.00077.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpgi.00077.2007%26sid%3Dliteratum%253Aachs%26aulast%3DRowlett%26aufirst%3DR.%2BM.%26aulast%3DChrestensen%26aufirst%3DC.%2BA.%26aulast%3DNyce%26aufirst%3DM.%26aulast%3DHarp%26aufirst%3DM.%2BG.%26aulast%3DPelo%26aufirst%3DJ.%2BW.%26aulast%3DCominelli%26aufirst%3DF.%26aulast%3DErnst%26aufirst%3DP.%2BB.%26aulast%3DPizarro%26aufirst%3DT.%2BT.%26aulast%3DSturgill%26aufirst%3DT.%2BW.%26aulast%3DWorthington%26aufirst%3DM.%2BT.%26atitle%3DMNK%2520kinases%2520regulate%2520multiple%2520TLR%2520pathways%2520and%2520innate%2520proinflammatory%2520cytokines%2520in%2520macrophages%26jtitle%3DAm.%2520J.%2520Physiol.%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2008%26volume%3D294%26issue%3D2%26spage%3DG452%26epage%3D459%26doi%3D10.1152%2Fajpgi.00077.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundler, R.</span></span> <span> </span><span class="NLM_article-title">Posttranscriptional regulation of TNFalpha expression via eukaryotic initiation factor 4E (eIF4E) phosphorylation in mouse macrophages</span>. <i>Cytokine+</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1016/j.cyto.2005.11.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.cyto.2005.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=16431125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlalurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=52-57&issue=1&author=K.+Anderssonauthor=R.+Sundler&title=Posttranscriptional+regulation+of+TNFalpha+expression+via+eukaryotic+initiation+factor+4E+%28eIF4E%29+phosphorylation+in+mouse+macrophages&doi=10.1016%2Fj.cyto.2005.11.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Posttranscriptional regulation of TNFα expression via eukaryotic initiation factor 4E (eIF4E) phosphorylation in mouse macrophages</span></div><div class="casAuthors">Andersson, Karolina; Sundler, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine+</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-57</span>CODEN:
                <span class="NLM_cas:coden">CYTIE9</span>;
        ISSN:<span class="NLM_cas:issn">1043-4666</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Resident mouse macrophages secrete tumor necrosis factor α (TNFα) upon challenge with LPS.  The prodn. of TNFα is controlled not only at the transcription of the gene, but also by strong posttranscriptional regulation.  When macrophages are stimulated with LPS different signal transduction pathways become activated.  Here the authors show that the combination of the 2 kinases, p38 and MEK and presumably ERK1/2 regulate translation of TNFα, through the downstream kinase Mnk1.  TNFα prodn. is inhibited in a concn.-dependent manner by CGP57380 (Mnk1 inhibitor).  The corresponding mRNA results show that the inhibition targets posttranscriptional regulation and is paralleled by inhibition of the phosphorylation of eukaryotic initiation factor 4E (eIF4E).  Unexpectedly, the activation/inhibition of MAPKAP kinase-2 (MK2) did not parallel TNFα prodn., arguing against a direct/immediate role for this kinase.  Based on these and previous results the authors propose that ARE-contg. TNFα mRNA requires phosphorylation of eIF4E for initiation of translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotHnMmgYJX9LVg90H21EOLACvtfcHk0lhdYf60FlxbaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlalurg%253D&md5=20b113e5c71f8bf01eff8f2ce50cbe94</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2005.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2005.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DK.%26aulast%3DSundler%26aufirst%3DR.%26atitle%3DPosttranscriptional%2520regulation%2520of%2520TNFalpha%2520expression%2520via%2520eukaryotic%2520initiation%2520factor%25204E%2520%2528eIF4E%2529%2520phosphorylation%2520in%2520mouse%2520macrophages%26jtitle%3DCytokine%252B%26date%3D2006%26volume%3D33%26issue%3D1%26spage%3D52%26epage%3D57%26doi%3D10.1016%2Fj.cyto.2005.11.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buxade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousseau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrice, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proud, C. G.</span></span> <span> </span><span class="NLM_article-title">The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2005.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.immuni.2005.06.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=177-189&issue=2&author=M.+Buxadeauthor=J.+L.+Parraauthor=S.+Rousseauauthor=N.+Shpiroauthor=R.+Marquezauthor=N.+Morriceauthor=J.+Bainauthor=E.+Espelauthor=C.+G.+Proud&title=The+Mnks+are+novel+components+in+the+control+of+TNF+alpha+biosynthesis+and+phosphorylate+and+regulate+hnRNP+A1&doi=10.1016%2Fj.immuni.2005.06.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2005.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2005.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DBuxade%26aufirst%3DM.%26aulast%3DParra%26aufirst%3DJ.%2BL.%26aulast%3DRousseau%26aufirst%3DS.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DMarquez%26aufirst%3DR.%26aulast%3DMorrice%26aufirst%3DN.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DEspel%26aufirst%3DE.%26aulast%3DProud%26aufirst%3DC.%2BG.%26atitle%3DThe%2520Mnks%2520are%2520novel%2520components%2520in%2520the%2520control%2520of%2520TNF%2520alpha%2520biosynthesis%2520and%2520phosphorylate%2520and%2520regulate%2520hnRNP%2520A1%26jtitle%3DImmunity%26date%3D2005%26volume%3D23%26issue%3D2%26spage%3D177%26epage%3D189%26doi%3D10.1016%2Fj.immuni.2005.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gkogkas, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoutorsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafarnejad, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prager-Khoutorsky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannakas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragkouli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nader, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konicek, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzinia, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacaille, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span> <span> </span><span class="NLM_article-title">Pharmacogenetic inhibition of eIF4E-dependent Mmp9 mRNA translation reverses fragile X syndrome-like phenotypes</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1742</span>– <span class="NLM_lpage">1755</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2014.10.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.celrep.2014.10.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=25466251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2gs7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1742-1755&issue=5&author=C.+G.+Gkogkasauthor=A.+Khoutorskyauthor=R.+Caoauthor=S.+M.+Jafarnejadauthor=M.+Prager-Khoutorskyauthor=N.+Giannakasauthor=A.+Kaminariauthor=A.+Fragkouliauthor=K.+Naderauthor=T.+J.+Priceauthor=B.+W.+Konicekauthor=J.+R.+Graffauthor=A.+K.+Tziniaauthor=J.+C.+Lacailleauthor=N.+Sonenberg&title=Pharmacogenetic+inhibition+of+eIF4E-dependent+Mmp9+mRNA+translation+reverses+fragile+X+syndrome-like+phenotypes&doi=10.1016%2Fj.celrep.2014.10.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacogenetic Inhibition of eIF4E-Dependent Mmp9 mRNA Translation Reverses Fragile X Syndrome-like Phenotypes</span></div><div class="casAuthors">Gkogkas, Christos G.; Khoutorsky, Arkady; Cao, Ruifeng; Jafarnejad, Seyed Mehdi; Prager-Khoutorsky, Masha; Giannakas, Nikolaos; Kaminari, Archontia; Fragkouli, Apostolia; Nader, Karim; Price, Theodore J.; Konicek, Bruce W.; Graff, Jeremy R.; Tzinia, Athina K.; Lacaille, Jean-Claude; Sonenberg, Nahum</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1742-1755</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Fragile X syndrome (FXS) is the leading genetic cause of autism.  Mutations in Fmr1 (fragile X mental retardation 1 gene) engender exaggerated translation resulting in dendritic spine dysmorphogenesis, synaptic plasticity alterations, and behavioral deficits in mice, which are reminiscent of FXS phenotypes.  Using postmortem brains from FXS patients and Fmr1 knockout mice (Fmr1-/y), we show that phosphorylation of the mRNA 5' cap binding protein, eukaryotic initiation factor 4E (eIF4E), is elevated concomitant with increased expression of matrix metalloproteinase 9 (MMP-9) protein.  Genetic or pharmacol. redn. of eIF4E phosphorylation rescued core behavioral deficits, synaptic plasticity alterations, and dendritic spine morphol. defects via reducing exaggerated translation of Mmp9 mRNA in Fmr1-/y mice, whereas MMP-9 overexpression produced several FXS-like phenotypes.  These results uncover a mechanism of regulation of synaptic function by translational control of Mmp-9 in FXS, which opens the possibility of new treatment avenues for the diverse neurol. and psychiatric aspects of FXS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDYFY_NYb2mbVg90H21EOLACvtfcHk0lhdYf60FlxbaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2gs7zM&md5=352bf1476c5f6c94d48e15026468767e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.10.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.10.064%26sid%3Dliteratum%253Aachs%26aulast%3DGkogkas%26aufirst%3DC.%2BG.%26aulast%3DKhoutorsky%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DR.%26aulast%3DJafarnejad%26aufirst%3DS.%2BM.%26aulast%3DPrager-Khoutorsky%26aufirst%3DM.%26aulast%3DGiannakas%26aufirst%3DN.%26aulast%3DKaminari%26aufirst%3DA.%26aulast%3DFragkouli%26aufirst%3DA.%26aulast%3DNader%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DT.%2BJ.%26aulast%3DKonicek%26aufirst%3DB.%2BW.%26aulast%3DGraff%26aufirst%3DJ.%2BR.%26aulast%3DTzinia%26aufirst%3DA.%2BK.%26aulast%3DLacaille%26aufirst%3DJ.%2BC.%26aulast%3DSonenberg%26aufirst%3DN.%26atitle%3DPharmacogenetic%2520inhibition%2520of%2520eIF4E-dependent%2520Mmp9%2520mRNA%2520translation%2520reverses%2520fragile%2520X%2520syndrome-like%2520phenotypes%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D9%26issue%3D5%26spage%3D1742%26epage%3D1755%26doi%3D10.1016%2Fj.celrep.2014.10.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grzmil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seebacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schibli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moncayo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmings, B. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of MNK pathways enhances cancer cell response to chemotherapy with Temozolomide and targeted radionuclide therapy</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1412</span>– <span class="NLM_lpage">1421</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2016.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.cellsig.2016.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=27289018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSqtLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2016&pages=1412-1421&issue=9&author=M.+Grzmilauthor=J.+Seebacherauthor=D.+Hessauthor=M.+Beheauthor=R.+Schibliauthor=G.+Moncayoauthor=S.+Frankauthor=B.+A.+Hemmings&title=Inhibition+of+MNK+pathways+enhances+cancer+cell+response+to+chemotherapy+with+Temozolomide+and+targeted+radionuclide+therapy&doi=10.1016%2Fj.cellsig.2016.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy</span></div><div class="casAuthors">Grzmil, Michal; Seebacher, Jan; Hess, Daniel; Behe, Martin; Schibli, Roger; Moncayo, Gerald; Frank, Stephan; Hemmings, Brian A.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1412-1421</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Current std.-of-care treatment for malignant cancers includes radiotherapy and adjuvant chemotherapy.  Here, we report increased MAP kinase-interacting kinase (MNK)-regulated phosphorylation of translation initiation factor 4E (eIF4E) in glioma cells upon temozolomide (TMZ) treatment and in medullary thyroid carcinoma (MTC) cells in response to targeted radionuclide therapy.  Depletion of MNK activity by using two MNK inhibitors, CGP57380 or cercosporamide, as well as by MNK1-specific knockdown sensitized glioblastoma (GBM) cells and GBM-derived spheres to TMZ.  Furthermore, CGP57380 treatment enhanced response of MTC cells to 177Lu-labeled gastrin analog.  In order to understand how MNK signaling pathways support glioma survival we analyzed putative MNK substrates by quant. phosphoproteomics in normal condition and in the presence of TMZ.  We identified MNK inhibitor-sensitive phosphorylation sites on eIF4G1, mutations of which either influenced eIF4E phosphorylation or glioma cell response to TMZ, pointing to altered regulation of translation initiation as a resistance mechanism.  Pharmacol. inhibition of overexpressed MNK1 by CGP57380 reduced eIF4E phosphorylation and induced assocn. of inactive MNK1 with eIF4G1.  Taken together, our data show an activation of MNK-mediated survival mechanisms in response to either glioma chemotherapy or MTC targeted radiation and suggest that inhibition of MNK activity represents an attractive sensitizing strategy for cancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5g475rtcdA7Vg90H21EOLACvtfcHk0lh8IG0Cd8A9gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSqtLrK&md5=6bea5edacac34f3517525bba93184643</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2016.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2016.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DGrzmil%26aufirst%3DM.%26aulast%3DSeebacher%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DD.%26aulast%3DBehe%26aufirst%3DM.%26aulast%3DSchibli%26aufirst%3DR.%26aulast%3DMoncayo%26aufirst%3DG.%26aulast%3DFrank%26aufirst%3DS.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26atitle%3DInhibition%2520of%2520MNK%2520pathways%2520enhances%2520cancer%2520cell%2520response%2520to%2520chemotherapy%2520with%2520Temozolomide%2520and%2520targeted%2520radionuclide%2520therapy%26jtitle%3DCell.%2520Signalling%26date%3D2016%26volume%3D28%26issue%3D9%26spage%3D1412%26epage%3D1421%26doi%3D10.1016%2Fj.cellsig.2016.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grzmil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lino, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moncayo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmings, B. A.</span></span> <span> </span><span class="NLM_article-title">MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-beta signaling pathway in human glioblastoma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2392</span>– <span class="NLM_lpage">2402</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-3112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1158%2F0008-5472.CAN-10-3112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=2392-2402&issue=6&author=M.+Grzmilauthor=P.+Morinauthor=M.+M.+Linoauthor=A.+Merloauthor=S.+Frankauthor=Y.+Wangauthor=G.+Moncayoauthor=B.+A.+Hemmings&title=MAP+kinase-interacting+kinase+1+regulates+SMAD2-dependent+TGF-beta+signaling+pathway+in+human+glioblastoma&doi=10.1158%2F0008-5472.CAN-10-3112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-3112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-3112%26sid%3Dliteratum%253Aachs%26aulast%3DGrzmil%26aufirst%3DM.%26aulast%3DMorin%26aufirst%3DP.%26aulast%3DLino%26aufirst%3DM.%2BM.%26aulast%3DMerlo%26aufirst%3DA.%26aulast%3DFrank%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMoncayo%26aufirst%3DG.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26atitle%3DMAP%2520kinase-interacting%2520kinase%25201%2520regulates%2520SMAD2-dependent%2520TGF-beta%2520signaling%2520pathway%2520in%2520human%2520glioblastoma%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D6%26spage%3D2392%26epage%3D2402%26doi%3D10.1158%2F0008-5472.CAN-10-3112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckerdt, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arslan, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clymer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horbinski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davuluri, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span> <span> </span><span class="NLM_article-title">MNK inhibition disrupts mesenchymal glioma stem cells and prolongs survival in a mouse model of glioblastoma</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">984</span>– <span class="NLM_lpage">993</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-16-0172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1158%2F1541-7786.MCR-16-0172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=27364770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslGisbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=984-993&issue=10&author=J.+B.+Bellauthor=F.+D.+Eckerdtauthor=K.+Alleyauthor=L.+P.+Magnussonauthor=H.+Hussainauthor=Y.+Biauthor=A.+D.+Arslanauthor=J.+Clymerauthor=A.+A.+Alvarezauthor=S.+Goldmanauthor=S.+Y.+Chengauthor=I.+Nakanoauthor=C.+Horbinskiauthor=R.+V.+Davuluriauthor=C.+D.+Jamesauthor=L.+C.+Platanias&title=MNK+inhibition+disrupts+mesenchymal+glioma+stem+cells+and+prolongs+survival+in+a+mouse+model+of+glioblastoma&doi=10.1158%2F1541-7786.MCR-16-0172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma</span></div><div class="casAuthors">Bell, Jonathan B.; Eckerdt, Frank D.; Alley, Kristen; Magnusson, Lisa P.; Hussain, Hridi; Bi, Yingtao; Arslan, Ahmet Dirim; Clymer, Jessica; Alvarez, Angel A.; Goldman, Stewart; Cheng, Shi-Yuan; Nakano, Ichiro; Horbinski, Craig; Davuluri, Ramana V.; James, C. David; Platanias, Leonidas C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">984-993</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Glioblastoma multiforme remains the deadliest malignant brain tumor, with glioma stem cells (GSC) contributing to treatment resistance and tumor recurrence.  We have identified MAPK-interacting kinases (MNK) as potential targets for the GSC population in glioblastoma multiforme.  Isoform-level subtyping using The Cancer Genome Atlas revealed that both MNK genes (MKNK1 and MKNK2) are upregulated in mesenchymal glioblastoma multiforme as compared with other subtypes.  Expression of MKNK1 is assocd. with increased glioma grade and correlated with the mesenchymal GSC marker, CD44, and coexpression of MKNK1 and CD44 predicts poor survival in glioblastoma multiforme.  In established and patient-derived cell lines, pharmacol. MNK inhibition using LY2801653 (merestinib) inhibited phosphorylation of the eukaryotic translation initiation factor 4E, a crucial effector for MNK-induced mRNA translation in cancer cells and a marker of transformation.  Importantly, merestinib inhibited growth of GSCs grown as neurospheres as detd. by extreme limiting diln. anal.  When the effects of merestinib were assessed in vivo using an intracranial xenograft mouse model, improved overall survival was obsd. in merestinib-treated mice.  Taken together, these data provide strong preclin. evidence that pharmacol. MNK inhibition targets mesenchymal glioblastoma multiforme and its GSC population.  These findings raise the possibility of MNK inhibition as a viable therapeutic approach to target the mesenchymal subtype of glioblastoma multiforme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzbXOivkr8_7Vg90H21EOLACvtfcHk0lh8IG0Cd8A9gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslGisbbM&md5=690d5b41dbbdfa81a470c54e09ad3a92</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-16-0172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-16-0172%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DJ.%2BB.%26aulast%3DEckerdt%26aufirst%3DF.%2BD.%26aulast%3DAlley%26aufirst%3DK.%26aulast%3DMagnusson%26aufirst%3DL.%2BP.%26aulast%3DHussain%26aufirst%3DH.%26aulast%3DBi%26aufirst%3DY.%26aulast%3DArslan%26aufirst%3DA.%2BD.%26aulast%3DClymer%26aufirst%3DJ.%26aulast%3DAlvarez%26aufirst%3DA.%2BA.%26aulast%3DGoldman%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DS.%2BY.%26aulast%3DNakano%26aufirst%3DI.%26aulast%3DHorbinski%26aufirst%3DC.%26aulast%3DDavuluri%26aufirst%3DR.%2BV.%26aulast%3DJames%26aufirst%3DC.%2BD.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26atitle%3DMNK%2520inhibition%2520disrupts%2520mesenchymal%2520glioma%2520stem%2520cells%2520and%2520prolongs%2520survival%2520in%2520a%2520mouse%2520model%2520of%2520glioblastoma%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2016%26volume%3D14%26issue%3D10%26spage%3D984%26epage%3D993%26doi%3D10.1158%2F1541-7786.MCR-16-0172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chrestensen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuman, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eschenroeder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worthington, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gram, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturgill, T. W.</span></span> <span> </span><span class="NLM_article-title">MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">4243</span>– <span class="NLM_lpage">4252</span>, <span class="refDoi"> DOI: 10.1074/jbc.M607368200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1074%2Fjbc.M607368200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=4243-4252&issue=7&author=C.+A.+Chrestensenauthor=J.+K.+Shumanauthor=A.+Eschenroederauthor=M.+Worthingtonauthor=H.+Gramauthor=T.+W.+Sturgill&title=MNK1+and+MNK2+regulation+in+HER2-overexpressing+breast+cancer+lines&doi=10.1074%2Fjbc.M607368200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M607368200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M607368200%26sid%3Dliteratum%253Aachs%26aulast%3DChrestensen%26aufirst%3DC.%2BA.%26aulast%3DShuman%26aufirst%3DJ.%2BK.%26aulast%3DEschenroeder%26aufirst%3DA.%26aulast%3DWorthington%26aufirst%3DM.%26aulast%3DGram%26aufirst%3DH.%26aulast%3DSturgill%26aufirst%3DT.%2BW.%26atitle%3DMNK1%2520and%2520MNK2%2520regulation%2520in%2520HER2-overexpressing%2520breast%2520cancer%2520lines%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26issue%3D7%26spage%3D4243%26epage%3D4252%26doi%3D10.1074%2Fjbc.M607368200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wheater, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaydes, J. P.</span></span> <span> </span><span class="NLM_article-title">The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.4161/cbt.10.7.12965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.4161%2Fcbt.10.7.12965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=20686366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVKrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=728-735&issue=7&author=M.+J.+Wheaterauthor=P.+W.+Johnsonauthor=J.+P.+Blaydes&title=The+role+of+MNK+proteins+and+eIF4E+phosphorylation+in+breast+cancer+cell+proliferation+and+survival&doi=10.4161%2Fcbt.10.7.12965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival</span></div><div class="casAuthors">Wheater, Matthew J.; Johnson, Peter W. M.; Blaydes, Jeremy P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">728-735</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">EIF4E is overexpressed in many tumors, including a high proportion of breast cancers.  EIF4E is an oncogene, and signaling pathways which promote eIF4E activity represent potential targets for therapeutic intervention in cancer.  MNKs phosphorylate eIF4E on serine 209, a modification that can be required for eIF4E-dependent cell transformation.  There is therefore a clear requirement to det. the role of MNKs in the proliferation and survival of cells from the major human tumors, such as breast cancer.  Phosphorylated eIF4E protein was readily detectable in some breast tumor samples, but was below the limits of detection in others.  Of six breast cancer cell lines representing the major subtypes of breast cancer, phosphorylated eIF4E was readily detectable in five of them, with MCF-7 cells displaying markedly lower levels.  Long term colony forming assays demonstrated that all the five lines with high levels of phosphorylated eIF4E were highly sensitive to a MNK inhibitor.  In short term assays, a range of responses was revealed.  MCF-7 cells were insensitive in both assays.  The anti-proliferative effects of the MNK inhibitor in breast cancer cells are primarily cytostatic, rather than cytotoxic, and are potentially due to the inhibition of cyclin D1 synthesis.  Our data provide evidence that the sensitivity of breast cancer cells to MNK inhibition may correlate with baseline levels of eIF4E phosphorylation, and suggest that a proportion of breast cancers could be sensitive to inhibiting MNK kinase activity, and that the presence of phosphorylated eIF4E could provide a biomarker for the identification of responsive tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV-LNAQtLdjbVg90H21EOLACvtfcHk0lh7TjA0p2oazQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVKrtQ%253D%253D&md5=b2ad022bde5142aa92b6e46d32c36c01</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4161%2Fcbt.10.7.12965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.10.7.12965%26sid%3Dliteratum%253Aachs%26aulast%3DWheater%26aufirst%3DM.%2BJ.%26aulast%3DJohnson%26aufirst%3DP.%2BW.%26aulast%3DBlaydes%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520role%2520of%2520MNK%2520proteins%2520and%2520eIF4E%2520phosphorylation%2520in%2520breast%2520cancer%2520cell%2520proliferation%2520and%2520survival%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2010%26volume%3D10%26issue%3D7%26spage%3D728%26epage%3D735%26doi%3D10.4161%2Fcbt.10.7.12965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nasr, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porco, J. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span> <span> </span><span class="NLM_article-title">EIF4F suppression in breast cancer affects maintenance and progression</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1038%2Fonc.2012.105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=861-871&issue=7&author=Z.+Nasrauthor=F.+Robertauthor=J.+A.+Porcoauthor=W.+J.+Mullerauthor=J.+Pelletier&title=EIF4F+suppression+in+breast+cancer+affects+maintenance+and+progression&doi=10.1038%2Fonc.2012.105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.105%26sid%3Dliteratum%253Aachs%26aulast%3DNasr%26aufirst%3DZ.%26aulast%3DRobert%26aufirst%3DF.%26aulast%3DPorco%26aufirst%3DJ.%2BA.%26aulast%3DMuller%26aufirst%3DW.%2BJ.%26aulast%3DPelletier%26aufirst%3DJ.%26atitle%3DEIF4F%2520suppression%2520in%2520breast%2520cancer%2520affects%2520maintenance%2520and%2520progression%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26issue%3D7%26spage%3D861%26epage%3D871%26doi%3D10.1038%2Fonc.2012.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adesso, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabretta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbagallo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capurso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilozzi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geremia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delle Fave, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sette, C.</span></span> <span> </span><span class="NLM_article-title">Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">2848</span>– <span class="NLM_lpage">2857</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1038%2Fonc.2012.306" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2848-2857&issue=23&author=L.+Adessoauthor=S.+Calabrettaauthor=F.+Barbagalloauthor=G.+Capursoauthor=E.+Pilozziauthor=R.+Geremiaauthor=G.+Delle+Faveauthor=C.+Sette&title=Gemcitabine+triggers+a+pro-survival+response+in+pancreatic+cancer+cells+through+activation+of+the+MNK2%2FeIF4E+pathway&doi=10.1038%2Fonc.2012.306"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.306%26sid%3Dliteratum%253Aachs%26aulast%3DAdesso%26aufirst%3DL.%26aulast%3DCalabretta%26aufirst%3DS.%26aulast%3DBarbagallo%26aufirst%3DF.%26aulast%3DCapurso%26aufirst%3DG.%26aulast%3DPilozzi%26aufirst%3DE.%26aulast%3DGeremia%26aufirst%3DR.%26aulast%3DDelle%2BFave%26aufirst%3DG.%26aulast%3DSette%26aufirst%3DC.%26atitle%3DGemcitabine%2520triggers%2520a%2520pro-survival%2520response%2520in%2520pancreatic%2520cancer%2520cells%2520through%2520activation%2520of%2520the%2520MNK2%252FeIF4E%2520pathway%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26issue%3D23%26spage%3D2848%26epage%3D2857%26doi%3D10.1038%2Fonc.2012.306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arslan, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentrem, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckerdt, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, H. G.</span></span> <span> </span><span class="NLM_article-title">Differential regulation of ZEB1 and EMT by MAPK-interacting protein kinases (MNK) and eIF4E in pancreatic cancer</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">216</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-15-0285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1158%2F1541-7786.MCR-15-0285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=26609108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFGlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=216-227&issue=2&author=K.+Kumarauthor=C.+R.+Chowauthor=K.+Ebineauthor=A.+D.+Arslanauthor=B.+Kwokauthor=D.+J.+Bentremauthor=F.+D.+Eckerdtauthor=L.+C.+Plataniasauthor=H.+G.+Munshi&title=Differential+regulation+of+ZEB1+and+EMT+by+MAPK-interacting+protein+kinases+%28MNK%29+and+eIF4E+in+pancreatic+cancer&doi=10.1158%2F1541-7786.MCR-15-0285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer</span></div><div class="casAuthors">Kumar, Krishan; Chow, Christina R.; Ebine, Kazumi; Arslan, Ahmet D.; Kwok, Benjamin; Bentrem, David J.; Eckerdt, Frank D.; Platanias, Leonidas C.; Munshi, Hidayatullah G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">216-227</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Human pancreatic ductal adenocarcinoma (PDAC) tumors are assocd. with dysregulation of mRNA translation.  In this report, it is demonstrated that PDAC cells grown in collagen exhibit increased activation of the MAPK-interacting protein kinases (MNK) that mediate eIF4E phosphorylation.  Pharmacol. and genetic targeting of MNKs reverse epithelial-mesenchymal transition (EMT), decrease cell migration, and reduce protein expression of the EMT-regulator ZEB1 without affecting ZEB1 mRNA levels.  Paradoxically, targeting eIF4E, the best-characterized effector of MNKs, increases ZEB1 mRNA expression through repression of ZEB1-targeting miRNAs, miR-200c and miR-141.  In contrast, targeting the MNK effector hnRNPA1, which can function as a translational repressor, increases ZEB1 protein without increasing ZEB1 mRNA levels.  Importantly, treatment with MNK inhibitors blocks growth of chemoresistant PDAC cells in collagen and decreases the no. of aldehyde dehydrogenase activity-pos. (Aldefluor+) cells.  Significantly, MNK inhibitors increase E-cadherin mRNA levels and decrease vimentin mRNA levels in human PDAC organoids without affecting ZEB1 mRNA levels.  Importantly, MNK inhibitors also decrease growth of human PDAC organoids.  Implications: These results demonstrate differential regulation of ZEB1 and EMT by MNKs and eIF4E, and identify MNKs as potential targets in pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodfpbuGZcxsbVg90H21EOLACvtfcHk0lh7TjA0p2oazQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFGlsLo%253D&md5=6fc52c2da0159cf4940dfc65de947394</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-15-0285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-15-0285%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DChow%26aufirst%3DC.%2BR.%26aulast%3DEbine%26aufirst%3DK.%26aulast%3DArslan%26aufirst%3DA.%2BD.%26aulast%3DKwok%26aufirst%3DB.%26aulast%3DBentrem%26aufirst%3DD.%2BJ.%26aulast%3DEckerdt%26aufirst%3DF.%2BD.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26aulast%3DMunshi%26aufirst%3DH.%2BG.%26atitle%3DDifferential%2520regulation%2520of%2520ZEB1%2520and%2520EMT%2520by%2520MAPK-interacting%2520protein%2520kinases%2520%2528MNK%2529%2520and%2520eIF4E%2520in%2520pancreatic%2520cancer%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2016%26volume%3D14%26issue%3D2%26spage%3D216%26epage%3D227%26doi%3D10.1158%2F1541-7786.MCR-15-0285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Altman, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe-Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span> <span> </span><span class="NLM_article-title">Negative regulatory effects of Mnk kinases in the generation of chemotherapy-induced antileukemic responses</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">778</span>– <span class="NLM_lpage">784</span>, <span class="refDoi"> DOI: 10.1124/mol.110.064642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1124%2Fmol.110.064642" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=778-784&issue=4&author=J.+K.+Altmanauthor=H.+Glaserauthor=A.+Sassanoauthor=S.+Joshiauthor=T.+Uedaauthor=R.+Watanabe-Fukunagaauthor=R.+Fukunagaauthor=M.+S.+Tallmanauthor=L.+C.+Platanias&title=Negative+regulatory+effects+of+Mnk+kinases+in+the+generation+of+chemotherapy-induced+antileukemic+responses&doi=10.1124%2Fmol.110.064642"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.064642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.064642%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DJ.%2BK.%26aulast%3DGlaser%26aufirst%3DH.%26aulast%3DSassano%26aufirst%3DA.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DWatanabe-Fukunaga%26aufirst%3DR.%26aulast%3DFukunaga%26aufirst%3DR.%26aulast%3DTallman%26aufirst%3DM.%2BS.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26atitle%3DNegative%2520regulatory%2520effects%2520of%2520Mnk%2520kinases%2520in%2520the%2520generation%2520of%2520chemotherapy-induced%2520antileukemic%2520responses%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26issue%3D4%26spage%3D778%26epage%3D784%26doi%3D10.1124%2Fmol.110.064642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ailles, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dylla, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muijtjens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zehnder, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotlib, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manz, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keating, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyers, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, I. L.</span></span> <span> </span><span class="NLM_article-title">Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>351</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa040258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1056%2FNEJMoa040258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=15306667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD2cXms1Oktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2004&pages=657-667&issue=7&author=C.+H.+Jamiesonauthor=L.+E.+Aillesauthor=S.+J.+Dyllaauthor=M.+Muijtjensauthor=C.+Jonesauthor=J.+L.+Zehnderauthor=J.+Gotlibauthor=K.+Liauthor=M.+G.+Manzauthor=A.+Keatingauthor=C.+L.+Sawyersauthor=I.+L.+Weissman&title=Granulocyte-macrophage+progenitors+as+candidate+leukemic+stem+cells+in+blast-crisis+CML&doi=10.1056%2FNEJMoa040258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML</span></div><div class="casAuthors">Jamieson, Catriona H. M.; Ailles, Laurie E.; Dylla, Scott J.; Muijtjens, Manja; Jones, Carol; Zehnder, James L.; Gotlib, Jason; Li, Kevin; Manz, Markus G.; Keating, Armand; Sawyers, Charles L.; Weissman, Irving L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">657-667</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: The progression of chronic myelogenous leukemia (CML) to blast crisis is supported by self-renewing leukemic stem cells.  In normal mouse hematopoietic stem cells, the process of self-renewal involves the β-catenin-signaling pathway.  The authors investigated whether leukemic stem cells in CML also use the β-catenin pathway for self-renewal.  METHODS: the authors used fluorescence-activated cell sorting to isolate hematopoietic stem cells, common myeloid progenitors, granulocyte-macrophage progenitors, and megakaryocyte-erythroid progenitors from marrow during several phases ofCML and from normal marrow.  BCR-ABL, β-catenin, and LEF-1 transcripts were compared by a quant. reverse-transcriptase-polymerase-chain-reaction assay in normal and CML hematopoietic stem cells and granulocyte-macrophage progenitors.  Confocal fluorescence microscopy and a lymphoid enhancer factor/T-cell factor reporter assay were used to detect nuclear,/3-catenin in these cells.  In vitro replatingv assays were used to identify self-renewing cells as candidate leukemic stem cells, and the dependence of self-renewal on β-catenin activation was tested by lentiviral transduction of hematopoietic progenitors with axin, an inhibitor of the β-catenin pathway.  RESULTS: The granulocyte-macrophage progenitor pool from patients with CML in blast crisis and imatinib-resistant CML was expanded, expressed BCR-ABL, and had elevated levels of nuclear β-catenin as compared with the levels in progenitors from normal marrow.  Unlike normal granulocyte-macrophage progenitors, CML granulocyte-macrophage progenitors formed self-renewing, replatable myeloid colonies, and in vitro self-renewal capacity was reduced by enforced expression of axin.  CONCLUSIONS: Activation of β-catenin in CML granulocyte-macrophage progenitors appears to enhance the self-renewal activity and leukemic potential of these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnCZBoiSHbTLVg90H21EOLACvtfcHk0lhSWUictK4svw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXms1Oktbg%253D&md5=92e0552ff2c3db8ba805919514e24b01</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa040258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa040258%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%2BH.%26aulast%3DAilles%26aufirst%3DL.%2BE.%26aulast%3DDylla%26aufirst%3DS.%2BJ.%26aulast%3DMuijtjens%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DZehnder%26aufirst%3DJ.%2BL.%26aulast%3DGotlib%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DManz%26aufirst%3DM.%2BG.%26aulast%3DKeating%26aufirst%3DA.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26aulast%3DWeissman%26aufirst%3DI.%2BL.%26atitle%3DGranulocyte-macrophage%2520progenitors%2520as%2520candidate%2520leukemic%2520stem%2520cells%2520in%2520blast-crisis%2520CML%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D351%26issue%3D7%26spage%3D657%26epage%3D667%26doi%3D10.1056%2FNEJMoa040258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arechiga, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melo, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, S. T.</span></span> <span> </span><span class="NLM_article-title">Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5716</span>– <span class="NLM_lpage">5722</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=5716-5722&issue=18&author=C.+Lyauthor=A.+F.+Arechigaauthor=J.+V.+Meloauthor=C.+M.+Walshauthor=S.+T.+Ong&title=Bcr-Abl+kinase+modulates+the+translation+regulators+ribosomal+protein+S6+and+4E-BP1+in+chronic+myelogenous+leukemia+cells+via+the+mammalian+target+of+rapamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLy%26aufirst%3DC.%26aulast%3DArechiga%26aufirst%3DA.%2BF.%26aulast%3DMelo%26aufirst%3DJ.%2BV.%26aulast%3DWalsh%26aufirst%3DC.%2BM.%26aulast%3DOng%26aufirst%3DS.%2BT.%26atitle%3DBcr-Abl%2520kinase%2520modulates%2520the%2520translation%2520regulators%2520ribosomal%2520protein%2520S6%2520and%25204E-BP1%2520in%2520chronic%2520myelogenous%2520leukemia%2520cells%2520via%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26issue%3D18%26spage%3D5716%26epage%3D5722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prabhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saadat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halbur, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruehauf, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, S. T.</span></span> <span> </span><span class="NLM_article-title">A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translation</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1188</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1209901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1038%2Fsj.onc.1209901" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1188-1200&issue=8&author=S.+Prabhuauthor=D.+Saadatauthor=M.+Zhangauthor=L.+Halburauthor=J.+P.+Fruehaufauthor=S.+T.+Ong&title=A+novel+mechanism+for+Bcr-Abl+action%3A+Bcr-Abl-mediated+induction+of+the+eIF4F+translation+initiation+complex+and+mRNA+translation&doi=10.1038%2Fsj.onc.1209901"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1209901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1209901%26sid%3Dliteratum%253Aachs%26aulast%3DPrabhu%26aufirst%3DS.%26aulast%3DSaadat%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHalbur%26aufirst%3DL.%26aulast%3DFruehauf%26aufirst%3DJ.%2BP.%26aulast%3DOng%26aufirst%3DS.%2BT.%26atitle%3DA%2520novel%2520mechanism%2520for%2520Bcr-Abl%2520action%253A%2520Bcr-Abl-mediated%2520induction%2520of%2520the%2520eIF4F%2520translation%2520initiation%2520complex%2520and%2520mRNA%2520translation%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26issue%3D8%26spage%3D1188%26epage%3D1200%26doi%3D10.1038%2Fsj.onc.1209901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landon, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muniandy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shetty, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehrmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peroutka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazan-Mamczarz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhardt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahurkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borden, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gartenhaus, R. B.</span></span> <span> </span><span class="NLM_article-title">MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">5413</span>, <span class="refDoi"> DOI: 10.1038/ncomms6413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1038%2Fncomms6413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=25403230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A280%3ADC%252BC2M3ptVOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=5413&author=A.+L.+Landonauthor=P.+A.+Muniandyauthor=A.+C.+Shettyauthor=E.+Lehrmannauthor=L.+Volponauthor=S.+Houngauthor=Y.+Zhangauthor=B.+Daiauthor=R.+Peroutkaauthor=K.+Mazan-Mamczarzauthor=J.+Steinhardtauthor=A.+Mahurkarauthor=K.+G.+Beckerauthor=K.+L.+Bordenauthor=R.+B.+Gartenhaus&title=MNKs+act+as+a+regulatory+switch+for+eIF4E1+and+eIF4E3+driven+mRNA+translation+in+DLBCL&doi=10.1038%2Fncomms6413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL</span></div><div class="casAuthors">Landon Ari L; Peroutka Raymond; Mazan-Mamczarz Krystyna; Steinhardt James; Muniandy Parameswary A; Houng Simone; Dai Bojie; Gartenhaus Ronald B; Shetty Amol C; Mahurkar Anup; Lehrmann Elin; Zhang Yongqing; Becker Kevin G; Volpon Laurent; Borden Katherine L</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5413</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The phosphorylation of eIF4E1 at serine 209 by MNK1 or MNK2 has been shown to initiate oncogenic mRNA translation, a process that favours cancer development and maintenance.  Here, we interrogate the MNK-eIF4E axis in diffuse large B-cell lymphoma (DLBCL) and show a distinct distribution of MNK1 and MNK2 in germinal centre B-cell (GCB) and activated B-cell (ABC) DLBCL.  Despite displaying a differential distribution in GCB and ABC, both MNKs functionally complement each other to sustain cell survival.  MNK inhibition ablates eIF4E1 phosphorylation and concurrently enhances eIF4E3 expression.  Loss of MNK protein itself downregulates total eIF4E1 protein level by reducing eIF4E1 mRNA polysomal loading without affecting total mRNA level or stability.  Enhanced eIF4E3 expression marginally suppresses eIF4E1-driven translation but exhibits a unique translatome that unveils a novel role for eIF4E3 in translation initiation.  We propose that MNKs can modulate oncogenic translation by regulating eIF4E1-eIF4E3 levels and activity in DLBCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRAX0_1tXXk2gRQsDqrjW_fW6udTcc2eYNF3flSaj6Urntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3ptVOnuw%253D%253D&md5=c74031f79715242324239fc9022c5cc6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fncomms6413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms6413%26sid%3Dliteratum%253Aachs%26aulast%3DLandon%26aufirst%3DA.%2BL.%26aulast%3DMuniandy%26aufirst%3DP.%2BA.%26aulast%3DShetty%26aufirst%3DA.%2BC.%26aulast%3DLehrmann%26aufirst%3DE.%26aulast%3DVolpon%26aufirst%3DL.%26aulast%3DHoung%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDai%26aufirst%3DB.%26aulast%3DPeroutka%26aufirst%3DR.%26aulast%3DMazan-Mamczarz%26aufirst%3DK.%26aulast%3DSteinhardt%26aufirst%3DJ.%26aulast%3DMahurkar%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DK.%2BG.%26aulast%3DBorden%26aufirst%3DK.%2BL.%26aulast%3DGartenhaus%26aufirst%3DR.%2BB.%26atitle%3DMNKs%2520act%2520as%2520a%2520regulatory%2520switch%2520for%2520eIF4E1%2520and%2520eIF4E3%2520driven%2520mRNA%2520translation%2520in%2520DLBCL%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D5413%26doi%3D10.1038%2Fncomms6413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span> <span> </span><span class="NLM_article-title">Targeting the eIF4F translation initiation complex: a critical nexus for cancer development</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-2789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1158%2F0008-5472.CAN-14-2789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=25593033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslWjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=250-263&issue=2&author=J.+Pelletierauthor=J.+Graffauthor=D.+Ruggeroauthor=N.+Sonenberg&title=Targeting+the+eIF4F+translation+initiation+complex%3A+a+critical+nexus+for+cancer+development&doi=10.1158%2F0008-5472.CAN-14-2789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development</span></div><div class="casAuthors">Pelletier, Jerry; Graff, Jeremy; Ruggero, Davide; Sonenberg, Nahum</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">250-263</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Elevated protein synthesis is an important feature of many cancer cells and often arises as a consequence of increased signaling flux channeled to eukaryotic initiation factor 4F (eIF4F), the key regulator of the mRNA-ribosome recruitment phase of translation initiation.  In many cellular and preclin. models of cancer, eIF4F deregulation results in changes in translational efficiency of specific mRNA classes.  Importantly, many of these mRNAs code for proteins that potently regulate crit. cellular processes, such as cell growth and proliferation, enhanced cell survival and cell migration that ultimately impinge on several hallmarks of cancer, including increased angiogenesis, deregulated growth control, enhanced cellular survival, epithelial-to-mesenchymal transition, invasion, and metastasis.  By being positioned as the mol. nexus downstream of key oncogenic signaling pathways (e.g., Ras, PI3K/AKT/TOR, and MYC), eIF4F serves as a direct link between important steps in cancer development and translation initiation.  Identification of mRNAs particularly responsive to elevated eIF4F activity that typifies tumorigenesis underscores the crit. role of eIF4F in cancer and raises the exciting possibility of developing new-in-class small mols. targeting translation initiation as antineoplastic agents.  Cancer Res; 75(2); 250-63. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrANjeFfkVBWLVg90H21EOLACvtfcHk0liRRUnqrhCpZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslWjsQ%253D%253D&md5=2b463beb4fa91704c0eb0ea32f9f2d8f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-2789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-2789%26sid%3Dliteratum%253Aachs%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DGraff%26aufirst%3DJ.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DSonenberg%26aufirst%3DN.%26atitle%3DTargeting%2520the%2520eIF4F%2520translation%2520initiation%2520complex%253A%2520a%2520critical%2520nexus%2520for%2520cancer%2520development%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26issue%3D2%26spage%3D250%26epage%3D263%26doi%3D10.1158%2F0008-5472.CAN-14-2789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koumakpayi, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brueschke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petroulakis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaboury, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandolfi, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span> <span> </span><span class="NLM_article-title">eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span> (<span class="NLM_issue">32</span>),  <span class="NLM_fpage">14134</span>– <span class="NLM_lpage">14139</span>, <span class="refDoi"> DOI: 10.1073/pnas.1005320107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1073%2Fpnas.1005320107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=20679199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCkt77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=14134-14139&issue=32&author=L.+Furicauthor=L.+Rongauthor=O.+Larssonauthor=I.+H.+Koumakpayiauthor=K.+Yoshidaauthor=A.+Brueschkeauthor=E.+Petroulakisauthor=N.+Robichaudauthor=M.+Pollakauthor=L.+A.+Gabouryauthor=P.+P.+Pandolfiauthor=F.+Saadauthor=N.+Sonenberg&title=eIF4E+phosphorylation+promotes+tumorigenesis+and+is+associated+with+prostate+cancer+progression&doi=10.1073%2Fpnas.1005320107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression</span></div><div class="casAuthors">Furic, Luc; Rong, Liwei; Larsson, Ola; Koumakpayi, Ismael Herve; Yoshida, Kaori; Brueschke, Andrea; Petroulakis, Emmanuel; Robichaud, Nathaniel; Pollak, Michael; Gaboury, Louis A.; Pandolfi, Pier Paolo; Saad, Fred; Sonenberg, Nahum</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">14134-14139, S14134/1-S14134/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Translational regulation plays a crit. role in the control of cell growth and proliferation.  A key player in translational control is eIF4E, the mRNA 5' cap-binding protein.  Aberrant expression of eIF4E promotes tumorigenesis and has been implicated in cancer development and progression.  The activity of eIF4e is dysregulated in cancer.  Regulation of eIF4E is partly achieved through phosphorylation.  However, the physiol. significance of eIF4E phosphorylation in mammals is not clear.  Here, we show that knock-in mice expressing a nonphosphorylatable form of eIF4E are resistant to tumorigenesis in a prostate cancer model.  By using a genome-wide anal. of translated mRNAs, we show that the phosphorylation of eIF4E is required for translational up-regulation of several proteins implicated in tumorigenesis.  Accordingly, increased phospho-eIF4E levels correlate with disease progression in patients with prostate cancer.  Our findings establish eIF4E phosphorylation as a crit. event in tumorigenesis.  These findings raise the possibility that chem. compds. that prevent the phosphorylation of eIF4E could act as anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ8P8LhNfeprVg90H21EOLACvtfcHk0lhJOa4qvpiu5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCkt77O&md5=591da9e2c3b401f12acbace4f1986221</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1005320107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1005320107%26sid%3Dliteratum%253Aachs%26aulast%3DFuric%26aufirst%3DL.%26aulast%3DRong%26aufirst%3DL.%26aulast%3DLarsson%26aufirst%3DO.%26aulast%3DKoumakpayi%26aufirst%3DI.%2BH.%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DBrueschke%26aufirst%3DA.%26aulast%3DPetroulakis%26aufirst%3DE.%26aulast%3DRobichaud%26aufirst%3DN.%26aulast%3DPollak%26aufirst%3DM.%26aulast%3DGaboury%26aufirst%3DL.%2BA.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26aulast%3DSaad%26aufirst%3DF.%26aulast%3DSonenberg%26aufirst%3DN.%26atitle%3DeIF4E%2520phosphorylation%2520promotes%2520tumorigenesis%2520and%2520is%2520associated%2520with%2520prostate%2520cancer%2520progression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26issue%3D32%26spage%3D14134%26epage%3D14139%26doi%3D10.1073%2Fpnas.1005320107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druker, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruehauf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gram, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, S. T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6496</span>– <span class="NLM_lpage">6509</span>, <span class="refDoi"> DOI: 10.1128/MCB.00477-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1128%2FMCB.00477-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=18694961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CitL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=6496-6509&issue=20&author=M.+Zhangauthor=W.+Fuauthor=S.+Prabhuauthor=J.+C.+Mooreauthor=J.+Koauthor=J.+W.+Kimauthor=B.+J.+Drukerauthor=V.+Trappauthor=J.+Fruehaufauthor=H.+Gramauthor=H.+Y.+Fanauthor=S.+T.+Ong&title=Inhibition+of+polysome+assembly+enhances+imatinib+activity+against+chronic+myelogenous+leukemia+and+overcomes+imatinib+resistance&doi=10.1128%2FMCB.00477-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance</span></div><div class="casAuthors">Zhang, Min; Fu, Wuxia; Prabhu, Sharmila; Moore, James C.; Ko, Je; Kim, Jung Woo; Druker, Brian J.; Trapp, Valerie; Fruehauf, John; Gram, Hermann; Fan, Hung Y.; Ong, S. Tiong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6496-6509</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Dysregulated mRNA translation is implicated in the pathogenesis of many human cancers including chronic myelogenous leukemia (CML).  Because our prior work has specifically implicated translation initiation in CML, we tested compds. that could modulate translation initiation and polysomal mRNA assembly.  Here, we evaluated the activity of one such compd., CGP57380, against CML cells and explored its mechanisms of action.  First, using polysomal mRNA profiles, we found that imatinib and CGP57380 could independently, and cooperatively, impair polysomal mRNA loading.  Imatinib and CGP57380 also synergistically inhibited the growth of Ba/F3-Bcr-Abl and K562 cells via impaired cell cycle entry and increased apoptosis.  Mechanistically, CGP57380 inhibited efficient polysomal assembly via two processes.  First, it enhanced imatinib-mediated inhibition of eukaryotic initiation factor 4F induction, and second, it independently impaired phosphorylation of ribosomal protein S6 on the preinitiation complex.  We also identified multiple substrates of the mTOR, Rsk, and Mnk kinases as targets of CGP57380.  Finally, we found a novel neg.-feedback loop to the mitogen-activated protein kinase/Mnk pathway that is triggered by CGP57380 and demonstrated that an interruption of the loop further increased the activity of the combination against imatinib-sensitive and -resistant CML cells.  Together, this work supports the inhibition of translation initiation as a therapeutic strategy for treating cancers fueled by dysregulated translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ_MpGlackBLVg90H21EOLACvtfcHk0lhJOa4qvpiu5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CitL%252FL&md5=f68b04dfb7c777c7582f499e66056937</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FMCB.00477-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00477-08%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DW.%26aulast%3DPrabhu%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DJ.%2BC.%26aulast%3DKo%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DTrapp%26aufirst%3DV.%26aulast%3DFruehauf%26aufirst%3DJ.%26aulast%3DGram%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DH.%2BY.%26aulast%3DOng%26aufirst%3DS.%2BT.%26atitle%3DInhibition%2520of%2520polysome%2520assembly%2520enhances%2520imatinib%2520activity%2520against%2520chronic%2520myelogenous%2520leukemia%2520and%2520overcomes%2520imatinib%2520resistance%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26issue%3D20%26spage%3D6496%26epage%3D6509%26doi%3D10.1128%2FMCB.00477-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">American Cancer Society</span>. <span> </span><span class="NLM_article-title">Treating Chronic
Myeloid Leukemia by Phase</span>. <a href="http://www.cancer.org/cancer/leukemia-chronicmyeloidcml/detailedguide/leukemia-chronic-myeloid-myelogenous-treating-treating-by-phase" class="extLink">http://www.cancer.org/cancer/leukemia-chronicmyeloidcml/detailedguide/leukemia-chronic-myeloid-myelogenous-treating-treating-by-phase</a> (accessed Aug 5, <span class="NLM_year">2015</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=American+Cancer+Society&title=Treating+Chronic%0AMyeloid+Leukemia+by+Phase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DTreating%2520Chronic%250AMyeloid%2520Leukemia%2520by%2520Phase%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loriaux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deininger, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druker, B. J.</span></span> <span> </span><span class="NLM_article-title">Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">396</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1172/JCI35721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1172%2FJCI35721" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=396-409&issue=1&author=A.+S.+Corbinauthor=A.+Agarwalauthor=M.+Loriauxauthor=J.+Cortesauthor=M.+W.+Deiningerauthor=B.+J.+Druker&title=Human+chronic+myeloid+leukemia+stem+cells+are+insensitive+to+imatinib+despite+inhibition+of+BCR-ABL+activity&doi=10.1172%2FJCI35721"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1172%2FJCI35721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI35721%26sid%3Dliteratum%253Aachs%26aulast%3DCorbin%26aufirst%3DA.%2BS.%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DLoriaux%26aufirst%3DM.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26atitle%3DHuman%2520chronic%2520myeloid%2520leukemia%2520stem%2520cells%2520are%2520insensitive%2520to%2520imatinib%2520despite%2520inhibition%2520of%2520BCR-ABL%2520activity%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26issue%3D1%26spage%3D396%26epage%3D409%26doi%3D10.1172%2FJCI35721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wieczorek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uharek, L.</span></span> <span> </span><span class="NLM_article-title">Management of Chronic Myeloid Leukemia Patients Resistant to Tyrosine Kinase Inhibitors Treatment</span>. <i>Biomarker Insights</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">Suppl 3</span>),  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.4137/BMI.S22431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.4137%2FBMI.S22431" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=49-54&issue=Suppl+3&author=A.+Wieczorekauthor=L.+Uharek&title=Management+of+Chronic+Myeloid+Leukemia+Patients+Resistant+to+Tyrosine+Kinase+Inhibitors+Treatment&doi=10.4137%2FBMI.S22431"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.4137%2FBMI.S22431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4137%252FBMI.S22431%26sid%3Dliteratum%253Aachs%26aulast%3DWieczorek%26aufirst%3DA.%26aulast%3DUharek%26aufirst%3DL.%26atitle%3DManagement%2520of%2520Chronic%2520Myeloid%2520Leukemia%2520Patients%2520Resistant%2520to%2520Tyrosine%2520Kinase%2520Inhibitors%2520Treatment%26jtitle%3DBiomarker%2520Insights%26date%3D2015%26volume%3D10%26issue%3DSuppl%25203%26spage%3D49%26epage%3D54%26doi%3D10.4137%2FBMI.S22431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eiring, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khorashad, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redwine, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gantz, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomicter, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraft, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowler, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partlin, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hare, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deininger, M. W.</span></span> <span> </span><span class="NLM_article-title">Beta-catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2328</span>– <span class="NLM_lpage">2337</span>, <span class="refDoi"> DOI: 10.1038/leu.2015.196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1038%2Fleu.2015.196" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=2328-2337&issue=12&author=A.+M.+Eiringauthor=J.+S.+Khorashadauthor=D.+J.+Andersonauthor=F.+Yuauthor=H.+M.+Redwineauthor=C.+C.+Masonauthor=K.+R.+Reynoldsauthor=P.+M.+Clairauthor=K.+C.+Gantzauthor=T.+Y.+Zhangauthor=A.+D.+Pomicterauthor=I.+L.+Kraftauthor=A.+D.+Bowlerauthor=K.+Johnsonauthor=M.+M.+Partlinauthor=T.+O%E2%80%99Hareauthor=M.+W.+Deininger&title=Beta-catenin+is+required+for+intrinsic+but+not+extrinsic+BCR-ABL1+kinase-independent+resistance+to+tyrosine+kinase+inhibitors+in+chronic+myeloid+leukemia&doi=10.1038%2Fleu.2015.196"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fleu.2015.196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2015.196%26sid%3Dliteratum%253Aachs%26aulast%3DEiring%26aufirst%3DA.%2BM.%26aulast%3DKhorashad%26aufirst%3DJ.%2BS.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DRedwine%26aufirst%3DH.%2BM.%26aulast%3DMason%26aufirst%3DC.%2BC.%26aulast%3DReynolds%26aufirst%3DK.%2BR.%26aulast%3DClair%26aufirst%3DP.%2BM.%26aulast%3DGantz%26aufirst%3DK.%2BC.%26aulast%3DZhang%26aufirst%3DT.%2BY.%26aulast%3DPomicter%26aufirst%3DA.%2BD.%26aulast%3DKraft%26aufirst%3DI.%2BL.%26aulast%3DBowler%26aufirst%3DA.%2BD.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DPartlin%26aufirst%3DM.%2BM.%26aulast%3DO%25E2%2580%2599Hare%26aufirst%3DT.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%26atitle%3DBeta-catenin%2520is%2520required%2520for%2520intrinsic%2520but%2520not%2520extrinsic%2520BCR-ABL1%2520kinase-independent%2520resistance%2520to%2520tyrosine%2520kinase%2520inhibitors%2520in%2520chronic%2520myeloid%2520leukemia%26jtitle%3DLeukemia%26date%3D2015%26volume%3D29%26issue%3D12%26spage%3D2328%26epage%3D2337%26doi%3D10.1038%2Fleu.2015.196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Topisirovic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culjkovic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neering, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borden, K. L.</span></span> <span> </span><span class="NLM_article-title">Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">8992</span>– <span class="NLM_lpage">9002</span>, <span class="refDoi"> DOI: 10.1128/MCB.23.24.8992-9002.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1128%2FMCB.23.24.8992-9002.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=14645512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslGqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=8992-9002&issue=24&author=I.+Topisirovicauthor=M.+L.+Guzmanauthor=M.+J.+McConnellauthor=J.+D.+Lichtauthor=B.+Culjkovicauthor=S.+J.+Neeringauthor=C.+T.+Jordanauthor=K.+L.+Borden&title=Aberrant+eukaryotic+translation+initiation+factor+4E-dependent+mRNA+transport+impedes+hematopoietic+differentiation+and+contributes+to+leukemogenesis&doi=10.1128%2FMCB.23.24.8992-9002.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis</span></div><div class="casAuthors">Topisirovic, Ivan; Guzman, Monica L.; McConnell, Melanie J.; Licht, Jonathan D.; Culjkovic, Biljana; Neering, Sarah J.; Jordan, Craig T.; Borden, Katherine L. B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8992-9002</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The eukaryotic translation initiation factor 4E (eIF4E) acts as both a key translation factor and as a promoter of nucleocytoplasmic transport of specific transcripts.  Traditionally, its transformation capacity in vivo is attributed to its role in translation initiation in the cytoplasm.  Here, we demonstrate that elevated eIF4E impedes granulocytic and monocytic differentiation.  Our subsequent mutagenesis studies indicate that this block is a result of dysregulated eIF4E-dependent mRNA transport.  These studies indicate that the RNA transport function of eIF4E could contribute to leukemogenesis.  We extended our studies to provide the first evidence that the nuclear transport function of eIF4E contributes to human malignancy, specifically in a subset of acute and chronic myelogenous leukemia patients.  We observe an increase in eIF4E-dependent cyclin D1 mRNA transport and a concomitant increase in cyclin D1 protein levels.  The aberrant nuclear function of eIF4E is due to abnormally large eIF4E bodies and the loss of regulation by the proline-rich homeodomain PRH.  We developed a novel tool to modulate this transport activity.  The introduction of IκB, the repressor of NF-κB, leads to suppression of eIF4E, elevation of PRH, reorganization of eIF4E nuclear bodies, and subsequent downregulation of eIF4E-dependent mRNA transport.  Thus, our findings indicate that this nuclear function of eIF4E can contribute to leukemogenesis by promoting growth and by impeding differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqza9v1b2g5TLVg90H21EOLACvtfcHk0lj4uwK7xDGx5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslGqtrg%253D&md5=3ddc2e0431d096aab2b3e15a8aee708c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.24.8992-9002.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.24.8992-9002.2003%26sid%3Dliteratum%253Aachs%26aulast%3DTopisirovic%26aufirst%3DI.%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DMcConnell%26aufirst%3DM.%2BJ.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DCuljkovic%26aufirst%3DB.%26aulast%3DNeering%26aufirst%3DS.%2BJ.%26aulast%3DJordan%26aufirst%3DC.%2BT.%26aulast%3DBorden%26aufirst%3DK.%2BL.%26atitle%3DAberrant%2520eukaryotic%2520translation%2520initiation%2520factor%25204E-dependent%2520mRNA%2520transport%2520impedes%2520hematopoietic%2520differentiation%2520and%2520contributes%2520to%2520leukemogenesis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26issue%3D24%26spage%3D8992%26epage%3D9002%26doi%3D10.1128%2FMCB.23.24.8992-9002.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saw, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janes, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, A. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzieri, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuah, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, S. T.</span></span> <span> </span><span class="NLM_article-title">Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">E2298</span>– <span class="NLM_lpage">2307</span>, <span class="refDoi"> DOI: 10.1073/pnas.1301838110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1073%2Fpnas.1301838110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E2298-2307&issue=25&author=S.+Limauthor=T.+Y.+Sawauthor=M.+Zhangauthor=M.+R.+Janesauthor=K.+Nacroauthor=J.+Hillauthor=A.+Q.+Limauthor=C.+T.+Changauthor=D.+A.+Frumanauthor=D.+A.+Rizzieriauthor=S.+Y.+Tanauthor=H.+Fanauthor=C.+T.+Chuahauthor=S.+T.+Ong&title=Targeting+of+the+MNK-eIF4E+axis+in+blast+crisis+chronic+myeloid+leukemia+inhibits+leukemia+stem+cell+function&doi=10.1073%2Fpnas.1301838110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1301838110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1301838110%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DS.%26aulast%3DSaw%26aufirst%3DT.%2BY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DJanes%26aufirst%3DM.%2BR.%26aulast%3DNacro%26aufirst%3DK.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DA.%2BQ.%26aulast%3DChang%26aufirst%3DC.%2BT.%26aulast%3DFruman%26aufirst%3DD.%2BA.%26aulast%3DRizzieri%26aufirst%3DD.%2BA.%26aulast%3DTan%26aufirst%3DS.%2BY.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DChuah%26aufirst%3DC.%2BT.%26aulast%3DOng%26aufirst%3DS.%2BT.%26atitle%3DTargeting%2520of%2520the%2520MNK-eIF4E%2520axis%2520in%2520blast%2520crisis%2520chronic%2520myeloid%2520leukemia%2520inhibits%2520leukemia%2520stem%2520cell%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D25%26spage%3DE2298%26epage%3D2307%26doi%3D10.1073%2Fpnas.1301838110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, M.</span></span> <span> </span><span class="NLM_article-title">BCR-ABL kinase is dead; long live the CML stem cell</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1172/JCI43605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1172%2FJCI43605" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=22-25&issue=1&author=A.+Perlauthor=M.+Carroll&title=BCR-ABL+kinase+is+dead%3B+long+live+the+CML+stem+cell&doi=10.1172%2FJCI43605"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1172%2FJCI43605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI43605%26sid%3Dliteratum%253Aachs%26aulast%3DPerl%26aufirst%3DA.%26aulast%3DCarroll%26aufirst%3DM.%26atitle%3DBCR-ABL%2520kinase%2520is%2520dead%253B%2520long%2520live%2520the%2520CML%2520stem%2520cell%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26issue%3D1%26spage%3D22%26epage%3D25%26doi%3D10.1172%2FJCI43605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sands, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copland, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheadon, H.</span></span> <span> </span><span class="NLM_article-title">Targeting self-renewal pathways in myeloid malignancies</span>. <i>Cell Commun. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">33</span>, <span class="refDoi"> DOI: 10.1186/1478-811X-11-33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1186%2F1478-811X-11-33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=23675967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVaqsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=33&issue=1&author=W.+A.+Sandsauthor=M.+Coplandauthor=H.+Wheadon&title=Targeting+self-renewal+pathways+in+myeloid+malignancies&doi=10.1186%2F1478-811X-11-33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting self-renewal pathways in myeloid malignancies</span></div><div class="casAuthors">Sands, William A.; Copland, Mhairi; Wheadon, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Cell Communication and Signaling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33</span>CODEN:
                <span class="NLM_cas:coden">CCSEC6</span>;
        ISSN:<span class="NLM_cas:issn">1478-811X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  A fundamental property of hematopoietic stem cells (HSCs) is the ability to self-renew.  This is a complex process involving multiple signal transduction cascades which control the fine balance between self-renewal and differentiation through transcriptional networks.  Key activators/regulators of self-renewal include chemokines, cytokines and morphogens which are expressed in the bone marrow niche, either in a paracrine or autocrine fashion, and modulate stem cell behavior.  Increasing evidence suggests that the downstream signaling pathways induced by these ligands converge at multiple levels providing a degree of redundancy in steady state hematopoiesis.  Here we will focus on how these pathways cross-talk to regulate HSC self-renewal highlighting potential therapeutic windows which could be targeted to prevent leukemic stem cell self-renewal in myeloid malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolwoPnMgpyurVg90H21EOLACvtfcHk0lgU7GoqnOs2kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVaqsrbJ&md5=6ca20b3a52e89051a60b8845e7f97522</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1186%2F1478-811X-11-33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1478-811X-11-33%26sid%3Dliteratum%253Aachs%26aulast%3DSands%26aufirst%3DW.%2BA.%26aulast%3DCopland%26aufirst%3DM.%26aulast%3DWheadon%26aufirst%3DH.%26atitle%3DTargeting%2520self-renewal%2520pathways%2520in%2520myeloid%2520malignancies%26jtitle%3DCell%2520Commun.%2520Signaling%26date%3D2013%26volume%3D11%26issue%3D1%26spage%3D33%26doi%3D10.1186%2F1478-811X-11-33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span> <span> </span><span class="NLM_article-title">Inhibiting the MNK-eIF4E-beta-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapy</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">2906</span>– <span class="NLM_lpage">2915</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.13772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.18632%2Foncotarget.13772" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=2906-2915&issue=2&author=Z.+Liauthor=Y.+Sunauthor=M.+Quauthor=H.+Wanauthor=F.+Caiauthor=P.+Zhang&title=Inhibiting+the+MNK-eIF4E-beta-catenin+axis+increases+the+responsiveness+of+aggressive+breast+cancer+cells+to+chemotherapy&doi=10.18632%2Foncotarget.13772"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.13772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.13772%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DP.%26atitle%3DInhibiting%2520the%2520MNK-eIF4E-beta-catenin%2520axis%2520increases%2520the%2520responsiveness%2520of%2520aggressive%2520breast%2520cancer%2520cells%2520to%2520chemotherapy%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26issue%3D2%26spage%3D2906%26epage%3D2915%26doi%3D10.18632%2Foncotarget.13772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">Targeting the eIF4E/beta-catenin axis sensitizes cervical carcinoma squamous cells to chemotherapy</span>. <i>Am. J. Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1203</span>– <span class="NLM_lpage">1212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=28386346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A280%3ADC%252BC1cvlsFWhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1203-1212&issue=3&author=H.+Xuauthor=Z.+Wangauthor=L.+Xuauthor=G.+Moauthor=G.+Duanauthor=Y.+Wangauthor=Z.+Sunauthor=H.+Chen&title=Targeting+the+eIF4E%2Fbeta-catenin+axis+sensitizes+cervical+carcinoma+squamous+cells+to+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the eIF4E/β-catenin axis sensitizes cervical carcinoma squamous cells to chemotherapy</span></div><div class="casAuthors">Xu Hai; Wang Zhiyin; Xu Lang; Mo Guoyan; Duan Gangfeng; Wang Yali; Sun Zhengang; Chen Hao</div><div class="citationInfo"><span class="NLM_cas:title">American journal of translational research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1203-1212</span>
        ISSN:<span class="NLM_cas:issn">1943-8141</span>.
    </div><div class="casAbstract">Chemotherapy has improved the clinical outcomes of cervical cancer patients.  However, patients develop chemoresistance, whose underlying mechanisms are not well understood.  In this study, we investigated the phosphorylation levels of eukaryotic translation initiation factor 4E (eIF4E) in cervical cancer cells subjected to chemotherapy.  Results showed that chemotherapeutic drugs significantly increased eIF4E phosphorylation at S209 in HeLa and SiHa cells.  Upregulation of phosphorylated eIF4E (p-eIF4E) levels has also been shown in cisplatin-resistant HeLa cells and has been observed to be a common response of cervical cancer patients undergoing chemotherapy.  We further showed that chemotherapeutic drugs increase β-catenin activity and mRNA levels of Wnt/β-catenin target genes in cervical cancer cells but not in eIF4E-depleted cells, suggesting that chemotherapeutic drugs activate Wnt/β-catenin signaling in an eIF4E-dependent manner.  Inhibiting eIF4E via siRNA knockdown or Wnt/β-catenin using the Wnt inhibitor pyrvinium effectively enhanced the anti-proliferative and pro-apoptotic effects of cisplatin in cervical cancer cells both in vitro and in vivo.  Our findings demonstrate that eIF4E/β-catenin signaling plays a positive regulatory role in the resistance of cervical cancer cell to chemotherapy and thus highlight the therapeutic value of eIF4E or β-catenin inhibition in overcoming chemoresistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSK455vL2Kz2K_dlEzl_fBafW6udTcc2eYKLJY8FQevqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvlsFWhtA%253D%253D&md5=57e3d89a5d737ee722201f30f3c00d7c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DMo%26aufirst%3DG.%26aulast%3DDuan%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DTargeting%2520the%2520eIF4E%252Fbeta-catenin%2520axis%2520sensitizes%2520cervical%2520carcinoma%2520squamous%2520cells%2520to%2520chemotherapy%26jtitle%3DAm.%2520J.%2520Transl.%2520Res.%26date%3D2017%26volume%3D9%26issue%3D3%26spage%3D1203%26epage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hehlmann, R.</span></span> <span> </span><span class="NLM_article-title">How I treat CML blast crisis</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1182/blood-2012-03-380147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1182%2Fblood-2012-03-380147" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=737-747&issue=4&author=R.+Hehlmann&title=How+I+treat+CML+blast+crisis&doi=10.1182%2Fblood-2012-03-380147"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-03-380147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-03-380147%26sid%3Dliteratum%253Aachs%26aulast%3DHehlmann%26aufirst%3DR.%26atitle%3DHow%2520I%2520treat%2520CML%2520blast%2520crisis%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26issue%3D4%26spage%3D737%26epage%3D747%26doi%3D10.1182%2Fblood-2012-03-380147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dreas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikulski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabritius, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzozka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rzymski, T.</span></span> <span> </span><span class="NLM_article-title">Mitogen-activated protein kinase (MAPK) interacting kinases 1 and 2 (MNK1 and MNK2) as targets for cancer therapy: recent progress in the development of MNK inhibitors</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">3025</span>– <span class="NLM_lpage">3053</span>, <span class="refDoi"> DOI: 10.2174/0929867324666170203123427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.2174%2F0929867324666170203123427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=28164761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1SqsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=3025-3053&issue=28&author=A.+Dreasauthor=M.+Mikulskiauthor=M.+Milikauthor=C.+H.+Fabritiusauthor=K.+Brzozkaauthor=T.+Rzymski&title=Mitogen-activated+protein+kinase+%28MAPK%29+interacting+kinases+1+and+2+%28MNK1+and+MNK2%29+as+targets+for+cancer+therapy%3A+recent+progress+in+the+development+of+MNK+inhibitors&doi=10.2174%2F0929867324666170203123427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors</span></div><div class="casAuthors">Dreas, Agnieszka; Mikulski, Maciej; Milik, Mariusz; Fabritius, Charles-Henry; Brzozka, Krzysztof; Rzymski, Tomasz</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3025-3053</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">MAP kinase-interacting kinases (MNK1 and MNK2) are often activated downstream of ERK and p38 MAPK in the MAP kinase family.  The role of MNKs in the development and progression of solid tumors and hematol. malignancies has been widely discussed, particularly in the context of cap dependent translation, regulated by phosphorylation of eIF4E.  MNK/eIF4E axis is involved in the expression of pro angiogenic, antiapoptotic, cell cycle, and motility proteins, such as MCL1, VEGF, MMP3, SNAIL, SMAD2, β-catenin or cyclin D1, and is essential during Ras and c Myc-induced transformation.  MNK1/2 emerged as eligible targets for drug discovery in oncol., based on the antitumor effects obsd. in genetic knockout and RNA interference expts. and at the same time lack of adverse effects in dual knockout animals. </P><P> There is a high interest in the development of pharmacol. inhibitors of MNK1/2 as not only tools for further basic research studies but also potential drugs in diseases characterized by deregulated translation.  Unfortunately, the role of MNK1/2 in cancer still remains elusive due to the absence of potent and selective probes.  Moreover, in many instances, hypotheses have been built reliant upon unspecific MNK1/2 inhibitors such as CGP57380 or cercosporamide.  Lately, the first two clin. programs targeting MNKs in oncol. have been revealed (eFT508 and BAY 1143269), although several other MNK programs are currently running at the preclin. stage.  This review aims to provide an overview of recent progress in the development of MNK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjWDeCrlHD07Vg90H21EOLACvtfcHk0lgU7GoqnOs2kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1SqsrnI&md5=c2a37d37d69521b11a38bb100e7964af</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F0929867324666170203123427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867324666170203123427%26sid%3Dliteratum%253Aachs%26aulast%3DDreas%26aufirst%3DA.%26aulast%3DMikulski%26aufirst%3DM.%26aulast%3DMilik%26aufirst%3DM.%26aulast%3DFabritius%26aufirst%3DC.%2BH.%26aulast%3DBrzozka%26aufirst%3DK.%26aulast%3DRzymski%26aufirst%3DT.%26atitle%3DMitogen-activated%2520protein%2520kinase%2520%2528MAPK%2529%2520interacting%2520kinases%25201%2520and%25202%2520%2528MNK1%2520and%2520MNK2%2529%2520as%2520targets%2520for%2520cancer%2520therapy%253A%2520recent%2520progress%2520in%2520the%2520development%2520of%2520MNK%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2017%26volume%3D24%26issue%3D28%26spage%3D3025%26epage%3D3053%26doi%3D10.2174%2F0929867324666170203123427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Targeting Mnks for cancer therapy</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.18632%2Foncotarget.453" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=118-131&issue=2&author=J.+Houauthor=F.+Lamauthor=C.+Proudauthor=S.+Wang&title=Targeting+Mnks+for+cancer+therapy&doi=10.18632%2Foncotarget.453"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.453%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DLam%26aufirst%3DF.%26aulast%3DProud%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DTargeting%2520Mnks%2520for%2520cancer%2520therapy%26jtitle%3DOncotarget%26date%3D2012%26volume%3D3%26issue%3D2%26spage%3D118%26epage%3D131%26doi%3D10.18632%2Foncotarget.453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knauf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brauchle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glueck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">New, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gram, H.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of eIF-4E on Ser 209 in response to mitogenic and inflammatory stimuli is faithfully detected by specific antibodies</span>. <i>Mol. Cell Biol. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1006/mcbr.2000.0217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1006%2Fmcbr.2000.0217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10891393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1Oksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2000&pages=205-211&issue=4&author=C.+Tschoppauthor=U.+Knaufauthor=M.+Brauchleauthor=M.+Zuriniauthor=P.+Ramageauthor=D.+Glueckauthor=L.+Newauthor=J.+Hanauthor=H.+Gram&title=Phosphorylation+of+eIF-4E+on+Ser+209+in+response+to+mitogenic+and+inflammatory+stimuli+is+faithfully+detected+by+specific+antibodies&doi=10.1006%2Fmcbr.2000.0217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of eIF-4E on Ser 209 in Response to Mitogenic and Inflammatory Stimuli Is Faithfully Detected by Specific Antibodies</span></div><div class="casAuthors">Tschopp, C.; Knauf, U.; Brauchle, M.; Zurini, M.; Ramage, P.; Glueck, D.; New, L.; Han, J.; Gram, H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell Biology Research Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">205-211</span>CODEN:
                <span class="NLM_cas:coden">MCBCFS</span>;
        ISSN:<span class="NLM_cas:issn">1522-4724</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Phosphorylation of Ser 209 is thought to modulate the activity of the cap-binding factor eIF-4E which is a crucial component in the initiation complex for cap-dependent translation of mRNA.  We report here the full reconstitution of the p38 Map kinase cascade leading to phosphorylation of eIF-4E in vitro and the generation of antibodies specific for phospho-serine 209 in eIF-4E.  These antibodies were used to probe the phosphorylation of eIF-4E in mammalian cells stimulated with mitogens and pro-inflammatory cytokines.  Treatment of human dermal fibroblasts with FCS led to a transient hyperphosphorylation, followed by hypophosphorylation and return to normal state phosphorylation at 16 h after the initial stimulation.  By using a potent small mol. wt. inhibitor of Mnk1, the upstream kinase for eIF-4E, we obsd. a rapid dephosphorylation of eIF-4E within 45 min after addn. of the inhibitor, suggesting a high turnover of phosphate on eIF-4E mediated by Mnk1 and a yet unidentified phosphatase.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotCmUVSQhgrLVg90H21EOLACvtfcHk0lhgw82v22Cf-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1Oksr8%253D&md5=48874e603139eb9d71cb28884905bd3a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1006%2Fmcbr.2000.0217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcbr.2000.0217%26sid%3Dliteratum%253Aachs%26aulast%3DTschopp%26aufirst%3DC.%26aulast%3DKnauf%26aufirst%3DU.%26aulast%3DBrauchle%26aufirst%3DM.%26aulast%3DZurini%26aufirst%3DM.%26aulast%3DRamage%26aufirst%3DP.%26aulast%3DGlueck%26aufirst%3DD.%26aulast%3DNew%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DGram%26aufirst%3DH.%26atitle%3DPhosphorylation%2520of%2520eIF-4E%2520on%2520Ser%2520209%2520in%2520response%2520to%2520mitogenic%2520and%2520inflammatory%2520stimuli%2520is%2520faithfully%2520detected%2520by%2520specific%2520antibodies%26jtitle%3DMol.%2520Cell%2520Biol.%2520Res.%2520Commun.%26date%3D2000%26volume%3D3%26issue%3D4%26spage%3D205%26epage%3D211%26doi%3D10.1006%2Fmcbr.2000.0217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knauf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gram, H.</span></span> <span> </span><span class="NLM_article-title">Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">5500</span>– <span class="NLM_lpage">5511</span>, <span class="refDoi"> DOI: 10.1128/MCB.21.16.5500-5511.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1128%2FMCB.21.16.5500-5511.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=11463832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslOjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=5500-5511&issue=16&author=U.+Knaufauthor=C.+Tschoppauthor=H.+Gram&title=Negative+regulation+of+protein+translation+by+mitogen-activated+protein+kinase-interacting+kinases+1+and+2&doi=10.1128%2FMCB.21.16.5500-5511.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2</span></div><div class="casAuthors">Knauf, Ursula; Tschopp, Claude; Gram, Hermann</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5500-5511</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Eukaryotic initiation factor 4E (eIF4E) is a key component of the translational machinery and an important modulator of cell growth and proliferation.  The activity of eIF4E is thought to be regulated by interaction with inhibitory binding proteins (4E-BPs) and phosphorylation by mitogen-activated protein (MAP) kinase-interacting kinase (MNK) on Ser209 in response to mitogens and cellular stress.  Here we demonstrate that phosphorylation of eIF4E via MNK1 is mediated via the activation of either the Erk or p38 pathway.  We further show that expression of active mutants of MNK1 and MNK2 in 293 cells diminishes cap-dependent translation relative to cap-independent translation in a transient reporter assay.  The same effect on cap-dependent translation was obsd. when MNK1 was activated by the Erk or p38 pathway.  In line with these findings, addn. of recombinant active MNK1 to rabbit reticulocyte lysate resulted in a reduced protein synthesis in vitro, and overexpression of MNK2 caused a decreased rate of protein synthesis in 293 cells.  By using CGP 57380, a novel low-mol.-wt. kinase inhibitor of MNK1, we demonstrate that eIF4E phosphorylation is not crucial to the formation of the initiation complex, mitogen-stimulated increase in cap-dependent translation, and cell proliferation.  Our results imply that activation of MNK by MAP kinase pathways does not constitute a pos. regulatory mechanism to cap-dependent translation.  Instead, we propose that the kinase activity of MNKs, eventually through phosphorylation of eIF4E, may serve to limit cap-dependent translation under physiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruNOjANWg6jLVg90H21EOLACvtfcHk0lhgw82v22Cf-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslOjtb0%253D&md5=e50d12905c25505de246ca9a80e3da83</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1128%2FMCB.21.16.5500-5511.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.21.16.5500-5511.2001%26sid%3Dliteratum%253Aachs%26aulast%3DKnauf%26aufirst%3DU.%26aulast%3DTschopp%26aufirst%3DC.%26aulast%3DGram%26aufirst%3DH.%26atitle%3DNegative%2520regulation%2520of%2520protein%2520translation%2520by%2520mitogen-activated%2520protein%2520kinase-interacting%2520kinases%25201%2520and%25202%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D21%26issue%3D16%26spage%3D5500%26epage%3D5511%26doi%3D10.1128%2FMCB.21.16.5500-5511.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kambe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizumi, M.</span></span> <span> </span><span class="NLM_article-title">Mnk1 is required for angiotensin II-induced protein synthesis in vascular smooth muscle cells</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1218</span>– <span class="NLM_lpage">1224</span>, <span class="refDoi"> DOI: 10.1161/01.RES.0000105570.34585.F2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1161%2F01.RES.0000105570.34585.F2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2003&pages=1218-1224&issue=12&author=M.+Ishidaauthor=T.+Ishidaauthor=H.+Nakashimaauthor=N.+Mihoauthor=K.+Miyagawaauthor=K.+Chayamaauthor=T.+Oshimaauthor=M.+Kambeauthor=M.+Yoshizumi&title=Mnk1+is+required+for+angiotensin+II-induced+protein+synthesis+in+vascular+smooth+muscle+cells&doi=10.1161%2F01.RES.0000105570.34585.F2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000105570.34585.F2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000105570.34585.F2%26sid%3Dliteratum%253Aachs%26aulast%3DIshida%26aufirst%3DM.%26aulast%3DIshida%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DMiho%26aufirst%3DN.%26aulast%3DMiyagawa%26aufirst%3DK.%26aulast%3DChayama%26aufirst%3DK.%26aulast%3DOshima%26aufirst%3DT.%26aulast%3DKambe%26aufirst%3DM.%26aulast%3DYoshizumi%26aufirst%3DM.%26atitle%3DMnk1%2520is%2520required%2520for%2520angiotensin%2520II-induced%2520protein%2520synthesis%2520in%2520vascular%2520smooth%2520muscle%2520cells%26jtitle%3DCirc.%2520Res.%26date%3D2003%26volume%3D93%26issue%3D12%26spage%3D1218%26epage%3D1224%26doi%3D10.1161%2F01.RES.0000105570.34585.F2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konicek, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peery, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumstorf, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowless, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iversen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yingling, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stancato, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1849</span>– <span class="NLM_lpage">1857</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-3298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1158%2F0008-5472.CAN-10-3298" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=1849-1857&issue=5&author=B.+W.+Konicekauthor=J.+R.+Stephensauthor=A.+M.+McNultyauthor=N.+Robichaudauthor=R.+B.+Peeryauthor=C.+A.+Dumstorfauthor=M.+S.+Dowlessauthor=P.+W.+Iversenauthor=S.+Parsonsauthor=K.+E.+Ellisauthor=D.+J.+McCannauthor=J.+Pelletierauthor=L.+Furicauthor=J.+M.+Yinglingauthor=L.+F.+Stancatoauthor=N.+Sonenbergauthor=J.+R.+Graff&title=Therapeutic+inhibition+of+MAP+kinase+interacting+kinase+blocks+eukaryotic+initiation+factor+4E+phosphorylation+and+suppresses+outgrowth+of+experimental+lung+metastases&doi=10.1158%2F0008-5472.CAN-10-3298"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-3298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-3298%26sid%3Dliteratum%253Aachs%26aulast%3DKonicek%26aufirst%3DB.%2BW.%26aulast%3DStephens%26aufirst%3DJ.%2BR.%26aulast%3DMcNulty%26aufirst%3DA.%2BM.%26aulast%3DRobichaud%26aufirst%3DN.%26aulast%3DPeery%26aufirst%3DR.%2BB.%26aulast%3DDumstorf%26aufirst%3DC.%2BA.%26aulast%3DDowless%26aufirst%3DM.%2BS.%26aulast%3DIversen%26aufirst%3DP.%2BW.%26aulast%3DParsons%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DK.%2BE.%26aulast%3DMcCann%26aufirst%3DD.%2BJ.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DFuric%26aufirst%3DL.%26aulast%3DYingling%26aufirst%3DJ.%2BM.%26aulast%3DStancato%26aufirst%3DL.%2BF.%26aulast%3DSonenberg%26aufirst%3DN.%26aulast%3DGraff%26aufirst%3DJ.%2BR.%26atitle%3DTherapeutic%2520inhibition%2520of%2520MAP%2520kinase%2520interacting%2520kinase%2520blocks%2520eukaryotic%2520initiation%2520factor%25204E%2520phosphorylation%2520and%2520suppresses%2520outgrowth%2520of%2520experimental%2520lung%2520metastases%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D5%26spage%3D1849%26epage%3D1857%26doi%3D10.1158%2F0008-5472.CAN-10-3298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basnet, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diab, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.ejmech.2015.09.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=539-550&author=T.+Teoauthor=Y.+Yangauthor=M.+Yuauthor=S.+K.+Basnetauthor=T.+Gillamauthor=J.+Houauthor=R.+M.+Schmidauthor=M.+Kumarasiriauthor=S.+Diabauthor=H.+Albrechtauthor=M.+J.+Sykesauthor=S.+Wang&title=An+integrated+approach+for+discovery+of+highly+potent+and+selective+Mnk+inhibitors%3A+Screening%2C+synthesis+and+SAR+analysis&doi=10.1016%2Fj.ejmech.2015.09.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DBasnet%26aufirst%3DS.%2BK.%26aulast%3DGillam%26aufirst%3DT.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DSchmid%26aufirst%3DR.%2BM.%26aulast%3DKumarasiri%26aufirst%3DM.%26aulast%3DDiab%26aufirst%3DS.%26aulast%3DAlbrecht%26aufirst%3DH.%26aulast%3DSykes%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DAn%2520integrated%2520approach%2520for%2520discovery%2520of%2520highly%2520potent%2520and%2520selective%2520Mnk%2520inhibitors%253A%2520Screening%252C%2520synthesis%2520and%2520SAR%2520analysis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D103%26spage%3D539%26epage%3D550%26doi%3D10.1016%2Fj.ejmech.2015.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diab, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basnet, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5-(2-(phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one derivatives as potent Mnk2 inhibitors: synthesis, SAR analysis and biological evaluation</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">972</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1002%2Fcmdc.201300552" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=962-972&issue=5&author=S.+Diabauthor=T.+Teoauthor=M.+Kumarasiriauthor=P.+Liauthor=M.+Yuauthor=F.+Lamauthor=S.+K.+Basnetauthor=M.+J.+Sykesauthor=H.+Albrechtauthor=R.+Milneauthor=S.+Wang&title=Discovery+of+5-%282-%28phenylamino%29pyrimidin-4-yl%29thiazol-2%283H%29-one+derivatives+as+potent+Mnk2+inhibitors%3A+synthesis%2C+SAR+analysis+and+biological+evaluation&doi=10.1002%2Fcmdc.201300552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300552%26sid%3Dliteratum%253Aachs%26aulast%3DDiab%26aufirst%3DS.%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DKumarasiri%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DF.%26aulast%3DBasnet%26aufirst%3DS.%2BK.%26aulast%3DSykes%26aufirst%3DM.%2BJ.%26aulast%3DAlbrecht%26aufirst%3DH.%26aulast%3DMilne%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25205-%25282-%2528phenylamino%2529pyrimidin-4-yl%2529thiazol-2%25283H%2529-one%2520derivatives%2520as%2520potent%2520Mnk2%2520inhibitors%253A%2520synthesis%252C%2520SAR%2520analysis%2520and%2520biological%2520evaluation%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26issue%3D5%26spage%3D962%26epage%3D972%26doi%3D10.1002%2Fcmdc.201300552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kosciuczuk, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleiro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroczynska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckerdt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blyth, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abedin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span> <span> </span><span class="NLM_article-title">Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1182/blood-2016-02-698704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1182%2Fblood-2016-02-698704" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=410-414&issue=3&author=E.+M.+Kosciuczukauthor=D.+Saleiroauthor=B.+Kroczynskaauthor=E.+M.+Beauchampauthor=F.+Eckerdtauthor=G.+T.+Blythauthor=S.+M.+Abedinauthor=F.+J.+Gilesauthor=J.+K.+Altmanauthor=L.+C.+Platanias&title=Merestinib+blocks+Mnk+kinase+activity+in+acute+myeloid+leukemia+progenitors+and+exhibits+antileukemic+effects+in+vitro+and+in+vivo&doi=10.1182%2Fblood-2016-02-698704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1182%2Fblood-2016-02-698704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2016-02-698704%26sid%3Dliteratum%253Aachs%26aulast%3DKosciuczuk%26aufirst%3DE.%2BM.%26aulast%3DSaleiro%26aufirst%3DD.%26aulast%3DKroczynska%26aufirst%3DB.%26aulast%3DBeauchamp%26aufirst%3DE.%2BM.%26aulast%3DEckerdt%26aufirst%3DF.%26aulast%3DBlyth%26aufirst%3DG.%2BT.%26aulast%3DAbedin%26aufirst%3DS.%2BM.%26aulast%3DGiles%26aufirst%3DF.%2BJ.%26aulast%3DAltman%26aufirst%3DJ.%2BK.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26atitle%3DMerestinib%2520blocks%2520Mnk%2520kinase%2520activity%2520in%2520acute%2520myeloid%2520leukemia%2520progenitors%2520and%2520exhibits%2520antileukemic%2520effects%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26issue%3D3%26spage%3D410%26epage%3D414%26doi%3D10.1182%2Fblood-2016-02-698704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic co-inhibition of Mnks and mTORC1 synergistically suppresses proliferation and perturbs cell cycle progression in blast crisis-chronic myeloid leukemia cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>357</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">612</span>– <span class="NLM_lpage">623</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2014.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.canlet.2014.12.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=25527453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislKguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2015&pages=612-623&issue=2&author=T.+Teoauthor=M.+Yuauthor=Y.+Yangauthor=T.+Gillamauthor=F.+Lamauthor=M.+J.+Sykesauthor=S.+Wang&title=Pharmacologic+co-inhibition+of+Mnks+and+mTORC1+synergistically+suppresses+proliferation+and+perturbs+cell+cycle+progression+in+blast+crisis-chronic+myeloid+leukemia+cells&doi=10.1016%2Fj.canlet.2014.12.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic co-inhibition of Mnks and mTORC1 synergistically suppresses proliferation and perturbs cell cycle progression in blast crisis-chronic myeloid leukemia cells</span></div><div class="casAuthors">Teo, Theodosia; Yu, Mingfeng; Yang, Yuchao; Gillam, Todd; Lam, Frankie; Sykes, Matthew J.; Wang, Shudong</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">612-623</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The Ras/Raf/MAPK and PI3K/Akt/mTORC1 cascades are two most aberrantly regulated pathways in cancers.  As MAPK-interacting kinases (Mnks) are part of the convergent node of these two pathways, and play a pivotal role in cellular transformation, targeting Mnks has emerged as a potential therapeutic strategy.  Herein, a dual-specific Mnk1/2 inhibitor MNKI-57 and a potent Mnk2-specific inhibitor MNKI-4 were selected for a panel screen against 28 human cancer cell lines.  The study reveals that MNKI-57 and MNKI-4 are most potent against leukemia cells KYO-1 (i.e. BC-CML) and KG-1 (i.e. AML).  Interestingly, we found that sensitivity of selected leukemia cells to Mnk inhibitors is correlated with the level of phosphorylated 4E-BP1 at Thr70.  The anti-proliferative effects of Mnk inhibitors are cytostatic in the sensitive KYO-1 cells, inducing significant G1 arrest via down-regulation of cyclin D1 expression.  In KYO-1 cells where Akt is not constitutively active, Mnk inhibitors increase the sensitivity of cells to rapamycin, resulting in a more pronounced anti-proliferative activity.  Remarkably, the synergistic anti-proliferative effects are assocd. with a marked de-phosphorylation of 4E-BP1 at Thr70.  Collectively, these data highlight the importance of 4E-BP1 as a key integrator in the MAPK and mTORC1 cascades, and suggest that a combined pharmacol. inhibition of mTORC1 and Mnk kinases offers an innovative therapeutic opportunity in BC-CML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonXVLjuzQn5rVg90H21EOLACvtfcHk0lhUmykJcHDvng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislKguw%253D%253D&md5=a6b1457af0a8430b7976195e8e1b9c5d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGillam%26aufirst%3DT.%26aulast%3DLam%26aufirst%3DF.%26aulast%3DSykes%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPharmacologic%2520co-inhibition%2520of%2520Mnks%2520and%2520mTORC1%2520synergistically%2520suppresses%2520proliferation%2520and%2520perturbs%2520cell%2520cycle%2520progression%2520in%2520blast%2520crisis-chronic%2520myeloid%2520leukemia%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D357%26issue%3D2%26spage%3D612%26epage%3D623%26doi%3D10.1016%2Fj.canlet.2014.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basnet, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic inhibition of MNKs in acute myeloid leukemia</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1124/mol.115.098012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1124%2Fmol.115.098012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=380-389&issue=2&author=T.+Teoauthor=F.+Lamauthor=M.+Yuauthor=Y.+Yangauthor=S.+K.+Basnetauthor=H.+Albrechtauthor=M.+J.+Sykesauthor=S.+Wang&title=Pharmacologic+inhibition+of+MNKs+in+acute+myeloid+leukemia&doi=10.1124%2Fmol.115.098012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.098012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.098012%26sid%3Dliteratum%253Aachs%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DLam%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBasnet%26aufirst%3DS.%2BK.%26aulast%3DAlbrecht%26aufirst%3DH.%26aulast%3DSykes%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPharmacologic%2520inhibition%2520of%2520MNKs%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26issue%3D2%26spage%3D380%26epage%3D389%26doi%3D10.1124%2Fmol.115.098012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amiri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafer, C. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a selective and potent inhibitor of mitogen-activated protein kinase-interacting kinases 1 and 2 (MNK1/2) utilizing structure-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3034</span>– <span class="NLM_lpage">3045</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01657</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3034-3045&issue=7&author=W.+Hanauthor=Y.+Dingauthor=Y.+Xuauthor=K.+Pfisterauthor=S.+Zhuauthor=B.+Warneauthor=M.+Doyleauthor=M.+Aikawaauthor=P.+Amiriauthor=B.+Appletonauthor=D.+D.+Stuartauthor=A.+Fanidiauthor=C.+M.+Shafer&title=Discovery+of+a+selective+and+potent+inhibitor+of+mitogen-activated+protein+kinase-interacting+kinases+1+and+2+%28MNK1%2F2%29+utilizing+structure-based+drug+design&doi=10.1021%2Facs.jmedchem.5b01657"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01657%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DW.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DPfister%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DWarne%26aufirst%3DB.%26aulast%3DDoyle%26aufirst%3DM.%26aulast%3DAikawa%26aufirst%3DM.%26aulast%3DAmiri%26aufirst%3DP.%26aulast%3DAppleton%26aufirst%3DB.%26aulast%3DStuart%26aufirst%3DD.%2BD.%26aulast%3DFanidi%26aufirst%3DA.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520selective%2520and%2520potent%2520inhibitor%2520of%2520mitogen-activated%2520protein%2520kinase-interacting%2520kinases%25201%2520and%25202%2520%2528MNK1%252F2%2529%2520utilizing%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D7%26spage%3D3034%26epage%3D3045%26doi%3D10.1021%2Facs.jmedchem.5b01657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eis, K.</span></span> <span> </span><span class="NLM_article-title">Amino-Substituted Imidazopyridazines</span>. <span class="NLM_patent">WO/2013/034570</span>, March 14, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=K.+Eis&title=Amino-Substituted+Imidazopyridazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEis%26aufirst%3DK.%26atitle%3DAmino-Substituted%2520Imidazopyridazines%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eis, K. P. F.</span>; <span class="NLM_string-name">Zorn, L.</span>; <span class="NLM_string-name">Scholz, A.</span>; <span class="NLM_string-name">Lienau, P.</span>; <span class="NLM_string-name">Gnoth, M.
J.</span>; <span class="NLM_string-name">Bömer, U.</span>; <span class="NLM_string-name">Günther, J.</span>; <span class="NLM_string-name">Hitchcock, M.</span></span> <span> </span><span class="NLM_article-title">Amino-Substituted Imidazopyridazines</span>. <span class="NLM_patent">WO/2013/087581</span>, June 20, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=K.+P.+F.+Eis&author=L.+Zorn&author=A.+Scholz&author=P.+Lienau&author=M.%0AJ.+Gnoth&author=U.+B%C3%B6mer&author=J.+G%C3%BCnther&author=M.+Hitchcock&title=Amino-Substituted+Imidazopyridazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEis%26aufirst%3DK.%2BP.%2BF.%26atitle%3DAmino-Substituted%2520Imidazopyridazines%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">National
Institutes of Health,
U.S. National Library of Medicine</span>. <span> </span><span class="NLM_article-title">Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination
With Intravenous Docetaxel</span>. <a href="https://clinicaltrials.gov/ct2/show/NCT02439346" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02439346</a> (accessed February 2, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=National%0AInstitutes+of+Health%2C%0AU.S.+National+Library+of+Medicine&title=Phase+I+Dose+Escalation+and+Expansion+of+Oral+BAY+1143269+in+Combination%0AWith+Intravenous+Docetaxel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DPhase%2520I%2520Dose%2520Escalation%2520and%2520Expansion%2520of%2520Oral%2520BAY%25201143269%2520in%2520Combination%250AWith%2520Intravenous%2520Docetaxel%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Webster, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegerski, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengeler, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reich, S. H.</span></span> <span> </span><span class="NLM_article-title">eFT508, a potent and selective mitogen-activated protein kinase interacting kinase (MNK) 1 and 2 inhibitor, is efficacious in preclinical models of diffuse large b-cell lymphoma (DLBCL)</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">1554</span>– <span class="NLM_lpage">1554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=1554-1554&issue=23&author=K.+R.+Websterauthor=V.+K.+Goelauthor=I.+N.+Hungauthor=G.+S.+Parkerauthor=J.+Stauntonauthor=M.+Nealauthor=J.+Molterauthor=G.+G.+Chiangauthor=K.+A.+Jessenauthor=C.+J.+Wegerskiauthor=S.+Sperryauthor=V.+Huangauthor=J.+Chenauthor=P.+A.+Thompsonauthor=J.+R.+Applemanauthor=S.+E.+Webberauthor=P.+A.+Sprengelerauthor=S.+H.+Reich&title=eFT508%2C+a+potent+and+selective+mitogen-activated+protein+kinase+interacting+kinase+%28MNK%29+1+and+2+inhibitor%2C+is+efficacious+in+preclinical+models+of+diffuse+large+b-cell+lymphoma+%28DLBCL%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWebster%26aufirst%3DK.%2BR.%26aulast%3DGoel%26aufirst%3DV.%2BK.%26aulast%3DHung%26aufirst%3DI.%2BN.%26aulast%3DParker%26aufirst%3DG.%2BS.%26aulast%3DStaunton%26aufirst%3DJ.%26aulast%3DNeal%26aufirst%3DM.%26aulast%3DMolter%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DJessen%26aufirst%3DK.%2BA.%26aulast%3DWegerski%26aufirst%3DC.%2BJ.%26aulast%3DSperry%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DP.%2BA.%26aulast%3DAppleman%26aufirst%3DJ.%2BR.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DReich%26aufirst%3DS.%2BH.%26atitle%3DeFT508%252C%2520a%2520potent%2520and%2520selective%2520mitogen-activated%2520protein%2520kinase%2520interacting%2520kinase%2520%2528MNK%2529%25201%2520and%25202%2520inhibitor%252C%2520is%2520efficacious%2520in%2520preclinical%2520models%2520of%2520diffuse%2520large%2520b-cell%2520lymphoma%2520%2528DLBCL%2529%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26issue%3D23%26spage%3D1554%26epage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Webster, K. R.</span></span> <span> </span><span class="NLM_article-title">eFT508: An oral, potent and highly selective inhibitor of mitogen-activated protein kinase interacting kinase (MNK) 1 and 2, a novel approach for the treatment of cancer</span>. Presented at the Annual Meeting of the American Association for Cancer Research, New Orleans, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=K.+R.+Webster&title=eFT508%3A+An+oral%2C+potent+and+highly+selective+inhibitor+of+mitogen-activated+protein+kinase+interacting+kinase+%28MNK%29+1+and+2%2C+a+novel+approach+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DWebster%26aufirst%3DK.%2BR.%26atitle%3DeFT508%253A%2520An%2520oral%252C%2520potent%2520and%2520highly%2520selective%2520inhibitor%2520of%2520mitogen-activated%2520protein%2520kinase%2520interacting%2520kinase%2520%2528MNK%2529%25201%2520and%25202%252C%2520a%2520novel%2520approach%2520for%2520the%2520treatment%2520of%2520cancer%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reich, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengeler, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemison, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaghafi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumpf, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegerski, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, K. R.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of pyridone-aminal eFT508 targeting dysregulated translation by selective mitogen-activated protein kinase interacting kinases 1 and 2 (MNK1/2) inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3516</span>– <span class="NLM_lpage">3540</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01795</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01795" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3516-3540&author=S.+H.+Reichauthor=P.+A.+Sprengelerauthor=G.+G.+Chiangauthor=J.+R.+Applemanauthor=J.+Chenauthor=J.+Clarineauthor=B.+Eamauthor=J.+T.+Ernstauthor=Q.+Hanauthor=V.+K.+Goelauthor=E.+Z.+Hanauthor=V.+Huangauthor=I.+N.+Hungauthor=A.+Jemisonauthor=K.+A.+Jessenauthor=J.+Molterauthor=D.+Murphyauthor=M.+Nealauthor=G.+S.+Parkerauthor=M.+Shaghafiauthor=S.+Sperryauthor=J.+Stauntonauthor=C.+R.+Stumpfauthor=P.+A.+Thompsonauthor=C.+Tranauthor=S.+E.+Webberauthor=C.+J.+Wegerskiauthor=H.+Zhengauthor=K.+R.+Webster&title=Structure-based+design+of+pyridone-aminal+eFT508+targeting+dysregulated+translation+by+selective+mitogen-activated+protein+kinase+interacting+kinases+1+and+2+%28MNK1%2F2%29+inhibition&doi=10.1021%2Facs.jmedchem.7b01795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition</span></div><div class="casAuthors">Reich, Siegfried H.; Sprengeler, Paul A.; Chiang, Gary G.; Appleman, James R.; Chen, Joan; Clarine, Jeff; Eam, Boreth; Ernst, Justin T.; Han, Qing; Goel, Vikas K.; Han, Edward Z. R.; Huang, Vera; Hung, Ivy N. J.; Jemison, Adrianna; Jessen, Katti A.; Molter, Jolene; Murphy, Douglas; Neal, Melissa; Parker, Gregory S.; Shaghafi, Michael; Sperry, Samuel; Staunton, Jocelyn; Stumpf, Craig R.; Thompson, Peggy A.; Tran, Chinh; Webber, Stephen E.; Wegerski, Christopher J.; Zheng, Hong; Webster, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3516-3540</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dysregulated translation of mRNA plays a major role in tumorigenesis.  Mitogen-activated protein kinase interacting kinases (MNK)1/2 are key regulators of mRNA translation integrating signals from oncogenic and immune signaling pathways through phosphorylation of eIF4E and other mRNA binding proteins.  Modulation of these key effector proteins regulates mRNA, which controls tumor/stromal cell signaling.  Compd. 23 (eFT508, 6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-2'H-spiro-[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione hydrochloride), an exquisitely selective, potent dual MNK1/2 inhibitor, was designed to assess the potential for control of oncogene signaling at the level of mRNA translation.  The crystal structure-guided design leverages stereoelectronic interactions unique to MNK culminating in a novel pyridone-aminal structure described for the first time in the kinase literature.  Compd. 23 has potent in vivo antitumor activity in models of diffuse large cell B-cell lymphoma and solid tumors, suggesting that controlling dysregulated translation has real therapeutic potential.  Compd. 23 is currently being evaluated in Phase 2 clin. trials in solid tumors and lymphoma.  Compd. 23 is the first highly selective dual MNK inhibitor targeting dysregulated translation being assessed clin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAp-3GOuZu8bVg90H21EOLACvtfcHk0ljeQgfSALI6zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlGhs7s%253D&md5=1254b674aa7e6d2037a06bc10e64e4da</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01795%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DS.%2BH.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DAppleman%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DClarine%26aufirst%3DJ.%26aulast%3DEam%26aufirst%3DB.%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DHan%26aufirst%3DQ.%26aulast%3DGoel%26aufirst%3DV.%2BK.%26aulast%3DHan%26aufirst%3DE.%2BZ.%26aulast%3DHuang%26aufirst%3DV.%26aulast%3DHung%26aufirst%3DI.%2BN.%26aulast%3DJemison%26aufirst%3DA.%26aulast%3DJessen%26aufirst%3DK.%2BA.%26aulast%3DMolter%26aufirst%3DJ.%26aulast%3DMurphy%26aufirst%3DD.%26aulast%3DNeal%26aufirst%3DM.%26aulast%3DParker%26aufirst%3DG.%2BS.%26aulast%3DShaghafi%26aufirst%3DM.%26aulast%3DSperry%26aufirst%3DS.%26aulast%3DStaunton%26aufirst%3DJ.%26aulast%3DStumpf%26aufirst%3DC.%2BR.%26aulast%3DThompson%26aufirst%3DP.%2BA.%26aulast%3DTran%26aufirst%3DC.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DWegerski%26aufirst%3DC.%2BJ.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DWebster%26aufirst%3DK.%2BR.%26atitle%3DStructure-based%2520design%2520of%2520pyridone-aminal%2520eFT508%2520targeting%2520dysregulated%2520translation%2520by%2520selective%2520mitogen-activated%2520protein%2520kinase%2520interacting%2520kinases%25201%2520and%25202%2520%2528MNK1%252F2%2529%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3516%26epage%3D3540%26doi%3D10.1021%2Facs.jmedchem.7b01795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cherian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poh, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraj, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joy, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwek, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wee, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choong, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies of mitogen activated protein kinase interacting kinase (MNK) 1 and 2 and BCR-ABL1 inhibitors targeting chronic myeloid leukemic cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3063</span>– <span class="NLM_lpage">3078</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01712</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01712" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3063-3078&issue=7&author=J.+Cherianauthor=K.+Nacroauthor=Z.+Y.+Pohauthor=S.+Guoauthor=D.+A.+Jeyarajauthor=Y.+X.+Wongauthor=M.+Hoauthor=H.+Y.+Yangauthor=J.+K.+Joyauthor=Z.+P.+Kwekauthor=B.+Liuauthor=J.+L.+Weeauthor=E.+H.+Ongauthor=M.+L.+Choongauthor=A.+Poulsenauthor=M.+A.+Leeauthor=V.+Pendharkarauthor=L.+J.+Dingauthor=V.+Manoharanauthor=Y.+S.+Chewauthor=K.+Sangthongpitagauthor=S.+Limauthor=S.+T.+Ongauthor=J.+Hillauthor=T.+H.+Keller&title=Structure-activity+relationship+studies+of+mitogen+activated+protein+kinase+interacting+kinase+%28MNK%29+1+and+2+and+BCR-ABL1+inhibitors+targeting+chronic+myeloid+leukemic+cells&doi=10.1021%2Facs.jmedchem.5b01712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01712%26sid%3Dliteratum%253Aachs%26aulast%3DCherian%26aufirst%3DJ.%26aulast%3DNacro%26aufirst%3DK.%26aulast%3DPoh%26aufirst%3DZ.%2BY.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DJeyaraj%26aufirst%3DD.%2BA.%26aulast%3DWong%26aufirst%3DY.%2BX.%26aulast%3DHo%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%2BY.%26aulast%3DJoy%26aufirst%3DJ.%2BK.%26aulast%3DKwek%26aufirst%3DZ.%2BP.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DWee%26aufirst%3DJ.%2BL.%26aulast%3DOng%26aufirst%3DE.%2BH.%26aulast%3DChoong%26aufirst%3DM.%2BL.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DDing%26aufirst%3DL.%2BJ.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DChew%26aufirst%3DY.%2BS.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DOng%26aufirst%3DS.%2BT.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26atitle%3DStructure-activity%2520relationship%2520studies%2520of%2520mitogen%2520activated%2520protein%2520kinase%2520interacting%2520kinase%2520%2528MNK%2529%25201%2520and%25202%2520and%2520BCR-ABL1%2520inhibitors%2520targeting%2520chronic%2520myeloid%2520leukemic%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D7%26spage%3D3063%26epage%3D3078%26doi%3D10.1021%2Facs.jmedchem.5b01712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarich, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albarran, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbano-Cuadrado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mateos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymundo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corrionero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fominaya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, J. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">6618</span>– <span class="NLM_lpage">6628</span>, <span class="refDoi"> DOI: 10.1021/jm1005513</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1005513" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6618-6628&issue=18&author=J.+Oyarzabalauthor=N.+Zarichauthor=M.+I.+Albarranauthor=I.+Palaciosauthor=M.+Urbano-Cuadradoauthor=G.+Mateosauthor=I.+Reymundoauthor=O.+Rabalauthor=A.+Salgadoauthor=A.+Corrioneroauthor=J.+Fominayaauthor=J.+Pastorauthor=J.+R.+Bischoff&title=Discovery+of+mitogen-activated+protein+kinase-interacting+kinase+1+inhibitors+by+a+comprehensive+fragment-oriented+virtual+screening+approach&doi=10.1021%2Fjm1005513"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm1005513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005513%26sid%3Dliteratum%253Aachs%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DZarich%26aufirst%3DN.%26aulast%3DAlbarran%26aufirst%3DM.%2BI.%26aulast%3DPalacios%26aufirst%3DI.%26aulast%3DUrbano-Cuadrado%26aufirst%3DM.%26aulast%3DMateos%26aufirst%3DG.%26aulast%3DReymundo%26aufirst%3DI.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DSalgado%26aufirst%3DA.%26aulast%3DCorrionero%26aufirst%3DA.%26aulast%3DFominaya%26aufirst%3DJ.%26aulast%3DPastor%26aufirst%3DJ.%26aulast%3DBischoff%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520mitogen-activated%2520protein%2520kinase-interacting%2520kinase%25201%2520inhibitors%2520by%2520a%2520comprehensive%2520fragment-oriented%2520virtual%2520screening%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D18%26spage%3D6618%26epage%3D6628%26doi%3D10.1021%2Fjm1005513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jauch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, M. C.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of the Mnk2 kinase domain reveal an inhibitory conformation and a zinc binding site</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1559</span>– <span class="NLM_lpage">1568</span>, <span class="refDoi"> DOI: 10.1016/j.str.2005.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.str.2005.07.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=1559-1568&issue=10&author=R.+Jauchauthor=S.+Jakelauthor=C.+Netterauthor=K.+Schreiterauthor=B.+Aicherauthor=H.+Jackleauthor=M.+C.+Wahl&title=Crystal+structures+of+the+Mnk2+kinase+domain+reveal+an+inhibitory+conformation+and+a+zinc+binding+site&doi=10.1016%2Fj.str.2005.07.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2005.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2005.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DJauch%26aufirst%3DR.%26aulast%3DJakel%26aufirst%3DS.%26aulast%3DNetter%26aufirst%3DC.%26aulast%3DSchreiter%26aufirst%3DK.%26aulast%3DAicher%26aufirst%3DB.%26aulast%3DJackle%26aufirst%3DH.%26aulast%3DWahl%26aufirst%3DM.%2BC.%26atitle%3DCrystal%2520structures%2520of%2520the%2520Mnk2%2520kinase%2520domain%2520reveal%2520an%2520inhibitory%2520conformation%2520and%2520a%2520zinc%2520binding%2520site%26jtitle%3DStructure%26date%3D2005%26volume%3D13%26issue%3D10%26spage%3D1559%26epage%3D1568%26doi%3D10.1016%2Fj.str.2005.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jauch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zweckstetter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, M. C.</span></span> <span> </span><span class="NLM_article-title">Mitogen-activated protein kinases interacting kinases are autoinhibited by a reprogrammed activation segment</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">4020</span>– <span class="NLM_lpage">4032</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1038%2Fsj.emboj.7601285" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=4020-4032&issue=17&author=R.+Jauchauthor=M.+K.+Choauthor=S.+Jakelauthor=C.+Netterauthor=K.+Schreiterauthor=B.+Aicherauthor=M.+Zweckstetterauthor=H.+Jackleauthor=M.+C.+Wahl&title=Mitogen-activated+protein+kinases+interacting+kinases+are+autoinhibited+by+a+reprogrammed+activation+segment&doi=10.1038%2Fsj.emboj.7601285"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601285%26sid%3Dliteratum%253Aachs%26aulast%3DJauch%26aufirst%3DR.%26aulast%3DCho%26aufirst%3DM.%2BK.%26aulast%3DJakel%26aufirst%3DS.%26aulast%3DNetter%26aufirst%3DC.%26aulast%3DSchreiter%26aufirst%3DK.%26aulast%3DAicher%26aufirst%3DB.%26aulast%3DZweckstetter%26aufirst%3DM.%26aulast%3DJackle%26aufirst%3DH.%26aulast%3DWahl%26aufirst%3DM.%2BC.%26atitle%3DMitogen-activated%2520protein%2520kinases%2520interacting%2520kinases%2520are%2520autoinhibited%2520by%2520a%2520reprogrammed%2520activation%2520segment%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26issue%3D17%26spage%3D4020%26epage%3D4032%26doi%3D10.1038%2Fsj.emboj.7601285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rucker, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albaugh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopiuk, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adrian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tompkins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreusch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prashad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, V.</span></span> <span> </span><span class="NLM_article-title">(R)-2-Phenylpyrrolidine substituted imidazopyridazines: a new class of potent and selective pan-TRK inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">567</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00050</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=562-567&issue=5&author=H.+S.+Choiauthor=P.+V.+Ruckerauthor=Z.+Wangauthor=Y.+Fanauthor=P.+Albaughauthor=G.+Chopiukauthor=F.+Gessierauthor=F.+Sunauthor=F.+Adrianauthor=G.+Liuauthor=T.+Hoodauthor=N.+Liauthor=Y.+Jiaauthor=J.+Cheauthor=S.+McCormackauthor=A.+Liauthor=J.+Liauthor=A.+Steffyauthor=A.+Culazzoauthor=C.+Tompkinsauthor=V.+Phungauthor=A.+Kreuschauthor=M.+Luauthor=B.+Huauthor=A.+Chaudharyauthor=M.+Prashadauthor=T.+Tuntlandauthor=B.+Liuauthor=J.+Harrisauthor=H.+M.+Seidelauthor=J.+Lorenauthor=V.+Molteni&title=%28R%29-2-Phenylpyrrolidine+substituted+imidazopyridazines%3A+a+new+class+of+potent+and+selective+pan-TRK+inhibitors&doi=10.1021%2Facsmedchemlett.5b00050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00050%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BS.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAlbaugh%26aufirst%3DP.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DGessier%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DHood%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DMcCormack%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSteffy%26aufirst%3DA.%26aulast%3DCulazzo%26aufirst%3DA.%26aulast%3DTompkins%26aufirst%3DC.%26aulast%3DPhung%26aufirst%3DV.%26aulast%3DKreusch%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DChaudhary%26aufirst%3DA.%26aulast%3DPrashad%26aufirst%3DM.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DHarris%26aufirst%3DJ.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DLoren%26aufirst%3DJ.%26aulast%3DMolteni%26aufirst%3DV.%26atitle%3D%2528R%2529-2-Phenylpyrrolidine%2520substituted%2520imidazopyridazines%253A%2520a%2520new%2520class%2520of%2520potent%2520and%2520selective%2520pan-TRK%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D5%26spage%3D562%26epage%3D567%26doi%3D10.1021%2Facsmedchemlett.5b00050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roux, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blenis, J.</span></span> <span> </span><span class="NLM_article-title">ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions</span>. <i>Microbiol. Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1128/MMBR.68.2.320-344.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1128%2FMMBR.68.2.320-344.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=15187187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsl2hu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2004&pages=320-344&issue=2&author=P.+P.+Rouxauthor=J.+Blenis&title=ERK+and+p38+MAPK-activated+protein+kinases%3A+a+family+of+protein+kinases+with+diverse+biological+functions&doi=10.1128%2FMMBR.68.2.320-344.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions</span></div><div class="casAuthors">Roux, Philippe P.; Blenis, John</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">320-344</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1092-2172</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  Conserved signaling pathways that activate the mitogen-activated protein kinases (MAPKs) are involved in relaying extracellular stimulations to intracellular responses.  The MAPKs coordinately regulate cell proliferation, differentiation, motility, and survival, which are functions also known to be mediated by members of a growing family of MAPK-activated protein kinases (MKs; formerly known as MAPKAP kinases).  The MKs are related serine/threonine kinases that respond to mitogenic and stress stimuli through proline-directed phosphorylation and activation of the kinase domain by extracellular signal-regulated kinases 1 and 2 and p38 MAPKs.  There are currently 11 vertebrate MKs in five subfamilies based on primary sequence homol.: the ribosomal S6 kinases, the mitogen- and stress-activated kinases, the MAPK-interacting kinases, MAPK activated protein kinases 2 and 3, and MK5.  In the last 5 yr, several MK substrates have been identified, which has helped tremendously to identify the biol. role of the members of this family.  Together with data from the study of MK-knockout mice, the identities of the MK substrates indicate that they play important roles in diverse biol. processes, including mRNA translation, cell proliferation and survival, and the nuclear genomic response to mitogens and cellular stresses.  In this article, we review the existing data on the MKs and discuss their physiol. functions based on recent discoveries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdh5NfM1SHwbVg90H21EOLACvtfcHk0lh258JT0eB4fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsl2hu7Y%253D&md5=62f54354912521eef889470360e019a7</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FMMBR.68.2.320-344.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.68.2.320-344.2004%26sid%3Dliteratum%253Aachs%26aulast%3DRoux%26aufirst%3DP.%2BP.%26aulast%3DBlenis%26aufirst%3DJ.%26atitle%3DERK%2520and%2520p38%2520MAPK-activated%2520protein%2520kinases%253A%2520a%2520family%2520of%2520protein%2520kinases%2520with%2520diverse%2520biological%2520functions%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2004%26volume%3D68%26issue%3D2%26spage%3D320%26epage%3D344%26doi%3D10.1128%2FMMBR.68.2.320-344.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><a href="http://www.schrodinger.com" class="extLink">www.schrodinger.com</a> (accessed
July 8, <span class="NLM_year">2012</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.schrodinger.com+%28accessed%0AJuly+8%2C+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desiraju, G. R.</span>; <span class="NLM_string-name">Steiner, T.</span></span> <i>The Weak Hydrogen Bond: In Structural Chemistry and Biology</i>; Oxford Scholarship Online; <span class="NLM_publisher-name">Oxford University Press</span>, <span class="NLM_year">2001</span>; p  <span class="NLM_fpage">507</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1093%2Facprof%3Aoso%2F9780198509707.001.0001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=507&author=G.+R.+Desiraju&author=T.+Steiner&title=The+Weak+Hydrogen+Bond%3A+In+Structural+Chemistry+and+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Facprof%3Aoso%2F9780198509707.001.0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1093%252Facprof%253Aoso%252F9780198509707.001.0001%26sid%3Dliteratum%253Aachs%26aulast%3DDesiraju%26aufirst%3DG.%2BR.%26btitle%3DThe%2520Weak%2520Hydrogen%2520Bond%253A%2520In%2520Structural%2520Chemistry%2520and%2520Biology%26pub%3DOxford%2520University%2520Press%26date%3D2001%26spage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guntapalli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abas, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodenreider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbeck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roland, J.</span></span> <span> </span><span class="NLM_article-title">Lead optimization of imidazopyrazines: a new class of antimalarial with activity on plasmodium liver stages</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">947</span>– <span class="NLM_lpage">950</span>, <span class="refDoi"> DOI: 10.1021/ml500244m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500244m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWjtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=947-950&issue=8&author=B.+Zouauthor=A.+Nagleauthor=A.+K.+Chatterjeeauthor=S.+Y.+Leongauthor=L.+J.+Tanauthor=W.+L.+Simauthor=P.+Mishraauthor=P.+Guntapalliauthor=D.+C.+Tullyauthor=S.+B.+Lakshminarayanaauthor=C.+S.+Limauthor=Y.+C.+Tanauthor=S.+N.+Abasauthor=C.+Bodenreiderauthor=K.+L.+Kuhenauthor=K.+Gagaringauthor=R.+Borboaauthor=J.+Changauthor=C.+Liauthor=T.+Hollenbeckauthor=T.+Tuntlandauthor=A.+M.+Zeemanauthor=C.+H.+Kockenauthor=C.+McNamaraauthor=N.+Katoauthor=E.+A.+Winzelerauthor=B.+K.+Yeungauthor=T.+T.+Diaganaauthor=P.+W.+Smithauthor=J.+Roland&title=Lead+optimization+of+imidazopyrazines%3A+a+new+class+of+antimalarial+with+activity+on+plasmodium+liver+stages&doi=10.1021%2Fml500244m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Optimization of Imidazopyrazines: A New Class of Antimalarial with Activity on Plasmodium Liver Stages</span></div><div class="casAuthors">Zou, Bin; Nagle, Advait; Chatterjee, Arnab K.; Leong, Seh Yong; Tan, Liying Jocelyn; Sim, Wei Lin Sandra; Mishra, Pranab; Guntapalli, Prasuna; Tully, David C.; Lakshminarayana, Suresh B.; Lim, Chek Shik; Tan, Yong Cheng; Abas, Siti Nurdiana; Bodenreider, Christophe; Kuhen, Kelli L.; Gagaring, Kerstin; Borboa, Rachel; Chang, Jonathan; Li, Chun; Hollenbeck, Thomas; Tuntland, Tove; Zeeman, Anne-Marie; Kocken, Clemens H. M.; McNamara, Case; Kato, Nobutaka; Winzeler, Elizabeth A.; Yeung, Bryan K. S.; Diagana, Thierry T.; Smith, Paul W.; Roland, Jason</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">947-950</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Imidazopyridine 1 was identified from a phenotypic screen against P. falciparum (Pf) blood stages and subsequently optimized for activity on liver-stage schizonts of the rodent parasite P. yoelii (Py) as well as hypnozoites of the simian parasite P. cynomolgi (Pc).  We applied these various assays to the cell-based lead optimization of the imidazopyrazines, exemplified by 3 (KAI407), and show that optimized compds. within the series with improved pharmacokinetic properties achieve causal prophylactic activity in vivo and may have the potential to target the dormant stages of P. vivax malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Svl3huKCOrVg90H21EOLACvtfcHk0liubA_CyWOhUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWjtrbN&md5=f52e2a7f04d1eba383794096bf283c2e</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fml500244m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500244m%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DB.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DLeong%26aufirst%3DS.%2BY.%26aulast%3DTan%26aufirst%3DL.%2BJ.%26aulast%3DSim%26aufirst%3DW.%2BL.%26aulast%3DMishra%26aufirst%3DP.%26aulast%3DGuntapalli%26aufirst%3DP.%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DTan%26aufirst%3DY.%2BC.%26aulast%3DAbas%26aufirst%3DS.%2BN.%26aulast%3DBodenreider%26aufirst%3DC.%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHollenbeck%26aufirst%3DT.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DZeeman%26aufirst%3DA.%2BM.%26aulast%3DKocken%26aufirst%3DC.%2BH.%26aulast%3DMcNamara%26aufirst%3DC.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DYeung%26aufirst%3DB.%2BK.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DRoland%26aufirst%3DJ.%26atitle%3DLead%2520optimization%2520of%2520imidazopyrazines%253A%2520a%2520new%2520class%2520of%2520antimalarial%2520with%2520activity%2520on%2520plasmodium%2520liver%2520stages%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D8%26spage%3D947%26epage%3D950%26doi%3D10.1021%2Fml500244m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7686</span>– <span class="NLM_lpage">7698</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.bmc.2013.10.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=7686-7698&issue=24&author=S.+Matsumotoauthor=N.+Miyamotoauthor=T.+Hirayamaauthor=H.+Okiauthor=K.+Okadaauthor=M.+Tawadaauthor=H.+Iwataauthor=K.+Nakamuraauthor=S.+Yamasakiauthor=H.+Mikiauthor=A.+Horiauthor=S.+Imamura&title=Structure-based+design%2C+synthesis%2C+and+evaluation+of+imidazo%5B1%2C2-b%5Dpyridazine+and+imidazo%5B1%2C2-a%5Dpyridine+derivatives+as+novel+dual+c-Met+and+VEGFR2+kinase+inhibitors&doi=10.1016%2Fj.bmc.2013.10.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DMiyamoto%26aufirst%3DN.%26aulast%3DHirayama%26aufirst%3DT.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DTawada%26aufirst%3DM.%26aulast%3DIwata%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DYamasaki%26aufirst%3DS.%26aulast%3DMiki%26aufirst%3DH.%26aulast%3DHori%26aufirst%3DA.%26aulast%3DImamura%26aufirst%3DS.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520imidazo%255B1%252C2-b%255Dpyridazine%2520and%2520imidazo%255B1%252C2-a%255Dpyridine%2520derivatives%2520as%2520novel%2520dual%2520c-Met%2520and%2520VEGFR2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D24%26spage%3D7686%26epage%3D7698%26doi%3D10.1016%2Fj.bmc.2013.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oguro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cary, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of novel VEGFR2 kinase inhibitors: discovery of [1,2,4]triazolo[1,5-a]pyridine derivatives with slow dissociation kinetics</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4714</span>– <span class="NLM_lpage">4729</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.bmc.2013.04.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=4714-4729&issue=15&author=Y.+Oguroauthor=D.+R.+Caryauthor=N.+Miyamotoauthor=M.+Tawadaauthor=H.+Iwataauthor=H.+Mikiauthor=A.+Horiauthor=S.+Imamura&title=Design%2C+synthesis%2C+and+evaluation+of+novel+VEGFR2+kinase+inhibitors%3A+discovery+of+%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5Dpyridine+derivatives+with+slow+dissociation+kinetics&doi=10.1016%2Fj.bmc.2013.04.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.042%26sid%3Dliteratum%253Aachs%26aulast%3DOguro%26aufirst%3DY.%26aulast%3DCary%26aufirst%3DD.%2BR.%26aulast%3DMiyamoto%26aufirst%3DN.%26aulast%3DTawada%26aufirst%3DM.%26aulast%3DIwata%26aufirst%3DH.%26aulast%3DMiki%26aufirst%3DH.%26aulast%3DHori%26aufirst%3DA.%26aulast%3DImamura%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520novel%2520VEGFR2%2520kinase%2520inhibitors%253A%2520discovery%2520of%2520%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255Dpyridine%2520derivatives%2520with%2520slow%2520dissociation%2520kinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D15%26spage%3D4714%26epage%3D4729%26doi%3D10.1016%2Fj.bmc.2013.04.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kannan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldwin, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraj, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chennamaneni, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacro, K.</span></span> <span> </span><span class="NLM_article-title">Probing the binding mechanism of Mnk inhibitors by docking and molecular dynamics simulations</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1021/bi501261j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi501261j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=32-46&issue=1&author=S.+Kannanauthor=A.+Poulsenauthor=H.+Y.+Yangauthor=M.+Hoauthor=S.+H.+Angauthor=T.+S.+Eldwinauthor=D.+A.+Jeyarajauthor=L.+R.+Chennamaneniauthor=B.+Liuauthor=J.+Hillauthor=C.+S.+Vermaauthor=K.+Nacro&title=Probing+the+binding+mechanism+of+Mnk+inhibitors+by+docking+and+molecular+dynamics+simulations&doi=10.1021%2Fbi501261j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fbi501261j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi501261j%26sid%3Dliteratum%253Aachs%26aulast%3DKannan%26aufirst%3DS.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DH.%2BY.%26aulast%3DHo%26aufirst%3DM.%26aulast%3DAng%26aufirst%3DS.%2BH.%26aulast%3DEldwin%26aufirst%3DT.%2BS.%26aulast%3DJeyaraj%26aufirst%3DD.%2BA.%26aulast%3DChennamaneni%26aufirst%3DL.%2BR.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DVerma%26aufirst%3DC.%2BS.%26aulast%3DNacro%26aufirst%3DK.%26atitle%3DProbing%2520the%2520binding%2520mechanism%2520of%2520Mnk%2520inhibitors%2520by%2520docking%2520and%2520molecular%2520dynamics%2520simulations%26jtitle%3DBiochemistry%26date%3D2015%26volume%3D54%26issue%3D1%26spage%3D32%26epage%3D46%26doi%3D10.1021%2Fbi501261j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karaman, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallant, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteridge, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edeen, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faraoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanov, Z. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritchard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span> <span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1038/nbt1358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&issue=1&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt1358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0lhh2ZZvfBe0EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26issue%3D1%26spage%3D127%26epage%3D132%26doi%3D10.1038%2Fnbt1358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plater, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastie, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klevernic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>408</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1042/BJ20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&issue=3&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+McLauchlanauthor=I.+Klevernicauthor=J.+S.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update&doi=10.1042%2FBJ20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0lhh2ZZvfBe0EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26issue%3D3%26spage%3D297%26epage%3D315%26doi%3D10.1042%2FBJ20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basnet, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diab, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure-activity relationship analysis and biological evaluation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.03.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.ejmech.2015.03.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=116-126&author=M.+Yuauthor=P.+Liauthor=S.+K.+Basnetauthor=M.+Kumarasiriauthor=S.+Diabauthor=T.+Teoauthor=H.+Albrechtauthor=S.+Wang&title=Discovery+of+4-%28dihydropyridinon-3-yl%29amino-5-methylthieno%5B2%2C3-d%5Dpyrimidine+derivatives+as+potent+Mnk+inhibitors%3A+synthesis%2C+structure-activity+relationship+analysis+and+biological+evaluation&doi=10.1016%2Fj.ejmech.2015.03.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.03.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.03.032%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DBasnet%26aufirst%3DS.%2BK.%26aulast%3DKumarasiri%26aufirst%3DM.%26aulast%3DDiab%26aufirst%3DS.%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DAlbrecht%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25204-%2528dihydropyridinon-3-yl%2529amino-5-methylthieno%255B2%252C3-d%255Dpyrimidine%2520derivatives%2520as%2520potent%2520Mnk%2520inhibitors%253A%2520synthesis%252C%2520structure-activity%2520relationship%2520analysis%2520and%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D95%26spage%3D116%26epage%3D126%26doi%3D10.1016%2Fj.ejmech.2015.03.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dabbah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar-Schneider, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zismanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartakover
Matalon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lishner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drucker, L.</span></span> <span> </span><span class="NLM_article-title">Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">770</span>, <span class="refDoi"> DOI: 10.1189/jlb.3A1115-510RR</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1189%2Fjlb.3A1115-510RR" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=27272311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFertLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2016&pages=761-770&issue=4&author=M.+Dabbahauthor=O.+Attar-Schneiderauthor=V.+Zismanovauthor=S.+Tartakover%0AMatalonauthor=M.+Lishnerauthor=L.+Drucker&title=Multiple+myeloma+cells+promote+migration+of+bone+marrow+mesenchymal+stem+cells+by+altering+their+translation+initiation&doi=10.1189%2Fjlb.3A1115-510RR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation</span></div><div class="casAuthors">Dabbah, Mahmoud; Attar-Schneider, Oshrat; Zismanov, Victoria; Matalon, Shelly Tartakover; Lishner, Michael; Drucker, Liat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">761-770</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Society for Leukocyte Biology</span>)
        </div><div class="casAbstract">The role of the bone marrow microenvironment in multiple myeloma pathogenesis and progression is well recognized.  Indeed, we have shown that coculture of bone marrow mesenchymal stem cells from normal donors and multiple myeloma cells comodulated translation initiation.  Here, we characterized the timeline of mesenchymal stem cells conditioning by multiple myeloma cells, the persistence of this effect, and the consequences on cell phenotype.  Normal donor mesenchymal stem cells were cocultured with multiple myeloma cell lines (U266, ARP1) (multiple myeloma-conditioned mesenchymal stem cells) (1.5 h,12 h, 24 h, 48 h, and 3 d) and were assayed for translation initiation status (eukaryotic translation initiation factor 4E; eukaryotic translation initiation factor 4G; regulators: mechanistic target of rapamycin, MNK, 4EBP; targets: SMAD family 5, nuclear factor κB, cyclin D1, hypoxia inducible factor 1, c-Myc) (immunoblotting) and migration (scratch assay, inhibitors).  Involvement of mitogen-activated protein kinases in mesenchymal stem cell conditioning and altered migration was also tested (immunoblotting, inhibitors).  Multiple myeloma-conditioned mesenchymal stem cells were recultured alone (1-7 d) and were assayed for translation initiation (immunoblotting).  Quant. polymerase chain reaction of extd. RNA was tested for microRNAs levels.  Mitogen-activated protein kinases were activated within 1.5 h of coculture and were responsible for multiple myeloma-conditioned mesenchymal stem cell translation initiation status (an increase of >200%, P < 0.05) and elevated migration (16 h, an increase of >400%, P < 0.05).  The bone marrow mesenchymal stem cells conditioned by multiple myeloma cells were reversible after only 1 d of multiple myeloma-conditioned mesenchymal stem cell culture alone.  Decreased expression of microRNA-199b and microRNA-125a (an increase of <140%, P < 0.05) in multiple myeloma-conditioned mesenchymal stem cells supported elevated migration.  The time- and proximity-dependent conditioning of normal donor mesenchymal stem cells in our model points to a dynamic interaction between multiple myeloma cells and the bone marrow niche, which causes profound changes in the nonmalignant bone marrow constituents.  Future studies are warranted to identify clin. relevant means of blocking this crosstalk and improving multiple myeloma therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgjDbkv0afFrVg90H21EOLACvtfcHk0liWBIJ4zlAW2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFertLzE&md5=f510f3a13fe5b722e02fac1bc9a3162d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1189%2Fjlb.3A1115-510RR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.3A1115-510RR%26sid%3Dliteratum%253Aachs%26aulast%3DDabbah%26aufirst%3DM.%26aulast%3DAttar-Schneider%26aufirst%3DO.%26aulast%3DZismanov%26aufirst%3DV.%26aulast%3DTartakover%2BMatalon%26aufirst%3DS.%26aulast%3DLishner%26aufirst%3DM.%26aulast%3DDrucker%26aufirst%3DL.%26atitle%3DMultiple%2520myeloma%2520cells%2520promote%2520migration%2520of%2520bone%2520marrow%2520mesenchymal%2520stem%2520cells%2520by%2520altering%2520their%2520translation%2520initiation%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2016%26volume%3D100%26issue%3D4%26spage%3D761%26epage%3D770%26doi%3D10.1189%2Fjlb.3A1115-510RR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Timpano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uniacke, J.</span></span> <span> </span><span class="NLM_article-title">Human cells cultured under physiological oxygen utilize two cap-binding proteins to recruit distinct mRNAs for translation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">10772</span>– <span class="NLM_lpage">10782</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.717363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1074%2Fjbc.M116.717363" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=10772-10782&issue=20&author=S.+Timpanoauthor=J.+Uniacke&title=Human+cells+cultured+under+physiological+oxygen+utilize+two+cap-binding+proteins+to+recruit+distinct+mRNAs+for+translation&doi=10.1074%2Fjbc.M116.717363"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.717363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.717363%26sid%3Dliteratum%253Aachs%26aulast%3DTimpano%26aufirst%3DS.%26aulast%3DUniacke%26aufirst%3DJ.%26atitle%3DHuman%2520cells%2520cultured%2520under%2520physiological%2520oxygen%2520utilize%2520two%2520cap-binding%2520proteins%2520to%2520recruit%2520distinct%2520mRNAs%2520for%2520translation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26issue%3D20%26spage%3D10772%26epage%3D10782%26doi%3D10.1074%2Fjbc.M116.717363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar-Schneider, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dabbah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zismanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartakover-Matalon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lishner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drucker, L.</span></span> <span> </span><span class="NLM_article-title">Mesenchymal stem cells secretomes’ affect multiple myeloma translation initiation</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">620</span>– <span class="NLM_lpage">630</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2016.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1016%2Fj.cellsig.2016.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=26976208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVOisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2016&pages=620-630&issue=6&author=H.+Marcusauthor=O.+Attar-Schneiderauthor=M.+Dabbahauthor=V.+Zismanovauthor=S.+Tartakover-Matalonauthor=M.+Lishnerauthor=L.+Drucker&title=Mesenchymal+stem+cells+secretomes%E2%80%99+affect+multiple+myeloma+translation+initiation&doi=10.1016%2Fj.cellsig.2016.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation</span></div><div class="casAuthors">Marcus, H.; Attar-Schneider, O.; Dabbah, M.; Zismanov, V.; Tartakover-Matalon, S.; Lishner, M.; Drucker, L.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">620-630</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Bone marrow mesenchymal stem cells' (BM-MSCs) role in multiple myeloma (MM) pathogenesis is recognized.  Recently, we have published that co-culture of MM cell lines with BM-MSCs results in mutual modulation of phenotype and proteome (via translation initiation (TI) factors eIF4E/eIF4GI) and that there are differences between normal donor BM-MSCs (ND-MSCs) and MM BM-MSCs (MM-MSCs) in this crosstalk.  Here, we aimed to assess the involvement of sol. BM-MSCs' (ND, MM) components, more easily targeted, in manipulation of MM cell lines phenotype and TI with specific focus on microvesicles (MVs) capable of transferring crit. biol. material.  We applied ND and MM-MSCs 72 h secretomes to MM cell lines (U266 and ARP-1) for 12-72 h and then assayed the cells' (viability, cell count, cell death, proliferation, cell cycle, autophagy) and TI (factors: eIF4E, teIF4GI; regulators: mTOR, MNK1/2, 4EBP; targets: cyclin D1, NFκB, SMAD5, cMyc, HIF1α).  Furthermore, we dissected the secretome into > 100 kDa and < 100 kDa fractions and repeated the expts.  Finally, MVs were isolated from the ND and MM-MSCs secretomes and applied to MM cell lines.  Phenotype and TI were assessed.  Secretomes of BM-MSCs (ND, MM) significantly stimulated MM cell lines' TI, autophagy and proliferation.  The dissected secretome yielded different effects on MM cell lines phenotype and TI according to fraction (> 100 kDa- repressed; < 100 kDa- stimulated) but with no assocn. to source (ND, MM).  Finally, in analyses of MVs extd. from BM-MSCs (ND, MM) we witnessed differences in accordance with source: ND-MSCs MVs inhibited proliferation, autophagy and TI whereas MM-MSCs MVs stimulated them.  These observations highlight the very complex communication between MM and BM-MSCs and underscore its significance to major processes in the malignant cells.  Studies into the influential MVs cargo are underway and expected to uncover targetable signals in the regulation of the TI/proliferation/autophagy cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4-PYAzhr54bVg90H21EOLACvtfcHk0liWBIJ4zlAW2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVOisrg%253D&md5=517dcd2dac3dfea0e7b9c94134eaa00a</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2016.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2016.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DMarcus%26aufirst%3DH.%26aulast%3DAttar-Schneider%26aufirst%3DO.%26aulast%3DDabbah%26aufirst%3DM.%26aulast%3DZismanov%26aufirst%3DV.%26aulast%3DTartakover-Matalon%26aufirst%3DS.%26aulast%3DLishner%26aufirst%3DM.%26aulast%3DDrucker%26aufirst%3DL.%26atitle%3DMesenchymal%2520stem%2520cells%2520secretomes%25E2%2580%2599%2520affect%2520multiple%2520myeloma%2520translation%2520initiation%26jtitle%3DCell.%2520Signalling%26date%3D2016%26volume%3D28%26issue%3D6%26spage%3D620%26epage%3D630%26doi%3D10.1016%2Fj.cellsig.2016.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">RCSB</span>. <span> </span><span class="NLM_article-title">Protein Data Bank</span>, <a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a> (accessed March
5, <span class="NLM_year">2013</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=RCSB&title=Protein+Data+Bank"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DProtein%2520Data%2520Bank%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS3: a force field providing broad coverage of drug-like small molecules and proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&issue=1&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+a+force+field+providing+broad+coverage+of+drug-like+small+molecules+and+proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0lhk4m98PSIXbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520a%2520force%2520field%2520providing%2520broad%2520coverage%2520of%2520drug-like%2520small%2520molecules%2520and%2520proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26issue%3D1%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribiere, G.</span></span> <span> </span><span class="NLM_article-title">Note sur la convergence de méthodes de directions conjuguées</span>. <i>Rev. Franc. Informat. Recherche Opérationelle, Sér. Rouge</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1051/m2an/196903R100351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1051%2Fm2an%2F196903R100351" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1969&pages=35-43&author=E.+Polakauthor=G.+Ribiere&title=Note+sur+la+convergence+de+m%C3%A9thodes+de+directions+conjugu%C3%A9es&doi=10.1051%2Fm2an%2F196903R100351"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1051%2Fm2an%2F196903R100351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1051%252Fm2an%252F196903R100351%26sid%3Dliteratum%253Aachs%26aulast%3DPolak%26aufirst%3DE.%26aulast%3DRibiere%26aufirst%3DG.%26atitle%3DNote%2520sur%2520la%2520convergence%2520de%2520m%25C3%25A9thodes%2520de%2520directions%2520conjugu%25C3%25A9es%26jtitle%3DRev.%2520Franc.%2520Informat.%2520Recherche%2520Op%25C3%25A9rationelle%252C%2520S%25C3%25A9r.%2520Rouge%26date%3D1969%26volume%3D16%26spage%3D35%26epage%3D43%26doi%3D10.1051%2Fm2an%2F196903R100351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duraiswamy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E. S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, W. W. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of a porcupine inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5889</span>– <span class="NLM_lpage">5899</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5889-5899&issue=15&author=A.+J.+Duraiswamyauthor=M.+A.+Leeauthor=B.+Madanauthor=S.+H.+Angauthor=E.+S.+W.+Tanauthor=W.+W.+V.+Cheongauthor=Z.+Keauthor=V.+Pendharkarauthor=L.+J.+Dingauthor=Y.+S.+Chewauthor=V.+Manoharanauthor=K.+Sangthongpitagauthor=J.+Alamauthor=A.+Poulsenauthor=S.+Y.+Hoauthor=D.+M.+Virshupauthor=T.+H.+Keller&title=Discovery+and+optimization+of+a+porcupine+inhibitor&doi=10.1021%2Facs.jmedchem.5b00507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00507%26sid%3Dliteratum%253Aachs%26aulast%3DDuraiswamy%26aufirst%3DA.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DAng%26aufirst%3DS.%2BH.%26aulast%3DTan%26aufirst%3DE.%2BS.%2BW.%26aulast%3DCheong%26aufirst%3DW.%2BW.%2BV.%26aulast%3DKe%26aufirst%3DZ.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DDing%26aufirst%3DL.%2BJ.%26aulast%3DChew%26aufirst%3DY.%2BS.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520porcupine%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D15%26spage%3D5889%26epage%3D5899%26doi%3D10.1021%2Facs.jmedchem.5b00507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraj, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E. S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span> <span> </span><span class="NLM_article-title">Scaffold hopping and optimization of maleimide based porcupine inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6678</span>– <span class="NLM_lpage">6692</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00662</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00662" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6678-6692&issue=15&author=S.+Y.+Hoauthor=J.+Alamauthor=D.+A.+Jeyarajauthor=W.+Wangauthor=G.+R.+Linauthor=S.+H.+Angauthor=E.+S.+W.+Tanauthor=M.+A.+Leeauthor=Z.+Keauthor=B.+Madanauthor=D.+M.+Virshupauthor=L.+J.+Dingauthor=V.+Manoharanauthor=Y.+S.+Chewauthor=C.+B.+Lowauthor=V.+Pendharkarauthor=K.+Sangthongpitagauthor=J.+Hillauthor=T.+H.+Kellerauthor=A.+Poulsen&title=Scaffold+hopping+and+optimization+of+maleimide+based+porcupine+inhibitors&doi=10.1021%2Facs.jmedchem.7b00662"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00662%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DJeyaraj%26aufirst%3DD.%2BA.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DG.%2BR.%26aulast%3DAng%26aufirst%3DS.%2BH.%26aulast%3DTan%26aufirst%3DE.%2BS.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DKe%26aufirst%3DZ.%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26aulast%3DDing%26aufirst%3DL.%2BJ.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DChew%26aufirst%3DY.%2BS.%26aulast%3DLow%26aufirst%3DC.%2BB.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DPoulsen%26aufirst%3DA.%26atitle%3DScaffold%2520hopping%2520and%2520optimization%2520of%2520maleimide%2520based%2520porcupine%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D15%26spage%3D6678%26epage%3D6692%26doi%3D10.1021%2Facs.jmedchem.7b00662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wendel, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe-Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teruya-Feldstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span> <span> </span><span class="NLM_article-title">Dissecting eIF4E action in tumorigenesis</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">3232</span>– <span class="NLM_lpage">3237</span>, <span class="refDoi"> DOI: 10.1101/gad.1604407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;key=10.1101%2Fgad.1604407" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=3232-3237&issue=24&author=H.+G.+Wendelauthor=R.+L.+Silvaauthor=A.+Malinaauthor=J.+R.+Millsauthor=H.+Zhuauthor=T.+Uedaauthor=R.+Watanabe-Fukunagaauthor=R.+Fukunagaauthor=J.+Teruya-Feldsteinauthor=J.+Pelletierauthor=S.+W.+Lowe&title=Dissecting+eIF4E+action+in+tumorigenesis&doi=10.1101%2Fgad.1604407"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1101%2Fgad.1604407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1604407%26sid%3Dliteratum%253Aachs%26aulast%3DWendel%26aufirst%3DH.%2BG.%26aulast%3DSilva%26aufirst%3DR.%2BL.%26aulast%3DMalina%26aufirst%3DA.%26aulast%3DMills%26aufirst%3DJ.%2BR.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DWatanabe-Fukunaga%26aufirst%3DR.%26aulast%3DFukunaga%26aufirst%3DR.%26aulast%3DTeruya-Feldstein%26aufirst%3DJ.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DDissecting%2520eIF4E%2520action%2520in%2520tumorigenesis%26jtitle%3DGenes%2520Dev.%26date%3D2007%26volume%3D21%26issue%3D24%26spage%3D3232%26epage%3D3237%26doi%3D10.1101%2Fgad.1604407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HW6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HW6','PDB','2HW6'); return false;">PDB: 2HW6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HW7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HW7','PDB','2HW7'); return false;">PDB: 2HW7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2AC3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2AC3','PDB','2AC3'); return false;">PDB: 2AC3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YMJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YMJ','PDB','4YMJ'); return false;">PDB: 4YMJ</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-100"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i118"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01714">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_06113"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the ACS Publications Web site at DOI: The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01714">10.1021/acs.jmedchem.7b01714</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Analysis of molecular dynamics of MNK2 with compound <b>4</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Analysis of molecular dynamics of MNK2 with compound <b>27</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Analysis of molecular dynamics of MNK2 with compound <b>45</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_003.pdf">PDF</a>)</p></li><li><p class="inline">SMILES strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_004.csv">CSV</a>)</p></li><li><p class="inline">Table S1, compounds with substitution at the 2 and 8 positions; Table S2, inactive C-3 heterocycles; Table S3, tetrazole replacement; Table S4, mouse pharmacokinetics data after p.o. administration for compounds <b>27</b>, <b>33</b>, and <b>37</b>; Table S5, selectivity screen of CGP-57380 and cercosporamide and <b>27</b> tested against a panel of 104 kinases; Table S6, other bicyclic cores; Table S7, CellTiter-Glo viability assay screen against 25 cell lines; Table S8, single agents and combination studies using <b>48</b> (ETC-206) and/or dasatinib on K562 mouse xenograft model; Figure S1, <i>in vivo</i> biomarker analysis of compound <b>48</b> and dasatinib combination on eIF4E and CRKL; microsomal stability determination; Cyp inhibition (IC<sub>50</sub>) determination; LogD determination; mouse and human PPB determination; and Caco-2 permeability (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_001.pdf">jm7b01714_si_001.pdf (3.07 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_002.pdf">jm7b01714_si_002.pdf (3.16 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_003.pdf">jm7b01714_si_003.pdf (3.23 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_004.csv">jm7b01714_si_004.csv (3.39 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01714/suppl_file/jm7b01714_si_005.pdf">jm7b01714_si_005.pdf (0.99 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01714&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-10%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01714%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01714" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c121adc12374","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
